Download ePoster Presentations

Less pain. Less opioids.
From the start.
OFIRMEV® provides significant pain relief*1
• OFIRMEV 1 g (Q6h) + patient-controlled analgesia (PCA) morphine demonstrated significant
pain relief vs placebo + PCA morphine (P<0.05 over 6 h)1
• OFIRMEV 1 g (Q6h) + PCA morphine showed greater reduction in pain intensity over 24 h
(SPID24)† compared to placebo + PCA morphine (P<0.001)2
OFIRMEV reduces opioid consumption*1
• OFIRMEV 1 g (Q6h) + PCA morphine significantly reduced morphine consumption vs placebo
+ PCA morphine (–46% over 6 h, P<0.01; –33% over 24 h, P<0.01)1
• The clinical benefit of reduced opioid consumption was not demonstrated
OFIRMEV from the start
• Consider administering the first dose of
OFIRMEV PreOp or post-induction
• Schedule OFIRMEV Q6h for first 24 h and
continue as clinically warranted
INDICATIONS AND USAGE
OFIRMEV® (acetaminophen) injection is indicated for the management of mild to
moderate pain, management of moderate to severe pain with adjunctive opioid
analgesics, and reduction of fever.
IMPORTANT RISK INFORMATION
WARNING: RISK OF MEDICATION ERRORS AND HEPATOTOXICITY
Take care when prescribing, preparing, and administering OFIRMEV
Injection to avoid dosing errors which could result in accidental overdose
and death. In particular, be careful to ensure that:
• the dose in milligrams (mg) and milliliters (mL) is not confused;
• the dosing is based on weight for patients under 50 kg;
• infusion pumps are properly programmed; and
• the total daily dose of acetaminophen from all sources does not exceed
maximum daily limits.
OFIRMEV contains acetaminophen. Acetaminophen has been associated
with cases of acute liver failure, at times resulting in liver transplant and
death. Most of the cases of liver injury are associated with the use of
acetaminophen at doses that exceed the recommended maximum daily
limits, and often involve more than one acetaminophen-containing product.
CONTRAINDICATIONS
• Acetaminophen is contraindicated in patients with:
− known hypersensitivity to acetaminophen or to any of the excipients in the
intravenous (IV) formulation.
− severe hepatic impairment or severe active liver disease.
WARNINGS AND PRECAUTIONS
• Administration of acetaminophen in doses higher than recommended may result
in hepatic injury, including the risk of liver failure and death. Do not exceed the
maximum recommended daily dose of acetaminophen. The maximum recommended
daily dose of acetaminophen includes all routes of acetaminophen administration
and all acetaminophen-containing products administered, including combination
products. Dosing errors could result in accidental overdose and death.
Please see Brief Summary of Full Prescribing Information, including
complete boxed warning, on the following page.
Mallinckrodt, the “M” brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of
a Mallinckrodt company. © 2014 Mallinckrodt. OFV1513 10/14 | OFIRMEV.com
• Use caution when administering acetaminophen in patients with the following
conditions: hepatic impairment or active hepatic disease, alcoholism, chronic
malnutrition, severe hypovolemia (e.g., due to dehydration or blood loss), or severe
renal impairment (creatinine clearance ≤ 30 mL/min).
• Rarely, acetaminophen may cause serious skin reactions such as acute generalized
exanthematous pustulosis (AGEP), Stevens-Johnson Syndrome (SJS), and toxic
epidermal necrolysis (TEN), which can be fatal.
• Hypersensitivity and anaphylaxis associated with the use of acetaminophen have
been reported. Clinical signs included swelling of the face, mouth, and throat,
respiratory distress, urticaria, rash, and pruritus.
• The antipyretic effects of OFIRMEV may mask fever.
ADVERSE REACTIONS
• Serious adverse reactions may include hepatic injury, serious skin reactions,
hypersensitivity, and anaphylaxis.
• Common adverse reactions in adults include nausea, vomiting, headache, and
insomnia. Common adverse reactions in pediatric patients include nausea, vomiting,
constipation, pruritus, agitation, and atelectasis.
USE IN SPECIFIC POPULATIONS
• Pregnancy: Pregnancy Category C. OFIRMEV should be given to a pregnant woman
only if clearly needed.
• Breast Feeding: While studies with OFIRMEV have not been conducted,
acetaminophen is secreted in human milk in small quantities after oral administration.
• Pediatrics: The effectiveness of OFIRMEV for the treatment of acute pain and fever
has not been studied in pediatric patients < 2 years of age.
To report SUSPECTED ADVERSE REACTIONS, contact Mallinckrodt
Pharmaceuticals, at 1.800.778.7898 or FDA at 1.800.FDA.1088 or
www.fda.gov/medwatch.
*Randomized, double-blind, placebo-controlled, single- and repeated-dose 24-h study (n=101). Patients received OFIRMEV
1 g + PCA morphine or placebo + PCA morphine the morning following total hip or knee replacement surgery. Primary
endpoint: pain relief measured on a 5-point verbal scale over 6 h. Morphine rescue was administered as needed.
†SPID24=sum of pain intensity differences, based on VAS score, from baseline, at 0 to 24 h.
References: 1. Sinatra RS, Jahr JS, Reynolds LW, et al. Efficacy and safety of single and repeated
administration of 1 gram intravenous acetaminophen injection (paracetamol) for pain management
after major orthopedic surgery. Anesthesiology. 2005;102:822-831. 2. Sinatra RS, Jahr JS, Reynolds L,
et al. Intravenous acetaminophen for pain after major orthopedic surgery: an expanded analysis.
Pain Pract. 2012;12:357-365.
2.4 Instructions for Intravenous Administration
For adult and adolescent patients weighing ≥ 50 kg requiring
1000 mg doses of OFIRMEV, administer the dose by inserting a vented
intravenous set through the septum of the 100 mL vial. OFIRMEV may
be administered without further dilution. Examine the vial contents
before dose preparation or administering. DO NOT USE if particulate
matter or discoloration is observed. Administer the contents of the
vial intravenously over 15-minutes. Use aseptic technique when
preparing OFIRMEV for intravenous infusion. Do not add other
medications to the OFIRMEV vial or infusion device.
For doses less than 1000 mg, the appropriate dose must be
withdrawn from the vial and placed into a separate container prior
to administration. Using aseptic technique, withdraw the appropriate
dose (650 mg or weight-based) from an intact sealed OFIRMEV vial and
place the measured dose in a separate empty, sterile container (e.g.
glass bottle, plastic intravenous container, or syringe) for intravenous
infusion to avoid the inadvertent delivery and administration of the
total volume of the commercially available container. The entire 100
mL vial of OFIRMEV is not intended for use in patients weighing less
than 50 kg. OFIRMEV is a single-use vial and the unused portion must
be discarded.
Place small volume pediatric doses up to 60 mL in volume in a
syringe and administer over 15 minutes using a syringe pump.
Monitor the end of the infusion in order to prevent the possibility
of an air embolism, especially in cases where the OFIRMEV infusion is
the primary infusion.
Once the vacuum seal of the glass vial has been penetrated, or the
contents transferred to another container, administer the dose of
OFIRMEV within 6 hours.
Do not add other medications to the OFIRMEV solution. Diazepam
and chlorpromazine hydrochloride are physically incompatible with
OFIRMEV, therefore do not administer simultaneously.
3 DOSAGE FORMS AND STRENGTHS
OFIRMEV is a sterile, clear, colorless, non pyrogenic, preservative
free, isotonic formulation of acetaminophen intended for intravenous
infusion. Each 100 mL glass vial contains 1000 mg acetaminophen
(10 mg/mL).
4 CONTRAINDICATIONS
Acetaminophen is contraindicated:
t in patients with known hypersensitivity to acetaminophen or to any
of the excipients in the intravenous formulation.
t in patients with severe hepatic impairment or severe active liver
disease.
5 WARNINGS AND PRECAUTIONS
5.1 Hepatic Injury
Administration of acetaminophen in doses higher than
recommended may result in hepatic injury, including the risk of liver
failure and death. Do not exceed the maximum recommended daily
dose of acetaminophen. The maximum recommended daily dose of
acetaminophen includes all routes of acetaminophen administration
and all acetaminophen-containing products administered, including
combination products.
Use caution when administering acetaminophen in patients with
Table 1: Dosing for Adults and Adolescents
the following conditions: hepatic impairment or active hepatic
Dose given
Dose given
Maximum single Maximum total
Age group
every 4 hours
every 6 hours
dose
daily dose of
disease, alcoholism, chronic malnutrition, severe hypovolemia
acetaminophen
(e.g., due to dehydration or blood loss), or severe renal impairment
(by all routes)
(creatinine clearance ≤ 30 mL/min).
650 mg
1000 mg
1000 mg
4000 mg in
Adults and
5.2 Serious Skin Reactions
24 hours
adolescents (13
years and older)
Rarely, acetaminophen may cause serious skin reactions such
weighing
≥ 50 kg
as acute generalized exanthematous pustulosis (AGEP), StevensJohnson Syndrome (SJS), and toxic epidermal necrolysis (TEN), which
Adults and
12.5 mg/kg
15 mg/kg
15 mg/kg
75 mg/kg in
adolescents (13
(up to 750 mg)
24 hours
can be fatal. Patients should be informed about the signs of serious
years and older)
(up to 3750 mg)
skin reactions, and use of the drug should be discontinued at the first
weighing
< 50 kg
appearance of skin rash or any other sign of hypersensitivity.
5.3 Risk of Medication Errors
2.3 Recommended Dosage: Children
Take care when prescribing, preparing, and administering OFIRMEV
Children 2 to 12 years of age: the recommended dosage of OFIRMEV (acetaminophen) Injection in order to avoid dosing errors which could
is 15 mg/kg every 6 hours or 12.5 mg/kg every 4 hours, with a result in accidental overdose and death. In particular, be careful to
maximum single dose of OFIRMEV of 15 mg/kg, a minimum dosing ensure that:
interval of 4 hours, and a maximum daily dose of acetaminophen of t the dose in milligrams (mg) and milliliters (mL) is not confused;
75 mg/kg per day.
t the dosing is based on weight for patients under 50 kg;
t infusion pumps are properly programmed; and
Table 2: Dosing for Children
t the total daily dose of acetaminophen from all sources does not
Dose given
Dose given
Maximum single Maximum total
Age group
exceed maximum daily limits.
every 4 hours
every 6 hours
dose
daily dose of
Brief Summary (For full Prescribing Information refer to package insert.)
WARNING: Risk of Medication Errors and Hepatotoxicity
Take care when prescribing, preparing, and administering OFIRMEV®
Injection to avoid dosing errors which could result in accidental
overdose and death. In particular, be careful to ensure that:
t the dose in milligrams (mg) and milliliters (mL) is not confused;
t the dosing is based on weight for patients under 50 kg;
t infusion pumps are properly programmed; and
t the total daily dose of acetaminophen from all sources does not
exceed maximum daily limits.
OFIRMEV contains acetaminophen. Acetaminophen has been
associated with cases of acute liver failure, at times resulting in liver
transplant and death. Most of the cases of liver injury are associated
with the use of acetaminophen at doses that exceed the maximum
daily limits, and often involve more than one acetaminophencontaining product (see WARNINGS).
1 INDICATIONS AND USAGE
OFIRMEV® (acetaminophen) injection is indicated for
t the management of mild to moderate pain
t the management of moderate to severe pain with adjunctive opioid
analgesics
t the reduction of fever.
2 DOSAGE AND ADMINISTRATION
2.1 General Dosing Information
OFIRMEV may be given as a single or repeated dose for the
treatment of acute pain or fever. No dose adjustment is required
when converting between oral acetaminophen and OFIRMEV dosing
in adults and adolescents who weigh 50 kg and above. Calculated
maximum daily dose of acetaminophen is based on all routes of
administration (i.e., intravenous, oral, and rectal) and all products
containing acetaminophen. Exceeding the maximum mg/kg daily
dose of acetaminophen as described in Tables 1 and 2 may result in
hepatic injury, including the risk of liver failure and death. To avoid
the risk of overdose, ensure that the total amount of acetaminophen
from all routes and from all sources does not exceed the maximum
recommended dose.
2.2 Recommended Dosage: Adults and Adolescents
Adults and adolescents weighing 50 kg and over: the recommended
dosage of OFIRMEV is 1000 mg every 6 hours or 650 mg every 4
hours, with a maximum single dose of OFIRMEV of 1000 mg, a
minimum dosing interval of 4 hours, and a maximum daily dose
of acetaminophen of 4000 mg per day (includes all routes of
administration and all acetaminophen-containing products including
combination products).
Adults and adolescents weighing under 50 kg: the recommended
dosage of OFIRMEV is 15 mg/kg every 6 hours or 12.5 mg/kg every
4 hours, with a maximum single dose of OFIRMEV of 15 mg/kg,
a minimum dosing interval of 4 hours, and a maximum daily
dose of acetaminophen of 75 mg/kg per day (includes all routes of
administration and all acetaminophen-containing products including
combination products).
acetaminophen
(by all routes)
Children 2 to
12 years of age
12.5 mg/kg
15 mg/kg
15 mg/kg
(up to 750 mg)
75 mg/kg in
24 hours
(up to 3750 mg)
5.4 Allergy and Hypersensitivity
There have been post-marketing reports of hypersensitivity and
anaphylaxis associated with the use of acetaminophen. Clinical
signs included swelling of the face, mouth, and throat, respiratory
distress, urticaria, rash, and pruritus. There were infrequent reports of
life-threatening anaphylaxis requiring emergent medical attention.
Discontinue OFIRMEV immediately if symptoms associated with
allergy or hypersensitivity occur. Do not use OFIRMEV in patients with
acetaminophen allergy.
6 ADVERSE REACTIONS
The most common adverse reactions in patients treated with OFIRMEV
were nausea, vomiting, headache, and insomnia in adult patients and
nausea, vomiting, constipation, pruritus, agitation, and atelectasis in
pediatric patients.
To report SUSPECTED ADVERSE REACTIONS, contact Cadence
Pharmaceuticals Inc. at 1-877-647-2239 or FDA at 1-800-FDA1088 or www.fda.gov/medwatch.
7 DRUG INTERACTIONS
7.1 Effects of other Substances on Acetaminophen
Substances that induce or regulate hepatic cytochrome enzyme
CYP2E1 may alter the metabolism of acetaminophen and increase
its hepatotoxic potential. The clinical consequences of these effects
have not been established. Effects of ethanol are complex, because
excessive alcohol usage can induce hepatic cytochromes, but
ethanol also acts as a competitive inhibitor of the metabolism of
acetaminophen.
7.2 Anticoagulants
Chronic oral acetaminophen use at a dose of 4000 mg/day has
been shown to cause an increase in international normalized ratio
(INR) in some patients who have been stabilized on sodium warfarin
as an anticoagulant. As no studies have been performed evaluating
the short-term use of OFIRMEV in patients on oral anticoagulants,
more frequent assessment of INR may be appropriate in such
circumstances.
8 USE IN SPECIFIC POPULATIONS
8.1 Pregnancy
Pregnancy Category C. There are no studies of intravenous
acetaminophen in pregnant women. OFIRMEV should be given to a
pregnant woman only if clearly needed.
8.3 Nursing Mothers
Caution should be exercised when OFIRMEV is administered to a
nursing woman.
8.4 Pediatric Use
Pediatric Use: The effectiveness of OFIRMEV for the treatment of acute
pain and fever has not been studied in pediatric patients less than 2 years
of age. The safety and effectiveness of OFIRMEV in pediatric patients
older than 2 years is supported by evidence from adequate and well
controlled studies in adults with additional safety and pharmacokinetic
data for this age group.
8.5 Geriatric Use
No overall differences in safety or effectiveness were observed
between geriatric subjects and younger subjects.
8.6 Patients with Hepatic Impairment
OFIRMEV is contraindicated in patients with severe hepatic
impairment or severe active liver disease and should be used with
caution in patients with hepatic impairment or active liver disease. A
reduced total daily dose of acetaminophen may be warranted.
8.7 Patients with Renal Impairment
In cases of severe renal impairment (creatinine clearance
≤ 30 mL/min), longer dosing intervals and a reduced total daily
dose of acetaminophen may be warranted.
Manufactured for:
Cadence Pharmaceuticals, Inc.
San Diego, CA 92130
Revised 1/2014
U.S. PATENT NUMBERS: 6,028,222; 6,992,218
OFIRMEV ® and CADENCE ® are trademarks of
Cadence Pharmaceuticals, Inc.
© 2014 Cadence Pharmaceuticals, Inc. All rights reserved.
OFV12821013BS
ASCRS Premier Partners
The American Society of Colon & Rectal Surgeons appreciates the role that health care companies play in helping the
Society maintain its focus on colorectal surgery and enhance the care its members provide to patients. ASCRS thanks
the following companies for their generous support of this year’s Annual Scientific Meeting.
PLATINUM
$100,000 +
Applied Medical
Ethicon
Intuitive Surgical, Inc.
Medtronic, plc
GOLD
$50,000 – $99,999
Mallinckrodt Pharmaceuticals
Medtronic & Covidien
SILVER
$25,000 – $49,999
American Medical Systems
Edwards Lifesciences
KARL STORZ Endoscopy-America, Inc.
Olympus Corporation of the Americas
Richard Wolf Medical Instruments Corporation
BRONZE
$5,000 – $24,999
BK Ultrasound
ConvaTec, Inc.
Merck & Co., Inc.
Salix Pharmaceuticals, Inc.
OTHER CONTRIBUTORS
ACell, Inc.  Carl Zeiss Meditec  CONMED  CooperSurgical  LABORIE
LifeCell, an Acelity Company  Novadaq Technologies, Inc.
Pacira Pharmaceuticals, Inc.  Redfield Corporation
Seiler Instrument & Manufacturing Co, Inc.  Stryker Endoscopy
THD America  The Prometheus Group  Torax Medical, Inc.
Zinnanti Surgical Design Group Inc.
2
Welcome
to the
ASCRS
Annual Meeting
May 30 – June 3, 2015
Hynes Convention Center & Sheraton Boston Hotel
Boston, Massachusetts
3
Echelon Flex™
A better grip
on movement
Now experience the least tissue
slippage during firing†
The ECHELON FLEX™ GST System* is uniquely designed for
better grip to provide you the least tissue slippage during
firing.† Its enhanced end effector and proprietary reloads with
Gripping Surface Technology now deliver 4X less tissue slippage‡
and reliable staple formation across
a range of tissue thicknesses.§
A better way to staple—
visit ethicon.com/gst or contact
your local sales representative
ECHELON FLEX™ GST
System with Gripping
Surface Technology
* System components include ECHELON FLEX™ Powered Plus Stapler and ENDOPATH ECHELON™ Reloads with
Gripping Surface Technology
† Benchtop testing in porcine stomach tissue. Mean tissue movement from after clamping on tissue to after firing
ECHELON FLEX Powered Plus Stapler (PSEE60A) and ECHELON Reload with GST vs ENDO GIA™ ULTRA Handle
(EGIAUSTND) and Endo GIA™ Reload with Tri-Staple™ Technology at 1.5, 2.5, 3.3 and 4.0mm tissue thicknesses
(1.5mm; GST60B 1.067mm vs EGIA60AMT 2.452mm p<0.001; 2.5mm: GST60G 1.148mm vs EGIA60AMT 3.261mm
p<0.001; 3.3mm: GST60T 0.642mm vs EGIA60AMT 4.806mm p<0.001; 4.0mm: GST60T 0.654mm vs EGIA60AXT
5.116mm p<0.001).
‡ Benchtop testing in porcine stomach tissue. Mean tissue movement from after clamping on tissue to after firing
ECHELON FLEX™ Powered Plus Stapler (PSEE60A) and ECHELON Reload with GST vs ENDO GIA™ ULTRA Handle
(EGIAUSTND) and Endo GIA™ Reload with Tri-Staple™ Technology at 3.3 and 4.0mm tissue thicknesses (3.3mm:
GST60T 0.642mm vs EGIA60AMT 4.806mm p<0.001; 4.0mm: GST60T 0.654mm vs EGIA60AXT 5.116mm p<0.001).
The third-party trademarks used herein are trademarks of their respective owners.
©2015 Ethicon, Inc. All rights reserved. 028739-150129
§ Porcine tissue thickness ranging from 1.0mm to 4.0mm measured at 8g/mm2 prior to firing. Tissue comfortably
compressed to closed staple height per IFU.
Page
ASCRS Executive Council . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .8
Program Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .8
Education Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .9
Online Evaluation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .10
Maintenance of Certification . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .11
General Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .12
Annual Named Lectures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .15
Masters in Colorectal Surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .16
Awards . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .17
Non-CME Corporate Forums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .18
Thanks to our Corporate Supporters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .19
On-Going Video Display . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21
Daily Schedule . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .22
Schedule-at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .28
Committee Meetings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .31
Past Presidents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .32
Saturday Program
Transanal Endoscopic Surgery Workshop . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33
AIN and HRA: What the Colorectal Surgeon Needs to Know Workshop . . . . . . . . . . . . . . . . . . . . . . . . . . . . .36
Laparoscopic Colectomy Symposium and Workshop . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .39
Optimal Management of Fecal Incontinence Symposium and Workshop . . . . . . . . . . . . . . . . . . . . . . . . . . .42
Robotic Colon and Rectal Surgery: Tips, Tricks, and Simulation
Symposium and Workshop . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .46
Symposium: Advanced Endoscopy and Endoluminal Surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48
Question Writing Workshop: How to Write Exam Questions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .50
Symposium: Improving Outcomes-Identifying and Managing
the Complex Surgical Patients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .51
Sunday Program
Core Subject Update . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .52
Symposium: Healthcare Economics in the ACA Era . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53
Symposium: Quality Initiatives in Clinical Practice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .54
Symposium: Laparoscopic Nuts & Bolts and Robotic Rivets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55
Symposium: Complications: Prevention and Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .57
Luncheon Symposium: Current Advances in the Management of Fecal Incontinence . . . . . . . . . . . . . . . .58
Luncheon Symposium: The Genetics of Colorectal Cancer and Cancer
Related Syndromes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .59
Welcome and Opening Announcements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60
Symposium: Technical Pearls – How it’s Really Done . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .61
Abstract Session: Neoplasia I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62
5
G E N E R A L I N F O R M AT I O N
Table of Contents
Table of Contents
Norman D. Nigro, MD, Research Lectureship . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .63
After Hours Debate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .64
Welcome Reception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .64
Monday Program
Meet the Professor Breakfasts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65
Residents’ Breakfast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65
Symposium: Robotic Colorectal Surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .66
Symposium: Rectal Cancer: Optimizing Outcomes through Techniques . . . . . . . . . . . . . . . . . . . . . . . . . . . . .67
Memorial Lectureship Honoring John M. MacKeigan, MD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .68
Presidential Address . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .68
Symposium: Navigating a Career Path in Colon and Rectal Surgery –
Orchestrating and Optimizing Career Transitions at All Levels . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .69
Abstract Session: Benign Colonic Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .70
Symposium: Past Presidents’ Panel: Controversies and Cases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .72
Abstract Session: Pelvic Floor/Anorectal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73
Harry E. Bacon, MD, Lectureship . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .75
Parviz Kamangar Humanities in Surgery Lectureship . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .75
Special Lecture: Trials and Tribulations of Clinical Research . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .76
What Receiving the Scholarship Means to Me . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .76
New Technologies Symposium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .77
Tuesday Program
Meet the Professor Breakfasts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .78
Symposium: Anorectal Disorders: Balancing Innovation with
Conventional Wisdom . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .79
Symposium: Update on Inflammatory Bowel Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .80
Ernestine Hambrick, MD, Lectureship . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .81
Symposium: Controversies in Rectal Cancer Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .82
Symposium: Ostomies: Location, Creation and Complications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .83
Abstract Session: General Surgery Forum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84
Masters in Colorectal Surgery Lectureship Honoring David J. Schoetz, Jr., MD . . . . . . . . . . . . . . . . . . . . . . .86
Women in Colorectal Surgery Luncheon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .86
Symposium: Anal Cancer: Prevention, Diagnosis and Treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .87
Abstract Session: Inflammatory Bowel Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .88
Abstract Session: Research Forum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89
Symposium: Medical Legal Symposium: How to Protect Yourself . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .91
Symposium: Anal Fistulas: Diagnosis, Imaging and Therapy – Rational Approaches . . . . . . . . . . . . . . . . .93
After Hours Debate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .94
Residents’ Reception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .94
6
Wednesday Program
Meet the Professor Breakfasts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .95
Symposium: Colon Cancer: Staging, Techniques and the Role of Adjuvant Therapy . . . . . . . . . . . . . . . . .96
Abstract Session: Outcomes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .97
ASCRS/SSAT Symposium: Challenges and Controversies: Surgical Management
of Advanced Disease and Recurrent Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .99
Abstract Session: Video Session . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100
Symposium: Optimizing Treatment for Rectal Prolapse, Constipation and
Obstructed Defecation Syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .102
Abstract Session: Neoplasia II . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103
Symposium: Enhanced Perioperative Care Pathways and Postoperative
Pain Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .105
Symposium: Is there a Paradigm Shift in the Management of Diverticular Disease? . . . . . . . . . . . . . . . .106
ASCRS Annual Business Meeting and State of the Society Address . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .107
ASCRS Annual Reception and Dinner Dance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .107
Exhibits, Posters, Faculty, Disclosures
ePosters of Distinction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .109
ePosters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .112
Featured Lecturers and Faculty . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .142
Disclosures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .149
Program Participant Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .154
Product Theaters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .156
Exhibits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .157
Maps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .172
The presentations, slides, and handouts provided in this program are the property of The
American Society of Colon and Rectal Surgeons. Attendees may not photograph, videotape,
audiotape or otherwise record or reproduce any of the presentations without express written
permission from ASCRS. Any attendee believed to be violating this restriction will be removed
from the session and may be prohibited from participating in further ASCRS events.
ASCRS Administrative Office
Diseases of the Colon & Rectum
85 West Algonquin Road, Suite 550
Arlington Heights, IL 60005
(847) 290-9184 • Fax: (847) 290-9203
www.fascrs.org
Pat Oldenburg
Managing Editor
Phone: (218) 769-4464
7
G E N E R A L I N F O R M AT I O N
Table of Contents
ASCRS Executive Council
Terry C. Hicks, MD
President
New Orleans, LA
Charles E. Littlejohn, MD
President Elect
Stamford, CT
Michael J. Stamos, MD
Past President
Orange, CA
Gerald A. Isenberg, MD
Vice President
Philadelphia, PA
Tracy L. Hull, MD
Secretary
Cleveland, OH
Patricia L. Roberts, MD
Treasurer
Burlington, MA
Steven D. Wexner, MD, PhD (Hon)
Research Foundation President
Weston, FL
Elisa H. Birnbaum, MD
Council Member (2013-2016)
St. Louis, MO
John E. Garry, MD
Member-at-Large (2012-2015)
Fresno, CA
David A. Margolin, MD
Member-at-Large (2013-2016)
New Orleans, LA
John R. T. Monson, MD
Council Member (2014-2017)
Rochester, NY
Deborah A. Nagle, MD
Member-at-Large (2012-2015)
Boston, MA
Heidi Nelson, MD
Council Member (2014-2017)
Rochester, MN
Bruce A. Orkin, MD
Council Member (2014-2017)
Chicago, IL
Harry T. Papaconstantinou, MD
Member-at-Large (2012-2015)
Temple, TX
Thomas E. Read, MD
Member-at-Large (2013-2016)
Burlington, MA
Program Committee
David Margolin, MD
Program Chair
Maher Abbas, MD
Karim Alavi, MD
Suraj Alva, MD
Louis Barfield, MD
Mariana Berho, MD
Joshua Bleier, MD
Joseph Carmichael, MD
Gentry Caton, MD
Bradley Champagne, MD
Hueylan Chern, MD
Philip Cole, MD
David Dietz, MD
Gary Dunn, MD
Sandy Fang, MD
Jeffrey Farma, MD
Emily Finlayson, MD
Joseph Frenkel, MD
Askash Gajjar, MD
Virgilio George, MD
Stephen Goldstone, MD
Lori Gordon, MD
Kerry Hammond, MD
Imran Hassan, MD
Alan Herline, MD
Daniel Herzig, MD
Terry Hicks, MD
Stefan Holubar, MD
Atif Iqbal, MD
Barry Jenkins, MD
Christine Jensen, MD
H. David Vargas, MD
Program Vice-Chair
Thomas Read, MD
Council Representative
Shane McNevin, MD
Genevieve Melton-Meaux, MD
John Migaly, MD
Nitin Mishra, MD
Husein Moloo, MD
R. Scott Nelson, DO
Jitesh Patel, MD
Walter Peters, Jr., MD
Janice Rafferty, MD
Jan Rakinic, MD
Jennifer Rea, MD
Craig Reickert, MD
Rocco Ricciardi, MD
Timothy Ridolfi, MD
Bruce Robb, MD
Brian Kann, MD
Joshua Katz, MD
Kevork Kazanjian, MD
Gregory Kennedy, MD
Pokala Kiran, MD
Walter Koltun, MD
Mukta Krane, MD
Alex Ky, MD
Anne Lin, MD
Charles Littlejohn, MD
Kim Lu, MD
Mari Madsen, MD
Mark Manwaring, MD
David Maron, MD
Elisabeth McLemore, MD
Disclosures of Executive Council and Program Committee are listed on pages 149-153.
8
Bashar Safar, MD
Chitra Sambasivan, MD
Dana Sands, MD
Tereza Sardinha, MD
Stephen Sentovich, MD
Josef Shehebar, MD
Matthew Sherman, MD
David Shibata, MD
Marc Singer, MD
Bradford Sklow, MD
Michael Stamos, MD
Scott Steele, MD
David Stewart, MD
Scott Strong, MD
Sanda Tan, MD
Alan Thorson, MD
Judith Trudel, MD
Kelly Tyler, MD
Mark Welton, MD
Steven Wexner, MD
Mark Whiteford, MD
Charles Whitlow, MD
Kirsten Wilkins, MD
Laurence Yee, MD
D. Mark Zebley, MD
Massarat Zutshi, MD
Annual Scientific Meeting Mission, Goal,
Purpose and Learning Objectives
Continuing Medical Education Credit
The American Society of Colon and Rectal Surgeons
(ASCRS) designates this live activity for a maximum of
45.75 AMA PRA Category 1 Credits™ . Physicians should
claim only the credit commensurate with the extent of
their participation in the activity. Attendees can earn
1 CME Credit hour for every 60 minutes of educational
time.
The goal of the American Society of Colon and Rectal
Surgeons’ Annual Scientific Meeting is to improve the
quality of patient care by maintaining, developing and
enhancing the knowledge, skills, professional performance
and multidisciplinary relationships necessary for the
prevention, diagnosis and treatment of patients with
diseases and disorders affecting the colon, rectum and
anus. The Annual Program Committee is dedicated to
meeting these goals.
Method of Participation
Participants must be registered for the conference and
attend the session(s). Each participant will enter a username and password for completion of the evaluations
for the ASCRS 2015 Annual Scientific Meeting; participants must complete an online evaluation form for each
session they attend to receive credit hours. There are no
prerequisites unless otherwise indicated.
This scientific program is designed to provide surgeons
with in-depth and up-to-date knowledge relative to
surgery for diseases of the colon, rectum and anus with
emphasis on patient care, teaching and research.
Presentation formats include podium presentations
followed by audience questions and critiques, panel
discussions, e-poster presentations, video presentations
and symposia focusing on specific state-of-the-art
diagnostic and treatment modalities.
Self-Assessment Credit
Many of the sessions offered will be designated as selfassessment MOC credit, applicable to Part 2 of the
ABCRS MOC program. In order to claim self- assessment
credit, attendees must take a post-test. Information/
instructions will be given to all meeting registrants.
The purpose of all sessions is to improve the quality of care
of patients with diseases of the colon and rectum.
At the conclusion of this meeting, participants should be
able to:
 Recognize new information in colon and rectal benign
and malignant treatments, including the latest in basic
and clinical research.
 Describe current concepts in the diagnosis and
treatment of diseases of the colon, rectum and anus.
 Apply knowledge gained in all areas of colon and rectal
surgery.
 Recognize the need for multidisciplinary treatment in
patients with diseases of the colon, rectum and anus.
ASCRS Mission
The American Society of Colon and Rectal Surgeons is
an association of surgeons and other professionals dedicated to assuring high quality patient care by advancing
the science through research and education for prevention and management of disorders of the colon, rectum
and anus.
Disclaimer
The primary purpose of the ASCRS Annual Meeting is
educational. Information, as well as technologies, products and/or services discussed, are intended to inform
participants about the knowledge, techniques and
experiences of specialists who are willing to share such
information with colleagues. A diversity of professional
opinions exist in the specialty and the views of the
American Society of Colon and Rectal Surgeons disclaims any and all liability for damages to any individual
attending this conference and for all claims which may
result from the use of information, technologies, products and/or services discussed at the conference.
This activity is supported by educational grants from
commercial interests. Complete information will be
provided to participants prior to the activity.
Target Audience
The program is intended for the education of colon and
rectal surgeons as well as general surgeons and others
involved in the treatment of diseases affecting the
colon, rectum and anus.
Accreditation
The American Society of Colon and Rectal
Surgeons (ASCRS) is accredited by the
Accreditation Council for Continuing
Medical Education (ACCME) to provide continuing
medical education for physicians.
Continued next page
9
G E N E R A L I N F O R M AT I O N
Education Information
Education Information
This activity is also supported by the following companies
through an independent educational grant consisting of
loaned durable equipment and disposable supplies.
• American Medical Systems
• Applied Medical
• BK Ultrasound
• Carl Zeiss Meditec
• CONMED
• CooperSurgical
• Ethicon
• Intuitive Surgical, Inc.
• KARL STORZ Endoscopy-America, Inc.
• LABORIE
• Medtronic & Covidien
• Medtronic, plc
• Olympus Corporation of the Americas
• Redfield Corporation
• Richard Wolf Medical Instruments Corporation
• Salix Pharmaceuticals, Inc.
• Seiler Instrument & Manufacturing Co, Inc
• Stryker Endoscopy
• The Prometheus Group
• Zinnanti Surgical Design Group Inc.
Disclosures and Conflict of Interest
In compliance with the standards of the Accreditation
Council for Continuing Medical Education and the
ASCRS, faculty has been requested to complete a Disclosure of Financial Relationships. Disclosures will be made
at the time of presentation, as well as included in the
Program Book and mobile app. All perceived conflicts of
interest will be resolved prior to presentation; and, if not
resolved, the presentation will be denied.
Educational Grant Commercial Supporters
This activity is supported by independent educational
grants from:
• American Medical Systems
• Applied Medical
• BK Ultrasound
• Edwards Lifesciences
• Ethicon
• Intuitive Surgical, Inc.
• KARL STORZ Endoscopy-America, Inc.
• LABORIE
• LifeCell, an Acelity Company
• Mallinckrodt Pharmaceuticals
• Medtronic & Covidien
• Medtronic, plc
• Merck & Co., Inc.
• Olympus Corporation of the Americas
• Richard Wolf Medical Instruments Corporation
• Salix Pharmaceuticals, Inc.
• The Prometheus Group
• Torax Medical, Inc.
SELF ASSESSMENT (MOC) CREDIT
Online Evaluation
ASCRS will again use a convenient online evaluation for
the 2015 Annual Meeting. This system will allow you to
complete evaluations online for all the certified CME
sessions you attend.
This year, WiFi will be available in the meeting rooms and
you can access the evaluation forms from your mobile
device. You can also access the forms from the kiosks
located on the 2nd Floor outside the Auditorium, or from
your home or office computer (recommended).
Online access:
http://www.pswebsurvey.com/ASCRS
You will be asked to enter your
Last Name and ID Number in order
to complete the evaluations.
Your ID Number is located on
your Registration Card and Badge.
Scan the QR Code
with your smartphone to
access the evaluation site.
Maintenance of Certification (MOC)
Self-Assessment
This year, portions of the Annual Meeting will be given for
MOC/Self-Assessment Credit.
These selected sessions for self-assessment are identified
in this Program as MOC Credit. Following the session,
attendees will be able to take an online post-session test
that must be completed and passed with a minimum
score of 75% in order to receive Self-Assessment (MOC)
Credit. If for some reason you do not pass the test, you
will receive the regular CME credit for the sessions
you attend.
Tests must be taken by July 31, 2015.
Online evaluations must be completed by July 31.
10
The 2015 scientific offerings assist the physician with the six core competencies first adopted by the Accreditation Council
for Graduate Medical Education (ACGME) and the American Board of Medical Specialties. Attendees are encouraged to
select areas of interest from the program which will enhance their knowledge and improve the quality of patient care.
1
Patient Care and Procedural Skills – Provide care that
is compassionate, appropriate and effective treatment for
health problems and to promote health.
2
Medical Knowledge – Demonstrate knowledge about
established and evolving biomedical, clinical and cognate
sciences and their application in patient care.
3
4
Professionalism – Demonstrate a commitment to
carrying out professional responsibilities, adherence to
ethical principles and sensitivity to diverse patient
populations.
5
Systems-based Practice – Demonstrate awareness of
and responsibility to larger context and systems of
healthcare. Be able to call on system resources to
provide optimal care (e.g. coordinating care across sites
or serving as the primary case manager when care
involves multiple specialties, professions or sites).
6
Practice-based Learning and Improvement – Able
to investigate and evaluate their patient care practices,
appraise and assimilate scientific evidence and improve
their practice of medicine.
Interpersonal and Communication Skills –
Demonstrate skills that result in effective information
exchange and teaming with patients, their families
and professional associates (e.g. fostering a
therapeutic relationship that is ethically sound, uses
effective listening skills with non-verbal and verbal
communication; working as both a team member and
at times as a leader).
The ASCRS assists the American Board of Colon and Rectal Surgery with a 4-part process
for continuous learning:
Part I – Professional Standing (Every 3 years)
Part III – Cognitive Expertise (Every 10 years)
• A valid, full and unrestricted medical license.
• Hospital privileges in the specialty, if clinically active.
• Chief of Staff Evaluation – contact information for the
chief of surgery and chair of credentials at the institution
where most work is performed.
• Successful completion of a secure recertification
examination, which may be taken three years prior to
certificate expiration. A full exam application is required.
All MOC requirements must be fulfilled up to this point to
apply.
Part II – Lifelong Learning and Self-Assessment
(Every 3 years)
• Continuing medical education (CME)—completion of at
least 90 hours of Category I CME relevant to the
physician’s practice over a three-year cycle.
• Completion of Self-assessment: Over a 3-year cycle, 50 of
the 90 Category I CME must include a self-assessment
activity – a written or electronic question-and-answer
exercise that assesses the physician’s understanding of the
material presented in the CME program.
• CARSEP or SESAP are suggested; however, any approved
CME credit that provides self-assessment greater that 75%
or passing score (including CME components for MOC)
will be accepted for Part II.
Part IV – Evaluation of Performance in Practice
(Every 3 years)
• Communications and interpersonal skills
• Ongoing participation in a national, regional or local
outcomes registry or quality assessment program (such
as SCIP, ACS NSQIP®, SQIP or the ACS case log system).
11
G E N E R A L I N F O R M AT I O N
Maintenance of Certification
General Information
Abstracts
Capturing of NPI Numbers
All abstract presentations are numbered
and available on the ASCRS website.
To view the abstracts, scan the QR code at
the right or go to the Annual Scientific Meeting page,
www.fascrs.org.
As part of the healthcare reform legislation, the
Physician Payment Sunshine Act requires medical
device, biologic, and drug companies to publicly
disclose gifts and payments made to physicians,
as of August 1, 2013.
To help our exhibitors and industry partners in fulfilling
the mandatory reporting provisions of the Sunshine
Act, ASCRS has requested US healthcare provider
attendees to supply their 10-digit NPI (National Provider
Identifier) number when registering for the 2015
Annual Scientific Meeting. The NPI will be imbedded in
the bar code data on the attendee’s badge. Exhibitors
can download the NPI information by scanning the
badge through a lead retrieval system so that they can
record and track any reportable transactions. For more
information on the capturing of the NPI number;
please visit the ASCRS website
Annual Meeting Mobile App
Download the FREE mobile app to maximize your
time at the Annual Meeting. Easily view the schedule,
exhibitors, speakers, and more! This mobile app is
available for all smartphones and tablet platforms –
iPhone, Blackberry and Android.
Download the free ASCRS Mobile App by scanning one
of the two QR Codes below:
iPhone or iPad
Android, or Blackberry
Child Care Services
http://ativ.me/6b8
Please contact the concierge at the hotel at which you
are staying for a list of bonded independent babysitters
and babysitting agencies.
http://ativ.me/6b9
Badge Designations
Blue . . . . . . . . . . . .Member/Fellow Physicians
Lime . . . . . . . . . . . .Member Resident/CR Fellows
Green . . . . . . . . . . .Member Allied Health/Nurses
Purple . . . . . . . . . .Non-Members
Orange . . . . . . . . .Non-Physicians
Red . . . . . . . . . . . . .Technical Exhibitors
Teal . . . . . . . . . . . . .Guests
Lt Orange . . . . . . .Press
Gray . . . . . . . . . . . .Meeting Technician/Workers
Fuchsia . . . . . . . . .Staff
Replacement badges – $10.00 each
Dinner Dance Tickets
Full-paying members and fellows who requested a
ticket for the Wednesday evening Dinner Dance will
receive a voucher as part of their packet. This voucher
must be exchanged for assigned table seating by
noon, Tuesday.
Non-members and others who wish to purchase tickets
may do so at the ASCRS Registration Desk. Please do
so as early as possible in order to meet the ticket
exchange deadline.
ePoster Displays
Boston Visitors Desk
ePoster viewing stations are located in Hall C (ePoster
area), Hall D (near booth #736), Hall C Foyer (by registration), outside Ballroom B (3rd Floor) and outside
Room 304 (3rd Floor).
A Boston Visitors desk will be available to all attendees
to make restaurant reservations, assist with city information and provide maps and brochures. This booth is
located in Hall C Foyer (2nd Floor) and will be available
during the following hours:
ePosters of Distinction will be presented during scheduled breaks in the Exhibit Hall. See pages 109-111.
Saturday . . . . . . . . . . . . . . . . . . .9:00 am – 5:00 pm
Sunday . . . . . . . . . . . . . . . . . . . .9:00 am – 5:00 pm
Monday . . . . . . . . . . . . . . . . . . . .9:00 am – 5:00 pm
Tuesday . . . . . . . . . . . . . . . . . . . .9:00 am – 5:00 pm
Wednesday . . . . . . . . . . . . . . . .9:00 am – 2:00 pm
Authors of ePosters have been assigned a specific time
frame to be at a designated monitor and available for
questions. See page 112-113 for more information.
12
Exhibit Hall
Photography/Video Recordings
More than 85 technical and scientific exhibitors will display their products and services in Exhibit Halls C&D
(2nd Floor) throughout the convention.
By registering for this meeting, attendees acknowledge
and agree that ASCRS or its agents may take photographs during events and may freely use those photographs in any media for ASCRS purposes, including but
not limited to news and promotional purposes.
ASCRS appreciates the support of its exhibitors and
urges all registrants to visit the displays.
The presentations, slides, and handouts provided in this
program are the property of ASCRS or used by permission. Meeting participants may not photograph, videotape, audiotape or otherwise record or reproduce any of
the presentations without express written permission
from ASCRS. Any attendee believed to be violating this
restriction will be removed from the session and may be
prohibited from participating in future ASCRS meetings.
Exhibit hours:
Sunday . . . . . . . . . . . . . . . . . . . .3:00 pm – 5:00 pm
Monday . . . . . . . . . . . . . . . . . . . .9:00 am – 4:30 pm
Tuesday . . . . . . . . . . . . . . . . . . .9:00 am – 2:00 pm
First Aid Station
A First Aid Station is located on Level 1 of the Hynes
Convention Center and is available during the
following hours:
Registration Desk Hours
Saturday . . . . . . . . . . . . . . . . . . .6:00 am – 6:30 pm
Sunday . . . . . . . . . . . . . . . . . . . .6:00 am – 7:30 pm
Monday . . . . . . . . . . . . . . . . . . . .5:15 am – 7:30 pm
Tuesday . . . . . . . . . . . . . . . . . . . .5:15 am – 7:30 pm
Wednesday . . . . . . . . . . . . . . . .5:15 am – 6:30 pm
The ASCRS Registration Desk is located in the Hynes
Convention Center, Hall C Foyer (2nd Floor).
Saturday . . . . . . . . . . . . . . . . . . .6:00 am – 6:00 pm
Sunday . . . . . . . . . . . . . . . . . . . .6:30 am – 6:00 pm
Monday . . . . . . . . . . . . . . . . . . . .6:00 am – 4:30 pm
Tuesday . . . . . . . . . . . . . . . . . . . .6:15 am – 4:00 pm
Wednesday . . . . . . . . . . . . . . . .6:15 am – 4:00 pm
Index of Participants
The names of all program speakers, with page numbers
to indicate their scheduled appearances, are listed on
pages 154-155.
Replacement badges – $10.00 each
Social Events
Networking Goes Viral with #ASCRS15
The ASCRS and the Research Foundation invite you to
attend the Welcome Reception on Sunday from
7:00 – 8:30 pm in the Grand Ballroom at the Sheraton
Boston Hotel. This event is complimentary to all
registered attendees. Enjoy hors d’oeuvres, refreshments
and networking.
Be a part of the Annual Meeting
conversation! Use hashtag #ASCRS15
in your meeting related tweets. Follow twitter.com/
fascrs_updates or facebook.com/fascrs and wear a
special meeting ribbon showing your support.
Share Facebook posts about the meeting from
facebook.com/fascrs.
This year the Welcome Reception will be known as
“Jersey Night.” Make sure to wear your team’s favorite
jersey (collegiate or professional) to show your colleagues which team you root for!
New Members
New members of the ASCRS will be identified by a
special ribbon affixed to their name badge. We
encourage you to introduce yourself and make our
new members welcome.
The Annual Dinner Dance is scheduled on Wednesday,
with the reception beginning at 7:00 pm and the dinner
at 8:00 pm in the Grand Ballroom at the Sheraton
Boston Hotel. There is no additional cost for a ticket for
full–paying members and fellows. Please remember to
exchange your Dinner Dance voucher for a seat
assignment no later than noon on Tuesday. The cost
for others is $75 per ticket.
QR Code
A “QR Code” enables your smartphone or tablet to
instantly access direct links on the internet. To use it,
download a free QR app (available from your phone’s
app store) if you don’t already have one. Next, take a
photo of the printed QR code and you’ll be instantly
connected to additional information.
13
G E N E R A L I N F O R M AT I O N
General Information
General Information
Package #2 ($55) includes:
Speaker Ready Room
Welcome Reception, 7:00 – 8:30 pm, Sunday,
Grand Ballroom, Sheraton Boston Hotel
All presentations MUST be made using submitted
PowerPoint or Keynote files. Please bring your presentation to the Speaker Ready Room at least EIGHT
hours (preferably 24 hours) prior to the start of the
session in which you are speaking. Presentations from
laptops and iPads will NOT be permitted.
Exhibit Hall Admission
Webcast Sessions
Selected sessions will be captured and made available
as webcasts on the ASCRS website following the
meeting.
The Speaker Ready Room is located in Room 201 and is
available to all program participants. Speakers are
requested to take advantage of this opportunity prior to
their presentation to review their slides.
WiFi – FREE
Friday . . . . . . . . . . . . . . . . . . . . .3:00 pm – 6:00 pm
Saturday . . . . . . . . . . . . . . . . . . .6:00 am – 6:30 pm
Sunday . . . . . . . . . . . . . . . . . . . .6:30 am – 6:30 pm
Monday . . . . . . . . . . . . . . . . . . . .6:30 am – 6:30 pm
Tuesday . . . . . . . . . . . . . . . . . . . .6:30 am – 6:00 pm
Wednesday . . . . . . . . . . . . . . . .6:30 am – 5:00 pm
Free WiFi is provided to all ASCRS attendees at the
Hynes Convention Center.
To access the free WiFi simply:
• Open your wireless connection
• Click continue and you will be connected to
the internet
Spouse/Guest Registration Options
Package #1 ($100) includes:
Welcome Reception, 7:00 – 8:30 pm, Sunday,
Grand Ballroom, Sheraton Boston Hotel
Annual Reception, 7:00 – 8:00 pm, Wednesday,
Grand Ballroom Foyer, Sheraton Boston Hotel
Annual Dinner Dance, 8:00 – 10:30 pm, Wednesday
Grand Ballroom, Sheraton Boston Hotel
Exhibit Hall Admission
Welcome Reception • Jersey Night!
7:00 – 8:30 pm • Grand Ballroom, Sheraton Boston Hotel
Wear your favorite team’s jersey to show your
colleagues which team you support.
Complimentary to all registered attendees.
14
Norman D. Nigro, MD, Research Lectureship
Parviz Kamangar
Humanities in Surgery Lectureship
Sunday, May 31 • 4:45 – 5:15 pm
Auditorium (2nd Floor)
Dr. Norman Nigro is recognized for his many contributions to the care of patients with diseases of the colon
and rectum; for his significant research in the prevention
of large bowel cancer and treatment of squamous cell
carcinoma of the anus and for his leadership role in his
chosen specialty and allied medical organizations.
Dr. Nigro generously contributed many years of dedication and service to the specialty through his activities in
the American Society of Colon and Rectal Surgeons
(ASCRS) and the American Board of Colon and Rectal
Surgery (ABCRS).
Monday, June 1 • 4:15 – 4:45 pm
Auditorium (2nd Floor)
This unique lectureship is funded by Mr. Parviz
Kamangar, a grateful patient, to remind physicians and
surgeons to place compassionate care at the top of the
list of priorities.
Ernestine Hambrick, MD, Lectureship
Tuesday, June 2 • 9:00 – 9:30 am
Auditorium (2nd Floor)
This lectureship honors Dr. Ernestine Hambrick for her
dedication to patients with colon and rectal disorders,
surgical students and trainees and the community at
large. The first woman to be board certified in colon and
rectal surgery, Dr. Hambrick provided excellent care to
patients and mentored numerous students, residents
and young surgeons during her clinical practice.
Dr. Hambrick founded the STOP Foundation to promote
screening and prevention of colon and rectal cancer. In
addition, she has volunteered many hours working for
the ASCRS including serving as Vice President.
Harry E. Bacon, MD, Lectureship
Monday, June 1 • 3:00 – 3:30 pm
Auditorium (2nd Floor)
Harry Ellicott Bacon was Professor and Chairman of the
Department of Proctology at Temple University Hospital.
His stellar contribution was the establishment of the
Journal, Diseases of the Colon and Rectum, of which he
was the Chief-Editor. He was a Past President of the
American Society of Colon and Rectal Surgeons and the
American Board of Colon and Rectal Surgery. Dr. Bacon
was the founder of the International Society of University Colon and Rectal Surgeons.
As a researcher and teacher of over 100 residents, he
was innovative in some operations that are forerunners
of sphincter saving procedures for cancer of the rectum
(pull-through operation) and inflammatory bowel
disease (ileoanal reservoir anastomosis).
Take Your Meeting Mobile
Target what you want to attend, learn and do at the ASCRS Annual Meeting with
the ASCRS mobile app – the app is free and the options are endless!
View all the annual meeting info right at your fingertips:
 Schedule of events
 Exhibitor list and details
 Speakers, sponsors and more
Download the free app today and
maximize your time at the meeting.
 To download a mobile version, scan one of the QR Codes on
the right.
 For all other devices, go to http://ativ.me/6ba.
15
iPhone or iPad
http://ativ.me/6b8
Android, or Blackberry
http://ativ.me/6b9
G E N E R A L I N F O R M AT I O N
Annual Named Lectures
Masters in Colorectal Surgery
Masters in Colorectal Surgery
This lectureship has been established to honor a different senior surgeon each year who has made a considerable
contribution to the specialty and the Society.
The following physicians have been honored as Masters in Colorectal Surgery.
This year’s Masters in Colorectal Surgery Lecture will take place on Tuesday from 11:45 am – 12:15 pm, in the
Auditorium (2nd Floor) and will be presented by Patricia L. Roberts, MD.
2015
David J. Schoetz, Jr., MD
2014
2013
2012
Eugene P. Salvati, MD
Victor W. Fazio, MD
Herand Abcarian, MD
2011
2010
Philip H. Gordon, MD
Stanley M. Goldberg, MD
16
Colorectal Society Regional Awards
The following awards will be chosen at the 2015 Annual Meeting and announced shortly after.
Each recipient will be given a plaque and a $500 cash award from the regional society sponsoring
the award. Awards are given for the best basic science or clinical paper presented from the podium
or as a poster.
 Chesapeake Society of Colon & Rectal Surgeons Award (Basic Science/Poster)
 Harry E. Bacon Foundation Award (Basic Science/Podium)
 Michigan Society of Colon & Rectal Surgeons Award (Clinical/Podium)
 New Jersey Society of Colon & Rectal Surgeons Award (Basic Science/Poster)
 New York Society of Colon & Rectal Surgeons Award (Clinical/Podium)
 Northwest Society of Colon & Rectal Surgeons Award (Clinical/Podium)
 Piedmont Society of Colon & Rectal Surgeons Award (Clinical/Podium)
 Southern California Society of Colon & Rectal Surgeons Award (Clinical/Poster)
ASCRS Award
 Best Paper Award
The recipient of this award will attend the Annual Meeting of the European Society of
Coloproctology in Dublin, Ireland, September 22-25, 2015.
Call for 2016 Abstracts
2016 ASCRS Annual Meeting
April 30 – May 4, 2016
Los Angeles Convention Center
Los Angeles, CA
Online Submission Site Opens
July 15th
Online Submission Site Closes
November 8th, 11:59 pm CST
Program Chair: Kirsten Wilkins, MD
Program Vice-Chairs: Joshua Bleier, MD and Scott Steele, MD
17
G E N E R A L I N F O R M AT I O N
Awards
Non-CME Corporate Forums
Following the close of Monday and Tuesday’s scientific session, all registrants are invited to attend the special
Corporate Forums at the Sheraton Boston Hotel.
NOT FOR
CREDIT
Corporate Forums are non-CME promotional offerings organized by industry and designed to enhance your educational
experience.
Monday, June 1
7:00 – 8:30 pm
Constitution Ballroom (2nd Floor)
Supported by Mallinckrodt Pharmaceuticals
OFIRMEV (acetaminophen) Injection:
A Non-Opioid, Non-NSAID Foundation for Multimodal Analgesia in the
Perioperative Patient
Presented by: Frank T. Sconzo, Jr., MD
This program will be a discussion of OFIRMEV (acetaminophen) Injection: a Non-Opioid Foundation for Multimodal
Analgesia in the Perioperative Patient. The program will go over the safety and efficacy of this product while also utilizing
case studies for discussion.
Also, visit Mallinckrodt Pharmaceuticals at Booth #329.
Tuesday, June 2
7:00 – 8:30 pm
Constitution Ballroom (2nd Floor)
7:00 – 8:30 pm
Republic Ballroom (2nd Floor)
Supported by Intuitive Surgical, Inc.
Supported by Medtronic, plc
UNCOVER Da Vinci® –
New Technology for Advancing
Minimally Invasive Surgery
Sacral Neuromodulation –
A Systemic Solution for the FI Patient
Presented by: Joshua Bleier, MD, and
Prof P. Ronan O’Connell, MD, FRCSI, FRCS (Glas), FRCS (Edin)
This event will focus on all aspects of robotic technology:
Ways to improve clinical outcomes, tips & tricks to increase
efficiency, as well as a glimpse at future technology. We
will begin with a presentation highlighting the clinical
experience with the latest robotic technology, followed by
a “behind the scenes” look at robotic technologies under
development. Hors d’oerves and beverages will be served.
Sacral Neuromodulation has become an established
therapy for the treatment of chronic fecal incontinence.
This program will present the safety, efficacy, and durability
of Sacral Neuromodulation and explore the theory of
Mechanism of Action. It will also examine the clinical use
of the therapy through a discussion of case studies.
Also, visit Intuitive Surgical, Inc. at Booth #401.
Also, visit Medtronic, plc at Booth #311.
18
ASCRS is grateful to the following companies and organizations
for their generous support of the following projects and programs this year:
ACell, Inc.
Ethicon
Co-supporter of the Monday Symposium on
New Technologies**.
Supporter of Tuesday’s Women in Colorectal Surgery
Luncheon… an advertisement in the Convention
Program Guide**… promotional e-Blasts**… Escalator
Clings**… co-supporter of Saturday's Laparoscopic
Colectomy Workshop*… the Sunday Symposium on
Laparoscopic Nuts and Bolts and Robotic Rivets… the
Sunday Symposium on Quality Initiatives in Clinical
Practice… the Monday Symposium on Rectal Cancer:
Optimizing Outcomes through Techniques… the Monday
Symposium on New Technologies**… and the Wednesday
Symposium on Enhanced Perioperative Care Pathways and
Postoperative Pain Management.
American Medical Systems
Partial support of the Sunday Symposium on Current
Advances in the Management of Fecal Incontinence… and
co-supporter of the Saturday’s Workshop on Optimal
Management of Fecal Incontinence*.
Applied Medical
Co-supporter Saturday's Laparoscopic Colectomy
Workshop*… the Saturday Workshop on Transanal
Endoscopic Surgery*… the Sunday Symposium on
Laparoscopic Nuts & Bolts and Robotic Rivets… the Sunday
Symposium on Quality Initiatives in Clinical Practice… and
partial support of the Tuesday Symposium on
Controversies in Rectal Cancer Management.
Intuitive Surgical, Inc.
Supporter of Saturday's Symposium and Workshop on
Robotic Colon and Rectal Surgery: Tips, Tricks, and
Simulation*… an advertisement in the Convention
Program Guide**… Non-CME Corporate Forum**…
Product Theater**… promotional e-blasts**…
co-supporter of the Monday Symposium on New
Technologies**… and partial support of the Monday
symposium on Robotic Colorectal Surgery.
BK Ultrasound
Co-supporter of the Saturday Workshop on Optimal
Management of Fecal Incontinence*.
Carl Zeiss Meditec
KARL STORZ Endoscopy-America, Inc.
In-kind support of Saturday's Workshop on AIN and HRA:
What the Colorectal Surgeon Needs to Know*.
Co-supporter of the Saturday Workshop on Transanal
Endoscopic Surgery*… in-kind support of Saturday's
Laparoscopic Colectomy Workshop*.
CONMED
In-kind support of Saturday's Workshop on AIN and HRA:
What the Colorectal Surgeon Needs to Know*.
LABORIE
Co-supporter of the Saturday Workshop on Optimal
Management of Fecal Incontinence*.
ConvaTec, Inc.
Supporter of a Product Theater**.
LifeCell, an Acelity Company
Co-supporter of the Tuesday Symposium on Ostomies:
Location, Creation and Complications.
CooperSurgical
In-kind support of Saturday's Workshop on AIN and HRA:
What the Colorectal Surgeon Needs to Know*.
Mallincrodt Pharmaceuticals
Supporter of an advertisement in the Convention
Program Guide**… Non-CME Corporate Forum**…
promotional e-blasts**… and co-supporter of the
Wednesday Symposium on Enhanced Perioperative Care
Pathways and Postoperative Pain Management.
Edwards Lifesciences
Co-supporter of Wednesday’s Symposium on
Enhanced Perioperative Care Pathways and Postoperative
Pain Management.
Medtronic, plc
Supporter of a Non-CME Corporate Forum**…
Badge Lanyards**… and co-supporter of the Saturday
Workshop on Optimal Management of Fecal Incontinence*.
*In-kind support
**Promotional support
19
G E N E R A L I N F O R M AT I O N
Thanks to our Corporate Supporters
Thanks to our Corporate Supporters
ASCRS is grateful to the following companies and organizations
for their generous support of the following projects and programs this year:
Medtronic & Covidien
Salix Pharmaceuticals, Inc.
Supporter of the Hotel Key Card**… co-supporter the
Saturday Laparoscopic Colectomy Workshop*… and the
Saturday Workshop on Transanal Endoscopic Surgery*.
Co-supporter of the Saturday Workshop on Optimal
Management of Fecal Incontinence.
Seiler Instrument &
Manufacturing Co, Inc.
Merck & Co., Inc.
Co-supporter of the Wednesday Symposium on
Enhanced Perioperative Care Pathways and Postoperative
Pain Management.
In-kind support of Saturday's Workshop on AIN and HRA:
What the Colorectal Surgeon Needs to Know*.
Stryker Endoscopy
Novadaq Technologies, Inc.
In-kind support of Saturday's Transanal Endoscopic
Surgery Workshop*.
Co-supporter of the Monday Symposium on
New Technologies**.
THD America
Olympus Corporation of the Americas
Co-supporter of the Monday Symposium on
New Technologies**.
Co-supporter of Saturday's Laparoscopic Colectomy
Workshop*.
The Prometheus Group
Pacira Pharmaceuticals, Inc.
Co-supporter of the Saturday Workshop on Optimal
Management of Fecal Incontinence*.
Co-supporter of the Monday Symposium on
New Technologies**.
Torax Medical, Inc.
Redfield Corporation
Co-supporter of the Saturday Workshop on Optimal
Management of Fecal Incontinence*… and the Monday
Symposium on New Technologies**.
In-kind support of Saturday's Workshop on AIN and HRA:
What the Colorectal Surgeon Needs to Know*.
Richard Wolf Medical
Instruments Corporation
Zinnanti Surgical Design Group Inc.
In-kind support of Saturday's Workshop on AIN and HRA:
What the Colorectal Surgeon Needs to Know*.
Co-supporter of Saturday’s Transanal Endoscopic
Surgery Workshop*.
The ASCRS Research Foundation thanks the following for their support of
the 2015 Meet the Challenge Fundraiser (list current as of April 6, 2015):
Chesapeake Colorectal Society
Chicago Society of Colon & Rectal Surgeons
Michigan Society of Colon & Rectal Surgeons
Midwest Society of Colon & Rectal Surgeons
New England Society of Colon & Rectal Surgeons
New Jersey Society of Colon & Rectal Surgeons
New York Society of Colon & Rectal Surgeons
Niagara Frontier Society of Colon & Rectal Surgeons
Northwest Society of Colon & Rectal Surgeons
Pennsylvania Society of Colon & Rectal Surgeons
Piedmont Society of Colon & Rectal Surgeons
Southern California Society of Colon & Rectal Surgeons
*In-kind support
**Promotional support
20
The following videos will be available for viewing in Room 210 (Convention Center), Saturday through Wednesday.
STATION 1
STATION 3
Surgical Approaches in the Reoperative Abdomen VR1
M.E. Kwiatt, C. Horne, D. Liska, F. Remzi, Cleveland, OH
Laparoscopic Splenic Flexure and Sigmoid
Resection for Adenocarcinoma and Diverticulitis
VR12
F. Stipa, E. Soricelli, A. Burza, P. Delle Site, Rome, Italy
Gracilis Muscle Interposition for the Management
of Recto Urethral Fistula Consequent
to Radiotherapy
VR2
D.F. Soares, R.A. Pinto, S.C. Nahas, C.S. Nahas,
C.S. Marques, M. Srougi, F.F. Busnardo, Sao Paulo, Brazil
A Technique of Laparoscopic Lateral Pelvic Lymph
Node Dissection Based on Vesicohypogastric Fascia
and Ureterohypogastric Nerve Fascia for Advanced
Low Rectal Cancer
VR13
A. Matsumoto, K. Arita, Tsuchiura City, Japan
Laparoscopic Repair of Ureteric Injury:
Psoas Hitch With Ureteric Reimplantation
VR3
A. Wong, Kensington, Australia, E. Gorgun, G. Haber,
M.A. Abbas, Cleveland, OH
The Single Port Hartmann’s Reversal: The Real
Benefit of Single Port in Colorectal Surgery
S. Malakorn, Bangkok, Thailand
VR4
Using New Technology to Improve Postoperative
Outcomes: Fluorescent Angiography for
Assessment of Perfusion in Colorectal Surgery
J.R. Flores-Gonzalez, D.S. Keller, J. Nieto, E.M. Haas,
Houston, TX
VR5
Laparoscopic Retro Rectal Tumor
M. Barussaud, Poitiers, France
Redo Ileal J Pouch Surgery for Mechanical
Pouch Dysfunction
VR15
E.A. Myers, D. Liska, J. Ashburn, F. Remzi, Cleveland, OH
Retromuscular Repair of Parastomal Hernias with
Transversus Abdominis Release: A Single Center
Experience with a Novel Technique
VR16
M. Wilson, J.S. Winder, L. Piper, E. Messaris, E. Pauli,
Hershey, PA
STATION 4
STATION 2
A Novel Technique of Perfoming a Stapled
Anastomosis Following Transanal Total
Mesorectal Excision
E. Bracey, N.C. Buchs, O. Jones, N. Mortensen,
R. Hompes, Oxford, UK
Robotic Transanal Surgery With Endoscopic
Suturing for Local Excision of a Rectal Neoplasm
VR10
S. Atallah, S. Annaberdyev, B. Martin-Perez, S. Larach,
Winter Park, FL, R. Hawes, Orlando, FL
Transvaginal Specimen Extraction after Combined
Robotic Anterior Resection and Hysterectomy:
A Natural Orifice Specimen Extraction Approach
to Rectal Cancer
VR11
A.W. Chae, E. Raskin, St. Louis Park, MN
Robotic Transanal Excision of Large Rectal Mass
J.N. Harr, V. Obias, Washington, DC
Bascom Cleft Lift Procedure: Step by Step
I. Gribovskaja-Rupp, M. Sun, C.O. Finne,
Minneapolis, MN
Transanal TME for Low Rectal Tumors in Males:
Avoiding Urethral Injury
P. Sylla, L. Bordeianou, D. Berger, Boston, MA
VR6
VR17
VR18
VR19
Transanal Total Mesorectal Excision: Working
Towards a Standardized Approach by Highlighting
Technical Aspects in Colorized Videoclips
VR20
E. Deleus, J. Knol, Hasselt, Belgium, S. Wexner,
Weston, FL
Modification of TAMIS Procedure
VR7
S.J. Marecik, J. Kaminski, T. Kamal, J. Park, L. Prasad,
G. Melich, Park Ridge, IL
Robotic LAR converted to Subtotal Colectomy: Use of the
Right Colon to Salvage a Difficult Colorectal Anastomosis
Due to Poor Collateral Perfusion
VR8
M.H. Hanna, A. Pigazzi, Orange, CA
Robotic Reduced-Port Anterior Resection for
Left-Sided Colon Cancer using the Da Vinci
Single-Site® Platform
S. Bae, W. Jeong, O. Bae, S. Baek, Daegu, Korea
VR14
Endoscopic Stenting of Rectosigmoid Cancer
VR21
A.A. Alkhatib, G. Santoro, M.A. Abbas, Abu Dhabi, United
Arab Emirates
VR9
21
G E N E R A L I N F O R M AT I O N
On-Going Video Display
Daily Schedule
All programs are held in the Hynes Convention Center unless otherwise noted.
HOURS
ROOM
Saturday, May 30
6:00 am – 6:00 pm
Registration for ASCRS Annual Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Hall C Foyer (2nd Floor)
6:00 am – 6:30 pm
Speaker Ready Room . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .201
6:30 am – 6:30 pm
On-Going Video Display . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .210
7:00 – 8:25 am
Transanal Endoscopic Surgery Workshop . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200
7:00 – 9:00 am
AIN and HRA: What the Colorectal Surgeon Needs to Know . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .311
7:30 – 11:45 am
Laparoscopic Colectomy Symposium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor)
7:30 am – noon
Optimal Management of Fecal Incontinence Symposium . . . . . . . . . . . . . . . . . . . . . . .Ballroom A (3rd Floor)
8:00 am – noon
Robotic Colon and Rectal Surgery: Tips, Tricks and
Simulation Symposium / Group A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .302-304
8:00 am – noon
Robotic Colon and Rectal Surgery: Tips, Tricks and
Simulation Hands-on Lab / Group B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .306
8:00 am – noon
Executive Council Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Fairfax (3rd Floor – Sheraton)
8:30 am – noon
Transanal Endoscopic Surgery Hands-on Lab / Group A . . . . . . . . . . . . . . . . . . . . . . . . . . . .202, 203, 204, 206
8:30 am – noon
Transanal Endoscopic Surgery Workshop / Group B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200
9:00 am – 12:15 pm
AIN and HRA: Group 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .311
9:00 am – 12:15 pm
AIN and HRA: Group 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .313
9:00 am – 12:15 pm
AIN and HRA: Group 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .312
10:05 – 10:15 am
Laparoscopic Colectomy Symposium Refreshment Break . . . . . . . . . . . . . . .Ballroom BC Foyer (3rd Floor)
10:05 – 10:15 am
Robotic Colon and Rectal Surgery Refreshment Break . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .302-304 Foyer
10:40 – 11:00 am
Optimal Management of Fecal Incontinence Refreshment Break . . . . . . . . .Ballroom A Foyer (3rd Floor)
11:45 am – 12:30 pm Laparoscopic Colectomy Luncheon (lab registrants only) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .301
Noon – 12:30 pm
Robotic Colon and Rectal Surgery Luncheon (lab registrants only) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .305
Noon – 12:30 pm
Optimal Management of Fecal Incontinence Luncheon
(lab registrants only) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .207
Noon – 1:00 pm
Transanal Endoscopic Surgery Lunch . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200
Noon – 1:00 pm
Alliance / American College of Surgeons Investigators Meeting . . . . . . .Hampton (3rd Floor – Sheraton)
12:15 – 12:30 pm
AIN and HRA: What the Colorectal Surgeon Needs to Know . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .311
12:30 – 3:30 pm
Question Writing Workshop: How to Write Exam Questions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .310
12:30 – 4:00 pm
Symposium: Advanced Endoscopy and Endoluminal Surgery . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor)
12:30 – 4:30 pm
Robotic Colon and Rectal Surgery: Tips, Tricks and
Simulation Hands-on Lab / Group A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .306
12:30 – 4:30 pm
Robotic Colon and Rectal Surgery: Tips, Tricks and
Simulation Symposium / Group B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .302-304
1:00 – 4:30 pm
Laparoscopic Colectomy Hands-on Session for Lab Registrants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Off-Site
1:00 – 4:30 pm
Optimal Management of Fecal Incontinence Hands-on Session
for Lab Registrants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Off-Site
1:00 – 4:30 pm
Transanal Endoscopic Surgery Workshop / Group A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200
1:00 – 4:30 pm
Transanal Endoscopic Surgery Hands-on Lab / Group B . . . . . . . . . . . . . . . . . . . . . . . . . . . .202, 203, 204, 206
2:20 – 2:30 pm
Robotic Colon and Rectal Surgery Refreshment Break . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .302-304 Foyer
3:45 – 4:15 pm
Refreshment Break . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC Foyer (3rd Floor)
22
Daily Schedule
All programs are held in the Hynes Convention Center unless otherwise noted.
HOURS
ROOM
Saturday, May 30 (continued)
4:00 – 5:30 pm
Symposium: Improving Outcomes-Identifying
and Managing the Complex Surgical Patients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor)
5:00 – 6:00 pm
OSTRiCh Consortium General Assembly . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .310
5:30 – 6:30 pm
Self-Assessment Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .300
6:30 am – 6:00 pm
Registration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Hall C Foyer (2nd Floor)
6:30 am – 6:30 pm
Speaker Ready Room . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .201
6:30 am – 6:30 pm
On-Going Video Display . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .210
7:00 – 8:00 am
CREST Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .300
7:00 – 8:00 am
Quality Assessment Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .203
7:00 – 9:00 am
Research Foundation Board of Trustees Meeting . . . . . . . . . . . . . . . . . . . . . . . .Fairfax (3rd Floor – Sheraton)
7:15 – 9:30 am
Core Subject Update . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
8:00 – 9:45 am
Symposium: Healthcare Economics in the ACA Era . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor)
8:00 – 10:00 am
New Technologies Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200
8:30 – 9:30 am
Professional Outreach Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .202
9:00 – 11:00 am
Research Foundation Research Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . .Gardner (3rd Floor – Sheraton)
9:00 – 11:00 am
Symposium: Quality Initiatives in Clinical Practice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom A (3rd Floor)
9:15 – 9:45 am
Refreshment Break . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium Foyer (2nd Floor) &
Ballroom BC Foyer (3rd Floor)
9:30 – 11:30 am
ACS Advisory Council . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Exeter (3rd Floor – Sheraton)
9:30 – 11:45 am
Symposium: Laparoscopic Nuts & Bolts and Robotic Rivets . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
9:45 – 11:45 am
Symposium: Complications: Prevention and Management . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor)
11:00 am – 12:30 pm DC&R Editorial Board Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .300
11:30 am – 12:30 pm Residents Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .202
11:30 am – 1:00 pm
ISUCRS Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Hampton (3rd Floor – Sheraton)
11:45 am – 1:00 pm
Research Foundation Fundraising Assistance Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .203
11:45 am – 1:15 pm
Luncheon Symposium: Current Advances in the
Management of Fecal Incontinence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor)
11:45 am – 1:15 pm
Luncheon Symposium: The Genetics of Colorectal
Cancer and Cancer Related Syndromes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .302-306
Noon – 1:00 pm
Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .205
Noon – 1:00 pm
Continuing Education Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200
Noon – 1:00 pm
Membership Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .206
1:15 – 2:00 pm
Welcome and Opening Announcements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
2:00 – 3:30 pm
Abstract Session: Neoplasia I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom A (3rd Floor)
2:00 – 4:00 pm
Symposium: Technical Pearls – How it's Really Done . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
3:00 – 5:00 pm
Exhibit Hours . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor)
4:00 – 4:45 pm
Refreshment Break in Exhibit Hall . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor)
Continued next page
23
D A I LY S C H E D U L E
Sunday, May 31
Daily Schedule
All programs are held in the Hynes Convention Center unless otherwise noted.
HOURS
ROOM
Sunday, May 31 (continued)
4:00 – 4:45 pm
ePoster Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor)
4:45 – 5:15 pm
Norman D. Nigro, MD, Research Lectureship . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
5:15 – 6:30 pm
After Hours Debate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
5:30 – 6:30 pm
International Council of Coloproctology Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .310
7:00 – 8:30 pm
Welcome Reception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Grand Ballroom
(2nd Floor – Sheraton)
8:30 – 11:30 pm
Young Surgeons Reception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Off-Site (Dillon's Restaurant)
9:30 pm – midnight
E.P. Salvati Society Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Fairfax (3rd Floor – Sheraton)
6:00 – 7:00 am
“Meet the Professor” Breakfasts
Monday, June 1
M-1
HNPCC and Polyposis: Knowing When to Operate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200
M-2
Quality Metrics and Colorectal Surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .202
M-3
Coding Pearls . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .203
M-4
The Management of T1 Rectal Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .206
M-5
How to Produce a High Quality Manuscript for Scientific Journals . . . . . . . . . . . . . . . . . . . . . . . .207
M-6
Rectal Prolapse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .300
6:00 – 7:00 am
Residents' Breakfast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Constitution Ballroom
(2nd Floor – Sheraton)
6:00 – 7:00 am
History of ASCRS Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .301
6:00 am – 4:30 pm
Registration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Hall C Foyer (2nd Floor)
6:30 am – 6:30 pm
Speaker Ready Room . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .201
6:30 am – 6:30 pm
On-Going Video Display . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .210
7:00 – 8:00 am
OSTRiCh Council Business Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .303
7:00 – 9:15 am
Symposium: Robotic Colorectal Surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor)
7:00 – 9:15 am
Symposium: Rectal Cancer: Optimizing Outcomes through Techniques . . . . . . . . .Auditorium (2nd Floor)
8:00 – 9:00 am
Rectal Cancer Coordinating Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .303
9:00 am – 4:30 pm
Exhibit Hours . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor)
9:15 – 9:45 am
Memorial Lectureship Honoring John M. MacKeigan, MD . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
9:45 – 10:15 am
Presidential Address . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
10:15 – 11:00 am
Refreshment Break in Exhibit Hall . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor)
10:15 – 11:00 am
ePoster Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor)
11:00 am – 12:30 pm Symposium: Navigating a Career Path in Colon and Rectal Surgery –
Orchestrating and Optimizing Career Transitions at All Levels . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
11:00 am – 12:30 pm Abstract Session: Benign Colonic Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom A (3rd Floor)
11:30 am – 12:30 pm Social Media Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .303
12:30 – 1:30 pm
Complimentary Box Lunch in Exhibit Hall . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor)
12:30 – 1:30 pm
ePoster Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor)
12:30 – 1:30 pm
Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .205
12:30 – 1:30 pm
Website Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .300
24
Daily Schedule
All programs are held in the Hynes Convention Center unless otherwise noted.
HOURS
ROOM
12:30 – 1:30 pm
Young Surgeons Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .301
12:30 – 1:30 pm
Past Vice Presidents' Luncheon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .305
12:35 – 1:30 pm
Product Theater: Intuitive Surgical, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor)
1:30 – 3:00 pm
Symposium: Past Presidents' Panel: Controversies and Cases . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
1:30 – 3:00 pm
Abstract Session: Pelvic Floor / Anorectal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom A (3rd Floor)
2:00 – 3:30 pm
Public Relations Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200
3:00 – 3:30 pm
Harry E. Bacon, MD, Lectureship . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
3:30 – 4:15 pm
Ice Cream and Refreshment Break in Exhibit Hall . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor)
3:30 – 4:15 pm
ePoster Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor)
4:00 – 5:00 pm
Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .205
4:15 – 4:45 pm
Parviz Kamangar Humanities in Surgery Lectureship . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
4:45 – 5:15 pm
Special Lecture: The Trials and Tribulations of Clinical Research:
Why Johnny Can't Add . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
5:15 – 5:20 pm
What Receiving the Scholarship Means to Me . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
5:20 – 6:45 pm
New Technologies Symposium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
5:30 – 6:30 pm
Healthcare Economics Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200
7:00 pm
Chicago Society of Colon & Rectal Surgeons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Off-Site
7:00 pm
Lahey Clinic Alumni Dinner . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Off-Site
7:00 pm
Minnesota Alumni Dinner . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Off-Site
7:00 pm
Ochsner Alumni Dinner . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Off-Site
7:00 – 8:30 pm
Non-CME Corporate Forum: Mallinckrodt Pharmaceuticals . . . . . . . . . . . . . . . . . . . . . . .Constitution Ballroom
(2nd Floor – Sheraton)
7:00 – 8:30 pm
Ferguson Surgical Society Cocktail Hour . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Hampton (3rd Floor – Sheraton)
7:00 – 8:30 pm
Lehigh Valley Health Network Alumni Reception . . . . . . . . . . . . . . . . . . . . . .Fairfax B (3rd Floor – Sheraton)
7:00 – 9:00 pm
Cleveland Clinic Annual Alumni Reception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Back Bay Ballroom Salon A
(2nd Floor – Sheraton)
7:00 – 9:00 pm
Icahn School of Medicine at Mount Sinai Division of
Colon & Rectal Surgery Alumni Reception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Café Apropos (Sheraton)
7:00 – 9:00 pm
Washington University Colon & Rectal Surgery Fellowship
Alumni Reception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Gardner (3rd Floor – Sheraton)
7:00 – 10:00 pm
Colon & Rectal Clinic of Orlando Alumni Dinner . . . . . . . . . . . . . . . . . . . . . . .Berkeley (3rd Floor – Sheraton)
6:15 am – 4:00 pm
Registration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Hall C Foyer (2nd Floor)
6:30 – 7:30 am
“Meet the Professor” Breakfasts
Tuesday, June 2
T-1
Enterocutaneous Fistulas, Anastomotic Leaks and other Catastrophes . . . . . . . . . . . . . . . . . . . .200
T-2
Modern Management of Fecal Incontinence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .202
T-3
Nonhealing Perineal Wounds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .203
T-4
Controversies: The Management of Intestinal Crohn's Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . .206
Continued next page
25
D A I LY S C H E D U L E
Monday, June 1 (continued)
Daily Schedule
All programs are held in the Hynes Convention Center unless otherwise noted.
HOURS
ROOM
Tuesday, June 2 (continued)
6:30 – 7:30 am
“Meet the Professor” Breakfasts (continued)
T-5
Pouch Problems and Solutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .207
T-6
Rectal Cancer: Difficult Cases and Controversies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .300
T-7
Colitis and Dysplasia Surveillance and Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .313
6:30 – 7:30 am
International Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .305
6:30 am – 6:00 pm
Speaker Ready Room . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .201
6:30 am – 6:00 pm
On-Going Video Display . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .210
7:30 – 9:00 am
Symposium: Anorectal Disorders: Balancing Innovation with
Conventional Wisdom . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor)
7:30 – 9:00 am
Symposium: Update on Inflammatory Bowel Disease . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
8:00 – 9:00 am
Exhibitor's Advisory Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .301
8:30 – 9:30 am
Operative Competency Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .303
9:00 – 9:30 am
Ernestine Hambrick, MD, Lectureship . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
9:00 am – 2:00 pm
Exhibit Hours . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor)
9:30 – 10:15 am
Refreshment Break in Exhibit Hall . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor)
9:30 – 10:15 am
ePoster Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor)
10:15 – 11:45 am
Symposium: Controversies in Rectal Cancer Management . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
10:15 – 11:45 am
Symposium: Ostomies: Location, Creation and Complications . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor)
10:15 – 11:45 am
Abstract Session: General Surgery Forum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom A (3rd Floor)
11:45 am – 12:15 pm Masters in Colorectal Surgery Lectureship
Honoring David J. Schoetz, Jr., MD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
12:15 – 12:45 pm
Past Presidents' and Spouses of Past Presidents' Reception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .202
12:15 – 1:30 pm
Complimentary Box Lunch in Exhibit Hall . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor)
12:15 – 1:30 pm
ePoster Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor)
12:15 – 1:30 pm
Women in Colorectal Surgery Luncheon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .304-306
12:15 – 1:30 pm
Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .205
12:15 – 1:30 pm
Regional Society Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .303
12:15 – 1:30 pm
Video Based Education Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .301
12:15 – 2:00 pm
Clinical Practice Guidelines Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200
12:15 – 2:00 pm
Fundamentals of Rectal Cancer Surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .300
12:20 – 1:30 pm
Product Theater: ConvaTec, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor)
12:45 – 1:30 pm
Past Presidents' Luncheon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .203
12:45 – 1:30 pm
Spouses of Past Presidents' Luncheon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .204
1:30 – 3:00 pm
Symposium: Anal Cancer: Prevention, Diagnosis and Treatment . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
1:30 – 3:00 pm
Abstract Session: Inflammatory Bowel Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor)
1:30 – 3:00 pm
Abstract Session: Research Forum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom A (3rd Floor)
3:00 – 4:30 pm
Symposium: Medical Legal Symposium: How to Protect Yourself . . . . . . . . . . . . . . .Ballroom BC (3rd Floor)
3:00 – 4:30 pm
Symposium: Anal Fistulas: Diagnosis, Imaging and Therapy –
Rational Approaches . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
26
Daily Schedule
All programs are held in the Hynes Convention Center unless otherwise noted.
HOURS
ROOM
4:00 – 5:00 pm
Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .201
4:30 – 5:00 pm
Refreshment Break . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium Foyer (2nd Floor)
5:00 – 6:15 pm
After Hours Debate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
6:30 – 8:00 pm
Residents' Reception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Back Bay Ballroom Salons CD
(2nd Floor – Sheraton)
7:00 – 8:30 pm
Non-CME Corporate Forum: Intuitive Surgical, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Constitution Ballroom
(2nd Floor – Sheraton)
7:00 – 8:30 pm
Non-CME Corporate Forum: Medtronic, plc . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Republic Ballroom
(2nd Floor – Sheraton)
6:15 am – 4:00 pm
Registration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Hall C Foyer (2nd Floor)
6:30 – 7:30 am
“Meet the Professor” Breakfasts
W-1
Complex Fistula . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200
W-2
Stage 4 Cancer (What to Do) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .202
W-3
Pilonidal Disease: Options and Outcomes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .203
W-4
Enhanced Recovery Pathways . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .206
W-5
Non-Operative Management of Rectal Cancer – the Right Patient . . . . . . . . . . . . . . . . . . . . . . . .207
W-6
Parastomal Hernia and Stoma Complications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .300
6:30 am – 5:00 pm
Speaker Ready Room . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .201
6:30 am – 5:00 pm
On-Going Video Display . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .210
7:30 – 9:00 am
Symposium: Colon Cancer: Staging, Techniques and the
Role of Adjuvant Therapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
7:30 – 9:00 am
Abstract Session: Outcomes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor)
9:00 – 10:30 am
ASCRS/SSAT Symposium: Challenges and Controversies:
Surgical Management of Advanced Disease and Recurrent Cancer . . . . . . . . . . . .Auditorium (2nd Floor)
9:00 – 10:30 am
Abstract Session: Video Session . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor)
10:30 – 11:00 am
Refreshment Break . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium Foyer (2nd Floor) &
Ballroom BC Foyer (3rd Floor)
Wednesday, June 3
11:00 am – 12:30 pm Symposium: Optimizing Treatment for Rectal Prolapse,
Constipation and Obstructed Defecation Syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
11:00 am – 12:30 pm Abstract Session: Neoplasia II . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor)
12:30 – 1:30 pm
Lunch Break . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .On Your Own
12:30 – 1:30 pm
Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .205
1:30 – 3:00 pm
Symposium: Enhanced Perioperative Care Pathways and
Postoperative Pain Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
3:00 – 4:30 pm
Symposium: Is there a Pardigm Shift in the Management of
Diverticular Disease? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor)
4:30 – 5:30 pm
ASCRS Annual Business Meeting and State of the Society Address . . . . . . . . . . . . . .Ballroom A (3rd Floor)
7:00 – 8:00 pm
ASCRS Annual Reception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Grand Ballroom Foyer
(2nd Floor – Sheraton)
8:00 – 10:30 pm
ASCRS Annual Dinner Dance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Grand Ballroom (2nd Floor – Sheraton)
27
D A I LY S C H E D U L E
Tuesday, June 2 (continued)
Schedule-at-a-Glance
SATURDAY, MAY 30
6:00 AM
6:15 AM
6:30 AM
6:45 AM
7:00 AM
7:15 AM
7:30 AM
7:45 AM
8:00 AM
8:15 AM
8:30 AM
8:45 AM
9:00 AM
9:15 AM
9:30 AM
9:45 AM
10:00 AM
10:15 AM
10:30 AM
10:45 AM
11:00 AM
11:15 AM
11:30 AM
11:45 AM
12:00 NOON
12:15 PM
12:30 PM
12:45 PM
1:00 PM
1:15 PM
1:30 PM
1:45 PM
2:00 PM
2:15 PM
2:30 PM
2:45 PM
3:00 PM
3:15 PM
3:30 PM
3:45 PM
4:00 PM
4:15 PM
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
5:45 PM
6:00 PM
6:15 PM
6:30 PM
6:45 PM
7:00 PM
7:15 PM
7:30 PM
7:45 PM
8:00 PM
8:15 PM
8:30 PM
8:45 PM
9:00 PM
9:15 PM
9:30 PM
9:45 PM
10:00 PM
Laparoscopic
Colectomy
Symposium
and
Workshop
(Didactic)
7:30 – 11:45 AM
Optimal
Management
of Fecal
Incontinence
Symposium
and Workshop
(Didactic)
AIN and HRA:
What the
Colorectal
Surgeon
Needs to Know
Workshop
7:00 AM – 12:30 PM
7:30 AM – NOON
Transanal
Endoscopic
Surgery
Workshop
Robotic Colon
and Rectal
Surgery: Tips,
Tricks, and
Simulation
Symposium
and Workshop
7:00 AM – 4:30 PM
8:00 AM – 4:30 PM
SYMPOSIUM:
Laparoscopic
Hands-on-Lab
(Off-site)
1:00 – 4:30 PM
Advanced
Endoscopy and
Endoluminal
Surgery
Optimal
Management
of Fecal
Incontinence
Hands-on-Lab
(Off-site)
Question
Writing
Workshop
12:30 – 3:30 PM
12:30 – 4:00 PM
1:00 – 4:30 PM
SYMPOSIUM:
Improving OutcomesIdentifying and Managing the
Complex Surgical Patients
4:00 – 5:30 PM
28
6:00 AM
6:15 AM
6:30 AM
6:45 AM
7:00 AM
7:15 AM
7:30 AM
7:45 AM
8:00 AM
8:15 AM
8:30 AM
8:45 AM
9:00 AM
9:15 AM
9:30 AM
9:45 AM
10:00 AM
10:15 AM
10:30 AM
10:45 AM
11:00 AM
11:15 AM
11:30 AM
11:45 AM
12:00 NOON
12:15 PM
12:30 PM
12:45 PM
1:00 PM
1:15 PM
1:30 PM
1:45 PM
2:00 PM
2:15 PM
2:30 PM
2:45 PM
3:00 PM
3:15 PM
3:30 PM
3:45 PM
4:00 PM
4:15 PM
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
5:45 PM
6:00 PM
6:15 PM
6:30 PM
6:45 PM
7:00 PM
7:15 PM
7:30 PM
7:45 PM
8:00 PM
8:15 PM
8:30 PM
8:45 PM
9:00 PM
9:15 PM
9:30 PM
9:45 PM
10:00 PM
Schedule-at-a-Glance
MONDAY, JUNE 1
Meet the
Professor Breakfasts
Residents’
Breakfast
6:00 – 7:00 AM
6:00 – 7:00 AM
SYMPOSIUM:
Core
Subject
Update
Rectal Cancer:
Optimizing Outcomes
through Techniques
SYMPOSIUM:
8:00 – 9:45 AM
SYMPOSIUM:
SYMPOSIUM:
Complications:
Prevention and
Management
9:30 – 11:45 AM
9:45 – 11:45 AM
SYMPOSIUM:
11:45 AM – 1:15 PM
9:00 – 11:00 AM
LUNCHEON SYMPOSIUM:
LUNCHEON SYMPOSIUM:
Current Advances in
the Management of
Fecal Incontinence
Memorial Lectureship Honoring John M. MacKeigan, MD
9:15 – 9:45 AM
Quality
Initiatives in
Clinical Practice
Laparoscopic
Nuts and Bolts
and Robotic
Rivets
7:00 AM – 9:15 PM
7:00 – 9:15 AM
Healthcare
Economics
in the ACA Era
7:15 – 9:30 AM
SYMPOSIUM:
Robotic Colorectal Surgery
The Genetics of
Colorectal
Cancer and Cancer
Related Syndromes
Presidential Address
9:45 – 10:15 AM
Refreshment Break and ePoster Presentations in Exhibit Hall
10:15 – 11:00 AM
SYMPOSIUM:
Navigating a Career Path in
Colon and Rectal Surgery –
Orchestrating and Optimizing
Career Transitions at All Levels
ABSTRACT SESSION:
Benign Colonic Disease
11:00 AM – 12:30 PM
11:00 AM – 12:30 PM
Complimentary Box Lunch and
ePoster Presentations in Exhibit Hall
11:45 AM – 1:15 PM
12:30 – 1:30 PM
Welcome and Opening Announcements
1:15 – 2:00 PM
SYMPOSIUM:
Technical
Pearls –
How it’s
Really Done
ABSTRACT SESSION:
SYMPOSIUM:
ABSTRACT SESSION:
Past Presidents’ Panel:
Controversies and Cases
Pelvice Floor/
Anorectal
1:30 – 3:00 PM
1:30 – 3:00 PM
Neoplasia I
2:00 – 3:30 PM
Harry E. Bacon, MD, Lectureship
3:00 – 3:30 PM
2:00 – 4:00 PM
Ice Cream & Refreshment Break
and ePoster Presentations in Exhibit Hall
Refreshment Break and
ePoster Presentations in Exhibit Hall
3:30 – 4:15 PM
Parviz Kamangar Humanities in Surgery Lectureship
4:00 – 4:45 PM
4:15 – 4:45 PM
Norman D. Nigro, MD, Research Lectureship
The Trials and Tribulations of Clinical Research: Why Johnny Can’t Add
4:45 – 5:15 PM
4:45 – 5:15 PM
International Scholarship Recipient Presentation
After Hours Debate
5:15 – 6:30 PM
New Technologies
Symposium
5:20 – 6:45 PM
Welcome Reception
7:00 – 8:30 PM
29
5:15 – 5:20 PM
6:00 AM
6:15 AM
6:30 AM
6:45 AM
7:00 AM
7:15 AM
7:30 AM
7:45 AM
8:00 AM
8:15 AM
8:30 AM
8:45 AM
9:00 AM
9:15 AM
9:30 AM
9:45 AM
10:00 AM
10:15 AM
10:30 AM
10:45 AM
11:00 AM
11:15 AM
11:30 AM
11:45 AM
12:00 NOON
12:15 PM
12:30 PM
12:45 PM
1:00 PM
1:15 PM
1:30 PM
1:45 PM
2:00 PM
2:15 PM
2:30 PM
2:45 PM
3:00 PM
3:15 PM
3:30 PM
3:45 PM
4:00 PM
4:15 PM
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
5:45 PM
6:00 PM
6:15 PM
6:30 PM
6:45 PM
7:00 PM
7:15 PM
7:30 PM
7:45 PM
8:00 PM
8:15 PM
8:30 PM
8:45 PM
9:00 PM
9:15 PM
9:30 PM
9:45 PM
10:00 PM
D A I LY S C H E D U L E
SUNDAY, MAY 31
6:00 AM
6:15 AM
6:30 AM
6:45 AM
7:00 AM
7:15 AM
7:30 AM
7:45 AM
8:00 AM
8:15 AM
8:30 AM
8:45 AM
9:00 AM
9:15 AM
9:30 AM
9:45 AM
10:00 AM
10:15 AM
10:30 AM
10:45 AM
11:00 AM
11:15 AM
11:30 AM
11:45 AM
12:00 NOON
12:15 PM
12:30 PM
12:45 PM
1:00 PM
1:15 PM
1:30 PM
1:45 PM
2:00 PM
2:15 PM
2:30 PM
2:45 PM
3:00 PM
3:15 PM
3:30 PM
3:45 PM
4:00 PM
4:15 PM
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
5:45 PM
6:00 PM
6:15 PM
6:30 PM
6:45 PM
7:00 PM
7:15 PM
7:30 PM
7:45 PM
8:00 PM
8:15 PM
8:30 PM
8:45 PM
9:00 PM
9:15 PM
9:30 PM
9:45 PM
10:00 PM
Schedule at a Glance
TUESDAY, JUNE 2
6:00 AM
6:15 AM
6:30 AM
6:45 AM
7:00 AM
7:15 AM
7:30 AM
7:45 AM
8:00 AM
8:15 AM
8:30 AM
8:45 AM
9:00 AM
9:15 AM
9:30 AM
9:45 AM
10:00 AM
10:15 AM
10:30 AM
10:45 AM
11:00 AM
11:15 AM
11:30 AM
11:45 AM
12:00 NOON
12:15 PM
12:30 PM
12:45 PM
1:00 PM
1:15 PM
1:30 PM
1:45 PM
2:00 PM
2:15 PM
2:30 PM
2:45 PM
3:00 PM
3:15 PM
3:30 PM
3:45 PM
4:00 PM
4:15 PM
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
5:45 PM
6:00 PM
6:15 PM
6:30 PM
6:45 PM
7:00 PM
7:15 PM
7:30 PM
7:45 PM
8:00 PM
8:15 PM
8:30 PM
8:45 PM
9:00 PM
9:15 PM
9:30 PM
9:45 PM
10:00 PM
WEDNESDAY, JUNE 3
Meet the
Professor Breakfasts
Meet the
Professor Breakfasts
6:30 – 7:30 AM
6:30 – 7:30 AM
SYMPOSIUM:
SYMPOSIUM:
SYMPOSIUM:
Anorectal Disorders:
Balancing Innovation with
Conventional Wisdom
Update on
Inflammatory
Bowel Disease
Colon Cancer:
Staging, Techniques and the
Role of Adjuvant Therapy
7:30 – 9:00 AM
7:30 – 9:00 AM
7:30 – 9:00 AM
Ernestine Hambrick, MD, Lectureship
ASCRS/SSAT SYMPOSIUM:
9:00 – 9:30 AM
Challenges and Controversies:
Surgical Management of
Advanced Disease and
Recurrent Cancer
Refreshment Break and
ePoster Presentations in Exhibit Hall
9:30 – 10:15 AM
7:30 – 9:00 AM
ABSTRACT SESSION:
Video Session
9:00 – 10:30 AM
9:00 – 10:30 AM
SYMPOSIUM:
SYMPOSIUM:
ABSTRACT SESSION:
Outcomes
Ostomies:
Controversies in
Location,
Rectal Cancer
Creation and
Management
Complications
10:15 – 11:45 AM
Refreshment Break in Foyer
ABSTRACT SESSION:
General
Surgery Forum
10:15 – 11:45 AM
10:15 – 11:45 AM
Masters in Colorectal Surgery Lectureship
11:45 AM – 12:15 PM
Honoring David Schoetz, Jr., MD
Women in
Complimentary Box Lunch
Colorectal
and ePoster Presentations
Surgery
in the Exhibit Hall
Luncheon
12:15 – 1:30 PM
10:30 – 11:00 AM
SYMPOSIUM:
Optimizing Treatment for
Rectal Prolapse, Constipation
and Obstructed
Defecation Syndrome
ABSTRACT SESSION:
Neoplasia II
11:00 AM – 12:30 PM
11:00 AM – 12:30 PM
Lunch on own
12:30 – 1:30 PM
12:15– 1:30 PM
SYMPOSIUM:
Anal Cancer:
Prevention,
Diagnosis and
Treatment
ABSTRACT SESSION:
ABSTRACT SESSION:
Inflammatory
Bowel Disease
Research
Forum
1:30 – 3:00 PM
1:30 – 3:00 PM
SYMPOSIUM:
Enhanced Perioperative Care
Pathways and Postoperative
Pain Management
1:30 – 3:00 PM
1:30 – 3:00 PM
SYMPOSIUM:
Medical Legal
Symposium:
How to Protect
Yourself
SYMPOSIUM:
SYMPOSIUM:
Anal Fistulas: Diagnosis,
Imaging and Therapy –
Rational Approaches
Is there a Paradigm Shift in
the Management of
Diverticular Disease?
3:00 – 4:30 PM
3:00 – 4:30 PM
3:00 – 4:30 PM
Refreshment Break in Foyer
4:30 – 5:00 PM
ASCRS Annual Business Meeting and
State of the Society Address
4:30 – 5:30 PM
After Hours Debate
5:00 – 6:15 PM
Residents’ Reception
6:30 – 8:00 PM
ASCRS Annual Reception
and Dinner Dance
Reception:
7:00 – 8:00 PM
Dinner Dance:
8:00 – 10:30 PM
30
6:00 AM
6:15 AM
6:30 AM
6:45 AM
7:00 AM
7:15 AM
7:30 AM
7:45 AM
8:00 AM
8:15 AM
8:30 AM
8:45 AM
9:00 AM
9:15 AM
9:30 AM
9:45 AM
10:00 AM
10:15 AM
10:30 AM
10:45 AM
11:00 AM
11:15 AM
11:30 AM
11:45 AM
12:00 NOON
12:15 PM
12:30 PM
12:45 PM
1:00 PM
1:15 PM
1:30 PM
1:45 PM
2:00 PM
2:15 PM
2:30 PM
2:45 PM
3:00 PM
3:15 PM
3:30 PM
3:45 PM
4:00 PM
4:15 PM
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
5:45 PM
6:00 PM
6:15 PM
6:30 PM
6:45 PM
7:00 PM
7:15 PM
7:30 PM
7:45 PM
8:00 PM
8:15 PM
8:30 PM
8:45 PM
9:00 PM
9:15 PM
9:30 PM
9:45 PM
10:00 PM
ASCRS and Research Foundation Committee Meetings
HOURS
ROOM
Saturday
8:00 am – noon
5:30 – 6:30 pm
Executive Council Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Fairfax (3rd Flr – Sheraton)
Self-Assessment Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 300
7:00 – 8:00 am
7:00 – 8:00 am
7:00 – 9:00 am
8:00 – 10:00 am
8:30 – 9:30 am
9:00 – 11:00 am
11:00 am –12:30 pm
11:30 am –12:30 pm
11:45 am – 1:00 pm
Noon – 1:00 pm
Noon – 1:00 pm
Noon – 1:00 pm
5:30 – 6:30 pm
CREST Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 300
Quality Assessment Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 203
Research Foundation Board of Trustees Meeting . . . . . . . . . . . . .Fairfax (3rd Flr – Sheraton)
New Technologies Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 200
Professional Outreach Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 202
Research Foundation Research Committee . . . . . . . . . . . . . . . . .Gardner (3rd Flr – Sheraton)
DC&R Editorial Board Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 300
Residents Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 202
Research Foundation Fundraising Assistance Committee . . . . . . . . . . . . . . . . . . . . .Room 203
Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 205
Continuing Education Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 200
Membership Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 206
International Council of Coloproctology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 310
Monday
6:00 – 7:00 am
8:00 – 9:00 am
11:30 am – 12:30 pm
12:30 – 1:30 pm
12:30 – 1:30 pm
12:30 – 1:30 pm
2:00 – 3:30 pm
4:00 – 5:00 pm
5:30 – 6:30 pm
History of ASCRS Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 301
Rectal Cancer Coodinating Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 303
Social Media Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 303
Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 205
Website Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 300
Young Surgeons Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 301
Public Relations Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 200
Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 205
Healthcare Economics Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 200
Tuesday
6:30 – 7:30 am
8:00 – 9:00 am
8:30 – 9:30 am
12:15 – 1:30 pm
12:15 – 1:30 pm
12:15 – 1:30 pm
12:15 – 2:00 pm
12:15 – 2:00 pm
1:30 – 3:30 pm
4:00 – 5:00 pm
International Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 305
Exhibitor’s Advisory Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 301
Operative Competency Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 303
Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 205
Regional Society Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 303
Video Based Education Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 301
Clinical Practice Guidelines Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 200
Fundamentals of Rectal Cancer Surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 300
Research Foundation Young Researchers Committee . . . . . . . . . . . . . . . .Ballroom A (3rd Flr)
Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 205
Wednesday
12:30 – 1:30 pm
Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 205
31
D A I LY S C H E D U L E
Sunday
ASCRS Past Presidents
*1978-1979 Donald M. Gallagher
*1899-1900 Joseph M. Mathews
*1938-1939 Dudley Smith
*1900-1901 James P. Tuttle
*1939-1940 Martin S. Kleckner
*1901-1902 Thomas C. Martin
*1940-1941 Clement J. Debere
*1902-1903 Samuel T. Earle
*1941-1942 Frederick B. Campbell
*1903-1904 William M. Beach
*1942-1944 Homer I. Silvers
*1904-1905 J. Rawson Pennington
*1944-1946 William H. Daniel
1983-1984 Stanley M. Goldberg
*1905-1906 Lewis H. Adler, Jr.
*1946-1947 Joseph W. Ricketts
*1984-1985 A.W. Martin Marino, Jr.
*1906-1907 Samuel G. Gant
*1947-1948 George H. Thiele
*1907-1908 A. Bennett Cooke
*1948-1949 Harry E. Bacon
*1986-1987 H. Whitney Boggs, Jr.
*1908-1909 George B. Evans
*1949-1950 Louis E. Moon
1987-1988 Frank J. Theuerkauf
*1909-1910 Dwight H. Murray
*1950-1951 Hoyt R. Allen
1988-1989 Herand Abcarian
*1910-1911 George J. Cooke
*1951-1952 Robert A. Scarborough
*1911-1912 John L. Jelks
*1952-1953 Newton D. Smith
1990-1991 Peter A. Volpe
*1912-1913 Louis J. Hirschman
*1953-1954 W. Wendell Green
1991-1992 Robert W. Beart, Jr.
*1913-1914 Joseph M. Mathews
*1954-1955 A.W. Martin Marino, Sr.
1992-1993 W. Patrick Mazier
*1914-1915 Louis J. Krause
*1955-1956 Stuart T. Ross
1993-1994 Samuel B. Labow
*1915-1916 T. Chittenden Hill
*1956-1957 Rufus C. Alley
1994-1995 Philip H. Gordon
*1916-1917 Alfred J. Zobel
*1957-1958 Julius E. Linn
1995-1996 Victor W. Fazio
*1917-1919 Jerome M. Lynch
*1958-1959 Karl Zimmerman
1996-1997 David A. Rothenberger
*1919-1920 Collier F. Martin
*1959-1960 Hyrum R. Reichman
1997-1998 Ira J. Kodner
*1920-1921 Alois B. Graham
*1960-1961 Walter A. Fansler
1998-1999 Lee E. Smith
*1921-1922 Granville S. Hanes
*1961-1962 Merrill O. Hines
1999-2000 H. Randolph Bailey
*1922-1923 Emmett H. Terrell
*1962-1963 Robert J. Rowe
* 2000-2001 John M. MacKeigan
*1923-1924 Ralph W. Jackson
*1963-1964 Robert A. Scarborough
2001-2002 Robert D. Fry
*1924-1925 Frank C. Yeomans
*1964-1965 Garnet W. Ault
2002-2003 Richard P. Billingham
*1925-1926 Descum C. McKenney
*1965-1966 Norman D. Nigro
2003-2004 David J. Schoetz, Jr.
*1926-1927 William H. Kiger
*1966-1967 Maus W. Stearns, Jr.
2004-2005 Bruce G. Wolff
*1927-1928 Louis A. Buie
*1967-1968 Raymond J. Jackman
2005-2006 Ann C. Lowry
*1928-1929 Edward G. Martin
*1968-1969 Neil W. Swinton
2006-2007 Lester Rosen
*1929-1930 Walter A. Fansler
*1969-1970 James A. Ferguson
*1930-1931 Dudley Smith
*1970-1971 Walter Birnbaum
2008-2009 Anthony J. Senagore
*1931-1932 W. Oakley Hermance
*1971-1972 Andrew Jack McAdams
2009-2010 James W. Fleshman
*1932-1933 Curtice Rosser
*1972-1973 John E. Ray
2010-2011 David E. Beck
*1933-1934 Curtis C. Mechling
*1973-1974 John H. Remington
2011-2012 Steven D. Wexner
*1934-1935 Louis A. Buie
*1974-1975 Rupert B. Turnbull
2012-2013 Alan G. Thorson
*1935-1936 Frank G. Runyeon
*1975-1976 Patrick H. Hanley
2013-2014 Michael J. Stamos
*1936-1937 Marion C. Pruitt
*1976-1977 John R. Hill
*1937-1938 Harry Z. Hibshman
*1977-1978 Alejandro F. Castro
*Deceased
32
1979-1980 Stuart H.Q. Quan
*1980-1981 Malcolm C. Veidenheimer
1981-1982 Bertram A. Portin
*1982-1983 Eugene S. Sullivan
1985-1986 Eugene P. Salvati
*1989-1990 J. Byron Gathright, Jr.
* 2007-2008 W. Douglas Wong
Saturday, May 30
UT
SOLD O
Transanal Endoscopic Surgery Workshop
1
2
6
8.5
CME
7:00 am – 4:30 pm
Room 200
Fee: $495 • Limit: 48 participants • Lunch Included • Registration Required
Didactic Session: 7:00 – 8:25 am
Transanal excision of tumors of the rectum has been limited by the technical difficulties of operating in a confined space
with inadequate instrumentation. Access to lesions higher than 6 cm from the anal verge is not feasible with standard
transanal techniques. Transanal endoscopic microsurgery (TEM) was designed to overcome these limitations and has proven
to be an invaluable endoscopic tool in treating rectal lesions which might otherwise require proctectomy. Over the last
several years, the armamentarium of transanal approach has increased with the development of two new platforms,
Transanal Endoscopic Operations (TEO) and Transanal Minimally Invasive Surgery (TAMIS). These platforms offer other
options for advanced transanal surgery.
Radical resection of the rectum for benign and malignant neoplasms is associated with rates of perioperative complications
and functional disorders that largely exceed the morbidity associated with other types of bowel resections. This has led
surgeons to attempt less invasive surgical alternatives including transanal excision and traditional endoscopic approaches.
Standard transanal excisional techniques are limited by instrumentation and anatomy to the distal 6-12 cm of the rectum
and are associated with substantial recurrence rates for benign and malignant disease. In the early 1980’s, transanal
endoscopic microsurgery (TEM) was described. In the past decade, its acceptance has increased and several authors have
demonstrated decreased recurrence rates for benign and early stage malignant neoplasms when compared to standard
transanal excision. Morbidity for TEM has been low and similar to transanal excision. With the recent introduction of new
devices (TEO, TAMIS/SILS) to perform transanal endoscopic resections, surgeons now have more flexibility in terms of
equipment and operative setup. Surgeons experienced in transanal endoscopic surgery (TES) have learned valuable lessons
in patient selection, operative setup, technical pearls and troubleshooting, and postoperative management that can
accelerate learning for those interested in adopting this technique.
Existing Gaps
What Is: Despite increased acceptance of TES and reported decreased rates of recurrence compared to standard transanal
excision, many colorectal surgeons have not adopted TES into their practices.
What Should Be: Comprehensive review of indications for transanal endoscopic microsurgery and of all devices currently
available, and hands-on practice in an inanimate lab training session under the guidance of experts, will allow for more
surgeons to adopt TES and offer it to patients as an alternative to radical resection when clinically indicated.
Objectives: At the conclusion of this session, participants should be able to: a) Recognize the surgical
indications and preoperative preparation for TES; b) Recall the operative set up, transanal devices and
equipment currently used to perform TES; c) Demonstrate how to troubleshoot technical difficulties during
TES; d) Explain intraoperative complications and postoperative management of patients undergoing TES;
e) Demonstrate the technical skills necessary to perform TES and become familiar with all the available transanal
devices; f ) Chart how to bill appropriately for the various TES techniques; g) Describe the requirements
necessary to start a TES program at their institution.
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
33
Continued next page
S AT U R D AY
Supported by independent educational grants and loaned durable equipment from:
Applied Medical
KARL STORZ Endoscopy-America, Inc.
Medtronic & Covidien
Richard Wolf Medical Instruments Corporation
Stryker Endoscopy
Saturday, May 30
Transanal Endoscopic Surgery Workshop (Continued)
Room 200
Co-Director: Peter Cataldo, MD, Burlington, VT
Co-Director: Joshua Bleier, MD, Philadelphia, PA
7:00 am
Introduction to TES: Past and Present
Peter Cataldo, MD, Burlington, VT
7:05 am
7:20 am
7:35 am
7:50 am
Indications for TES, Patient Selection
Dana Sands, MD, Weston, FL
Excision and Suturing Techniques (all
platforms)
Peter Cataldo, MD, Burlington, VT
8:05 am
Oncology Results
Joshua Bleier, MD, Philadelphia, PA
Complications
Scott Steele, MD, Fort Lewis, WA
8:25 am
Break into Groups
Setup and Positioning (all platforms)
Theodore Saclarides, MD, Maywood, IL
Group A – Hands-on Lab
Group B – TES Panel Discussion with Videos
8:30 am – noon
Rooms 202, 203, 204, 206
8:30 am – noon
Room 200
Peter Cataldo, MD, Lab Director
Joshua Bleier, MD, Workshop Director
TEO (Room 203)
Skandan Shanmugan, MD, Philadelphia, PA; Patricia Sylla,
MD, New York, NY; Brian Valerian, MD, Albany, NY
Panel: Liliana Bordeianou, MD, Boston, MA; Rodrigo Perez,
MD, Sao Paulo, Brazil; Theodore Saclarides, MD,
Maywood, IL; Mark Whiteford, MD, Portland, OR
TEM (Room 202)
Traci Hedrick, MD, Charlottesville, VA; Dana Sands, MD,
Weston, FL; Elizabeth Raskin, St. Paul, MN
Participants are welcome to bring questions and difficult
cases to the panel.
Noon
Lunch (Room 200)
SILS (Room 206)
Eric Haas, MD, Houston, TX; Jaime Sanchez, MD, Tampa, FL;
Scott Steele, MD, Fort Lewis, WA
TAMIS (Room 204)
Sergio Larach, MD, Orlando, FL; Elisabeth McLemore, MD,
Los Angeles, CA; Theodoros Voloyiannis, MD, Houston, TX
Noon
Lunch (Room 200)
Continued next page
34
Saturday, May 30
Transanal Endoscopic Surgery Workshop (Continued)
Group A – TES Panel Discussion with Videos
Group B – Hands-on Lab
1:00 – 4:30 pm
Room 200
1:00 – 4:30 pm
Rooms 202, 203, 204, 206
Joshua Bleier, MD, Workshop Director
Peter Cataldo, MD, Lab Director
Panel: Charles Finne, MD, Minneapolis, MN; Jorge Marcet,
MD, Tampa, FL; Bruce Orkin, MD, Chicago, IL;
Theodore Saclarides, MD, Maywood, IL; Mark
Whiteford, MD, Portland, OR
TEO (Room 203)
Elisabeth McLemore, MD, Los Angeles, CA; Patricia Sylla,
MD, New York, NY; Brian Valerian, MD, Albany, NY
TEM (Room 202)
Traci Hedrick, MD, Charlottesville, VA; Dana Sands, MD,
Weston, FL; Elizabeth Raskin, St. Paul, MN
Participants are welcome to bring questions and difficult
cases to the panel.
Adjourn
SILS (Room 206)
Eric Haas, MD, Houston, TX; Jaime Sanchez, MD, Tampa, FL;
Scott Steele, MD, Fort Lewis, WA
TAMIS (Room 204)
Sergio Larach, MD, Orlando, FL; Theodoros Voloyiannis, MD,
Houston, TX
4:30 pm
35
Adjourn
S AT U R D AY
4:30 pm
Saturday, May 30
UT
SOLD O
AIN and HRA: What the Colorectal Surgeon
Needs to Know Workshop
1
2
4
6
5.25
CME
7:00 am – 12:30 pm
Rooms 311, 312, 313
Fee: $495 • Limit: 45 participants • Registration Required
Supported by independent educational grants consisting of loaned durable equipment from:
Carl Zeiss Meditec
CONMED
CooperSurgical
Redfield Corporation
Seiler Instrument & Manufacturing Co, Inc.
Zinnanti Surgical Design Group Inc.
The incidence of anal cancer is increasing due to rising rates of human papilloma virus (HPV) infection. HPV infection can
lead to anal intraepithelial neoplasia (AIN) that can be identified with high-resolution anoscopy (HRA). While colon and
rectal surgeons are very familiar with the evaluation and treatment of anal cancer, many do not know how to identify the
anal cancer precursor, AIN, with HRA.
Through a didactic and hands-on educational initiative, we will review HPV infections and the indications and use
of HRA for AIN. The participants will be divided into three groups and will have rotations between didactic, hands-on and
video sessions.
Existing Gaps
What Is: While colon and rectal surgeons understand the evaluation and treatment of anal cancer, many are not skilled at
the evaluation and treatment of AIN and use of HRA.
What Should Be: Colon and rectal surgeons should have a thorough understanding of AIN. In addition, colon and rectal
surgeons should have an understanding of how to use HRA to evaluate and treat AIN. Finally, surgeons should know all the
treatment options available for patients with AIN.
Director: Stephen Goldstone, MD, New York, NY
Assistant Director: Naomi Jay, NP, PhD, San Francisco, CA
Room 311
7:00 am
Welcome
Stephen Goldstone, MD, New York, NY
7:05 am
Intro to HPV: Scope of the Problem
Joel Palefsky, MD, San Francisco, CA
7:20 am
How to Diagnose AIN: Screening and
Diagnostics
J. Michael Berry-Lawhorn, MD, San Francisco, CA
Naomi Jay, NP, PhD, San Francisco, CA
7:40 am
HRA Findings of AIN
Naomi Jay, NP, PhD, San Francisco, CA
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
36
8:00 am
HRA Guided Treatment Options
Stephen Goldstone, MD, New York, NY
Joel Palefsky, MD, San Francisco, CA
8:40 am
Panel Discussion/Questions
J. Michael Berry-Lawhorn, MD, San Francisco, CA
Stephen Goldstone, MD, New York, NY
Naomi Jay, NP, PhD, San Francisco, CA
Joel Palefsky, MD, San Francisco, CA
Continued next page
Saturday, May 30
AIN and HRA: What the Colorectal Surgeon
Needs to Know Workshop (continued)
9:00 am
9:30 am
Group 2
Lesion Identification (understanding lesion
patterns to differentiate LG from HG)
(Room 311)
Naomi Jay, NP, PhD, San Francisco, CA
Hands-on Workshop: HRA Including Use of the
Colposcope and Biopsy Techniques (Room 312)
J. Michael Berry-Lawhorn, MD, San Francisco, CA
Stephen Goldstone, MD, New York, NY
9:00 am
HRA the Movie (Room 313)
Joel Palefsky, MD, San Francisco, CA
9:30 am
Lesion Identification (understanding lesion
patterns to differentiate LG from HG)
(Room 311)
Naomi Jay, NP, PhD, San Francisco, CA
10:00 am HRA the Movie (Room 313)
Joel Palefsky, MD, San Francisco, CA
10:00 am Hands-on Workshop: HRA Including Use of the
Colposcope and Biopsy Techniques (Room 312)
J. Michael Berry-Lawhorn, MD, San Francisco, CA
Stephen Goldstone, MD, New York, NY
10:30 am Refreshment Break in Foyer
10:30 am Refreshment Break in Foyer
10:45 am IRC and Hyfrecator Movie (Room 313)
Stephen Goldstone, MD, New York, NY
10:45 am Cases: Identifying Lesions, Determining Sites
for Biopsies (Room 311)
J. Michael Berry-Lawhorn, MD, San Francisco, CA
11:15 am Hands-on Workshop: HRA Treatment
(Room 312)
Naomi Jay, NP, PhD, San Francisco, CA
Joel Palefsky, MD, San Francisco, CA
11:15 am IRC and Hyfrecator Movie (Room 313)
Stephen Goldstone, MD, New York, NY
11:45 am Hands-on Workshop: HRA Treatment
(Room 312)
Naomi Jay, NP, PhD, San Francisco, CA
Joel Palefsky, MD, San Francisco, CA
11:45 am Cases: Identifying Lesions, Determining Sites
for Biopsies (Room 311)
J. Michael Berry-Lawhorn, MD, San Francisco, CA
Continued next page
37
S AT U R D AY
Group 1
Saturday, May 30
AIN and HRA: What the Colorectal Surgeon
Needs to Know Workshop (continued)
Group 3
9:00 am
9:30 am
Groups 1-3
Room 311
Hands-on Workshop: HRA Including Use of the
Colposcope and Biopsy Techniques (Room 312)
J. Michael Berry-Lawhorn, MD, San Francisco, CA
Stephen Goldstone, MD, New York, NY
12:15 pm Panel Discussion/Questions
J. Michael Berry-Lawhorn, MD, San Francisco, CA
Stephen Goldstone, MD, New York, NY
Naomi Jay, NP, PhD, San Francisco, CA
Joel Palefsky, MD, San Francisco, CA
HRA the Movie (Room 313)
Joel Palefsky, MD, San Francisco, CA
12:30 pm Adjourn
10:00 am Lesion Identification (understanding lesion
patterns to differentiate LG from HG)
(Room 311)
Naomi Jay, NP, PhD, San Francisco, CA
10:30 am Refreshment Break in Foyer
10:45 am Hands-on Workshop: HRA Treatment
(Room 312)
Naomi Jay, NP, PhD, San Francisco, CA
Joel Palefsky, MD, San Francisco, CA
11:15 am Cases: Identifying Lesions, Determining Sites
for Biopsies (Room 311)
J. Michael Berry-Lawhorn, MD, San Francisco, CA
11:45 am IRC and Hyfrecator Movie (Room 313)
Stephen Goldstone, MD, New York, NY
Objectives: At the conclusion of this session, participants should be able to: a) Describe the prevalence of anal
HPV infection; b) Recognize how to best diagnose AIN; c) Demonstrate how to perform high resolution
anoscopy; d) Identify treatment options available for AIN.
38
Saturday, May 30
UT
SOLD O
Laparoscopic Colectomy Symposium
and Workshop
2
4.25
MOC
4
6
*
4.25
CME
Didactic Session: 7:30 – 11:45 am
Didactic is open to all registrants (Complimentary)
Ballroom BC (3rd Floor)
Didactic Session: 7:30 – 11:45 am
The utilization of laparoscopic techniques to perform colon and rectal resections has been expanding for years,
and will continue to do so in the face of new technological developments and advancement in instrumentation. Thought
and opinion leaders continue to develop new techniques that simplify laparoscopic colorectal procedures and foster
adoption of minimally invasive approaches. In the effort to ensure the best outcomes for our patients, it is essential that
practicing colorectal surgeons have a solid grasp on key concepts for the performance of laparoscopic colorectal surgery.
The many issues often encountered when performing minimally invasive colon and rectal surgery will be addressed:
• Technical Descriptions
- Medial to lateral approach
- Lateral to medial approach
- Stapling
- Safe Energy utilization
- Hand assist colectomy
• New Technologies
- Single site
- Florescence imaging
• New Techniques
• Review of Laparoscopic and
Anatomic Principles
• Port Placement Philosophy
• Procedural Reviews
- Right colectomy
- Left colectomy
- Proctectomy
- Rectopexy
- Hartmann reversal
- Peristomal hernia repair
This symposium will address laparoscopic colectomy techniques, with an emphasis on creative and excellence in teaching
followed by a workshop that will allow for hands-on experience.
Co-Director: Amir Bastawrous, MD, Seattle, WA
Co-Director: Eric K. Johnson, MD, Fort Lewis, WA
7:30 am
Right Colectomy, the Laparoscopic
Gateway Drug
Marc Singer, MD, Chicago, IL
8:00 am
Video Presentation Medial to Lateral
Right Colectomy
Nell Maloney Patel, MD, New Brunswick, NJ
7:45 am
Video Presentation Inferior to Superior
Right Colectomy
Imran Hassan, MD, Iowa City, IA
8:15 am
Anastomotic Options
Alan Harzman, MD, Columbus, OH
8:30 am
Panel Discussion
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
39
Continued next page
S AT U R D AY
Supported by independent educational grants and loaned durable equipment from:
Applied Medical
Ethicon
KARL STORZ Endoscopy-America, Inc.
Medtronic & Covidien
Olympus Corporation of the Americas
Saturday, May 30
Laparoscopic Colectomy Symposium and Workshop (Continued)
Ballroom BC (3rd Floor)
8:45 am
Laparoscopic Left Colectomy, the
Next Challenge
Konstantin Umanskiy, MD, Chicago, IL
9:00 am
Video Presentation – Medial to Lateral
Left Colectomy
Tal Raphaeli, MD, Humble, TX
9:15 am
Video Presentation – Splenic Flexure
Approaches
John Griffin, MD, Salt Lake City, UT
9:30 am
HALS-Role and Advantages
Darren Pollock, MD, Seattle, WA
9:45 am
10:30 am Video Presentation – TME
Slawomir Marecik, MD, Park Ridge, IL
10:45 am Video Presentation – Tips for the
Difficult Pelvis
Daniel Herzig, MD, Portland, OR
11:00 am Panel Discussion
11:15 am Complications and Challenges
Eric K. Johnson, MD, Fort Lewis, WA
11:45 am Adjourn
11:45 am Lunch Provided for Hands-on Lab Participants
(Room 301)
Panel Discussion
12:30 pm Bus Departs for Tufts Medical Center from the
Lower Level of the Hynes Convention Center
10:05 am Refreshment Break in Foyer
10:15 am Laparoscopic Proctectomy and TME,
the Differentiator
Joseph Carmichael, MD, Orange, CA
Continued next page
40
Saturday, May 30
Laparoscopic Colectomy Symposium and Workshop (Continued)
UT
SOLD O
Hands-on Lab Session: 1:00 – 4:30 pm • Limit 20 • Fee: $595
Lunch Included for Hands-on Lab Registrants • Registration Required
Location for Hands-on Lab: Tufts Medical Center, 136 Harrison Avenue, Boston, MA 02111
Transportation will be provided
3.5
CME
Existing Gaps
What Is: Despite the evidence supporting improved outcomes with the use of minimally invasive techniques, adoption has
been slow. At least 50% of colectomies continue to be performed utilizing traditional open techniques. Even among
fellowship of trained colon and rectal surgeons, most do not use laparoscopy routinely in their practice. While some cases
require an open approach, many more do not. These techniques cannot be learned from a textbook.
12:30 pm – Bus departs from the Lower Level, Boylston Street entrance of the Hynes Convention Center
UT
SOLD O
1:00 – 4:30 pm (Off Site)
Hands-on Session for Lab Registrants
Tufts Medical Center, 136 Harrison Avenue, Boston, MA 02111
(Registration Required)
Demonstrate the knowledge you aquired during the morning symposium to strengthen your skills. We will begin with
laparoscopic right colectomy, then left colectomy, then low anterior resection, hand assist, and SILS.
Faculty for hands-on session includes:
Amir Bastawrous, MD, Seattle, WA; Joseph Carmichael, MD, Orange, CA; John Griffin, MD, Salt Lake City, UT;
Alan Harzman, MD, Columbus, OH; Imran Hassan, MD, Cedar Rapids, IA; Daniel Herzig, MD, Portland, OR;
Eric K. Johnson, MD, Fort Lewis, WA; Nell Maloney Patel, MD, New Brunswick, NJ; Slawomir Marecik, MD, Park Ridge, IL;
Darren Pollock, MD, Seattle, WA; Tal Raphaeli, MD, Humble, TX; Marc Singer, MD, Chicago, IL; Konstantin Umanskiy, MD,
Chicago, IL
Objectives: At the conclusion of this session, participants should be able to: a) Discuss the potential advanced
approaches to complex situations encountered during laparoscopic colorectal resection; b) Describe the
appropriate utilization of available stapling and energy technology; c) Reproduce the basic approaches to right
and left colectomy; d) Explain tips and tricks of laparoscopic rectal mobilization and e) Describe potential
advantages to the robotic approach to pelvic dissection.
41
S AT U R D AY
What Should Be: New and experienced colorectal surgeons should have access to quality educational material as well as
the opportunity to take a hands-on approach to learning the most up-to-date minimally invasive techniques for colorectal
resection. Because of the nature of many of the problems encountered, experts in several fields should be able to
personally pass on knowledge built from experience with these issues. A better understanding of basic and complex
principles will assist the surgeon in providing quality care, optimizing outcomes and ensuring future personal, practice, and
institutional revenue in a competitive market.
Saturday, May 30
Optimal Management of Fecal Incontinence
Symposium and Workshop
1
4.25
MOC
2
4
5
6
*
4.25
CME
Didactic Session: 7:30 am – noon
Ballroom A (3rd Floor)
Didactic is open to all registrants (Complimentary)
Supported by independent educational grants and loaned durable equipment from:
American Medical Systems
BK Ultrasound
LABORIE
Medtronic, plc
Salix Pharmaceuticals, Inc.
The Prometheus Group
Torax Medical, Inc.
Didactic Session: 7:30 am – noon
The prevalence of fecal incontinence is difficult to estimate as it is frequently underreported due to embarrassment
and reluctance of patients to discuss symptoms with their physicians. Patients with fecal incontinence can benefit from
specialized assessment with ultrasound, manometry, motility testing and defecography.
The surgical treatment of fecal incontinence in the United States has been limited. Sphincter repair has good short-term
results, but continence tends to deteriorate over time. The placement of an artificial bowel sphincter has a high morbidity
and revision rate. Diverting colostomy is generally a last resort. Both sacral nerve stimulation (SNS) and the injection of
bulking agents have been used for many years in the urologic field. These treatment modalities have recently become
recognized in the field of colorectal surgery for the treatment of fecal incontinence. In addition to these new procedures,
there are additional procedures being investigated such as the pelvic sling and magnetic anal sphincter.
Through a didactic course and hands-on laboratory session, we will address the workup and management of patients with
fecal incontinence including the review of both traditional as well as emerging procedures that are used to treat this
condition. The lecture portion will be followed by a workshop that will allow for hands-on experience as well as the
discussion of cases.
Existing Gaps
What Is: Anorectal and physiology testing play an important role in the assessment of patients with anorectal and pelvic
floor disorders. The accuracy of these examinations depends upon the operator’s ability to perform the exam and properly
interpret the results.
Despite the introduction of new treatment modalities into the field of colorectal surgery, many colorectal surgeons have
not adopted either procedure into their practice.
What Should Be: It is important that colorectal surgeons develop hands-on expertise in the use of anorectal ultrasound in
order to effectively manage patients with fecal incontinence.
Objectives: At the conclusion of this session, participants should be able to: a) Explain the initial assessment
and management of patients with fecal incontinence; b) Demonstrate and interpret endorectal ultrasound;
c) Identify with the interpretation of anal manometry; d) Describe and interpret defecography; e) Distinguish the
operative setup, identification of landmarks and steps for optimal lead placement in the performance of SNS;
f ) Recall the postoperative management of patients with an Interstim implant including troubleshooting
difficulties; g) Recognize when and how to inject bulking agents into the anal canal; h) Outline the clinical
results of procedures for fecal incontinence; i) Distinguish alternatives to these procedures.
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
42
Continued next page
Saturday, May 30
Optimal Management of Fecal Incontinence
Symposium and Workshop (Continued)
Co-Director: Anders Mellgren, MD, PhD, Chicago, IL
Co-Director: Kelly Garrett, MD, New York, NY
Lab Assistants: Susan Asuncion, RN, Chicago, IL; Ashley Gabion, RN, Minneapolis, MN
Mary Roen, RN, Minneapolis, MN; and Ester Trinos, NP, Chicago, IL
Introductions
Anders Mellgren, MD, PhD, Chicago, IL
Kelly Garrett, MD, New York, NY
7:40 am
Initial Assessment of Patients with Fecal
Incontinence
Joshua Bleier, MD, Philadelphia, PA
7:50 am
Ultrasound Technique and Image
Interpretation
Johan Nordenstam, MD, PhD, Chicago, IL
8:10 am
Normal Anorectal Ultrasound Anatomy
Andreas Kaiser, MD, Los Angeles, CA
8:20 am
Normal Pelvic Floor Ultrasound Anatomy
Giulio Santoro, MD, PhD, Abu Dhabi, United
Arab Emirates
8:30 am
Ultrasound in the Assessment of Patients with
Fecal Incontinence
Liliana Bordeianou, MD, Boston, MA
8:40 am
Ultrasound in the Assessment of Pelvic
Floor Disorders
Sthela Murad-Regadas, MD, PhD, Fortaleza,
Brazil
8:50 am
Radiologic Evaluation of Pelvic Floor
Amy Thorsen, MD, Minneapolis, MN
9:00 am
Anorectal Manometry Technique and
Interpretation
Sarah Vogler, MD, Minneapolis, MN
9:30 am
Non-surgical Treatment of Fecal Incontinence
Kelly Garrett, MD, New York, NY
9:40 am
9:50 am
10:00 am Injectable Bulking Agents: Clinical Results
Wilhelm Graf, MD, PhD, Uppsala, Sweden
10:10 am Sacral Nerve Stimulation: Steps of the
Procedure
Margarita Murphy, MD, Pleasant, SC
10:20 am Sacral Nerve Stimulation: Postoperative
Complications and Troubleshooting
Steven Siegel, MD, St. Paul, MN
10:30 am Sacral Nerve Stimulation: Clinical Results
Klaus Matzel, MD, Erlangen, Germany
10:40 am Refreshment Break in Foyer
11:00 am The Role of Secca in the Management of Fecal
Incontinence
Mariana Berho, MD, Hollywood, FL
11:20 am Treat the Prolapse! The Role of Ventral
Rectopexy
Andre D’Hoore, MD, PhD, Leuven, Belgium
11:30 am When to Consider an Artificial Bowel Sphincter
Shane McNevin, MD, Spokane, WA
11:40 am Emerging Therapies: Topas Sling Procedure
and Initial Results
Massarat Zutshi, MD, Cleveland, OH
11:50 am Emerging Therapies: Magnetic Anal Sphincter
and Initial Results
Paul-Antoine Lehur, MD, PhD, Nantes, France
The Role of Overlapping Sphincteroplasty
Ian Paquette, MD, Cincinnati, OH
Noon
Adjourn
Noon
Lunch Provided for Hands-on Lab Participants
(Room 207)
12:30 pm Bus Departs for Tufts Medical Center from the
Lower Level of the Hynes Convention Center
Injectable Bulking Agents: How I do It
Mitchell Bernstein, MD, New York, NY
Continued next page
43
S AT U R D AY
7:30 am
Saturday, May 30
Optimal Management of Fecal Incontinence
Symposium and Workshop (Continued)
Hands-on Lab Session: 1:00 – 4:30 pm • Limit 80 • Fee: $495
Lunch Included for Hands-on Lab Registrants • Registration Required
3.0
CME
Location for Hands-on Lab: Tufts Medical Center, 136 Harrison Avenue, Boston, MA 02111
Transportation will be provided
12:30 pm – Bus departs from the Lower Level, Boylston Street entrance of the Hynes Convention Center
Hands-on Training
1:00 – 2:40 pm
Hands-on Sessions
Groups 1-9
1:00 pm
1:15 pm
1:35 pm
SNS
Dr. Siegel
Group 1
Injectional
Therapy
Dr. Graf
Group 2
Ultrasound
Dr. Santoro
Manometry
ABS
Dr. Bordeianou
Group 3
Ultrasound
Dr. Santoro
Group 4
SNS
Dr. Paquette
Injectional
Therapy
Dr. Bernstein
Group 5
Ultrasound
Dr. Murad-Regadas
Group 7
SNS
Dr. Murphy
Injectional
Therapy
Dr. Vogler
Injectional
Therapy
Dr. Graf
SNS
Dr. Paquette
Injectional
Therapy
Dr. Bernstein
Manometry
ABS
Dr. McNevin
Ultrasound
Dr. Thorsen
SNS
Dr. Murphy
Injectional
Therapy
Dr. Vogler
2:10 pm
2:25 pm
Injectional
Therapy
Dr. Graf
Manometry
ABS
Dr. Bordeianou
Ultrasound
Dr. Santoro
Manometry
ABS
Dr. Bordeianou
Ultrasound
Dr. Murad-Regadas
Manometry
ABS
Dr. Zutshi
Ultrasound
Dr. Thorsen
Group 9
SNS
Dr. Siegel
Manometry
ABS
Dr. McNevin
Group 6
Group 8
1:50 pm
Manometry
ABS
Dr. Zutshi
SNS
Dr. Siegel
Injectional
Therapy
Dr. Bernstein
Manometry
ABS
Dr. McNevin
Ultrasound
Dr. Murad-Regadas
SNS
Dr. Paquette
Injectional
Therapy
Dr. Vogler
Manometry
ABS
Dr. Zutshi
Ultrasound
Dr. Thorsen
SNS
Dr. Murphy
Case Discussions
Groups 10-18
2:40 pm
Drs. Joshua Bleier, Kelly Garrett, Paul-Antoine Lehur, Klaus Matzel,
Anders Mellgren, Steven Siegel, Amy Thorsen, Steven Wexner
Break
Continued next page
44
Saturday, May 30
Optimal Management of Fecal Incontinence
Symposium and Workshop (Continued)
Hands-on Training
2:50 – 4:30 pm
Hands-on Sessions
2:50 pm
Injectional
Therapy
Dr. Graf
Manometry
ABS
Dr. Bordeianou
Ultrasound
Dr. Santoro
Group 13
SNS
Dr. Paquette
Injectional
Therapy
Dr. Bernstein
Ultrasound
Dr. Murad-Regadas
Group 16
SNS
Dr. Murphy
Injectional
Therapy
Dr. Vogler
Injectional
Therapy
Dr. Graf
SNS
Dr. Paquette
Injectional
Therapy
Dr. Bernstein
Manometry
ABS
Dr. McNevin
Ultrasound
Dr. Thorsen
SNS
Dr. Murphy
Injectional
Therapy
Dr. Vogler
4:00 pm
4:15 pm
Injectional
Therapy
Dr. Graf
Manometry
ABS
Dr. Bordeianou
Ultrasound
Dr. Santoro
Manometry
ABS
Dr. Bordeianou
Ultrasound
Dr. Murad-Regadas
Manometry
ABS
Dr. Zutshi
Ultrasound
Dr. Thorsen
Group 18
SNS
Dr. Siegel
Manometry
ABS
Dr. McNevin
Group 15
Group 17
3:40 pm
Ultrasound
Dr. Santoro
Group 12
Group 14
3:25 pm
SNS
Dr. Siegel
Group 10
Group 11
3:05 pm
Manometry
ABS
Dr. Zutshi
SNS
Dr. Siegel
Injectional
Therapy
Dr. Bernstein
Ultrasound
Dr. Murad-Regadas
SNS
Dr. Paquette
Injectional
Therapy
Dr. Vogler
4:30 pm
SNS
Dr. Murphy
Drs. Joshua Bleier, Kelly Garrett, Paul-Antoine Lehur, Klaus Matzel,
Anders Mellgren, Steven Siegel, Amy Thorsen, Steven Wexner
Adjourn
45
Manometry
ABS
Dr. Zutshi
Ultrasound
Dr. Thorsen
Case Discussions
Groups 1-9
Manometry
ABS
Dr. McNevin
S AT U R D AY
Groups 10-18
Saturday, May 30
UT
SOLD O
Robotic Colon and Rectal Surgery: Tips, Tricks,
and Simulation Symposium and Workshop
1
2
6
*
4.0 - 8
CME.0
Didactic Session 8:00 am – noon or 12:30 – 4:30 pm
Didactic is open to all meeting registrants (complimentary).
Rooms 302 – 304
4.0
MOC
Supported by an independent educational grant and loaned durable equipment from Intuitive Surgical, Inc.
Hands-on Lab Session: 8:00 am – noon or 12:30 – 4:30 pm • Limit 36 • Fee: $495
Lunch Included for Hands-on Lab Registrants • Registration Required
Robotic colon and rectal surgery has slowly gained interest and traction among the membership. New instruments,
technology, and techniques are constantly being added to the field. A combination of video and lectures highlighting the
new techniques and instruments will provide an opportunity for surgeons to learn about the advances in the field.
Existing Gaps
What Is: Robotic surgery has slowly gained acceptance for use in rectal cancer and in pelvic surgery, but many colon and
rectal surgeons have not adopted robotics into their practices.
What Should Be: Studies have demonstrated the effectiveness of the use of simulation combined with videos and lectures
to facilitate adoption of a new or advanced technique. The speakers will attempt to bridge the knowledge gap associated
with the implementation, use, and outcomes of robotics to educate colon and rectal surgeons on how best to use and
adopt robotics into their practice.
Co-Director: Vincent Obias, MD, Washington, DC
Co-Director: Elizabeth Raskin, MD, St. Paul, MN
Lab Assistants: Jamie Cannon, MD, Birmingham, AL; Joseph Martz, MD, New York, NY;
John Byrn, MD, Iowa City, IA; and Cesar Santiago, MD, Tampa, FL
Group A
Group B
8:00 am – noon
Didactic Lectures (complimentary)
(Rooms 302 – 304)
8:00 am – noon
Hands-on with Robotic Simulators
(Room 306)
12:30 – 4:30 pm
Hands-on with Robotic Simulators
(Room 306)
12:30 – 4:30 pm
Didactic Lectures (complimentary)
(Rooms 302 – 304)
Objectives: At the conclusion of this session, participants should be able to: a) Describe the basic techniques of
robotic port placement and docking; b) Define the anatomy of the colon, its vasculature and retroperitoneum
from a robotic perspective; c) Explain the sequence of steps necessary to perform robotic procedures safely; and
d) Identify what new technology there is concerning robotics, and how it can help their patients.
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
46
Continued next page
Saturday, May 30
Robotic Colon and Rectal Surgery: Tips, Tricks, and
Simulation Symposium and Workshop (Continued)
Group A – Didactic
Group B – Hands-on with Simulators
Ticket Required
Rooms 302-304
8:00 am – noon
Robotic Surgery – Starting Up
Jeffrey S. Cohen, MD, Marietta, GA
8:25 am
Tips in Docking the Robot and How to do Safe
Robotic Surgery
Deborah Nagle, MD, Boston, MA
8:50 am
Robotic Low Anterior Resection
John Marks, MD, Wynnewood, PA
9:15 am
Robotic Abdominoperineal Resection
George Chang, MD, Houston, TX
9:40 am
Panel Discussion
Group B – Didactic
Rooms 302-304
12:30 – 4:30 pm
12:30 pm Robotic Surgery-Starting Up
Jeffrey S. Cohen, MD, Marietta, GA
10:05 am Refreshment Break in Foyer
12:55 pm Tips in Docking the Robot and How to do Safe
Robotic Surgery
Deborah Nagle, MD, Boston, MA
10:15 am Robotic Surgery for Pelvic Floor Diseases
I. Emre Gorgun, MD, Cleveland, OH
10:30 am Robotic Multiport Right Hemicolectomy with
Intracorporeal Anastamosis
Robert Cleary, MD, Ann Arbor, MI
10:55 am Novel New Techniques in Robotics – Single
Incision, Parastomal Hernia Repair, J pouch,
Transanal Surgery
Jorge Lagares-Garcia, MD, Charleston, SC
11:20 am Robotic New Instruments: Firefly, Stapler,
Vessel Sealer, and Xi
Eduardo Parra-Davila, MD, Celebration, FL
1:20 pm
Robotic Low Anterior Resection
John Marks, MD, Wynnewood, PA
1:50 pm
Robotic Abdominoperineal Resection
George Chang, MD, Houston, TX
2:10 pm
Panel Discussion
2:20 pm
Refreshment Break in Foyer
2:30 pm
Robotic Surgery for Pelvic Floor Diseases
I. Emre Gorgun, MD, Cleveland, OH
2:55 pm
Robotic Multiport Right Hemicolectomy with
Intracorporeal Anastamosis
Robert Cleary, MD, Ann Arbor, MI
3:20 pm
Novel New Techniques in Robotics – Single
Incision, Parastomal Hernia Repair, J pouch,
Transanal Surgery
Jorge Lagares-Garcia, MD, Charleston, SC
3:45 pm
Robotic New Instruments: Firefly, Stapler,
Vessel Sealer, and Xi
Eduardo Parra-Davila, MD, Celebration, FL
4:10 pm
Panel Discussion
4:30 pm
Adjourn
11:45 am Panel Discussion
Group A – Hands-on with Simulators
Ticket Required
Room 306
Noon – Complimentary Lunch (Room 305)
12:30 – 4:30 pm
47
S AT U R D AY
8:00 am
Room 306
8:00 am – noon
Noon – Complimentary Lunch (Room 305)
Saturday, May 30
Symposium
Advanced Endoscopy and Endoluminal Surgery
1
2
5
6
*
3.5
CME
12:30 – 4:00 pm
Ballroom BC (3rd Floor)
There has been significant expansion of new techniques and instrumentations for advancement of endoscopic
procedures. These techniques broaden our ability to perform more complex procedures in much less invasive ways.
As colorectal surgeons, we are uniquely positioned to adopt these techniques and to lead in this field.
A number of new, advanced endoscopic techniques have been developed over the past few years. These techniques have
not only broadened the ability of the endoscopist to successfully scope all patients but they also allow identification and
treatment of colonic pathologies such as polyps, cancer, and inflammatory bowel disease. New endoscopic techniques have
resulted in higher cecal intubation rates and lesion identification. Enhanced imaging technology increases polyp detection.
Endoscopic clipping can control bleeding and treat colonic perforation. Colonic stenting is a non-operative means of
treating colonic obstruction and can convert a two-stage operation into a one-stage procedure. Extended submucosal
dissection and the use of both CO2 and laparoscopic assistance have allowed surgeons to resect more complex colonic
lesions without major surgery.
Existing Gaps
What Is: Colorectal surgeons may be unfamiliar with several new techniques to improve the success rate of colonoscopy as
well as imaging techniques for lesion identification. A significant number of surgeons are not performing endoscopic
submucosal resection of colorectal neoplasia or combined laparo-endoscopic resection. With the continued advances of
technology in endoluminal therapy, surgeons will need training to incorporate these methods into their practice.
What Should Be: Surgeons need to have a comprehensive understanding of the newer visualization techniques as well as
the indications and uses for endoscopic submucosal resection, colonic stenting, and endoscopic clipping. This important
learning session will provide the basis for the meaningful implementation of these newer endoluminal techniques and
improve their patients’ colorectal care.
Co-Director: Peter Marcello, MD, Burlington, MA
Co-Director: Sang Lee, MD, New York, NY
12:30 pm Introductions
Peter Marcello, MD, Burlington, MA
1:10 pm
12:35 pm Difficult Colonoscopy: Tricks and New
Techniques for Getting to the Cecum
Daniel Feingold, MD, New York, NY
Endoscopic Submucosal Dissection:
Another Perspective
I. Emre Gorgun, MD, Cleveland, OH
1:25 pm
12:45 pm Advanced Endoscopic Imaging: Polyps and
Dysplasia Detection
David Rivadeneira, MD, Woodbury, NY
The Future of ESD and Full Thickness
Endoluminal Resection with Closure
Sergey Kantsevoy, MD, PhD, Baltimore, MD
1:50 pm
Panel Discussion/Questions
2:10 pm
Combine Endoscopic Laparoscopic
Surgery (CELS)
Sang Lee, MD, New York, NY
12:55 pm Beyond Polypectomy: EMR and ESD
Richard Whelan, MD, New York, NY
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
48
Continued next page
Saturday, May 30
Advanced Endoscopy and Endoluminal Surgery (Continued)
2:25 pm
Technical Tips for Endoluminal Stenting
Maher Abbas, MD, Abu Dhabi, United
Arab Emirates
3:10 pm
Future Endoscopic Tool Box: New Tools,
Changing Paradigms?
Jeffrey Milsom, MD, New York, NY
2:40 pm
Colonic Stenting
Jeffrey Marks, MD, Cleveland, OH
3:25 pm
Panel Discussion/Questions
4:00 pm
Adjourn
2:55 pm
Endoluminal Management of Anastomotic
Complications
Govind Nandakumar, MD, New York, NY
Photo Credit: Greater Boston Convention & Visitors Bureau
S AT U R D AY
Objectives: At the conclusion of this session, participants should be able to: a) Demonstrate methods to
improve cecal intubation rates and lesion detection; b) State the available enhanced endoscopic visualization
techniques; c) Recognize the indications and uses for endoscopic submucosal resection for colorectal neoplasia;
d) Recognize the indications and technical aspects of combined laparoscopic and endoscopic resection of
colorectal neoplasia; e) Outline the indication and utility of colonic stent placement and f ) Recall all available
techniques for endoscopic closure of bowel wall.
Hynes Convention Center
49
Saturday, May 30
Question Writing Workshop:
How to Write Exam Questions
2
3
4
*
12:30 – 3:30 pm
Room 310
Limit 70 • Registration Required
2.75
CME
There are multiple areas of examination in the realm of colon and rectal surgery that require written questions to
assess knowledge. These include the certifying written exam, the recertification exam, CARSITE, and CARSEP among others.
Despite looking straightforward, it is extremely difficult to write a good exam question. Many concepts are controversial
and what is not controversial can become trivial. There are basic guidelines that help the writer and this is a skill that can be
learned and improve with practice. In recent years emphasis has been placed on how to write an acceptable exam question
and guidelines have been published by organizations such as the National Board of Medical Examiners.
Existing Gaps
What Is: Most professionals such as colon and rectal surgeons feel that it is easy to write high quality questions. However
the majority of questions that are submitted for review each year are rejected or have fundamental flaws that require
significant revisions before they can be accepted for use.
What Should Be: There should be many interested members that are able to write high quality questions that can be used
with minimal to no revisions.
Director: Tracy Hull, MD, Cleveland, OH
12:30 pm Introduction
Tracy Hull, MD, Cleveland, OH
1:45 pm
Fundamental Problems with Questions
Marcus Burnstein, MD, Toronto, ON, Canada
12:45 pm What Is a Key Concept?
Najjia Mahmoud, MD, Philadelphia, PA
2:05 pm
Refreshment Break in Foyer
2:15 pm
Let's Write Questions
3:00 pm
Questions Review
3:15 pm
Conclusion
3:30 pm
Adjourn
1:05 pm
Formatting the Stem: Tips
Shane McNevin, MD, Spokane, WA
1:25 pm
Formatting the Answers: Avoiding
Common Errors
Glenn Ault, MD, Los Angeles, CA
Objectives: At the conclusion of this session, participants should be able to: a) Identify fundamental problems
with construction of written questions; b) Explain the sequential thinking process used to write an acceptable
question and understand key concepts; c) Demonstrate how to write a stem for a question; d) Prepare a twostep question that combines diagnosis and management and format the answers in an acceptable form; and
e) Recall what happens to a question after it is submitted by a writer before it is used in a test.
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
50
Saturday, May 30
Symposium
Improving Outcomes-Identifying and
Managing the Complex Surgical Patients
1
2
4
5
6
*
1.5
CME
4:00 – 5:30 pm
Ballroom BC (3rd Floor)
1.5
MOC
In this symposium, by making use of evidence-based recommendations, each lecture will include not only
diagnostic and therapeutic guidelines, but will also provide a narrative by the presenter (where appropriate) on
his/her operative technical details and perioperative “tips and tricks” that they utilize in the management of these complex
surgical challenges. In other cases, they will lend their personal insight into situations where data may be more sparse, but
individual and collective experience is paramount to making sound decisions and thereby optimizing patient outcomes.
Furthermore, we will focus on the initial assessment of risk and intervention methods utilized to minimize perioperative
complications. The presenters will focus on expanding the audience’s understanding of the details that make these
situations challenging, while offering evidence and experience-based solutions for surgeons of all levels to better care for
these complex patients. The underlying focus will be on providing pragmatic and understandable solutions that can be
readily implemented by surgeons of varying experience to successfully treat complex colorectal problems.
Existing Gaps
What Is: Surgeons are faced with complex decisions in determining the optimal care for patients with difficult colorectal
surgery disease. Multiple options exist regarding the assessment, optimization, surgical treatment, and post-operative
management of these patients, while less is understood about what the ideal method is.
What Should Be: This symposium will be useful to colorectal, general and oncologic surgeons who are increasingly called
upon to care for patients with complex colorectal diseases. Furthermore, this symposium will be of particular interest to the
surgeons-in-training, and the general and colorectal surgeon who is often called upon to manage a variety of complications
and dilemmas that may be outside of his or her specialty or niche within colorectal surgery.
Director: Scott Steele, MD, Fort Lewis, WA
Assistant Director: Sean Langenfeld, MD, Omaha, NE
4:00 pm
Introduction
Scott Steele, MD, Fort Lewis, WA
4:03 pm
4:15 pm
4:27 pm
4:39 pm
Perioperative Risk Assessment: Who, What,
When and Why?
W. Donald Buie, MD, Calgary, AB, Canada
Functional Problems after Colorectal Surgery:
When the Surgery Goes “Great” but Problems
Arise: Now What?
Liliana Bordeianou, MD, Boston, MA
4:51 pm
The Body’s Response to Surgical Stress: What
Every Clinician Should Know
Anjali Kumar, MD, Washington, DC
Enhanced Recovery Pathways: Beyond
the Basics
Conor Delaney, MD, PhD, Cleveland, OH
5:03 pm
Cases/Panel Discussion
5:30 pm
Adjourn
Intra-operative Nightmares: The Intraoperative Consult When Things Go Wrong
Bradley Davis, MD, Cincinnati, OH
Objectives: At the conclusion of this session, participants should be able to: a) Discuss the ideal preoperative risk
assessment and how to identify high-risk patients, optimize patients and maximize outcomes; b) Describe the importance of
the body’s response to surgical stress and how to minimize the negative aspects of this natural phenomenon; c) Describe
the multimodal and surgical approach to technical failures and challenging situations that arise intra-operatively and
methods to minimize secondary complications; d) Discuss options for patients with functional problems following colorectal
surgery in the presence and absence of complications; and e) Identify the components and importance of enhanced
recovery pathways and how the outcomes extend beyond the benefits of individual element to the collective care plan.
51
S AT U R D AY
This multidisciplinary symposium will serve as a comprehensive discussion of the topics listed above with emphasis on the
pathologic assessment, surgical technique, adjuvant therapy, and genetic testing to improve outcomes.
Sunday, May 31
Core Subject Update
1
2
6
*
2.25
CME
7:15 – 9:30 am
Auditorium (2nd Floor)
The Core Subject Update was developed to assist in the education and recertification of colon and rectal surgeons.
Twenty-four core subjects have been chosen and are presented in a four-year rotating cycle. Presenters are experts on their
selected topics and present evidence-based reviews on the current diagnosis, treatment and controversies of these
diseases. Following each presentation, a brief discussion period is moderated by the course director. A written summary of
each talk is available on the ASCRS website, and questions developed from each presentation are included in the American
Board of Colon and Rectal Surgery’s recertification question bank.
Director: Justin Maykel, MD, Worcester, MA
7:15 am
Anatomy/Physiology/Complications
Todd Francone, MD, Burlington, MA
8:21 am
Crohn’s Disease
Karim Alavi, MD, Worcester, MA
7:32 am
Discussion
8:38 am
Discussion
7:37 am
STD’s
Cindy Kin, MD, Stanford, CA
8:43 am
Endoscopy/Polyps
Rebecca Hoedema, MD, Grand Rapids, MI
7:54 am
Discussion
9:00 am
Discussion
7:59 am
Constipation
Amy Thorsen, MD, Minneapolis, MN
9:05 am
Advanced Colon and Rectal Cancer
Gregory Kennedy, MD, PhD, Madison, WI
8:16 am
Discussion
9:22 am
Discussion
9:30 am
Adjourn
Objectives: At the conclusion of this session, participants should be able to a) Recognize the complications
commonly associated with colorectal surgical procedures and understand the methods of prevention and
treatment; b) Describe the common sexually transmitted diseases of the anorectum and be able to provide
comprehensive treatment plans; c) Explain the different types of constipation as well as the evaluation process and
medical and surgical treatment options; d) Demonstrate an understanding of Crohn’s disease including the
presentation, medical management and surgical options for small intestine, colon, rectal, and anal involvement;
e) Recognize the indications for endoscopic evaluation of the colon as well as endoscopic options for lesion
diagnosis and treatment; and f ) Describe the presentation, evaluation, surgical treatment and oncologic
management of advanced colon and rectal cancer.
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
52
Sunday, May 31
Symposium
Healthcare Economics in the ACA Era
3
4
5
6
*
1.75
CME
8:00 – 9:45 am
Ballroom BC (3rd Floor)
The Affordable Care and Accountability Act of 2012 (ACA) set in motion changes to the American Healthcare
system, the likes of which have never been seen before in the United States.
These changes are significantly altering the way medicine is delivered by providers, including hospitals and individual
physicians. While the primary thrust of the legislation was to increase access to healthcare for millions of Americans,
implementation of the ACA has ushered in a variety of other measures that are dramatically changing how medicine is
practiced.
Existing Gaps
What Is: The Affordable Care Act and critical elements that are related to it including value-based purchasing, ICD-10, valuebased care and the Acountable Care organization, meaningful use, and the two midnight rule.
What Should Be: Surgeons need to have an understanding about key environmental changes impacting their practice.
Understanding the ACA and critical initiatives that are creating significant change in the healthcare environment will help
to make them much more successful.
Director: James Merlino, MD, Chicago, IL
Assistant Director: David O’Brien, MD, Portland, OR
Affordable Care Act: What it Means and How
We Can Cope
Stephen Sentovich, MD, Duarte, CA
8:20 am
Moving from Volume to Value; How We will be
Paid Differently
Frank Opelka, MD, New Orleans, LA
8:30 am
Meaningful Use and its Impact on the
Physician Practice
Guy Orangio, MD, New Orleans, LA
8:40 am
ICD-10; Delayed, but Not Forgotten
David Maron, MD, Weston, FL
8:50 am
New Models of Care Delivery
Jeffrey L. Cohen, MD, Hartford, CT
9:00 am
Update on the Two Midnight Rule
W. Brian Perry, MD, San Antonio, TX
9:20 am
Discussion
9:45 am
Adjourn
S U N D AY
8:00 am
Objectives: At the conclusion of this session, participants should be able to: a) Discuss the impact of the
Affordable Care Act on providers; b) Describe and understand the importance of value-based-care delivery;
c) Recall how critical elements of the affordable care act relate to physician practice; d) Describe and understand
updates on value-based purchasing, meaningful use, ICD-10, and the two-midnight rule.
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
53
Sunday, May 31
Symposium
Quality Initiatives in Clinical Practice
1
5
6
*
9:00 – 11:00 am
Ballroom A (3rd Floor)
2.0
CME
Supported by independent educational grants from:
Applied Medical
Ethicon
Quality improvement is integral to clinical practice. Ongoing efforts to improve the quality of surgical care have
had a significant and positive impact on patient outcomes. While participation in national initiatives such as SCIP and
NSQIP is important, it is crucial that we actively use data to change quality of care within our own institutions and practices.
Existing Gaps
What Is: Although surgeons are aware of national quality initiatives, few have the tools to implement quality initiatives
within their own institution.
What Should Be: Surgeons should understand the quality improvement process, be able to implement quality initiatives
and access data to evaluate effectiveness.
Co-Director: Arden Morris, MD, Ann Arbor, MI
Co-Director: Larissa Temple, MD, New York, NY
9:00 am
Building the Systems and Culture
of Prevention
Elizabeth Wick, MD, Baltimore, MD
9:10 am
Six Sigma, Lean, Rapid Results: What Do They
All Mean?
Nancy Baxter, MD, PhD, Toronto, ON, Canada
9:20 am
Steps to a Successful Quality Improvement
Project
Robert Cima, MD, Rochester, MN
9:40 am
Measuring Success of Quality Improvement
Genevieve Melton-Meaux, MD, Minneapolis, MN
9:50 am
Leveraging IT to Improve Outcomes
Allison McCoy, PhD, New Orleans, LA
10:00 am Improving Outcomes: Decreasing Readmission
Deborah Nagle, MD, Boston, MA
10:08 am Improving Outcomes: Decreasing Length
of Stay
Julie Thacker, MD, Durham, NC
10:16 am Improving Processes: Leveraging the
Electronic Medical Record
Stefan Holubar, MD, Lebanon, NH
10:25 am Panel Discussion
11:00 am Adjourn
Objectives: At the conclusion of this session, participants should be able to: a) Identify the principals of a
culture of safety and quality improvement; b) Recognize methods used to develop quality improvement
initiatives; c) Describe the practical steps to implementing and maintaining a quality improvement project;
d) Define how to evaluate the success of a quality improvement initiative.
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
54
Sunday, May 31
Symposium
Laparoscopic Nuts & Bolts and Robotic Rivets
1
2.25
MOC
2
5
6
*
2.25
CME
9:30 – 11:45 am
Auditorium (2nd Floor)
Supported by independent educational grants from:
Applied Medical
Ethicon
Laparoscopic and robotic surgical techniques are an integral part of modern colorectal surgical practice.
The education of surgeons in these techniques occurs in a variety of settings including fellowship training, industrysponsored training programs, and professional society continuing medical education programs. In this symposium, state of
the art laparoscopic and robotic approaches to common colorectal conditions are presented by experts in the field. The
educational format will be short videos followed by question and answer sessions. The aim of this symposium is to expand
the knowledge base in the areas of laparoscopic and robotic colorectal surgery.
Existing Gaps
What Is: Laparoscopic and robotic colorectal surgical techniques are developing at a rapid pace. Continuing medical
education for surgeons in practice to learn these techniques are limited.
What Should Be: Periodic educational programs that allow practicing surgeons to learn basic and advanced laparoscopic
and robotic colorectal surgical techniques.
9:35 am
Lap Right Colectomy: Complete Mesocolic
Excision
Hermann Kessler, MD, PhD, Cleveland, OH
10:20 am Splenic Flexure: The Inside Passage, IMV
Gateway to the Lesser Sac
Armando Melani, MD, Barretos, Brazil
9:40 am
Single Incision Colectomy: Steps to Success for
the Right and Transverse Colon
Jamie Murphy, MD, London, United Kingdom
10:25 am Splenic Flexure: Give Me a Hand (HALS)
Kelly Garrett, MD, New York, NY
9:45 am
Taking Control: Clip, Seal, or Staple the
Large Vessels?
Karin Hardiman, MD, PhD, Ann Arbor, MI
10:30 am Splenic Flexure: A Robot in Your Corner
Meagan Costedio, MD, Cleveland, OH
10:35 am TME: A Hand for the Holy Planes (HALS)
Matthew Mutch, MD, St. Louis, MO
9:50 am
Laparoscopic Ileocolic Resection for Crohn’s
Disease: What to Do When It’s Really Stuck
Sanghyun Kim, MD, New York, NY
10:40 am TME: Mr. Roboto
David Etzioni, MD, Phoenix, AZ
9:55 am
Laparoscopic Hartmann’s Reversal
Armen Aboulian, MD, Cleveland, OH
10:45 am TME: Laparoscopic Cylindrical APR. Nothing
to Waist
Yi-Qian Nancy You, MD, Houston, TX
10:00 am Laparoscopic IPAA: Making the Pouch Reach
Every Time
David Larson, MD, Rochester, MN
10:50 am Panel Discussion
10:05 am Panel Discussion
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
55
Continued next page
S U N D AY
Director: Mark Whiteford, MD, Portland, OR
Assistant Director: Jon Vogel, MD, Aurora, CO
Sunday, May 31
Laparoscopic Nuts & Bolts and Robotic Rivets (Continued)
11:00 am Laparoscopic Parastomal Hernia Repair
Scott Steele, MD, Fort Lewis, WA
11:20 am Laparoscopic Rectopexy: Anterior or
Posterior Approach?
Christopher Cunningham, MBChB, Oxford,
United Kingdom
11:05 am Laparoscopic Stapling of the Low Rectum:
Maximizing the Odds of Using a Minimum of
Staple Loads
David Maron, MD, Weston, FL
11:25 am Panel Discussion
11:45 am Adjourn
11:10 am Laparoscopic Colorectal Anastomosis:
There’s an Air-Leak. Now What?
Jason Hall, MD, Burlington, MA
11:15 am Robotic Mishaps: Getting Into and Out
of Trouble
Alessio Pigazzi, MD, PhD, Orange, CA
Photo Credit: Greater Boston Convention & Visitors Bureau
Objectives: At the conclusion of this session, participants should be able to: a) Perform basic and advanced
laparoscopic and robotic colorectal surgical techniques while avoiding surgical complications; b) Identify
complications that can occur while recognizing various approaches to common and extraordinary surgical
problems; c) Describe to their patients the pros and cons of laparoscopic and robotic techniques.
The USS Constitution was nicknamed "Old Ironsides," after the War of 1812, when shots from
the British appeared to bounce off her thick oak hull as if it were made from iron.
56
Sunday, May 31
Symposium
Complications: Prevention and Management
1
2.0
MOC
2
6
*
9:45 – 11:45 am
Ballroom BC (3rd Floor)
2.0
CME
Complication prevention and management guides every aspect of our treatment paradigms. Although the
preoperative assessment is a broad, more global patient evaluation, it is comprised of many data points, including
the pathology, aspects of the particular planned procedure, the current and past health issues of the patient and
postoperative care. The challenge to the surgeon is to take this detailed evaluation and use it to optimize operative
outcomes while minimizing perioperative and postoperative morbidity. The increasing complexity of our patient’s medical
and surgical issues and the expectation for perfect outcomes makes management evermore daunting. Furthermore, the
increasing oversight of surgical outcomes, individual and institutional costs, and patient satisfaction make the prevention
and management of surgical complications crucial to the successful practice of surgery in the current era.
Existing Gaps
What Is: The increasingly complex nature of patient care and the lack of evidenced based treatment algorithms for
complications in colon and rectal surgery make management of the varied complications challenging.
What Should Be: Treatment algorithms for colorectal surgical complications should be evidence and consensus based to
allow for management that optimizes outcomes, limits costs and improves patient satisfaction.
Co-Director: John Eggenberger, MD, Ypsilanti, MI
Co-Director: Harry Reynolds, MD, Cleveland, OH
9:57 am
Locally Advanced and Recurrent Rectal
Cancers: Avoiding and Treating Complications
in the Difficult Pelvis
Heidi Nelson, MD, Rochester, MN
10:45 am Global Surgery Challenges in 2015
Rudolph Rustin, MD, Huye, Rwanda
10:57 am How Do We Prevent Perioperative
Anastomotic Complications: Surgical
Technique and/or Manipulation of the
Microbiome?
John Alverdy, MD, Chicago, IL
The Problematic Low Rectal Anastomosis:
Dealing with Stacking, Stenosis, Bleeding and
Disruption
Kirk Ludwig, MD, Milwaukee, WI
11:09 am Optimization of Patient Satisfaction Despite
Adversity: Complication Prevention and
Management in the Era of Surgical Outcome
Tracking
James Merlino, MD, Chicago, IL
10:09 am Management of the Stenotic, Bleeding,
Leaking or Fistulizing Colonic Anastomosis
Michael McGee, MD, Chicago, IL
10:21 am Understanding Perioperative Anticoagulation
with Emphasis on Novel Anticoagulants, Antiplatlet Agents, Drug Eluting Stents, and DVT
Teresa Carman, MD, Cleveland, OH
11:22 am Panel Discussion
11:45 am Adjourn
10:33 am C. Dificile Colitis: Resect, Divert, Antibiotics, or
Transplant?
Mark Manwaring, MD, Greenville, NC
Objectives: At the conclusion of this session, participants should be able to: a) Define strategies to avoid and manage
complications arising during resections of locally advanced or recurrent rectal cancers; b) Describe strategies to avoid and
treat complications of coloanal anastomoses, including stenosis, bleeding, and disruption with presacral abscess and chronic
fistula; c) Discuss management strategy in the patient with ileocolic, colocolic, or colorectal anastomotic bleeding, leak,
obstruction and fistula; d) Manage and limit complications in the urgent operation of patients on novel anticoagulation
agents, antiplatelet agents and drug eluting stents; e) Explain how gut bacteria and subsequent host pathogen interactions
may influence anastomotic healing; f ) Describe optimal prevention and management of parastomal and ventral hernias in
the colorectal surgical patient; g) Establish medical and surgical treatment algorithms for the management of difficile
infection; and h) Develop strategies of complication prevention and management that optimize patient outcomes,
expectations and the “patient experience” in an era in which, increasingly, surgeons are being measured and compared with
their peers by hospitals, third party payers and governmental agencies.
57
S U N D AY
9:45 am
Sunday, May 31
Luncheon Symposium
Parallel Session 1-A
Current Advances in the Management
of Fecal Incontinence
1
2
6
*
1.5
CME
11:45 am – 1:15 pm
Ballroom BC (3rd Floor)
Supported in part by an independent educational grant from American Medical Systems
Control of fecal material is a complex process that involves coordinated interaction of the colon, rectum, and
anus. Also, there are many aspects of fecal incontinence which include various degrees of control for gas, liquid, and
solid material. This is further complicated when there is associated urgency. Campaigns designed to make patients and
caregivers aware of the debility associated with fecal incontinence have led to more patients seeking help. Many times
patients have searched the internet and come with many questions that caregivers may not be able to address.
Existing Gaps
What Is: There are many treatments available and unclear recommendations when a treatment should be considered for
a patient.
What Should Be: Caregivers should be aware of all current treatment options and what is projected to be available in the
future. They also should be able to individualize treatment to meet the needs and symptoms of the specific patient.
Director: Tracy L. Hull, MD, Cleveland, OH
Assistant Director: Liliana Bordeianou, MD, Boston, MA
11:45 am How Do We Assess Fecal Incontinence to
Individualize Treatment Plans?
Ian Paquette, MD, Cincinnati, OH
12:25 pm What are the Options when the Primary
Surgical Options Fail (an Algorithm
for Choices)
Alex Ky, MD, New York, NY
11:55 am What About Sphincter Repair, Radiofrequency,
and the Artificial Bowel Sphincter?
Anders Mellgren, MD, PhD, Chicago, IL
12:35 pm Are Stem Cells Going to be Available Soon?
Massarat Zutshi, MD, Cleveland, OH
12:10 pm What are the Newest Treatments (Injectables
and Sacral Nerve Stimulation)?
Klaus Matzel, MD, Erlangen, Germany
12:45 pm Panel and Case Presentations
1:15 pm
Adjourn
Objectives: At the conclusion of this session, participants should be able to: a) Name acceptable treatments for
fecal incontinence; b) Recall where injectable therapy and sacral nerve stimulation fit into the treatment
options; c) Prepare an acceptable algorithm for treatment options for fecal incontinence when the primary
option fails; d) Describe the limitations of multiple treatments and alternative therapies and; e) Define the
development of stem cells for fecal incontinence treatment.
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
58
Sunday, May 31
Luncheon Symposium
Parallel Session 1-B
The Genetics of Colorectal Cancer
and Cancer Related Syndromes
1
2
3
6
*
1.5
CME
11:45 am – 1:15 pm
Rooms 302-306
1.5
MOC
Central to our understanding of colorectal cancer biology are the cellular genetic alterations that lead to the
development of cancer, whether these are related to a hereditary or acquired gene mutation. Roughly one third of
colorectal cancers have some hereditary component, and approximately 10% are related to a hereditary colorectal cancer
syndrome such as non-polyposis (Lynch syndrome and hereditary nonpolyposis colorectal cancer (HNPCC)) or polyposis
syndromes (adenomatous polyposes (like FAP and MYH-associated polyposis), hamartomatous polyposes, and serrated
polyposis). Multiple strategies have emerged to help identify these hereditary syndromes through screening and other
methods. Once the diagnosis is made, timing and extent of surgical treatment as well as the subsequent surveillance of the
patient and their families is dependent on an understanding of the implications of the outcomes of genetic testing. It is
essential that the ASCRS membership be up-to-date regarding the genetics of colorectal cancer, the means to diagnose the
most common hereditary cancer syndromes, the application of genetic knowledge to patient care, and the latest surgical
and surveillance strategies for the most common syndromes.
Existing Gaps
What Is: In their routine daily practice, clinicians do not often appreciate the relevance of understanding cancer genetics
and its impact on cancer development, and thus patients and families with hereditary cancer syndromes frequently go
unrecognized. As a result, these patients and their families are not diagnosed and therefore do not receive appropriate
treatment, surveillance, and/or genetic counseling.
What Should Be: Patients with hereditary cancer syndromes are readily identified and offered appropriate counseling and
medical and surgical therapy. Surgical strategies should also include understanding of the appropriate timing and extent of
resection as well as appropriate post-operative surveillance.
11:45 am Introduction
Paul Wise, St. Louis, MO
12:20 pm Lynch Syndrome/HNPCC: When to Operate,
How Much to Take, and Why
Molly Cone, MD, Nashville, TN
11:50 am Colorectal Cancer Genetics: Making Sense of
the Alphabet Soup
James Church, MD, Cleveland, OH
Noon
12:30 pm Hereditary Cancer Syndrome Surveillance:
You’ve Done the Colectomy, So Now What?
Craig Messick, MD, Houston, TX
Recognizing the Red Flags: Does My Patient
Have Hereditary Colorectal Cancer?
Heather Hampel, MS, LGC, Columbus, OH
12:40 pm Panel and Case Discussion
1:15 pm
Adjourn
12:10 pm Polyposis Syndromes: When to Operate, How
Much to Take, and Why
Timothy Sadiq, MD, Chapel Hill, NC
Objectives: At the conclusion of this session, participants should be able to: a) Identify the genetics of colorectal
cancer and the genetics of the various hereditary colorectal cancer syndromes; b) Describe the methods by
which patients with hereditary colorectal cancer syndromes might be identified in a surgical practice, including
screening methods to diagnose the most common syndrome(s); c) Define the appropriate operations for the
polyposis and non-polyposis syndromes, the best timing for those operations, why they should be performed,
and the evidence to support these decisions; d) Describe the post-colectomy surveillance routines for the
hereditary colorectal cancer syndromes as well as any practical extracolonic surveillance routines and the
evidence to support them.
59
S U N D AY
Director: Paul Wise, MD, St. Louis, MO
Assistant Director: Matthew Kalady, MD, Cleveland, OH
Sunday, May 31
Welcome and Opening Announcements
1:15 – 2:00 pm
Auditorium (2nd Floor)
Terry Hicks, MD, New Orleans, LA
President, ASCRS
Paul Shellito, MD, Boston, MA
Kelly Tyler, MD, Springfield, MA
Local Arrangements Co-Chairs
David Margolin, MD, New Orleans, LA
Program Chair
Steven Wexner, MD, Weston, FL
President, ASCRS Research Foundation
H. David Vargas, MD, New Orleans, LA
Program Vice-Chair
Roberta Muldoon, MD, Nashville, TN
Public Relations Chair
Photo Credit: Greater Boston Convention & Visitors Bureau
Jason Hall, MD, Burlington, MA
Awards Chair
Faneuil Hall Marketplace
60
Sunday, May 31
Symposium
Parallel Session 2-A
Technical Pearls – How it’s Really Done
1
2.0
MOC
2
6
*
2.0
CME
2:00 – 4:00 pm
Auditorium (2nd Floor)
It is clear that master surgeons exist, and that these surgeons perform operations with techniques they have
learned from experience. These learned “tricks” often allow a surgeon to perform operations in a way that most
cannot. When asked to describe what they do to complete these procedures, the master surgeon often cannot verbalize it
as these techniques have become a part of their muscle memory. In this symposium, we will ask these surgical masters
to demonstrate these techniques in this open forum. Different approaches to these maneuvers will then be reviewed
and discussed.
Existing Gaps
What Is: Surgical skill varies widely resulting in disparate patient outcomes for the treatment of many common
surgical diseases.
What Should Be: A patient undergoing surgical treatment of common disease should be able to get treatment in their
community and expect the same high level treatment as the patient treated by the surgical master for the same
common disease.
2:00 pm
Transabdominal Approaches to Rectal
Prolapse – Cutting Edge vs Tried and True
Mark Arnold, MD, Columbus, OH
2:50 pm
Laparoscopy in the Super Obese – Tips to Get
it Done
Conor Delaney, MD, PhD, Cleveland, OH
2:10 pm
Approaches to Complex Fistula Disease:
Outcomes and My Preferred Options
Susan Gearhart, MD, Baltimore, MD
3:00 pm
A Simple Operation that Needs More Work –
the Perfect Ileostomy
John Pemberton, MD, Rochester, MN
2:20 pm
Bowel Preservation in Crohn’s Disease –
Complex Decisions for Complex Procedures
Robin McLeod, MD, Toronto, ON, Canada
3:15 pm
Transanal Excision and Tumor Scatter – How to
Achieve a Negative Margin
Theodore Saclarides, MD, Maywood, IL
2:30 pm
Parastomal Hernia Repair – Local Repair versus
Stoma Resite
Kirk Ludwig, MD, Milwaukee, WI
3:25 pm
Gracilis Interposition to Treat Complex
Fistula Disease
Steven Wexner, MD, Weston, FL
2:40 pm
Finding the Ureter and Taking Down the
Splenic Flexure in the Reoperative Abdomen
Charles Friel, MD, Charlottesville, VA
3:35 pm
Panel Discussion
4:00 pm
Adjourn
Objectives: At the conclusion of this session, participants should be able to: a) Identify the approach of a
surgical master to rectal prolapse; b) Describe principles of prevention of injury to the spleen when mobilizing
the splenic flexure; c) State the proper technique to performing a gracilis interposition procedure d) Name the
options available to perform a loop ileostomy; e) Describe the role of novel approaches to rectopexy; and
f ) Recognize the factors that need to be considered in the management of colonic polyps.
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
61
S U N D AY
Co-Director: Michael Stamos, MD, Orange, CA
Co-Director: Gregory Kennedy, MD, PhD, Madison, WI
Sunday, May 31
Abstract Session
Parallel Session 2-B
Neoplasia I
1
2
*
1.5
CME
2:00 – 3:30 pm
Ballroom A (3rd Floor)
Co-Moderators: Melanie Morris, MD, Birmingham, AL and Jennifer Ayscue, MD, Washington, DC
2:00 pm
Impact of Hospital Volume on Quality
Indices for Rectal Cancer Surgery in British
Columbia, Canada
S1
R. McColl*, M.J. Raval, T.P. Phang,
A.A. Karimuddin, C.J. Brown, C. Mcgahan,
E. Cai, Vancouver, BC, Canada
2:07 pm
Discussion
2:10 pm
Transanal Endoscopic Microsugery (TEM)
following Neoadjuvant Chemoradiation
for Rectal Cancer – Is Salvaging Local
Recurrences Too Little Too Late?
R. Perez, A. Habr-Gama*, G.P. São Julião,
I. Proscurshim, L.M. Fernandez, J. GamaRodrigues, Sao Paulo, Brazil
S2
2:17 pm
Discussion
2:20 pm
Transanal Total Mesorectal Excision:
The Oxford Experience
S3
N.C. Buchs*, G. Nicholson, T. Yeung,
N. Mortensen, C. Cunningham, O. Jones,
S. Ashraf, R. Guy, R. Hompes, Oxford, United
Kingdom
2:27 pm
Discussion
2:30 pm
Determining the Optimal Timing for
Initiation of Adjuvant Chemotherapy after
Resection for Stage II/III Colon Cancer
S4
Z. Sun*, M. Abdelgadir Adam, J. Kim,
D. Nussbaum, E. Benrashid, C.R. Mantyh,
J. Migaly, Durham, NC
2:37 pm
2:40 pm
Observation versus Surgical Resection
in Patients with Rectal Cancer Who
Achieved Complete Clinical Response
after Neoadjuvant Chemoradiotherapy:
Preliminary Results of a Randomized
Trial (NCT02052921)
S.C. Nahas, C.S. Nahas*, U. Ribeiro, Jr.,
C. Sparapan Marques, G. C. Cotti, C. Ortega,
R. Azambuja, A. Chen, P. Hoff, I. Cecconello,
Sao Paulo, Brazil
2:47 pm
Discussion
2:50 pm
Surgical Resection of the Primary Tumor
in Stage IV Colorectal Cancer without
Metastasectomy is Associated with
Improved Overall Survival Compared to
Chemotherapy/Radiation Therapy Alone
B.C. Gulack*, D. Nussbaum, J.E. Keenan,
A.M. Ganapathi, Z. Sun, M. Worni, J. Migaly,
C. Mantyh, Durham, NC
S5
S6
2:57 pm
Discussion
3:00 pm
Correlation between Extramural
Vascular Invasion (EMVI) and DNA
Hypermethylation in Rectal Cancer
S7
H.G. Jones*, R. Radwan, G. Jenkins, N. Williams,
P. Griffiths, J. Beynon, D. Harris, Swansea,
United Kingdom
3:07 pm
Discussion
Discussion
Continued next page
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
62
*Presenting Author
Sunday, May 31
Neoplasia I (Continued)
Waist Hip Ratio Better Predicts
Oncological Quality of Resection and
Outcome after Colon Cancer Surgery than
Body Mass Index
S8
N. Hetsch, D. Leonard*, A. Kartheuser,
A. van Maanen, Brussels, Belgium; H. Paterson,
Edinburgh, United Kingdom; F. Penninckx,
Leuven, Belgium
3:17 pm
Discussion
3:20 pm
Q&A
3:30 pm
Adjourn
Objectives: At the conclusion of this session, participants should be able to: (S1) Identify the volume of rectal
cancer surgery being performed in British Columbia, Canada; explain how rectal cancer surgery is performed at
high versus low volume hospitals in British Columbia, Canada; describe the impact hospital volume has on
achieving quality indices in rectal cancer surgery; (S2) State the challenges in salvage resection for recurrent
rectal cancer following CRT and TEM; describe the oncological outcomes of patients with unfavorable
pathological features following CRT and TEM; (S3) Demonstrate the technical details and the outcomes
following TATME; explain the advantages of this approach; (S4) Describe the importance of timely
administration of adjuvant chemotherapy after oncologic colon resection; develop measures to improve
adjuvant therapy utilization rates in colon cancer; (S5) Recall whether conservative (non operative) approach is
similar to total mesorectal excision (TME) in patients with complete clinical response after neoadjuvant
chemoradiotherapy (CRT); identify all the strict criteria that define a patient with a rectal cancer treated by
neoadjuvant chemoradiotherapy as a complete clinical responder; (S6) Discuss the potential benefits of a noncurative resection in stage IV colorectal cancer; discuss the prognosis for patients with stage IV colorectal
cancer; (S7) Recall further understanding in the field of epigenetics; recognize a need for biological markers to
define treatment choice of cancer patients and; (S8) Analyze the influence of obesity on the oncological
outcome after colon cancer surgery; define knowledge in colon cancer prognostic factors.
Refreshment Break in Exhibit Hall
& ePoster Presentations
S U N D AY
3:10 pm
(See pages 112-113 for schedule.)
4:00 – 4:45 pm
Norman D. Nigro, MD, Research Lectureship
4:45 – 5:15 pm
Auditorium (2nd Floor)
The Evolution of Minimally Invasive
Surgery for Colorectal Cancer:
Past, Present, and Future
Professor Antonio Lacy, MD, PhD
Barcelona, Spain
Introduction: Steven Wexner, MD
63
.5
CME
Sunday, May 31
After Hours Debate
1
2
*
1.25
CME
5:15 – 6:30 pm
Auditorium (2nd Floor)
REFRESH MENTS W I L L B E S ERV ED
All surgical specialties have certain topics/diseases that contain controversy. Understanding the optimal
treatment plan for patients often depends on a physician’s ability to see clarity in these lines of gray. Debates are
excellent tools to show differences in perspective and opinion regarding these topics. They effectively challenge and break
down surgical dogma and open people to new points of view. They often help audience members crystalize their own
values and beliefs. Speakers with passionate views about opposing treatment, with clear guidelines for the debate, can
effectively create an effective and novel learning environment. Furthermore, an assertive and experienced moderator can
challenge the speakers and engage the audience to both optimize critical thinking and illustrate what treatment plan may
be best for different scenarios.
Existing Gaps
What Is: The role of surgical skills testing is an area of evolving discussion. There are different and often opposing views on
it’s appropriateness, indication and it’s utility in surgical education and certification. Surgeons are unsure what effect this
will have in the future. While laparoscopic surgery has become more and more mainstream, there is still some question
about the efficacy and outcomes of laparoscopic node positive rectal cancer surgery.
What Should Be: Surgeons should have a clearer vision of the role of skill testing in relation to certification and
recertification. They also need a better understanding of the role of laparoscopic rectal cancer surgery as opposed to colon
cancer surgery.
Moderator: James Fleshman, MD, Dallas, TX
5:15 pm
Surgical Skills Testing
Helen MacRae, MD, Toronto, ON, Canada vs
Charles Whitlow, MD, New Orleans, LA
5:45 pm
Laparoscopic Surgery for Stage 3
Rectal Cancer
Richard Whelan, MD, New York, NY vs
Scott Steele, MD, Fort Lewis, WA
6:30 pm
Adjourn
Objectives: At the conclusion of this session, participants should be able to: a) Recognize the role of skill testing
in relation to certification and recertification; b) Describe the evidence and practical implications for performing
or avoiding mechanical bowel preparation; and c) Explain the outcomes in minimally invasive surgery for the
treatment of node positive rectal cancer.
Welcome Reception
7:00 – 8:30 pm
Grand Ballroom • Sheraton Boston Hotel
• Jersey Night! •
Wear your favorite team’s jersey to show your colleagues which team you support.
The Welcome Reception will be held at the Sheraton Boston Hotel and is complimentary to
all registered attendees. The event will feature hors d’oeuvres, cocktails and entertainment.
The Research Foundation will join forces with ASCRS to welcome all at this reception.
64
Monday, June 1
Meet the Professor Breakfasts
6:00 – 7:00 am
Limit: 30 per breakfast • Fee $40 • Tickets Required • Continental Breakfast
Registrants are encouraged to bring problems and questions to this informal discussion.
Code
Subject/Faculty
M-1
HNPCC and Polyposis: Knowing
When to Operate
Charles Ternent, MD, Omaha, NE
Matthew Kalady, MD, Cleveland, OH
M-2
M-3
Code
Subject/Faculty
Room
Room 200
M-4
UT
SOLD O
The Management of T1 Rectal Cancer
Robert Madoff, MD, Minneapolis, MN
Maher Abbas, MD, Abu Dhabi,
United Arab Emirates
Quality Metrics and
Colorectal Surgery
Juan Nogueras, MD, Weston, FL
Rocco Ricciardi, MD, Burlington, MA
Room 202
M-5
How to Produce a High Quality
Room 207
Manuscript for Scientific Journals
Thomas Read, MD, Burlington, MA
W. Donald Buie, MD, Calgary, AB, Canada
Coding Pearls
Guy Orangio, MD, New Orleans, LA
Stephen Sentovich, MD, Duarte, CA
Room 203
M-6
Rectal Prolapse
Room 300
Stanley Goldberg, MD, Minneapolis, MN
Brooke Gurland, MD, Cleveland, OH
Room 206
Objectives: At the conclusion of this session, participants should be able to: a) Describe the procedures and
approaches discussed in this session.
Residents’ Breakfast
6:00 – 7:00 am
Constitution Ballroom
Sheraton Boston Hotel
1.0
CME
The Road Less Traveled or the High
Road? Charting a Path to Success
Michael Stamos, MD
Chair Department of Surgery
University of California, Irvine Health
Orange, CA
Open to Residents Only
Registration Required
65
M O N D AY
UT
SOLD O
Room
1.0
CME
Monday, June 1
Symposium
Parallel Session 3-A
Robotic Colorectal Surgery
1
2.25
MOC
2
5
6
*
2.25
CME
7:00 – 9:15 am
Ballroom BC (3rd Floor)
Supported in part by an independent educational grant from Intuitive Surgical, Inc.
While the practice of surgery continues to evolve with respect to new techniques and technology, it remains
critical that the attention of surgeons and society as a whole focus on improving the quality of patient care.
Innovations therefore must be assessed through science and experience in order that these goals are achieved. Controversy
over the cost, potential complications, training, highlighted in both the lay press and scientific publications, demonstrate
the need for this discussion. These unanswered questions regarding the use of robotic surgery represent fertile ground
from which a robust discussion can ensue. Therefore, a need exists to review the current state of the robotics in order that
surgeons are informed of ongoing and future studies pertaining to the use of robotic surgery.
Existing Gaps
What Is: The approach and use of robotic surgery remains varied and diverse. To date, few institutions exist with large
experiences in colorectal disease. Moreover, the appropriate application of robotics is often based on local prevailing
customs and expertise due to limited data and training.
What Should Be: Surgeons should understand the appropriate application of robotic technics and a basis for literature
reported outcomes in colorectal surgery. In addition, surgeons should have a basic understanding of the potential pitfalls
and costs associated with this approach.
Director: David Larson, MD, Rochester, MN
Assistant Director: Scott Kelley, MD, Rochester, MN
7:00 am
What's New with the Robot (Tools,
Capabilities) and How Might it Improve
My Practice
Howard Ross, MD, Philadelphia, PA
7:15 am
The Evidence: Where are We?
David Jayne, MD, Leeds, United Kingdom
7:30 am
Role of Robotics in Colon Surgery?
Julio Garcia-Aguilar, MD, PhD, New York, NY
7:45 am
The Costs of Robotics, Pitfalls and Economics
Robert Cleary, MD, Ann Arbor, MI
8:00 am
Complex Pelvic Surgery, Techniques and Tricks
Amir Bastawrous, MD, Seattle, WA
8:15 am
Robotic Rectal Cancer Surgery and RoboticIntersphincteric Resection
Jin Cheon Kim, MD, Seoul, South Korea
8:30 am
Economics of Robotics
Craig Rezac, MD, New Brunswick, NJ
8:45 am
Questions and Panel Discussion
9:15 am
Adjourn
Objectives: At the conclusion of this session, participants should be able to: a) Identify the capabilities and tools
associated with different robotic technologies; b) Describe the principles derived from the literature on the
benefit or lack of benefit from a robotic approach; c) Recall the proper technical issues of both abdominal and
pelvic robotic surgery; d) Describe the current and ongoing trials of robotic surgery; and e) Distinguish the
financial burden associated with robotic surgery and the opportunities for cost savings.
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
66
Monday, June 1
Symposium
Parallel Session 3-B
Rectal Cancer:
Optimizing Outcomes through Techniques
1
2
5
6
*
2.25
CME
7:00 – 9:15 am
Auditorium (2nd Floor)
Supported in part by an independent educational grant from Ethicon
With continued technological advancements and their implementation into surgical practice, the number of
surgical approaches for the management of rectal cancer continues to expand. Depending on the stage and location
of the rectal cancer and patient co-morbidities and wishes, one surgical approach may be preferred over another.
Nevertheless, regardless of surgical approach, short-term and long-term oncological and functional results are greatly
dependent on surgical technique.
The purpose of this symposium is to present expert commentaries by high-volume surgeons on the essential technical
components of a broad range of specific open and minimally invasive surgical approaches commonly used for the
management of rectal cancer.
Existing Gaps
What Is: Although colorectal surgeons are trained in all the different surgical options for rectal cancer management, the
science and art in a specific surgical technique are mastered after years of practice and experience.
What Should Be: This Symposium aims to highlight and disseminate optimal surgical techniques used by expert high
volume surgeons in the surgical management of rectal cancer.
7:00 am
Introduction
José Guillem, MD, New York, NY
7:05 am
Open Low Anterior Resection
Robert Madoff, MD, Minneapolis, MN
7:15 am
Open Ultra-Low Resection with Coloanal
Anastomosis: Mucosectomy vs
Intersphincteric Resection
Thomas Read, MD, Burlington, MA
7:25 am
7:35 am
Abdominal Perineal Resection:
Prone Position/Cylindrical Approach:
When and How?
Torbjörn Holm, MD, Stockholm, Sweden
ALaCaRT: Australian Laparoscopic Cancer of
the Rectum Trial
Andrew Stevenson, MD, Chermside, Australia
7:45 am
Discussion and Cases
8:00 am
Robotic Rectal Cancer Resections
Slawomir Marecik, MD, Park Ridge, IL
8:10 am
TEM/TAMIS
Sergio Larach, MD, Orlando, FL
8:20 am
Transanal Total Mesorectal Excision
Antonio Lacy, MD, PhD, Barcelona, Spain
8:30 am
Results of Robotic vs Laparoscopic Resection
for Rectal Cancer: ROLARR Study
Alessio Pigazzi, MD, PhD, Orange, CA
8:40 am
Discussion
9:15 am
Adjourn
Objectives: At the conclusion of this session, participants should be able to: a) Describe the most commonly
performed and evolving open and minimally invasive surgical approaches for rectal cancer with an emphasis on
proper patient selection and optimal surgical technique; and b) Identify specific preferred techniques, potential
technical difficulties and pitfalls in order to assure optimal oncological and functional outcome.
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
67
M O N D AY
Director: José Guillem, MD, New York, NY
Assistant Director: Patricia Sylla, MD, New York, NY
Monday, June 1
Memorial Lectureship
Honoring John M. MacKeigan, MD
9:15 – 9:45 am
Auditorium (2nd Floor)
A Short Walk Through the History of
the Quality Movement
.5
CME
Martin Luchtefeld, MD
Chief, Div. of Colon and Rectal Surgery
Clinical Asst. Professor, MSU College of Medicine
Ferguson Clinic-Spectrum Health Medical Group
Spectrum Health
Grand Rapids, MI
Introduction: Anthony Senagore, MD
Presidential Address
9:45 – 10:15 am
Auditorium (2nd Floor)
A Surgeon’s Puzzle:
“The Missing Pieces”
.5
CME
Terry C. Hicks, MD
Vice Chair, Dept. of Colon and Rectal Surgery
Ochsner Clinic
Clinical Professor of Surgery, LSU, School of Medicine
New Orleans, LA
Introduction: Michael Stamos, MD
Refreshment Break in Exhibit Hall
& ePoster Presentations
(See pages 112-113 for schedule.)
10:15 – 11:00 am
68
Monday, June 1
Symposium
Parallel Session 4-A
Navigating a Career Path in
Colon and Rectal Surgery – Orchestrating and
Optimizing Career Transitions at All Levels
3
4
*
11:00 am – 12:30 pm
Auditorium (2nd Floor)
1.5
CME
Surgeons at all phases of their career face difficult decisions about potential transitions in their professional and
personal lives. The optimal strategic approach to these life changing events can be elusive and may lead to a “trial by
error” experience with dramatic consequences. We must try to understand that these changes come from the demands
of our conscience and not from our mental resolution. Furthermore, not every opportunity is growth, as all movement is
not forward.
Existing Gaps
What Is: Graduating colorectal residents and attending surgeons looking for a career change receive very little counseling
and pragmatic advice to assist them in their potential transition to a new position.
What Should Be: Career transitions should be approached and handled by an individual with a team of mentors and
advisors. The absence of this “team” can be balanced by national courses and symposia with speakers well educated in
this arena.
Director: Bradley Champagne, MD, Cleveland, OH
Assistant Director: Andrew Russ, MD, Knoxville, TN
11:00 am Life after Training – You are Now the
Attending of Record!
Mark Manwaring, MD, Greenville, NC
11:36 am A View from Above – How to Effectively Lead
a Team!
Michael Stamos, MD, Orange, CA
11:12 am Mid-Life Crisis, Build your Own or Lead from
the Center!
Gregory Kennedy, MD, PhD, Madison, WI
11:48 am Emotional Intelligence – The Real Key
to Success
James Fleshman, MD, Dallas, TX
11:24 am From Private Practice to Hospital Acquisition –
Lifestyle, Dollars and Sense!
Wayne Ambroze, MD, Atlanta, GA
Noon
Question and Answer
12:30 pm Adjourn
thoughtful and strategic approach to the first years in practice after training; b) Describe the key components to
the decision making process when a surgeon is deciding between moving to another position with potential
leadership opportunities vs. staying in their current role; c) Identify the current challenges with private practice
and why hospital based practice may be advantageous; d) Recognize how to turn a vision into reality by
effective implementation of the strategic plan; and e) Identify that mental toughness and emotional intelligence
are difficult to measure but are the cornerstone of personal and professional success.
Complimentary Box Lunch in Exhibit Hall
& ePoster Presentations
(See pages 112-113 for schedule.)
12:30 – 1:30 pm
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
69
M O N D AY
Objectives: At the conclusion of this session, participants should be able to: a) Recognize the importance of a
Monday, June 1
Abstract Session
Parallel Session 4-B
Benign Colonic Disease
1
3
*
1.5
CME
11:00 am – 12:30 pm
Ballroom A (3rd Floor)
Co-Moderators: Maher Abbas, MD, Abu Dhabi, UAE and Jennifer Rea, MD, Lexington, KY
11:39 am Conservatively Treated Diverticular
Abscess Associated with High Risk of
Recurrence and Disease Complications
S13
B. Devaraj, W. Liu*, K. Cologne, A.M. Kaiser,
Los Angeles, CA
11:00 am Surgical Site Infection following Colorectal
Surgery: In the Eye of the Beholder?
S9
T.L. Hedrick*, A. Harrigan, B. Umapathi,
R. Sawyer, C.M. Friel, Charlottesville, VA
11:07 am Discussion
11:46 am Discussion
11:09 am Diverticulitis in the United States:
A Decade Analysis of Changing Trends
S10
M.H. Hanna*, Z. Moghadamyeghaneh,
G. Hwang, L. Malellari, S.D. Mills, J.C. Carmichael,
M.J. Stamos, A. Pigazzi, Orange, CA
11:49 am Killingback Award Winner
High vs low Urine Output Targets in
Elective Surgical Patients: A Randomized
Clinical Trial
S15
J. Puckett*, J. De Zoysa, M. Kluger, Auckland,
New Zealand; S. Palmer, .J Pickering, Z. Endre,
Christchurch, New Zealand; M. Soop, Auckland,
New Zealand
11:16 am Discussion
11:19 am Sigmoid Colectomy for Acute Diverticulitis in
Immunosuppressed vs. Immunocompetent
Patients: Outcomes from the ACS-NSQIP
Database
S11
A. Al-Khamis*, J. Abou Khalil, C. Vasilevsky,
N. Morin, G. Ghitulescu, P. Gordon, M. Demian,
J. Faria, M. Boutros, Montreal, QC, Canada
11:56 am Discussion
11:59 am The Current State of Colorectal Surgery
Training: A Survey of Program Directors,
Current Colorectal Residents, and Recent
Colorectal Graduates.
S16
M.B. Bailey*, P.E. Miller, S. Pawlak, M. Thomas,
H. Vargas, T. Hicks, C. Whitlow, D. Beck,
D. Margolin, New Orleans, LA
11:26 am Discussion
11:29 am The Readmission After Acute Diverticulitis
(RAD) Score – A Nomogram for Determining
60-day Readmission Risk for Diverticulitis
Patients Using 145,325 Admissions from
the State Inpatient Database (SID)
(2006-2011).
S12
V. Chakravorty*, K. Mahendraraj,
R.S. Chamberlain, Livingston, NJ
12:06 pm Discussion
12:09 pm Q&A
12:30 pm Adjourn
11:36 am Discussion
Continued next page
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
70
*Presenting Author
Monday, June 1
Benign Colonic Disease (Continued)
Objectives: At the conclusion of this session, participants should be able to: (S9) Define the ASEPSIS score for
evaluating surgical site infection; recognize the inter-rater variability between surgeons in defining surgical site
infection; (S10) Recognize changing trends in incidence and treatment of diverticulitis nationwide; identify risk
factors for mortality in the middle-ages and elderly patient groups with diverticulitis; (S11) Recognize the
impact of immunosuppression on mortality following colectomies for acute sigmoid diverticulitis in the
emergency; describe the impact of immunosuppression on morbidity following colectomies for acute sigmoid
diverticulitis in the emergency; (S12) Analyze the demographic and clinical factors that increase the risk of
readmission following an index admission for acute; define a predictive nomogram capable of identifying and
stratifying patients at greatest risk of readmission based upon factors present during the index admission;
(S13) Analyze the natural course and outcomes of intermediate severity cases of diverticulitis, i.e. patients with
abscess at time of presentation; analyze the impact of CT-guided drainage of diverticular abscess on the overall
outcome; (S15) Recognize that a low perioperative UO target is not inferior to a high UO target and;
(S16) Identify current trends in colorectal training; review objective data on the competitiveness of
colorectal training.
Complimentary Box Lunch in Exhibit Hall
& ePoster Presentations
(See pages 112-113 for schedule.)
M O N D AY
12:30 – 1:30 pm
71
Monday, June 1
Symposium
Parallel Session 5-A
Past Presidents’ Panel: Controversies and Cases
1
2
4
*
1.5
CME
1:30 – 3:00 pm
Auditorium (2nd Floor)
The management of complicated colorectal disorders is what differentiates this specialty from general surgery.
Colorectal surgeons are often called upon to manage complex medical and surgical conditions, especially reoperative
surgery. This session will highlight the strategies of senior colorectal surgeons’ management of the most complicated
reoperative conditions addressed by our specialty.
• Recurrent Anal Fissures
• Recurrent Rectal Cancer
• Hemorrhoid Disease
• Inflammatory Bowel Disease
• Complex Fistula
Existing Gaps
What Is: Many surgeons are comfortable with the straightforward management of common colorectal conditions. Complex
cases, reoperative surgery and those with complications are often referred to a tertiary care center.
What Should Be: Surgeons should be familiar with the management options for complicated colorectal diseases and the
potential interventions necessary to provide satisfactory outcomes.
Director: Steven Wexner, MD, Weston, FL
1:30 pm
Recurrent Anal Fissures
Richard Billingham, MD, Seattle, WA
2:15 pm
Inflammatory Bowel Disease
Michael Stamos, MD, Orange, CA
1:45 pm
Recurrent Rectal Cancer
H. Randolph Bailey, MD, Houston, TX
2:30 pm
Complex Fistula
Ann Lowry, MD, St. Paul, MN
2:00 pm
Hemorrhoid Disease
Lester Rosen, MD, West Palm Beach, FL
2:45 pm
Roundtable Discussion
3:00 pm
Adjourn
Objectives: At the conclusion of this session, participants should be able to: a) Recognize the management
options of recurrent anal fissures, complex anal fistula, hemorrhoid disease, rectal cancer and IBD; and
b) Identify the technique of colonoscopy and how to manage potential complicated lesions endoscopically.
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
72
Monday, June 1
Abstract Session
Parallel Session 5-B
Pelvic Floor/Anorectal
1
2
*
1.5
CME
1:30 – 3:00 pm
Ballroom A (3rd Floor)
Co-Moderators: Jason Mizell, MD, Little Rock, AR and Amy Halverson, MD, Chicago, IL
Treatment of Fecal Incontinence with
Gatekeeper™ Implantation
S18
A. Heydari*, E. Merolla, S. Giuratrabocchetta,
M. Piccoli, G. Melotti, Modena, Italy;
R. Fazlalizadeh, Orange, CA
2:09 pm
Long Term Efficacy of Sacral Nerve
Stiumlation for Fecal Incontinence –
A Single Center Experience
J.B. Cowley*, P.W. Waudby, H. O'Grady,
G.S. Duthie, Beverley, United Kingdom
1:37 pm
Discussion
2:16 pm
Discussion
1:39 pm
The Impact of a Novel Vaginal Bowel
Control System on Bowel Function
S19
M.G. Varma*, San Francisco, CA; C.A. Matthews,
Chapel Hill, NC; H. Richter, Birmingham, AL
2:19 pm
1:46 pm
Discussion
Percutaneous Tibial Nerve Stimulation
has Sustained Benefit in the Treatment of
Fecal Incontinence at 12 Months
S23
J.B. Cowley*, P.W. Waudby, H. O'Grady,
G.S. Duthie, Beverley, United Kingdom
1:49 pm
The Effect of Coexisting Pelvic Floor
Disorders on Fecal Incontinence
Quality of Life Scores: A Prospective
Survey-Based Study
S20
L. Bordeianou, C.W. Hicks*, A. Olariu, L.R. Savitt,
S.J. Pulliam, M. Weinstein, P. Sylla,
M.M. Wakamatsu, Boston, MA; T. Rockwood,
Minneapolis, MN; J. Kuo, Waltham, MA
2:26 pm
Discussion
2:29 pm
Outcomes of Re-Implantation of
Sacral Neurostimulation for Fecal
Incontinence are Similar to Those of
First Time Implants
S24
A. Cracco*, A. Chadi, S. Wexner, F. Rodrigues,
G. DaSilva, Weston, FL; M. Zutshi, B. Gurland,
Cleveland, OH
S22
1:56 pm
Discussion
2:36 pm
Discussion
1:59 pm
The TOPAS™ Treatment for Fecal
Incontinence: A Close Look at
Complications
S21
M. Zutshi*, Cleveland, OH; A. Mellgren,
Chicago, IL; D.E. Fenner, Ann Arbor, MI;
V. Lucente, Allentown, PA; P. Culligan, Summit,
NJ; M. Nihira, Oklahoma City, OK
2:39 pm
2:06 pm
Discussion
Use of Biofeedback Combined with Diet
for Treatment of Obstructed Defecation
Associated with Paradoxical Contraction of
Puborectalis Muscles (Anismus). Predictive
Factors and Short-term Outcome
S25
S.M. Murad-Regadas*, F.S. Regadas, C. Bezerra,
M.C. Oliveira, F. Regadas Filho, R. Vasconcelos,
S. Almeida, G. Fernandes, Ceara, Brazil
2:46 pm
Discussion
Continued next page
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
73
*Presenting Author
M O N D AY
1:30 pm
Monday, June 1
Pelvic Floor/Anorectal (Continued)
2:49 pm
Ligation of Intersphincteric Fistula Tract
(LIFT) versus LIFT-Plug Procedure in
Patients with Transsphincteric Anal
Fistula: A Multicenter Prospective
Randomized Trial.
S26
Z. Wang*, J. Han, Y. Zheng, J. Cui, C. Chen,
Beijing, China; X. Wang, X. Che, Shan'xi, China;
W. Song, Tianjin, China
2:56 pm
Discussion
3:00 pm
Adjourn
Objectives: At the conclusion of this session, participants should be able to: (S18) distinguish the possible
complications after the Fecal Incontinence treatment; describe minimal invasive approach for fecal incontinence
treatment; distinguish the possible complications after the fecal incontinence treatment; (S19) Describe the
vaginal bowel control (VBC) system; describe the impact of the VBC system on bowel function; (S20) Describe
the association between severity of fecal incontinence and fecal incontinence quality of life; recognize how
coexisting pelvic floor disorders affect fecal incontinence quality of life scores among patients with fecal
incontinence; (S21) Examine the local and distant complications related to the TOPAS procedure; evaluate if
mesh related complications in the Urogyn literature apply to the Topas System; (S22) Recognize the long term
efficacy of SNS; develop their practice regarding the long term use of SNS for fecal incontinence; (S23) Analyze
the effect of PTNS over a 1 year period; recognize alternative therapies and their success in the treatment of
faecal incontinence; (S24) Detect the outcomes of reimplantation of Sacral Neurostimulation for Fecal
Incontinence; recognize that the outcomes of reimplantation of SNS for fecal in-continence are comparable to
the first implantation; (S25) Analyze the effect of biofeedback combined with diet in treating patients with
obstructed defecation associated anismus; identify factors influencing the outcomes in biofeedback associated
with diet in the treatment of obstructed defecation due to anismus; (S26) Describe effect of LIFT and LIFT-plug
for transsphincteric anal fistula; explain the difference in outcome of LIFT and LIFT-plug for transsphincteric
anal fistula.
74
Monday, June 1
Harry E. Bacon, MD, Lectureship
3:00 – 3:30 pm
Auditorium (2nd Floor)
Changes in Student and Residency
Education in Surgery: Unanticipated
Consequences and Challenges
.5
CME
Hiram C. Polk, Jr., MD
Ben A. Reid, Sr. Professor of Surgery, Emeritus
Former Chair, Department of Surgery,
School of Medicine, University of Louisville
Louisville, KY
Introduction: Terry Hicks, MD
Ice Cream & Refreshment Break in Exhibit Hall
& ePoster Presentations
(See pages 112-113 for schedule.)
3:30 – 4:15 pm
Parviz Kamangar
Humanities in Surgery Lectureship
4:15 – 4:45 pm
Auditorium (2nd Floor)
Spirituality and Faith in Serious Illness
.5
CME
Robert L. Fine, MD, FACP, FAAHPM
Clinical Director
Office of Clinical Ethics and Palliative Care
Baylor Scott and White Health, Dallas, TX
Clinical Associate Professor of Internal Medicine
and Medical Humanities, Texas A&M College
of Medicine
M O N D AY
Introduction: Ira Kodner, MD
75
Monday, June 1
Special Lecture
4:45 – 5:15 pm
Auditorium (2nd Floor)
The Trials and Tribulations of Clinical
Research: Why Johnny Can’t Add
Thomas Read, MD
Lahey Hospital and Medical Center
Dept. of Colon and Rectal Surgery
Burlington, MA
5:15 – 5:20 pm
Auditorium (2nd Floor)
What Receiving the Scholarship Means to Me
Alex Emmanuel Elobu, MD
Mulago Hospital
Kampala, Uganda
ASCRS International Scholarship Recipient
76
.5
CME
Monday, June 1
No CME Credit Awarded
New Technologies Symposium
REFRESH MENTS W I L L B E S ERV ED
5:20 – 6:45 pm
Auditorium (2nd Floor)
Supported by independent educational grants from:
ACell, Inc.
Novadaq Technologies, Inc.
Pacira Pharmaceuticals, Inc.
THD America
Torax Medical, Inc.
The New Technologies Session is dedicated to the principle that through imagination and innovation, many of the most
challenging problems in the field of colon and rectal surgery can be solved. Impactful new innovations in the area of
colorectal surgery; pharma, devices, prototypes, techniques and approaches will be the focus of this session.
This session will feature presentations on the latest advances in colorectal surgery.
Existing Gaps
What Is: No platform to discuss emerging technologies exists for colorectal surgery today.
What Should Be: The ASCRS annual meeting will serve as a major conduit through which new and emerging technologies
for colorectal surgery will be showcased. This session will also serve as an educational platform to learn about drug and
device development and process for FDA approval.
5:20 pm
Welcome
Eric Haas, MD, Houston, TX and Sonia
Ramamoorthy, MD, La Jolla, CA
5:57 pm
Advances in Surgical Stapling: ECHELON
FLEX™ GST System
David Longcope, MD, Denver, CO
5:21 pm
Anorectal Fistula Closure with the New
OTSC Proctology
R.L. Prosst, W. Ehni, Stuttgart, Germany;
A.K. Joos, D. Bussen, A. Herold, Mannheim,
Germany
6:04 pm
Future Robotic Single Port System
Vincent Obias, MD, Washington, DC
6:11 pm
New Advances in Fluorescent Imaging
Ovunc Bardakcioglu, MD, Las Vegas, NV
Pilot Study of a Novel Multimodal Pain
Management Strategy – Evaluating the Impact
on Patient Outcomes
Deborah Keller, MD, Houston, TX
6:18 pm
Regenerative Medicine in Problematic
Colorectal Applications
Vincent Obias, MD, Washington, DC
Sylys: A Novel Surgical Sealant with the
Potential to Reduce Anastomotic Leaks
Deborah Nagle, MD, Boston, MA
6:25 pm
5:43 pm
Five Years of Sphincter Preserving Anal Fistula
Repair Using the FiLaC Laser System
A. Wilhelm, Cologne, Germany
Transanal Hemorrhoidal Deasterialization:
Advances on Technique and New Data
Samir Agarwal, MD, Washington, DC
6:32 pm
5:50 pm
FENIX® – A Magnetic Sphincter Augmentation
Device for Fecal Incontinence: An “Attractive”
Approach”
Paul-Antoine Lehur, MD, PhD, Nantes, France
Are You Ready to Repair Hernias Differently?
The First Hybrid Hernia-Repair Device
Eric Johnson, MD, Fort Lewis, WA
6:39 pm
Clinical Value of the Olympus 3D Imaging
Solution
I. Emre Gorgun, MD, Cleveland, OH
6:45 pm
Adjourn
5:29 pm
5:36 pm
Objectives: At the conclusion of this session, participants should be able to: a) Identify and employ emerging technologies
relating to colorectal surgical issues; b) Recognize personal gaps in knowledge which will lead to further independent study;
and c) Recognize safe and effective strategies to correct common colorectal disease processes.
77
M O N D AY
Co-Director: Sonia Ramamoorthy, MD, La Jolla, CA
Co-Director: Eric Haas, MD, Houston, TX
Tuesday, June 2
Meet the Professor Breakfasts
6:30 – 7:30 am
Limit: 30 per breakfast • Fee $40 • Tickets Required • Continental Breakfast
Registrants are encouraged to bring problems and questions to this informal discussion.
Code
Subject/Faculty
T-1
UT
SOLD O
Enterocutaneous Fistulas,
Anastomotic Leaks and other
Catastrophes
David Beck, MD, New Orleans, LA
Joseph Carmichael, MD, Orange, CA
T-2
UT
SOLD O
Modern Management of
Fecal Incontinence
Kelly Garrett, MD, New York, NY
Amy Halverson, MD, Chicago, IL
Room
1.0
CME
Code
Subject/Faculty
Room 200
T-5
Pouch Problems and Solutions
Feza Remzi, MD, Cleveland, OH
David Larson, MD, Rochester, MN
Bonnie Alvey, APRN, WOCN, ACNS-BC,
New Orleans, LA
Room 207
Room 202
T-6
Rectal Cancer: Difficult Cases and
Controversies
James Fleshman, MD, Dallas, TX
Kirk Ludwig, MD, Milwaukee, WI
Room 300
T-3
Nonhealing Perineal Wounds
Room 203
Martin Luchtefeld, MD, Grand Rapids, MI
Jon Hourigan, MD, Lexington, KY
T-7
T-4
Controversies: The Management of
Intestinal Crohn's Disease
Sandra Beck, MD, Lexington, KY
Phillip Fleshner, MD, Los Angeles, CA
Colitis and Dysplasia Surveillance
Room 313
and Management
David Etzioni, MD, Phoenix, AZ
Randolph Steinhagen, MD, New York, NY
Room 206
Room
Photo Credit: Greater Boston Convention & Visitors Bureau
Objectives: At the conclusion of this session, participants should be able to: a) describe the procedures and
approaches discussed in this session.
Situated on the waterfront, the JFK Library & Musuem offers glorious unobstructed views of the city and the ocean.
78
Tuesday, June 2
Symposium
Parallel Session 6-A
1
1.5
MOC
2
5
6
T U E S D AY
Anorectal Disorders:
Balancing Innovation with Conventional Wisdom
*
1.5
CME
7:30 – 9:00 am
Ballroom BC (3rd Floor)
Billions of dollars are spent annually in the U.S. by patients on their own and as prescribed by a physician to
manage the symptoms of a wide range of anorectal conditions. Surgical treatments include state of the art
technologies and methods that have remained unchanged since the time of Shakespeare and even the Pharaohs. Do the
newer approaches to these conditions provide better outcomes at reasonable cost, or just novelty and an opportunity to
advance one’s practice by being the “first kid on the block to have the newest toy?”
This symposium seeks to juxtapose the newest advances against the tried and true. We plan to review the emerging
technologies with regard to outcomes and efficacy and also “bang for the buck” look at the improvements and innovation
vs cost. There will be an in-depth discussion of how to integrate new technology into your anorectal practice and when to
stick with what you were taught in fellowship.
Existing Gaps
What Is: A variety of emerging techniques and technologies that span the practice of anorectal surgery. The adoption and
support for these changes in practice is often industry driven. The distinct benefit at possibly increased cost is not always
known by the patient or the practitioner. Many different approaches, new and old, are currently applied across practices.
What Should Be: Surgeons adopting the newest innovative treatments and technologies should know the benefits and
costs of these newer approaches in comparison to proven methods. The practitioners should be aware of potential risks or
benefits of adopting new methods. Evolving changes in surgical techniques need to be compared to established standards
using an evidence based approach, free from commercial bias.
Director: Thomas Cataldo, MD, Boston, MA
Assistant Director: Vitaliy Poylin, MD, Boston, MA
7:30 am
Latest Advances in Guided Hemorrhoid
Ligation
Vincent Obias, MD, Washington, DC
8:10 am
Management of Fistula-in-Ano: From
Shakespeare to the Space Shuttle
Brian Kann, MD, New Orleans, LA
7:40 am
Hemorrhoidectomy – Do We Need to Reinvent
the Wheel?
Syed Husain, MD, Columbus, OH
8:20 am
Ventral Rectopexy for Obstructed Defecation
P. Ronan O'Connell, MD, Dublin, Ireland
8:30 am
Discussion
7:50 am
Management of Chronic Anal Fissures, to Rub
on, Inject in, or Cut Through
Elizabeth Raskin, MD, St. Paul, MN
9:00 am
Adjourn
8:00 am
Injectable and Implantable Treatments for
Fecal Incontinence
Nishit Shah, MD, Providence, RI
Objectives: At the conclusion of this session, participants should be able to: a) Identify the newest techniques
for management of symptomatic hemorrhoids, fistula-in-ano, anal fissure, rectal prolapse and incontinence;
b) Review the newest innovations with respect to cost, risk, complications and success compared to well
established techniques and technologies; and c) Plan for incorporation of innovative methods for management
of anorectal conditions in the existing practice of colorectal surgery.
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
79
Tuesday, June 2
Symposium
Parallel Session 6-B
Update on Inflammatory Bowel Disease
1
2
5
6
*
7:30 – 9:00 am
Auditorium (2nd Floor)
1.5
MOC
1.5
CME
The management of Crohn’s disease and ulcerative colitis continues to evolve as we learn more about the genetics
of these diseases. Additionally, our management of patients with IBD has changed greatly with new drug development,
which then has downstream impact on their surgical therapy. Therefore, it is crucial to have a comprehensive understanding of these aspects of Crohn’s disease and ulcerative colitis in order to provide the most comprehensive care for
these patients.
Our understanding of the genetics of Crohn’s disease and to a lesser extent, ulcerative colitis, has grown greatly in the past
decade. The advances have to do with the discovery of the NOD2 gene and advances in technology such as the high
throughput genetics. This understanding has led to improvement in identifying high-risk patients, and defining disease
phenotypes. The introduction and expansion of biologic agents in the treatment of inflammatory bowel disease (IBD) has
provided an effective alternative to long-term steroid therapy. Immunomodulator therapy is so widespread that it is
uncommon for any patient with Crohn’s or ulcerative colitis to not be treated with one of these agents. Data clearly
supports its use in the acute and maintenance settings, but the long-term impact of the drugs on these patients regarding
the need for surgery and quality of life remains controversial. Pouchitis is the most common complication associated with
restorative proctocolectomies. The majority of cases are easily treated with antibiotics but a subset of these patients
develops chronic pouchitis that is antibiotic dependent or requires immunomodulators to treat. We are gaining an
increasing understanding of the pathophysiology of pouchitis and its treatments. Perianal Crohn’s disease presents some of
the greatest challenges to the patient and surgeon. The main goal for treating patients with perianal disease is focused
control of symptoms and rarely on cure or eradication. It remains unclear how the widespread use of biologic therapy has
impacted the surgical management of these patients. Restorative proctocolectomy with an ileal anal pouch has become the
surgical standard of care for patients with ulcerative colitis. This procedure can be done in one, two or three stages, and the
best approach remains controversial.
Existing Gaps
What Is: Our understanding of the genetics, pathophysiology, medical therapy and surgical therapy of IBD is constantly
changing.
What Should Be: Surgeons should understand the genetic basis, the indications and outcomes associated with medical
management, and the surgical principles for the treatment of IBD in today’s world of medicine.
Director: Matthew Mutch, MD, St. Louis, MO
Assistant Director: Marc Singer, MD, Chicago, IL
7:30 am
Introduction
Matthew Mutch, MD, St. Louis, MO
7:36 am
7:49 am
8:02 am
8:19 am
Genetics of IBD – What Have We Learned?
David Stewart, Sr., MD, Hershey, PA
Perianal Crohn’s Disease – Has Biologic
Therapy Changed our Surgical Principles?
Justin Maykel, MD, Worcester, MA
8:28 am
Immunomodulators and Biologic Agents for
Intestinal Disease – Surgery vs Drugs
Sekhar Dharmarajan, MD, St. Louis, MO
Restorative Proctocolectomy – 3 Stage vs
2 Stage vs 1 Stage
Timothy Geiger, MD, Nashville, TN
8:41 am
Panel Discussion/Questions
9:00 am
Adjourn
Chronic Pouchitis – What Is it and How Do I
Treat it?
David Dietz, MD, Cleveland, OH
Objectives: At the conclusion of this session, participants should be able to: a) Recognize the genetics of IBD;
b) Identify the impact of medical therapy on the treatment of Crohn’s disease; c) Recognize the pathophysiology
and treatment of chronic pouchitis; d) Describe the principle of managing perianal Crohn’s disease; and
e) Evaluate the indications for 3 stage, 2 stage, and 1 stage restorative proctocolectomy.
80
Tuesday, June 2
9:00 – 9:30 am
Auditorium (2nd Floor)
Diverticulitis: What’s New
.5
CME
Lisa Strate, MD, MPH
Associate Professor of Medicine
Department of Medicine
Division of Gastroenterology
University of Washington
Harborview Medical Center
Seattle, WA
Introduction: Ann Lowry, MD
Refreshment Break in Exhibit Hall
& ePoster Presentations
(See pages 112-113 for schedule.)
Photo Credit: Greater Boston Convention & Visitors Bureau
9:30 – 10:15 am
81
T U E S D AY
Ernestine Hambrick, MD, Lectureship
Tuesday, June 2
Symposium
Parallel Session 7-A
Controversies in Rectal Cancer Management
1
2
5
6
*
10:15 – 11:45 am
Auditorium (2nd Floor)
1.5
CME
Supported in part by an independent educational grant from Applied Medical
Rectal cancer management is changing as new evidence emerges regarding the benefits of multidisciplinary
treatment and techniques for optimizing surgical outcomes. Specifically, the need of routine preoperative
radiotherapy, the role for long-course chemoradiotherapy versus short course radiotherapy alone, the management of
patients with complete clinical response following chemoradiation, and the role of adjuvant therapy following neoadjuvant
chemoradiation, are all unsolved clinical dilemmas. Some of this debate has been informed by improvements in surgical
outcomes and our improved understanding of the impact of circumferential margins at resection, for both proximal and
distal rectal cancers.
Existing Gaps
What Is: Current treatment guidelines for patients with rectal cancer do not account for the underlying heterogeneity of
rectal cancers with respect to treatment response or risk for recurrence.
What Should Be: Surgeons should have an understanding about the determinants of outcomes following multidisciplinary
treatment for rectal cancer and how treatment may be tailored to maximize oncologic outcome while minimizing the risk
for unnecessary toxicity.
Director: George Chang, MD, Houston, TX
Assistant Director: Fergal Fleming, MD, Rochester, NY
10:15 am The CRM is Widely Clear: Is Routine
Preoperative Radiotherapy Still Necessary?
Peter Sagar, MD, Leeds, United Kingdom
11:15 am Adjuvant Chemotherapy Following
Neoadjuvant CXRT for Rectal Cancer: Does
Anybody Benefit?
Yi-Qian Nancy You, MD, Houston, TX
10:30 am Preoperative Radiotherapy for Rectal Cancer:
When to Go Short and When to Go Long.
Alexander Heriot, MD, Melbourne, VIC, Australia
11:30 am Discussion
11:45 am Adjourn
10:45 am I Don’t See Residual Tumor, What Should I Do?
Julio Garcia-Aguilar, MD, PhD, New York, NY
11:00 am Managing Minimally Invasive TME: Top Down
or Bottom Up?
John R.T. Monson, MD, Rochester, NY
Objectives: At the conclusion of this session, participants should be able to: a) Discuss treatment heterogeneity
among patients with rectal cancer; b) Describe issues in the management of rectal cancer patients with a
clinical complete response to neoadjuvant chemoradiation therapy; c) Discuss the evidence regarding adjuvant
chemotherapy for rectal cancer patients following neoadjuvant chemoradiation therapy; d) Discuss critical
issues related to circumferential resection margins during rectal cancer surgery; and e) Discuss the critical issues
within the evolving area of transanal TME.
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
82
Tuesday, June 2
Symposium
Parallel Session 7-B
1
2
3
5
*
10:15 – 11:45 am
Ballroom BC (3rd Floor)
1.5
MOC
1.5
CME
Supported in part by an independent educational grant from LifeCell, an Acelity Company
Despite improvements in surgical technique and enterostomal therapy care, complications following stoma
creation are very common. The rate of stoma-specific complications in the literature varies between 10% and 70%,
and is dependent on the length of follow-up and the definition of “complication.” Complications include peristomal skin
irritation, leakage, high output, dehydration, ischemia, retraction, stenosis, and recurrence of the disease for which a stoma
was created, such as Crohn’s disease.
Participants will be updated on how to construct intestinal stomas as well as how to prevent and treat stoma-related
complications. This symposium will discuss the techniques of stoma siting and marking, stoma construction, prevention
and management of complications including parastomal hernia, and management of patients with high-volume outputs.
Technical tips to avoid complications and facilitate construction will be emphasized. Quality of life for patients with stomas
will also be discussed.
Existing Gaps
What Is: Construction and management of stomas remains challenging and stoma-related complications remain high. Often
the surgeon is the primary provider in the management of these complications, and many surgeons lack the experience
necessary to adequately treat them.
What Should Be: Surgeons should know multiple options for stoma creation. Additionally, physicians should have an
understanding of how to prevent and treat stoma-related complications.
Co-Director: Deborah Nagle, MD, Boston, MA
Co-Director: Joseph Carmichael, MD, Orange, CA
10:15 am Patient Education and Stoma Site Selection
A. Murray Corliss, RN, CWOCN, Boston MA
11:00 am Other Stoma Complications Other Than Hernia
Walter Peters, Jr., MD, Columbia, MO
10:30 am Ostomy Selection, Construction and
Technical Challenges
Neil Hyman, MD, Chicago, IL
11:15 am Complicated Cases/Panel Discussion
10:45 am
11:45 am Adjourn
Parastomal Hernias: The Controversy
Continues
Michael Rosen, MD, Cleveland, OH
Objectives: At the conclusion of this session, participants should be able to: a) Discuss the preoperative
optimization of patient to prevent stoma-related complications; b) Describe methods to medically manage
common peristomal problems; c) Describe techniques to prevent and repair parastomal hernias; d) Discuss
methods of managing patients with stoma retraction, stenosis, prolapse, and peristomal skin problems; and
e) Describe methods of managing patients with high-volume output stomas.
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
83
T U E S D AY
Ostomies: Location, Creation and Complications
Tuesday, June 2
Abstract Session
Parallel Session 7-C
General Surgery Forum
1.5
CME
10:15 – 11:45 am
Ballroom A (3rd Floor)
Co-Moderators: Lisa Haubert, MD, Houston, TX and Brian Valerian, MD, Albany, NY
10:15 am Bariatric Surgery Modulates IBDAssociated Microbiome Patterns in a
Murine Model
GS1
A. Vinci*, S. Li, M.J. Stamos, A. Pigazzi, Orange,
CA; S. Jellbauer, M. Raffatellu, Irvine, CA
10:48 am Adjuvant Chemoradiation in the
Management of T2N0 Rectal Cancer:
A Population Based Clinical Outcomes
Study Involving 4,054 Patients from the
Surveillance Epidemiology and End
Result (SEER) Database (1973–2010)
GS4
K. Mahendraraj*, V. Chakravorty, N. Ghalyaie,
R.S. Chamberlain, West Orange, NJ
10:21 am Discussant
Elizabeth He, MD, Maywood, IL
10:24 am Discussion
10:54 am Discussant
Melissa Felinski, MD, Cincinnati, OH
10:26 am Combining Old with New: Bowel Rest and
Biologic Therapy Aid in the Surgical and
Medical Management of Penetrating
Ileocolic Crohn’s Disease
GS2
M.D. Wagner*, M. McNally, J. Duncan,
Bethesda, MD, N. Jaqua, M. Ally, J. Betteridge,
Bethesda, MD
10:57 am Discussion
10:59 am Does Cyanoacrylate Glue Reinforcement
Reduce Anastomotic Failure? Results of an
Experimental Comparative Study
GS5
W. Gaertner, Minneapolis, MN;
E. Nunez-Garcia, I. Baley-Spindel, J. MedinaLeon, R. Sordo-Mejia*, Mexico City, DF, Mexico
10:32 am Discussant
Jessica Cohan, MD, San Francisco, CA
11:05 am Discussant
Christine Choi, MD, Hershey, PA
10:35 am Discussion
10:37 am Laparoscopic Radical Resection after
Transanal Endoscopic Microsurgery:
Is it Feasible and Safe?
M. Masse*, A. Bouchard, A. Laliberté,
A. Lebrun, S. Drolet, Quebec, QC, Canada
11:08 am Discussion
GS3
11:10 am Colonoscopy after Left-Sided Diverticulitis:
Utility or Futility?
GS6
A.S. Walker*, J. Bingham, K. Janssen,
E.K. Johnson, S.R. Steele, Tacoma, WA;
J.A. Maykel, Worcester, MA; O. Ocampo, West
Fairview, Quezon City, Philippines; J.P. Gonzalez,
Cebu, Philippines
10:43 am Discussant
Ira Leeds, MD, Baltimore, MD
10:46 am Discussion
11:16 am Discussant
Grace Hwang, MD, Orange, CA
11:19 am Discussion
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
84
Continued next page
*Presenting Author
General Surgery Forum (Continued)
11:21 am Robotic versus Open Total Mesorectal
Excision: A Comparison of Clinical and
Pathologic Outcomes
J.L. Agnew* F.M. Chory, P.D. Strombom,
G. Bonomo, New York, NY; K.A. Melstrom,
W.E. Enker, J.E. Martz, New York, NY
11:32 am Relative Benefits and Risks of Alternative
Modes of Bowel Preparation to Prevent SSI
following Elective Colorectal Resection
GS8
N. Esnaola, Philadelphia, PA; S. Koller*, R. Smith,
S. Jayarajan, M. Philp, H.M. Ross, H. Pitt,
Philadelphia, PA
GS7
11:27 am Discussant
Benjamin Crawshaw, MD, Cleveland, OH
11:38 am Discussant
Mark Hanna, MD, Orange, CA
11:30 am Discussion
11:41 am Discussion
11:45 am Adjourn
Objectives: At the conclusion of this session, participants should be able to: (GS1) Identify intestinal bacterial
flora and molecular patterns in Inflammatory bowel disease; the complex interplay between the proinflammatory state of obesity and IBD; recognize that IBD-associated microbiome patterns may be a possible
beneficial target of bariatric surgery, and this therapeutic approach may modulate the mechanisms of specific
commensal-host interactions and immune responses; (GS2) Recognize the sub population of Crohn's patients
with penetrating phenotype; develop a plan of management for Crohn's patients presenting with fistula and/or
abscess that potentially minimizes surgical risk and improves outcome; (GS3) Recognize the necessity for radical
resection in some patient after TEM; determine the feasibility of laparoscopic TME after TEM; (GS4) Determine
whether patients with T2N0 rectal cancer (stage IB) derive similar survival benefit from adjuvant therapy as
T3/T4 or N1 disease; determine additional factors influencing survival in T2N0 rectal cancer (stage IB);
(GS5) Analyze the experimental use of N-butyl-2-cyanoacrylate glue for anastomotic reinforcement; analyze the
impact of N-butyl-2-cyanoacrylate glue on peritoneal healing, specifically adhesion formation; (GS6) Identify
those patients that require a colonoscopy after an acute episode of diverticulitis; advocate counseling to
patients on the follow-up plan after an episode of diverticulitis; build to the literature regarding post
diverticulitis colonoscopy; (GS7) Analyze the surgical and pathologic outcomes of robotic and open total
mesorectal excisions performed for rectal adenocarcinoma; compare differences in short-term clinical outcomes
after open and robotic total mesorectal excisions; and (GS8) Recognize the ways in which different types of
bowel preparations are associated with surgical site infections following elective colorectal resections.
85
T U E S D AY
Tuesday, June 2
Tuesday, June 2
Masters in Colorectal Surgery Lectureship
Honoring David J. Schoetz, Jr., MD
11:45 am – 12:15 pm
Auditorium (2nd Floor)
The Value of Mentorship
.5
CME
Patricia L. Roberts, MD
Chair, Division of Surgery, Lahey Hospital and
Medical Center, Burlington, MA
Professor of Surgery, Tufts University School of
Medicine, Boston, MA
Introduction: Thomas Read, MD
Complimentary Box Lunch in the Exhibit Hall
& ePoster Presentations
(See pages 112-113 for schedule.)
12:15 – 1:30 pm
Women in Colorectal Surgery
Luncheon
12:15 – 1:30 pm
Complimentary • Registration Required
Rooms 304 – 306
The Women’s Luncheon offers an opportunity to renew
friendships and make new contacts. Female surgeons,
residents and medical students attending the
Annual Meeting are welcome. Trainees are particularly
encouraged to attend as the Women’s Luncheon provides
an opportunity to meet experienced colon and
rectal surgeons from a variety of settings.
Supported by Ethicon
86
Tuesday, June 2
Symposium
Parallel Session 8-A
1
2
5
6
*
1.5
CME
1:30 – 3:00 pm
Auditorium (2nd Floor)
Anal cancer, unlike colorectal cancer, has been increasing in prevalence over the last 20 years. While the
treatment of anal cancer has largely remained unchanged, the definitions of what constitutes an anal cancer have
changed. Further, the terminology for the anal cancer precursor lesion, high-grade squamous intraepithelial lesion (HSIL)
has been standardized. Finally, studies have shown that untreated precursor lesions may progress to anal cancer
substantiating the proposal that treatment of precursor lesions may decrease anal cancer rates. This session will review
the current understanding of prevention, diagnosis and treatment of premalignant and malignant lesions of the anus
and perianus.
Existing Gaps
What Is: There is confusion about how to define lesions in the perianus as anal or perianal; along with confusion about
efficacy and the need for treatment of premalignant lesions of the perianus. There is mixed usage of old terminology for
anal and perianal lesions.
What Should Be: There will be a common understanding of what constitutes anal and perianal. There will be a common
of standard terminology that applies to the lower anogenital tract and has been promulgated by the American College
of Pathology.
Director: Mark Welton, MD, Stanford, CA
Assistant Director: Janice Rafferty, MD, Cincinnati, OH
1:30 pm
Introductions
Mark Welton, MD, Stanford, CA
Janice Rafferty, MD, Cincinnati, OH
1:35 pm
Anatomic and Histologic Definitions
John Migaly, MD, Durham, NC
1:50 pm
Who Should be Screened for Anal Cancer?
Rocco Ricciardi, MD, Burlington, MA
2:05 pm
How to Do the Screening and Who Should
Do It?
Bruce Robb, MD, Indianapolis, IN
2:20 pm
How Do We Manage Pre-Cancerous Lesions?
Natalie Kirilcuk, MD, Stanford, CA
2:35 pm
What Is the Treatment and Expected
Outcomes of Patients with Anal Cancer Both
Immuncompetent and Immunocompromised?
Larissa Temple, MD, New York, NY
2:50 pm
Panel Discussion
3:00 pm
Adjourn
Objectives: At the conclusion of this session, participants should be able to: a) Explain the current terminology
surrounding histologic findings of squamous lesions of the anus and perianus; b) Explain the current
terminology used to define lesions of the anus and perianus as either anal or perianal; and c) Describe the
current treatment recommendations for anal and perianal cancer.
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
87
T U E S D AY
Anal Cancer: Prevention, Diagnosis and Treatment
Tuesday, June 2
Abstract Session
Parallel Session 8-B
Inflammatory Bowel Disease
1
2
*
1.5
CME
1:30 – 3:00 pm
Ballroom BC (3rd Floor)
Co-Moderators: Imran Hassan, MD, Cedar Rapids, IA and Feza Remzi, MD, Cleveland, OH
1:30 pm
IBD: A Growing and Vulnerable Cohort
of Hospitalized Patients with Clostridium
Difficile Infection
S27
A. Mabardy*, J. Coury, L. Ozcan, J. McCarty,
A. Merchant, C. Armstrong, A. Hackford, H. Dao,
Boston, MA
1:37 pm
Discussion
1:40 pm
Clostridium Difficile Infection in
Ulcerative Colitis: Can Alteration of the
Gut-Associated Microbiome Contribute to
Pouch Failure?
S28
K. Skowron*, M. Rubin, R.D. Hurst, N. Hyman,
K. Umanskiy, Chicago, IL; B. Lapin, Evanston, IL
1:47 pm
Discussion
1:50 pm
Does Stool Leakage Increase in Aging
Ileal Pouches?
H. Kim*, L. Sun, B. Gurland, T.L. Hull,
M. Zutshi, Cleveland, OH
Discussion
2:00 pm
Proctocolectomy: Impact on Relationship
Quality in Ulcerative Colitis Patients and
their Partners
S30
J.N. Cohan*, J. Rhee, E. Finlayson, M.G. Varma,
San Francisco, CA
Discussion
2:10 pm
Rates of Colectomy for Ulcerative Colitis
in the Era of Biologic Therapy
C. Kin*, M.L. Welton, C. Woo, Stanford, CA;
A.L. Lightner, Los Angeles, CA
Discussion
2:20 pm
ESCP Best Paper
The Healing Effect of Mesenchymal
Adipose-Tissue-Derived Stem Cells on
Colonic Anastomosis Under
Ischaemic Condition
S32
Tony W.C. Mak*, Don W.C. Chin, Janet F.Y. Lee,
Paul B.S. Lai, Anthony W.I. Lo, Ping Kuen Lam,
Simon S.M. Ng, Shatin, Hong Kong
2:27 pm
Discussion
2:30 pm
Kono-S Anastomosis Devised for Aurgical
Prophylaxis of Anastomotic Recurrence in
Crohn’s Disease: A Multicenter Study in
Japan and the United States
S33
T. Kono*, Sapporo, Japan; A. Fichera, M. Krane,
Seattle, WA; K. Maeda, Nagoya, Japan;Y. Sakai,
Kyoto, Japan; H. Ohge, Hiroshima, Japan;
M. Shimada, Tokushima, Japan; D. Rubin,
Chicago, IL; A. Maemoto, Sapporo, Japan;
F. Michelassi, New York, NY
2:37 pm
Discussion
2:40 pm
Ileostomy Closure Site Fascial
Reinforcement with Cross Linked
Acellular Porcine Dermis Biologic Mesh
Yields No Incisional Hernias at 1 Year
of Follow-Up
M. Brozovich*, Wexford, PA
S29
1:57 pm
2:07 pm
2:17 pm
S31
2:47 pm
Discussion
2:50 pm
Q&A
3:00 pm
Adjourn
S34
Objectives: At the conclusion of this session, participants should be able to: (S27) Describe recent trends in the prevalence of
inflammatory bowel disease in hospitalized patients with Clostridium difficile infection; compare the mortality and colectomy rates
associated with inflammatory bowel disease for hospitalized patients with Clostridium difficile infection; (S28) Analyze the association of
C. difficile colitis with pouch failure; assess the risk of pouch reconstruction after Clostridium difficile colitis in the native colon;
(S29) Analyze the occurrence of severe fecal incontinence in IPAA patients in long-term; describe the risk factors for fecal incontinence
after IPAA in long-term; (S30) Discuss changes in ulcerative colitis patients' personal relationships after proctocolectomy; consider the role
of gender in relationship quality before and after proctocolectomy in patients with ulcerative colitis; (S31) Recognize the likelihood of a
surgical hospitalization for ulcerative colitis since the approval of infliximab; discuss the factors that increase the odds of an operation for
ulcerative colitis; (S32) Describe the use of adipose-derived stem cells effectiveness; (S33) Describe a novel anastomotic technique for
surgical prophylaxis of anastomotic recurrence in Crohn’s disease; develop a surgical plan of management for Crohn’s disease;
(S34) Demonstrate how to improve outcomes; explain how to reduce hernia rate and reoperation.
*Presenting Author
88
Tuesday, June 2
Parallel Session 8-C
Research Forum
1.5
CME
1:30 – 3:00 pm
Ballroom A (3rd Floor)
Co-Moderators: Emily Finlayson, MD, San Francisco, CA and David Stewart, Sr., MD, Hershey, PA
1:30 pm
Lymph Node Stromal Cell Microvesicles
Mediate Colon Cancer Metastasis
RF1
D. Margolin, P.E. Miller, H. Green-Matrana,
E. Flemington, X. Zhang, L. Li*, New Orleans, LA
2:09 pm
Discussant
Melissa Times, MD, Detroit, MI
2:12 pm
Discussion
2:14 pm
Mesenchymal Stem Cells following Local
Electrical Stimulation Improves Function in a
Rat Anal Sphincter Injury Model at a Time
Remote from Injury
RF5
L. Sun*, Z. Xie, M. Zutshi, M. Damaser,
Cleveland, OH
1:36 pm
Discussant
Evan Messaris, MD, Hershey, PA
1:39 pm
Discussion
1:41 pm
Diverticulitis and Crohn’s Disease Have
Distinct But Overlapping Tumor Necrosis
Superfamily 15 (TNFSF15) Haplotypes
RF2
T.M. Connelly*, Dublin, Ireland; C.S. Choi,
A. Berg, J. Coble, W. Koltun, Hershey, PA
2:20 pm
Discussant
Joseph Carmichael, MD, Orange, CA
2:33 pm
Discussion
1:47 pm
Discussant
Mukta Krane, MD, Seattle, WA
2:25 pm
1:50 pm
Discussion
1:52 pm
Combination Therapy for Colorectal Cancer
Metastasis using an Orthotopic Xenograft
Model
RF3
D. Margolin, B.A. Reuter, L. Li*, X. Zhang, New
Orleans, LA
Antitumor Activity of Dietary
Phytochemicals in Colorectal Cancer
RF6
B. Megna*, C. Diaz-Diaz, P. Carney, M. Nukaya,
G.D. Kennedy, Madison, WI
2:31 pm
Discussant
Jason Hall, MD, Burlington, MA
2:34 pm
Discussion
2:36 pm
Mesna and Hydroxypropyl Methylcellulose
Assists in Delayed Submucosal dDssection
in a Rabbit Cecal Model
RF7
G. Subhas*, M. Patel, J.S. Bhullar, V. Mittal,
Southfield, MI
2:42 pm
Discussant
Konstantin Umanskiy, MD, Chicago, IL
2:45 pm
Discussion
1:58 pm
Discussant
Fergal Fleming, MD, Rochester, NY
2:01 pm
Discussion
2:03 pm
Depletion of let-7 microRNAs in the
Intestinal Epithelium Promotes Upregulation
of Oncofetal mRNAs and Intestinal
Carcinogenesis
RF4
A.N. Jeganathan*, R. Mizuno, A.K. Rustgi,
Philadelphia, PA; B.B. Madison, St. Louis, MO
Continued next page
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
89
*Presenting Author
T U E S D AY
Abstract Session
Tuesday, June 2
Research Forum (Continued)
2:47 pm
Genetic Heterogeneity in Rectal Cancer –
Identification of Subpopulations of Tumor
Cells Resistant to Neoadjuvant CRT
RF8
R. Perez*, F. Bettoni, A. Camargo,
E. Donnard, B. Correia, F. Koyama, P. Galante,
A. Habr-Gama, J. Gama-Rodrigues,
Sao Paulo, Brazil
2:53 pm
Discussant
Anne Lin, MD, Los Angeles, CA
2:56 pm
Discussion
3:00 pm
Adjourn
Objectives: At the conclusion of this session, participants should be able to: (RF1) Describe the role microvesicles play in cell to cell communication; explain the role lymph node stroma plays in colorectal cancer;
(RF2) Gain an understanding of the concept of a genetic haplotype using a well-established Crohn's disease
haplotype; review the data suggesting a role for a genetic predisposition in diverticulitis, including the TNFSF15
gene; (RF3) Analyze the ability of AMD3100 to inhibit CRC metastasis to the liver in a mouse model; differentiate
primary tumor burden from metastatic tumor burden, and appreciate the biochemical basis for this
differentiation; (RF4) Demonstrate the effects of let-7 miRNA downregulation in the intestinal epithelium as
pertaining to carcinogenesis; identify Hmga2, an oncofetal mRNA, as an enhancer of stem cell phenotype and a
marker of invasive adenocarcinoma; (RF5) Describe the therapeutic implications of using low grade electrical
stimulation at a time remote from injury as a stimulus for mesenchymal stem cell directed sphincter muscle
regeneration; evaluate a rat model of chronic anal sphincter injury and minimal-invasive therapy for muscle
regeneration; (RF5) Explain the antitumor effects of cruciferous vegetable metabolites against human colorectal
cancer cells in vitro, and the potential role for the aryl hydrocarbon receptor in their mechanism; evaluate a rat
model of chronic anal sphincter injury and minimal-invasive therapy for muscle regeneration; (RF6) Explain the
antitumor effects of cruciferous vegetable metabolites against human colorectal cancer cells in vitro, and the
potential role for the aryl hydrocarbon receptor in their mechanism; describe the clinical chemopreventive
potential that dietary phytochemicals could have in the setting of colon and rectal cancer; (RF7) Explain the
option of endoscopic submucosal dissection for large polyps which are not amenable for simple snare
polypectomy; describe chemicals such as Mesna and Hydroxypropyl Methycellulose can be used to assist
delayed submucosal dissection; and (RF8) Describe specific mutations may be associated with resistance or
sensitivity to CRT in rectal cancer; realize there may be a subpopulation of cancer cells that is enriched among
tumours that are unresponsive to CRT.
90
Tuesday, June 2
Symposium
Parallel Session 9-A
3
1.5
MOC
4
*
1.5
CME
3:00 – 4:30 pm
Ballroom BC (3rd Floor)
Although traditionally physicians have focused on professional liability related to medical care delivery, the world
has become more complex and now legal exposure extends to many other interactions. Physicians must understand
the importance to maintain a professional and constructive relationship with their patients, while accurately and
contemporaneously documenting the facts of the encounter. An accurate and complete medical record is essential to
confirm both the thought process at the time but also the immediately available facts. However, all surgeons will face
complications and managing both the discussion around the occurrence and the management of the complication are
important components for reducing the risk of litigation. There is a current trend at the institutional level to “apologize”;
however, this process must be managed well to avoid confusing adverse outcome from actual error in the minds of the
patient and his/her family.
The complexity of the medical billing process is another area of increasing risk to the colorectal surgeon. Once again
accurate documentation is essential to support a claim submission. The surgeon should also understand the process for
correct code selection, use of tracking codes, and modifier use to support accurate reimbursement.
Existing Gaps
What Is: Communication is an important component which reduces the risk of having a medical malpractice claim filed
against you. However, given the current climate even recognized treatment complications are a potential risk of such
action. Currently, many colorectal surgeons are unfamiliar with the value of appropriate, timely, and accurate
documentation of clinical encounters to reduce exposure should a malpractice claim be filed. The entire process from
discovery through trial is something generally unfamiliar to many colorectal surgeons and these topics are rarely taught
during training. In addition, most colorectal surgeons are unfamiliar with the various rules and regulations related to both
documentation of clinical encounters and claims submissions. These gaps include knowledge of criteria for E/M code
selection, modifier use, and implementation of correct coding initiative rules to allow accurate and complete claims
submission. Similarly, the majority of colorectal surgeons have little knowledge or understanding of employment contract
law and the interactions of these requirements with Stark provisions and other complex issues related to moving from
private practice to corporate employment. Finally, direct contracting with large payors is a major challenge for colorectal
surgeons. It is important to fully understand the complex language surrounding patient volumes, quality indicators and
reporting, preauthorization rules, claims denials and claims adjudication.
What Should Be: The colorectal surgeon should understand his/her role and the specific components of clinical
documentation and claim submission for patient encounters. Equally so, the colorectal surgeon considering selling his/her
practice or directly entering corporate employment after training should be able to discuss the key components of a
contract for such employment. Colorectal surgeons should fully understand their rights and privileges under contractual
relationships with insurers to assure full and complete reimbursement while limiting unnecessary administrative overhead.
Objectives: At the conclusion of this session, participants should be able to: a) Formulate the role of timely and
accurate clinical documentation in reducing exposure in a medical liability action against a colorectal surgeon;
b) Explain the process of a medical liability action against a colorectal surgeon; c) Implement appropriate
clinical documentation, code selection, and modifier use for accurate claim submission to insurance payors;
d) Review the components of employment contracts and the rights and privileges expected by a colorectal
surgeon transitioning from either private practice or residency training into full time corporate employment;
and e) Define the components of contractual relationships with payors to assure full and prompt
reimbursement while avoiding legal exposures (ie Stark regulations etc).
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
91
Continued next page
T U E S D AY
Medical Legal Symposium: How to Protect Yourself
Tuesday, June 2
Medical Legal Symposium: How to Protect Yourself (Continued)
Co-Director: Conor Delaney, MD, PhD, Cleveland, OH
Co-Director: Kyle Cologne, MD, Los Angeles, CA
Professional Liability
Michael Stamos, MD, Orange, CA
4:00 pm
Insurance Contracting
Frank Opelka, MD, New Orleans, LA
3:20 pm
Medical Documentation Billing
Guy Orangio, MD, New Orleans, LA
4:20 pm
Panel Discussion
4:30 pm
Adjourn
3:40 pm
Employment Contracting
Martin Luchtefeld, MD, Grand Rapids, MI
Photo Credit: Greater Boston Convention & Visitors Bureau
3:00 pm
92
Tuesday, June 2
Symposium
Parallel Session 9-B
1
2
5
6
T U E S D AY
Anal Fistulas: Diagnosis, Imaging and
Therapy – Rational Approaches
*
1.5
CME
3:00 – 4:30 pm
Auditorium (2nd Floor)
Anal fistula represents one of the most common and challenging anorectal diseases encountered by surgeons.
The principles of successful treatment include appropriate diagnosis, destruction of the internal opening with
preservation of sphincter function. Primary lay-open fistulotomy has a high success rate in treating fistulas; however, most
surgeons are reluctant to perform this procedure in instances where substantial impairment of continence may result. As a
result, several alternative treatments have been pursued which do not involve anal sphincter division. Rectal mucosal
advancement flap, lateral intersphincteric fistula transaction (LIFT), and collagen plug have all been described as sphincter
sparing fistula treatments with varying degrees of success. Understanding the indications, limitations, and success rates of
the various treatment modalities would allow for more effective and efficient treatment of fistula in ano.
Existing Gaps
What Is: There are many treatment options for the treatment of anal fistulas. The goals of fistula resolution and sphincter
preservation appear to be at odds given current treatments. Multiple options are available in the management of chronic
anal fissures.
What Should Be: Surgeons will understand the appropriate diagnosis indications, success rates, and complications of the
treatments available for anal fistulas.
Director: Charles Whitlow, MD, New Orleans, LA
Assistant Director: Jennifer Beaty, MD, Omaha, NE
3:00 pm
Fistulotomy – Does it Still Have a Place?
M. Benjamin Hopkins, MD, Raleigh, NC
3:52 pm
LIFT
Sean Langenfeld, MD, Omaha, NE
3:13 pm
Setons – How and When
Jason Hall, MD, Burlington, MA
4:05 pm
New Innnovations for Fistulas
James McCormick, DO, Pittsburgh, PA
3:26 pm
Advancement Flaps – 90% Success! Really?
Donald Kim, MD, Grand Rapids, MI
4:18 pm
Discussion
4:30 pm
Adjourn
3:39 pm
Fistula Plugs and Glue
Michael Snyder, MD, Houston, TX
Objectives: At the conclusion of this session, participants should be able to: a) Define the different treatment
modalities available for anal fistula; and b) Develop an algorithm for the management of different types of
anal fistula.
Refreshment Break in Auditorium Foyer
4:30 – 5:00 pm
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
93
Tuesday, June 2
After Hours Debate
1
REFRESH MENTS W I L L B E S ERV ED
*
2
1.25
CME
5:00 – 6:15 pm
Auditorium (2nd Floor)
All surgical specialties have certain topics/diseases that contain controversy. Understanding the optimal
treatment plan for patients often depends on a physician’s ability to see clarity in these lines of gray. Debates are
excellent tools to show differences in perspective and opinion regarding these topics. They effectively challenge and break
down surgical dogma and open people to new points of view. They often help audience members crystalize their own
values and beliefs. Speakers with passionate views about opposing treatment, with clear guidelines for the debate, can
effectively create an effective and novel learning environment. Furthermore, an assertive and experienced moderator can
challenge the speakers and engage the audience to both optimize critical thinking and illustrate what treatment plan may
be best for different scenarios.
Existing Gaps
What Is: Treatment of chronic anal fissure has evolved to the point that surgery is studiously avoided in favor of different
medical regimens. Rectal prolapse surgery in the form of transabdominal rectopexy has become a minimally invasive
procedure – including increasing use of the robot.
What Should Be: Treatment of anal fissures should be appropriately balanced between operative and non-operative
approaches. Operations with the robot should be justifiable with respect to outcomes and cost.
Moderator: David Schoetz, Jr., MD, Burlington, MA
5:00 pm
Anal Fissure – Is It a Surgical Disease?
Debating: Phillip Fleshner, MD, Los Angeles, CA
vs Neil Hyman, MD, Chicago, IL
5:30 pm
Rectal Prolapse in the Robotic Age
Debating: Bradley Champagne, MD, Cleveland, OH
vs Todd Francone, MD, Burlington, MA
6:15 pm
Adjourn
Objectives: At the conclusion of this session, participants should be able to: a) Develop a sensible approach to
the cure of chronic anal fissure; and b) Evaluate the appropriate operative techniques for performance of
transabdominal rectopexy.
Residents’ Reception
6:30 – 8:00 pm
Back Bay Ballroom Salons CD
Sheraton Boston Hotel
General Surgery residents will have an opportunity to
network and interact with colorectal program directors.
Open to general surgery residents and
colorectal program directors only.
94
Wednesday, June 3
Meet the Professor Breakfasts
Code
Subject/Faculty
W-1
UT
SOLD O
Complex Fistula
Ann Lowry, MD, St. Paul, MN
Scott Strong, MD, Cleveland, OH
W-2
Room
1.0
CME
Code
Subject/Faculty
Room 200
W-5
Stage 4 Cancer (What to Do)
Room 202
Eric Szilagy, MD, Detroit, MI
Julio Garcia-Aguilar, MD, PhD, New York, NY
Non-Operative Management of
Room 207
Rectal Cancer – the Right Patient
Robert Fry, MD, Philadelphia, PA
Rodrigio Perez, MD, PhD, Sao Paulo, Brazil
W-6
Parastomal Hernia and
Stoma Complications
W. Brian Perry, MD, San Antonio, TX
Walter Peters, Jr., MD, Columbia, MO
W-3
Pilonidal Disease: Options
and Outcomes
Richard Billingham, MD, Seattle, WA
Eric Johnson, MD, Fort Lewis, WA
Room 203
W-4
Enhanced Recovery Pathways
Room 206
Craig Reickert MD, Detroit, MI
Conor Delaney, MD, PhD, Cleveland, OH
Objectives: At the conclusion of this session, participants should be able to: a) Describe the procedures and
approaches discussed in this session.
95
Room
Room 300
W E D N E S D AY
6:30 – 7:30 am
Limit: 30 per breakfast • Fee $40 • Tickets Required • Continental Breakfast
Registrants are encouraged to bring problems and questions to this informal discussion.
Wednesday, June 3
Symposium
Parallel Session 10-A
Colon Cancer: Staging, Techniques
and the Role of Adjuvant Therapy
1
2
5
6
*
1.5
CME
7:30 – 9:00 am
Auditorium (2nd Floor)
1.5
MOC
The past 50 years has seen substantial progress in our understanding and in the management of colon and rectal
cancer (CRC). Surveillance colonoscopy with resection of premalignant polyps has led to a decreased incidence of
CRC even though compliance with the recommendations is suboptimal. Epidemiologic and genetic information allow us to
identify individuals at risk for cancer and should allow us to prevent the disease in many individuals. Patients diagnosed
with advanced CRC live much longer than in the past, and many are cured. This is attributed to many factors, including
cross-sectional imaging that properly stages patient and identifies metastases earlier, new surgical approaches and
numerous new chemotherapies. Higher resolution imaging modalities have improved the ability to properly stage
patients; surgical advances include minimally invasive procedures and laparoscopic-assisted procedures and safer and
more extensive lymphatic clearance. Biologic therapies have not yet been maximized, but we are learning when and where
some should be used. Soon we expect to be staging patients by biologic and genetic characteristics rather than by gross
pathology-treating patients based on biologic features but preferably identifying people at risk and preventing
CRC altogether.
Existing Gaps
What Is: Colon cancer surgery is performed by a large number of general and colorectal surgeons in the country. Even in
the elective setting a large number of cases are performed through a laparotomy, with incomplete preoperative staging
and limited lymphatic clearance. Furthermore the use of adjuvant chemotherapy varies extensively across specialties,
practice types and patient populations.
What Should Be: Surgeons should understand proper staging and surgical techniques, indications for adjuvant therapy and
the need for a multidisciplinary evaluation and management of colon cancer patients.
Director: Alessandro Fichera, MD, Seattle, WA
Assistant Director: Martin Weiser, MD, New York, NY
7:30 am
Introduction
Martin Weiser, MD, New York, NY
7:35 am
7:50 am
8:05 am
8:20 am
Preoperative Staging: What Does the Surgeon
Need to Know?
Lawrence Schwartz, MD, New York, NY
Stage II Colon Cancer. Who Needs Adjuvant
Chemo and Why?
Blase Polite, MD, Chicago, IL
8:35 am
Going Beyond MIS in Colon Cancer Surgery:
Less is More
Peter Marcello, MD, Burlington, MA
Molecular Classification of Colorectal Cancer:
Current Status
David Shibata, MD, Tampa, FL
8:50 am
Panel Discussion
9:00 am
Adjourn
Total Mesocolic Resection for Colon Cancer:
Magic Bullet?
Hermann Kessler, MD, PhD, Cleveland, OH
Objectives: At the conclusion of this session, participants should be able to: a) Describe the use of imaging for
preoperative staging; b) Identify when to recommend MIS in the management of colon cancer; c) Define basic theories of
lymphatic clearance; and d) Recognize new criteria and prognostic factors as indication for adjuvant therapy.
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
96
Wednesday, June 3
Abstract Session
Parallel Session 10-B
Outcomes
1.5
CME
7:30 – 9:00 am
Ballroom BC (3rd Floor)
7:30 am
Frailty Predicts Death, Disability and
Institutionalization in Patients Undergoing
Elective Colectomy
S35
D. Mukkai Krishnamurty*, Z. Torgersen,
S.J. Langenfeld, A. Kallam, J. Johanning,
R.A. Forse, Omaha, NE
7:37 am
Discussion
7:39 am
Decreased Narcotic Consumption with
the Addition of IV-Acetaminophen in
Colorectal Patients: A Prospective,
Randomized, Double-Blinded, PlaceboControlled Study
S36
C. Juergens , C. Ogg, W. Sergent, J. Ying,
A.H. Aryaie*, S. Lalezari, T. Husted, C. Ratermann,
Cincinnati, OH
7:59 am
The Temporary Cessation of Clopidogrel
and the Risk of Thrombotic or Bleeding
Events in Patients Undergoing
Colonoscopy
S38
P.E. Miller*, M. Bailey, M. Thomas, S. Pawlak,
D. Beck, T. Hicks, H. Vargas, C. Whitlow,
D. Margolin, New Orleans, LA
8:06 am
Discussion
8:09 am
Extending the Mandate for ExtendedDuration Thromboprophylaxis: Risk Factors
for Post-Discharge Venothromboembolism
in Colorectal Resections
S39
J.C. Iannuzzi*, C.T. Aquina, A.S. Rickles,
B.J. Hensley, K. Noyes, J. Monson, F. Fleming,
Rochester, NY
7:46 am
Discussion
8:16 am
Discussion
7:49 am
Patients Prefer Propofol for Conscious
Sedation at Colonoscopy When Compared
to Midazolam and Fentanyl
S37
C. Schroeder*, R. Tocco-Bradley, J. Obear,
C. Kaoutzanis, R.K. Cleary, K. Welch,
Ann Arbor, MI
8:19 am
A Model of Cost Reduction and
Standardization: Improved Cost Savings
While Maintaining the Quality of Care
S40
M. Guzman*, K. Umanskiy, Chicago, IL; M. Gitelis,
J.G. Linn, M.B. Ujiki, J.P. Muldoon, Evanston, IL
8:26 am
Discussion
7:56 am
Discussion
Continued next page
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
97
*Presenting Author
W E D N E S D AY
Co-Moderators: Sekhar Dharmarajan, MD, St. Louis, MO and Eric Szilagy, MD, Detroit, MI
Wednesday, June 3
Outcomes (Continued)
8:29 am
8:36 am
Failing to Prepare is Preparing to Fail:
A Single Blinded Randomized Controlled
Trial to Determine the Impact of a
Preoperative Instructional Video on
Resident's Ability to Perform Laparoscopic
Colectomy
S41
B. Crawshaw*, C.P. Delaney, W.C. Mustain,
A.J. Russ, S. Shanmugan, B.J. Champagne,
Cleveland, OH; S.R. Steele, Tacoma, WA; D. Lee,
Albany, NY
8:39 am
Surgical Specialization Increases
Lymph Node Yield: Evidence From a
National Database
A.N. Jeganathan*, S. Shanmugan, J. Bleier,
G.M. Hall, E.C. Paulson, Philadelphia, PA
8:46 am
Discussion
8:56 am
Q&A
9:00 am
Adjourn
Discussion
Objectives: At the conclusion of this session, participants should be able to: (S35) Recognize the effect of frailty
on outcomes after elective colectomy; advocate assessment of frailty as a part of pre-operative evaluation of
patients undergoing elective colectomy procedures; (S36) Evaluate effect of IV acetaminophen on decreasing
post-operative opioid consumption in patients undergoing colo-rectal surgeries; evaluate return of GI function,
length of hospital stay and occurrence of ileus when IV acetaminophen is used in patients undergoing
colorectal surgeries; (S37) Analyze the difference in patient satisfaction in receiving Propofol in comparison to
Midazolam and Fentanyl; analyze the difference in recovery time in patients receiving Propofol in comparison to
Midazolam and Fentanyl; (S38) Analyze the risk of thrombotic event when Clopidogrel is temporarily stopped
prior to colonoscopy; analyze the post-polypectomy bleeding risk when plavix is restarted during the postprocedure period; determine if the risk of stopping plavix is greater than the benefit provided by minimal
reduction in bleeding events; (S39) Determine risk factors for post-discharge venothromboembolism following
colorectal resections; analyze whether ulcerative colitis is a high risk group that should be considered for postdischarge thromboprophylaxis; (S40) Describe the causes of cost variability in performing laparoscopic
appendectomy; explain the framework for improving operative cost savings; (S41) Determine the challenges of
general surgery training in the setting of limited work hours; explain the benefits of brief additional preparatory
material including an instructional video prior to surgery on the performance and training of general surgery
residents and; (S42) Define the role of fellowship training in lymph node recovery following surgery for
colorectal cancer; identify hospital-related factors conferring significant increases in nodal identification.
98
S42
Wednesday, June 3
ASCRS/SSAT Symposium
Parallel Session 11-A
Challenges and Controversies: Surgical Management
of Advanced Disease and Recurrent Cancer
2
5
6
*
1.5
CME
9:00 – 10:30 am
Auditorium (2nd Floor)
The surgical and medical treatment of early stage colon and rectal cancer is fairly straightforward and a number
of guidelines exist (NCCN, American Cancer Society, ASCRS) to help clinicians manage their patients with cancer.
However, there are many complex situations that are difficult to manage and strategies for dealing with locally advanced
disease, various patterns of distant metastatic disease and recurrent disease are not covered in guidelines. In addition,
advances in chemotherapy mean that patients with advanced disease are surviving for longer periods of time and during
these extended survival periods, surgeons are not infrequently asked to intervene in ways that in the past may have not
been considered even remotely reasonable. In this setting, clinicians face issues that require discussion and direction. The
aim of this session will be to offer evidence-based guidance to clinicians faced with difficult issues centered on treating
advanced and recurrent colon and rectal cancer.
Existing Gaps
What Is: There are many complex situations that are difficult to manage, and strategies for dealing with locally advanced
disease, various patterns of distant metastatic disease and recurrent disease are not covered in guidelines. That, with
advances in chemotherapy allowing patients to live longer, means surgeons are asked to intervene in ways that in the past
may have not been reasonable.
What Should Be: Surgeons should be able to use evidence-based guidance when faced with difficult issues centered on
treating advanced and recurrent colon and rectal cancer.
Director: Kirk Ludwig, MD, Milwaukee, WI
Assistant Director: Julio Garcia-Aguilar, MD, PhD, New York, NY
9:00 am
New Chemotherapy Paradigms for Stage 4
Disease: Can the Surgeon Help by Reducing
Tumor Burden and Does this Make Sense?
Cathy Eng, MD, Houston, TX
9:36 am
Contemporary Management of Carcinomatosis
from Colon or Rectal Cancer: What Is
Reasonable and Possible?
Kiran Turaga, MD, Milwaukee, WI
9:12 am
Epithelial-Mesenchymal Transition and
Somatic Alteration in Colorectal Cancer with
and without Peritoneal Carcinomatosis
Yury Shelygin, MD, Moscow, Russia
9:48 am
Chasing Advanced Lymph Node Disease:
When and Why?
Alessandro Fichera, MD, Seattle, WA
9:24 am
Managing Liver Metastases: Staged Resection,
Combined Resection, or Liver First?
Michael D'Angelica, MD, New York, NY
10:00 am Case Discussion and Questions
10:30 am Adjourn
Objectives: At the conclusion of this session, participants should be able to: a) Explain new chemotherapeutic
regimens for treating Stage 4 colorectal cancer and the role of the surgeon in treating Stage 4 disease;
b) Describe contemporary management of carcinomatosis from colorectal cancer; and c) Explain when and
why it might be reasonable to do extended dissections and lymph node dissections for colorectal cancer.
Refreshment Break in Foyer
10:30 – 11:00 am
99
W E D N E S D AY
1
Wednesday, June 3
Abstract Session
Parallel Session 11-B
Video Session
1.5
CME
9:00 – 10:30 am
Ballroom BC (3rd Floor)
Co-Moderators: Konstantin Umanskiy, MD, Chicago, IL and Brian Valerian, MD, Albany, NY
9:00 am
Martius Flap For
BEST VIDEO
Rectovaginal Fistulas
WV1
K. Kniery*, E.K. Johnson, S. Steele, Tacoma, WA
9:07 am
Discussion
9:10 am
Robotic-Assisted Repair of
Rectal Prolapse
WV2
J. Mino*, M. Zutshi, B. Gurland, Cleveland, OH
9:17 am
Discussion
9:20 am
Transperineal Minimally Invasive
Approach in Miles Operation
WV3
S. Hasegawa*, R. Takahashi, K. Hida, K. Kawada,
Y. Sakai, Kyoto, Japan; S. Kato, Y. Kadokawa,
Y. Asao, Tenri, Japan
9:27 am
Discussion
9:30 am
Laparoscopic Repair of Perineal Hernia
S. Brathwaite*, S. Husain, A. Harzman,
Columbus, OH
9:37 am
Discussion
9:40 am
Full Thickness Excision for Benign Colon
Polyps Using Combined Endoscopic
Laparoscopic Surgery
WV5
P.R. O'Mahoney*, J.W. Milsom, J.D. Smith,
S.W. Lee, New York, NY
9:47 am
Discussion
9:50 am
Robotic-Assisted Low Anterior
Resection with Transanal Extraction:
Single Stapling Technique and
Fluorescence Evaluation of Bowel
Perfusion
M.D. Jafari*, J.C. Carmichael, A. Pigazzi,
Orange, CA
WV4
9:57 am
Discussion
10:00 am Transanal Minimally Invasive
Surgery with Inadvertent Rectal Injury
and Repair
M. Harfouche*, M. Philp, H.M. Ross,
Philadelphia, PA
WV7
10:07 am Discussion
10:10 am Laparoscopic Low Anterior Resection,
Transanal Total Mesorectal Endoscopic
Resection for Low Rectal Cancer
WV8
M.H. Hanna*, G. Hwang, L. Malellari, A. Pigazzi,
Orange, CA
10:17 am Discussion
10:20 am Wide Local Excision of Perianal
Paget’s Disease with Gluteal Flap
Reconstruction
WV9
G. Melich*, K. Kochar, J. Calata, A. Pai, J. Park,
L. Prasad, S. Marecik, Park Ridge, IL
10:27 am Discussion
10:30 am Adjourn
WV6
Continued next page
*Presenting Author
100
Wednesday, June 3
Objectives: At the conclusion of this session, participants should be able to: (WV1) Describe the preoperative
considerations that must be accounted for to allow the bulbocavernosus flap the greatest chance of success at
resolving a rectovaginal fistula; explain the key operative techniques to successfully repair a rectovaginal fistula
with a Martius flap; (WV2) Demonstrate the technique of abdominal ventral rectopexy; demonstrate the
benefits of robotic assistance in abdominal ventral rectopexy; (WV3) Clarify better visualization of surgical
anatomy around anal canal; describe how to perform minimally invasive transperineal approach for Miles
operation; (WV4) Identify patients at high risk for post-operative perineal hernia; identify the operative steps
necessary to perform laparoscopic repair of perineal hernia with mesh placement; (WV5) Explain the minimally
invasive treatment options available to avoid colectomy in challenging benign colon polyps; describe the
technical steps involved in full thickness excision of benign colon polyps using combined endoscopic
laparoscopic surgery; (WV6) Demonstrate the anatomy and technical steps of a low anterior resection using not
only a robotic assisted laparoscopic technique, but also to demonstrate single stapling technique with transanal extraction; practice the use of endoscopy in conjunction with fluorescence imaging to assess tissue
viability; demonstrate the change in resection margin secondary to the use of fluorescence imaging despite
good perfusion under white/visible light; (WV7) Identify a patient population and disease process that is
amenable to Transanal Minimally Invasive Surgery (TAMIS); recognize the unique challenges of performing
TAMIS; recall how to avoid rectal injury during TAMIS, and how to manage it if it occurs; (WV8) Explain the
method of resection of low rectal cancer with a combination of a laparoscopic and transanal endoscopic
technique allowing for sphincter preservation and complete mesorectal excision; demonstrate transanal
specimen extraction allowing specimen retrieval without the need for an abdominal incision; and (WV9)
Describe necessary preoperative workup of perianal Paget’s disease; discuss technical issues involved in wide
local excision and anal reconstruction for perianal Paget’s disease.
Refreshment Break in Foyer
10:30 – 11:00 am
101
W E D N E S D AY
Video Session (Continued)
Wednesday, June 3
Symposium
Parallel Session 12-A
Optimizing Treatment for Rectal Prolapse,
Constipation and Obstructed Defecation Syndrome
1
2
5
6
*
1.5
CME
11:00 am – 12:30 pm
Auditorium (2nd Floor)
1.5
MOC
The management of rectal prolaspe has been the debate for 100 years since Moschowitz first described its
pathogenesis. Since that time, over 100 operations have been described for the correction of prolapse of the rectum.
The operative approaches can be roughly divided into abdominal and perineal categories. The evaluation process and
decision making with respect to the choice of surgical procedure and specific techniques will be reviewed. The surgical
management of constipation requires a thorough understanding of both colonic function and the evacuatory mechanism.
The evaluation of patients with these disorders and their surgical treatment options will be presented.
Existing Gaps
What Is: Many surgeons are unfamiliar with all of the new approaches to repair rectal prolapse. They do not have
experience with different fixation and minimally invasive techniques available. Surgeons frequently are not familiar
with the physiologic testing available for the evaluation of constipation and their significance and impact on surgical
decision making.
What Should Be: Surgeons should be comfortable with several fixation techniques to repair prolapse. They should
have an understanding of the different repairs available and their utility in treating different patient populations. Surgeons
should be familiar with the physiologic evaluation tools available for constipated patients and have a strategy for
surgical management.
Director: Dana Sands, MD, Weston, FL
Assistant Director: Virginia Shaffer, MD, Atlanta, GA
11:00 am Functional Disorders: What Tests are
Necessary?
Heidi Bahna, MD, Miami, FL
11:45 am Constipation: Surgical Indications and
Outcomes
Massarat Zutshi, MD, Cleveland, OH
11:15 am Rectal Prolapse Abdominal Repairs: Fixation
and Resection Techniques
Brooke Gurland, MD, Cleveland, OH
Noon
11:30 am Rectal Prolapse Perineal Repairs: Still Relevant
in the Era of Laparoscopy?
Joseph Carmichael, MD, Orange, CA
12:15 pm Discussion
Obstructed Defecation: Is it Surgically
Correctable?
Liliana Bordeianou, MD, Boston, MA
12:30 pm Adjourn
Objectives: At the conclusion of this session, participants should be able to: a) Describe the abdominal
approaches and different fixation techniques available for treatment of rectal prolapse; b) Explain the perineal
approaches and different resection techniques for the treatment of rectal prolapse; c) Describe the value of
laparoscopy in the management of prolapse; d) Identify the tools available to evaluate constipation and
evacuatory dysfunction; and e) Plan a treatment algorithm for the management of constipation in different
clinical settings.
Lunch on your own
12:30 – 1:30 pm
*This session addresses MOC requirements as explained on page 11.
See pages 149-153 for disclosures.
102
Wednesday, June 3
Abstract Session
Parallel Session 12-B
Neoplasia II
1.5
CME
11:00 am – 12:30 pm
Ballroom BC (3rd Floor)
11:00 am Colorectal Specialization Improves
Survival in Colorectal Cancer
S44
G.M. Hall*, J. Bleier, A.N. Jeganathan,
S. Shanmugan, E.C. Paulson, Philadelphia, PA
11:07 am Discussion
11:11 am Enhanced Recovery Protocols in
Colorectal Scheduled Surgery:
Could We Do Better By Doing Less?
J. Ramirez*, E. Redondo, P. Royo, J. Gracia,
B. Calvo, P. Carrera, Zaragoza, Spain
11:51 am Relative Value of Restaging MRI, CT
and PET after Preoperative
Chemoradiation for Rectal Cancer
S49
D. Schneider*, A.C. Lynch, S. Warrier, A.G. Heriot,
T. Akhurst, M. Michael, S. Ngan, East Melbourne,
VIC, Australia
11:58 am Discussion
S45
11:18 am Discussion
11:21 am Does CD10 Expression Predict Lymph
Node Metastasis in Colorectal Cancer?
S46
I. Bernescu*, A. Reichstein, M. Luchtefeld,
J. Ogilvie, A. Davis, W. Chopp, Grand Rapids, MI
11:28 am Discussion
11:31 am Robotic Colorectal Surgery: How Honest are
the Authors’ Conclusions? An Assessment
of Reporting and Interpretation of the
Primary Outcomes
S47
B. Howe, J. Van Koughnett, London, ON, Canada;
S.V. Patel, New York, NY; S. Wexner, Weston, FL
11:38 am Discussion
11:41 am Features Associated with Metastases
Among Well-Differentiated Neuroendocrine
(Carcinoid) Tumors of the Appendix:
The Significance of Small Vessel Invasion
in Addition to Size
S48
D.A. Kleiman*, B.M. Finnerty, T. Beninato,
R. Zarnegar, G. Nandakumar, T.J. Fahey, III,
S.W. Lee, New York, NY
12:01 pm Predictors of Outcome for Endoscopic
Colorectal Stenting
S50
M.A. Abbas*, G. Kharabadze, Abu Dhabi, United
Arab Emirates
12:08 pm Discussion
12:11 pm British Traveling Fellow
Outcome of Robotic versus Laparoscopic
Abdominoperial Resection and
Evaluation of Early Experience of
Robotic Colorectal Surgery
S51
R. Mathew*, S.C. Chaudhri, Leicester, UK,
S.H. Kim, Seoul, South Korea
12:17 pm Discussion
12:20 pm Surgical Site Infection Rates following
Implementation of a Colorectal Closure
Bundle in Elective Colorectal Surgeries
A. Ghuman*, C.J. Brown, A.A. Karimuddin,
M.J. Raval, T.P. Phang, Vancouver, Canada
S52
12:27 pm Discussion
12:30 pm Adjourn
11:48 am Discussion
Continued next page
*Presenting Author
103
W E D N E S D AY
Co-Moderators: Badma Bashankaev, MD, Moscow, Russia and Eric Weiss, MD, Weston, FL
Wednesday, June 3
Neoplasia II (Continued)
Objectives: At the conclusion of this session, participants should be able to: (S44) Advocate the difference in
colorectal cancer survival between colorectal specialists and general surgeons; explain factors of colorectal
specialization that contribute to improved outcomes in colorectal cancer; (S45) Analyze the components of an
ERAS protocol in order to know the weight each one has in the success of it; arrange to help surgeons to
employ current best practice to enhance the recovery of patients undergoing major colorectal surgery;
(S46) Explain the benefit of identifying biomarkers able to better predict lymph node metastasis in colorectal
cancer; analyze the controversial status of CD10 as one of the biomarkers that could correlate with presence or
absence of lymph node metastasis in colorectal cancers; (S47) Recognize common methods of misinterpretation
in studies with equivocal results; recognize how frequent misinterpretation occurs in robotic surgery studies;
(S48) Describe the natural history and typical presentation of well-differentiated neuroendocrine tumors of the
appendix; identify histopathologic risk factors for metastatic disease which may aid in the selection of patients
for additional surgical resection to clear regional lymph nodes; (S49) Compare the impact of different imaging
modalities on restaging rectal cancers post neoadjuvant therapy; evaluate the effect of PET restaging on
management and stage changes after neoadjuvant therapy for rectal cancer; (S50) Determine short and longterm outcome of endoscopic colorectal stenting; list the factors that impact outcome; differentiate between
technical and clinic success and; (S52) Recognize critical appraisal of colorectal care bundles; identify risk factors
associated with higher SSI rates in colorectal surgery.
Lunch on your own
12:30 – 1:30 pm
104
Wednesday, June 3
Symposium
Enhanced Perioperative Care Pathways
and Postoperative Pain Management
2
5
6
*
1.5
CME
1:30 – 3:00 pm
Auditorium (2nd Floor)
Supported by independent educational grants from:
Edwards Lifesciences
Ethicon
Mallinckrodt Pharmaceuticals
Merck & Co., Inc.
Enhanced recovery perioperative care principles are widely reported to decrease complications and to improve
outcomes such as length of stay and cost. Many protocol examples are reported, and significant protocol differences
exist. Unless involved in creating a protocol before now, one will find the current literature and recommendations
intimidating, and in some aspects, conflicting. The impact reputedly reported and the importance of implementation of
evidence based practices, however, require that we critically consider these principles in our practices.
In this symposium, the basic and controversial elements defined in the enhanced recovery literature, including
postoperative pain management, will be discussed. Systematic implementation strategies will be shared, and case examples
will be used to critically discuss care elements.
Existing Gaps
What Is: The literature of enhanced recovery abounds with varied examples rather than practice parameters or
practical guides.
What Should Be: A systematic guide to implementing enhanced recovery would allow broad adoption of essential evidence
based best care elements and would improve outcomes, decrease variability, and lower costs of colorectal surgery.
Director: Julie Thacker, MD, Durham, NC
Assistant Director: David Beck, MD, New Orleans, LA
1:30 pm
Essential Elements
Robin Anderson, BSN, RN, Durham, NC
2:15 pm
Critical Review of Published Protocols
Elizabeth Wick, MD, Baltimore, MD
1:45 pm
Head of the Table – The Role of the
Anesthesiologist in Achieving Success
Robert Thiele, MD, Charlottesville, VA
2:30 pm
Details and Outcomes
Conor Delaney, MD, PhD, Cleveland, OH
2:45 pm
Debate and Discussion
2:00 pm
Multimodality Postoperative Pain
Management
Eric Haas, MD, Houston, TX
3:00 pm
Adjourn
Objectives: At the conclusion of this session, participants should be able to: a) Explain the current evidence of
enhanced recovery principles; b) Define for their practices, the elements most essential to implement; c) Define
for their health care systems the best implementation strategy; d) Describe available methods to manage
postoperative pain; and e) Recognize the outcomes they are most likely to impact with enhanced recovery
implementation and how to monitor these outcomes.
105
W E D N E S D AY
1
Wednesday, June 3
Symposium
Is there a Paradigm Shift in the
Management of Diverticular Disease?
1
2
5
6
*
1.5
CME
3:00 – 4:30 pm
Auditorium (2nd Floor)
The management of diverticular disease has significantly changed in the past 10 years. More patients are
managed with antibiotics and drainage for acute complicated diverticulitis, and avoiding emergent trips to the
operating room. Even among those who are taken to the operating room, the traditional resection with Hartmann’s closure
of the rectum is being replaced by washout and drain placement, or even resection with primary anastomosis. Even the use
of antibiotics in uncomplicated disease is changing, with data showing no benefit of the treatment to the disease process.
Those who are conservatively managed, undergo washout, or have recurrences will then present for consideration of
elective resection. This has created a shift in the outpatient management as more patients present after hospitalization for
complex disease. Deciding who will benefit from surgery has become more complex over time.
Existing Gaps
What Is: Who needs an operation, who can be medically managed, and what are the risks of each approach?
What Should Be: A clearer approach to both emergent and elective disease management.
Director: Timothy Geiger, MD, Nashville, TN
Assistant Director: Mukta Krane, MD, Seattle, WA
3:00 pm
Learning from History – The Evolution of the
Management of Diverticulitis
Patricia Roberts, MD, Burlington, MA
3:15 pm
Epidemiology and Etiology of Diverticular
Disease – More than Nuts and Seeds
Cary Aarons, MD, Philadelphia, PA
3:30 pm
Emergent Management of Acute Diverticulitis
Scott Strong, MD, Cleveland, OH
3:45 pm
Elective Management of Diverticular Disease –
Who Needs Surgery?
David Flum, MD, Seattle, WA
4:00 pm
Right-Sided Disease, Postoperative
Recurrences, Diverticular Disease in Younger
Patients and Other Unusual Presentations
James Yoo, MD, Boston, MA
4:15 pm
Discussion
4:30 pm
Adjourn
Objectives: At the conclusion of this session, participants should be able to: a) Recognize the current literature
on the etiology of diverticulosis and risks of recurrent disease; b) Distinguish the management of acute
diverticulitis both in the hospitalized patient and in the outpatient settings; c) Recognize the current surgical
approaches for acute diverticulitis, and the literature supporting each procedure; and d) Assemble a logical
approach for management of recurrent disease.
106
Wednesday, June 3
ASCRS Annual Business Meeting
and State of the Society Address
ASCRS
Annual Reception
and Dinner Dance
Reception
7:00 – 8:00 pm
Grand Ballroom Foyer
Sheraton Boston Hotel
Dinner Dance 8:00 – 10:30 pm
Grand Ballroom
Sheraton Boston Hotel
Tickets Required
Future Meetings
April 30 – May 4, 2016
May 19 – 23, 2018
Los Angeles Convention Center
J.W. Marriott L.A. Live
Los Angeles, CA
Music City Center
Omni Nashville Hotel
Nashville, TN
June 10 – 14, 2017
June 1 – 5, 2019
Washington State Convention Center
Sheraton Seattle Hotel
Seattle, WA
Cleveland Convention Center
Hilton Cleveland Downtown Hotel
Cleveland, OH
107
W E D N E S D AY
4:30 – 5:30 pm
Ballroom A (3rd Floor)
Wednesday, June 3
ASCRS Annual Business Meeting
and State of the Society Address
4:30 – 5:30 pm • Ballroom A (3rd Floor)
Agenda
I.
II.
III.
IV.
V.
VI.
VII.
VIII
IX.
X.
XI.
XII.
XIII.
XIV.
XV.
XVI.
XVII.
XVIII.
Call to Order – Dr. Terry Hicks
Approval of 2014 Business Meeting Minutes – Dr. Terry Hicks
Memorials – Dr. Tracy Hull
Treasurer’s Report – Dr. Patricia Roberts
Scientific Program Report – Drs. David Margolin and H. David Vargas
DC&R Editor-in-Chief Report – Dr. Robert Madoff
Awards Committee Report – Dr. Jason Hall
Website Committee Report – Dr. David Margolin
Barton Hoexter Best Video Award – Dr. Terry Hicks
Research Foundation Report – Dr. Steven Wexner
The American Board of Colon and Rectal Surgeons – Dr. David Schoetz
Election and Elevations of Members
State of the Society Address – Dr. Terry Hicks
Nominating Committee Report – Dr. Michael Stamos
New Business
Introduction of New President
Next Meeting: April 30 – May 4, 2016, Los Angeles Convention Center,
Los Angeles, CA
Adjourn
2015 – 2016 ASCRS Slate of Officers and Members-at-Large
The ASCRS Nominating Committee submits the following slate of Officers and Members-at-Large for election:
President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Charles E. Littlejohn, MD
President Elect . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Patricia L. Roberts, MD
Vice President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Guy R. Orangio, MD
Secretary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Tracy L. Hull, MD
Treasurer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Neil H. Hyman, MD
Members-at-Large:
Julio Garcia-Aguilar, MD, PhD (2015-2018)
Samuel C. Oommen, MD (2015-2018)
Feza H. Remzi, MD (2015-2018)
108
ePoster Presentations
ePosters of Distinction: The following ePosters have been designated as “ePosters of Distinction” and will be presented
from the ePoster Theater in the Exhibit Hall, at the dates and times indicated. They can be accessed from any of the
ePoster viewing monitors in the exhibit hall and in various common areas.
Moderator: Luca Stocchi, MD, Cleveland, OH
PD1006 Effect of Surgery on Quality of Life of Patients
with Locally Recurrent Rectal Cancer
Monday, 10:30 am
ePoster Theater
Neoplastic Disease
G. Pellino*, G. Sciaudone, G. Candilio,
S. Canonico, F. Selvaggi, Naples, Aversa (CE), Italy
PD1000 A Surgical Decision Aid for Patients with
Ulcerative Colitis
Sunday, 4:10 pm
ePoster Theater
Inflammatory Bowel Disease
J.N Cohan*, M.G. Varma, E. Finlayson, E. Ozanne,
J.L. Sewell, U. Mahadevan, D. Dohan, San
Francisco, CA, Lebanon, NH
PD1001 Total Proctocolectomy with Ileal Pouch Anal
Anastomosis: Does Disease Influence
Outcomes?
Sunday, 4:15 pm
ePoster Theater
Inflammatory Bowel Disease
A. Murray*, R.P. Kiran, D.E. Estrada Trejo, J. Rein,
C. Chiuzan, New York, NY
PD1008 Risk Factors for Perineal Wound Complications
after Abdominoperinal Resection: Analysis of
the ACS NSQIP Database
Monday, 10:40 am
ePoster Theater
Neoplastic Disease
A. Althumairi*, J. Canner, S. Gearhart, B. Safar,
S.H. Fang, E. Wick, J. Efron, Baltimore, MD
PD1002 Effect of Complex Surgical Interventions on
Postoperative Recurrence in Patients with
Crohn’s Disease
Sunday, 4:20 pm
ePoster Theater
Inflammatory Bowel Disease
R.A. Hodin*, L. Bordeianou, A. Ananthakrishnan,
D. Nguyen, J. Sauk, V. Yajnik, A. Olariu, Boston,
MA
PD1009 T4N0 Colon Cancer: Does Natural History
Warrant Adjuvant Chemotherapy?
Monday, 10:45 am
ePoster Theater
Neoplastic Disease
J.L. Agnew*, F.M. Chory, P.D. Strombom,
G. Bonomo, G. Aharonoff, K.A. Melstrom,
W.E. Enker, J.E. Martz, New York, NY
PD1003 Racial Disparities in Readmissions for Patients
with Inflammatory Bowel Disease (IBD) after
Colorectal Surgery
Sunday, 4:25 pm
ePoster Theater
Inflammatory Bowel Disease
D. Gunnells*, M.S. Morris, A. DeRussy, A.A. Gullick,
J.A. Cannon, M.T. Hawn, D.I. Chu, Birmingham, AL
Moderator: John Migaly, MD, Durham, NC
PD1004 Expression of Cystathionine-β-Synthase in
Normal Colonic Mucosa, Colon
Adenocarcinoma, and Inflammatory Bowel
Disease
Sunday, 4:30 pm
ePoster Theater
Inflammatory Bowel Disease
P. Johnson*, A.A. Mrazek, J.R. Zatarain, C. Chao,
M.R. Hellmich, I.V. Pinchuk, G. Luthra, C. Szabo,
Galveston, TX
PD1010 Hybrid PET/MRI versus PET/CT in the Staging
and Restating of Colorectal Cancer: Initial
Clinical Experience
Monday, 12:35 pm
ePoster Theater
Neoplastic Disease
B. Crawshaw*, C.P. Delaney, H.L. Reynolds,
N. Nguyen, S. Krishnamurthi, R.M. Paspulati,
Cleveland, OH, Pittsburgh, PA
PD1005 Small Bowel Adenocarcinoma of Crohn’s
Disease Patients in the United States
Monday, 10:25 am
ePoster Theater
Neoplastic Disease
N.E. Wieghard*, J.I. Young, B.C. Sheppard,
V.L. Tsikitis, S.I. Mongoue-Tchokote, M. Mori,
Biostatistics, Portland, OR
*All ePoster presenters are listed first unless otherwise noted.
109
EPOSTERS
PD1007 Considering Value in Rectal Cancer Surgery: An
Analysis of Costs and Outcomes Based on the
Open and Laparoscopic and Robotic Approach
for Protectomy
Monday, 10:35 am
ePoster Theater
Neoplastic Disease
J. Silva Velazco*, D. Dietz, L. Stocchi, M. Costedio,
E. Gorgun, M. Kalady, H. Kessler, I. Lavery,
Cleveland, OH
ePoster Presentations
PD1011 The Usefulness of Anorectal and Endovaginal
3D Ultrasound in the Evaluation of Sphincter
and Pubovisceral Muscles Defects Using a
Novel Scoring Systems in Women with Fecal
Incontinence after Vaginal Delivery
Monday, 12:40 pm
ePoster Theater
Other Benign Disease
S.M. Murad-Regadas*, F.S. Regadas, G. Fernandes,
I. Dealcanfreitas, M.C. Oliveira, L.V. Rodrigues,
F. Regadas Filho, M. Cruz, Fortaleza, Ceara, Brazil
PD1017 Training Model for Transanal TME Using a
Human Cadaver Model: Initial Experience.
Monday, 1:10 pm
ePoster Theater
Other Benign Disease
P. Sylla*, M. Whiteford, Boston, MA Portland, OR
PD1018 PERFACT Procedure (Proximal superficial
cauterization, emptying regularly of fistula
tracts and curettage of tracts): A New Concept
to Treat Highly Complex Anal Fistula
Monday, 1:15 pm
ePoster Theater
Other Benign Disease
P. Garg*, V. Gupta, P. lakhtaria, Haryana, India,
Chandigarh, India, New York, NY
PD1012 CT Mesenteric Angiography and Embolisation
in Bleeding Diverticular Disease – It Works for
Us, it May Work for You
Monday, 12:45 pm
ePoster Theater
Other Benign Disease
N. Thiruchelvam*, J. Ngu, Singapore
Moderator: Robert Sinnott, DO, Allentown, PA
PD1019 Does Sacral Neuromodulation for Slow Transit
Constipation Work in the Long Term? A Single
Centre Experience
Monday, 3:45 pm
ePoster Theater
Other Benign Disease
V. Garimella*, R. Padwick, M. Spencer, D. Latham,
M. Farmer, Leamington Spa, United Kingdom
PD1013 Safety and Efficacy of Stapled
Hemorrhoidopexy over Conventional
Hemorrhoidectomy – A Prospective
Randomized Trial.
Monday, 12:50 pm
ePoster Theater
Other Benign Disease
S.S. Nahid*, K. Azad, G.M. Salahuddin,
N.H. Masum, Dhaka, Bangladesh
PD1020 Management of Diverticular Abscesses with
Non-Surgical Drainage: Is There a Need for
Interval Resection?
Monday, 3:50 pm
ePoster Theater
Other Benign Disease
C. Knapp, M.I. Brand*, B.A. Orkin, Chicago, IL
PD1014 Clinical Experience of Anorectal Myectomy in
the Treatment of Internal Anal Sphincter
Achalasia in Young Adults
Monday, 12:55 pm
ePoster Theater
Other Benign Disease
I.H. Ozerhan, E. Samadov*, N. Ersoz, M.F. Can,
G. Yagci, Ankara, Turkey
PD1021 Impact of Obesity on Short-term Outcomes
after Laparoscopic Colorectal Resections:
A Multivariate Analysis.
Monday, 3:55 pm
ePoster Theater
Outcomes
A. Harzman, M. Arnold, S. Husain, Y. Lianbo,
S. Tuthill*, Columbus, OH
PD1015 Doppler-guided Hemorrhoidal Artery Ligation
with Suture Mucopexy vs. Suture Mucopexy
Alone for Treatment of Hemorrhoids Grade
III. A Prospective-Randomized Controlled Trial.
Monday, 1:00 pm
ePoster Theater
Other Benign Disease
F. Aigner*, J. Pratschke, I. Kronberger, A. Loizides,
L. Gruber, H. Gruber, Berlin, Germany, Innsbruck,
Austria
PD1022 Variations in Laparoscopic Colectomy
Utilization in Different Hospitals in the
United States
Monday, 4:00 pm
ePoster Theater
Outcomes
Z. Moghadamyeghaneh*, J.C. Carmichael,
S.D. Mills, A. Pigazzi, M.J. Stamos, Orange, CA
PD1016 Is Sacral Nerve Stimulation on Patients with
Anal Sphincter Defects More than 60 Degrees
Helpful?
Monday, 1:05 pm
ePoster Theater
Other Benign Disease
R. Wei*, A. Vogler, C. Jensen, M.P. Spencer, Hong
Kong, Minneapolis, MN
PD1023 Post Hospital Discharge Venous
Thromboembolism in Colorectal Surgery
Monday, 4:05 pm
ePoster Theater
Outcomes
Z. Moghadamyeghaneh*, J.C. Carmichael,
S.D. Mills, A. Pigazzi, M.J. Stamos, Orange, CA
*All ePoster presenters are listed first unless otherwise noted.
110
ePoster Presentations
Moderator: Jonathan Efron, MD, Baltimore, MD
PD1031 Impact of the Specific Extraction-Site Location
on the Risk of Incisional Hernia and Wound
Infection after Laparoscopic Colorectal
Resection
Tuesday, 12:30 pm
ePoster Theater
Outcomes
C. Benlice*, L. Stocchi, M. Costedio, E. Gorgun,
H. Kessler, Cleveland, OH
PD1024 Rates of Complications and Outcomes after
Interhospital Transfer versus Direct Admission
in Colorectal Surgery: Implications for Pay-forPerformance Models
Tuesday, 9:40 am
ePoster Theater
Outcomes
S.P. Sharp*, D. Ata, D.B. Johnson, S.L. Bestle,
D. Chismark, D.J. Canete, D.T. Valerian, D. Lee,
Albany, NY
PD1025 Patient Preferences for Outcomes following
Abdominal Surgery: GI Symptom Tolerance
Tuesday, 9:45 am
ePoster Theater
Outcomes
T. Kauf, M.H. Potashman; C. Poulos*, J. Posner,
A.B. Hauber, E. Viscusi, M. Aeder, Lexington, MA,
Philadelphia, PA, Cleveland, OH, Research
Triangle Park, NC
PD1033 Home Hospitalization Care (HHC) as
implementation of Enhanced Recovery after
Colorectal Surgery (ERACS) program
Tuesday, 12:40 pm
ePoster Theater
Outcomes
C. Cagigas-Fernández*, A. Calero-Lillo, M. Gomez
Ruiz, J. Alonso Martin, J. Manuel Palazuelos,
I. Martín-Parra, J. Castillo-Diego, M. Gomez Fleitas, Santander, Cantanbria, Spain
PD1026 Can Electroacupuncture Reduce the Duration
of Postoperative Ileus and Hospital Stay after
Laparoscopic Surgery for Mid and Low Rectal
Cancer? A Prospective Cohort Study with
Matched Historic Controls
Tuesday, 9:50 am
ePoster Theater
Outcomes
S.S. Ng*, W. Leung, T.W. Mak, S.S. Hon, D.K. Ngo,
S. Chu, N.O. Mak, J.F. Lee, Hong Kong
PD1034 High Variability in Nosocomial Clostridium
Difficile Infection Rates among Both Surgeons
and Hospitals following Colorectal Resection
Tuesday, 12:45 pm
ePoster Theater
Outcomes
C.T. Aquina*, C.P. Probst, B.J. Hensley,
J.C. Iannuzzi, K. Noyes, J. Monson, F.J. Fleming,
Rochester, New York
PD1028 Risk of Surgical Site Infection Varies Based on
Location of Disease and Segment of Colorectal
Resection for Cancer: Time to Adjust QualityMonitoring Metrics?
Tuesday, 9:55 am
ePoster Theater
Outcomes
A. Murray*, R. Teja Pasam, D.E. Estrada Trejo,
D. Feingold, S. Lee-Kong, R.P. Kiran, New York, NY
PD1035 Racial Disparities in Hospital Length-of-Stay
(LOS) for Patients after Elective Colorectal
Surgery
Tuesday, 12:50 pm
ePoster Theater
Outcomes
D.I. Chu*, A. DeRussy, D. Gunnells, A.A. Gullick,
J.A. Cannon, M.T. Hawn, M.S. Morris,
Birmingham, AL
Moderator: Ovunc Bardakcioglu, MD, Las Vegas, NV
PD1029 3-D Laparoscopic Colorectal Surgery - The
Robot of the Future?
Tuesday, 12:20 pm
ePoster Theater
Outcomes
M.N. Lamb, K. Cologne, A.M. Kaiser*, Los
Angeles, CA
PD1037 Comparison of LIFT and Fistulotomy in
Treatment of Intersphincteric and Low
Transsphincteric Anal Fistula: Prospective
Randomized Study
Tuesday, 12:55 pm
ePoster Theater
Other Benign Disease
E. Yardimci*, M. Hasbahceci, E. Aysan,
H. Bektasoglu, U.O. Idiz, M. Muslumanoglu,
G. Cipe, Istanbul, Turkey
PD1030 Risk Factors and Predictors of Prolonged
Postoperative Ileus after Colectomy: An
Assessment from Nationwide ProcedureTargeted Cohort
Tuesday, 12:25 pm
ePoster Theater
Outcomes
A. Rencuzogullari*, C. Benlice, M. Costedio, X. Liu,
F. Remzi, E. Gorgun, Cleveland, OH
*All ePoster presenters are listed first unless otherwise noted.
111
EPOSTERS
PD1032 Reinforcement of Fascial Closure by
Polyglactin-Mesh to Prevent Abdominal Wound
Dehiscence following Open Colorectal Surgery
Tuesday, 12:35 pm
ePoster Theater
Outcomes
L. Lesalnieks*, Surgery, M. Baladov, K. Ikhlawi,
Gelsenkirchen, Germany, Munich, Germany
ePoster Presentations
General ePosters: The authors of each ePoster have been assigned a specific time frame to be at a designated monitor
and available for questions. The following ePosters can be accessed from any of the ePoster viewing monitors in the
exhibit hall and in various common areas.
The viewing screens will feature user-friendly touch screen controls to allow you to easily select the poster you want
to view.
ePoster Presentations
MONITOR #1
located in Hall C
Sunday, 4:00 – 4:45 pm
P1063, P1081, P1109, P1283, P1296,
P1298
Monday, 10:15 – 11:00 am
P1080, P1082, P1084, P1086, P1088,
P1090, P1092, P1093,
Monday, 12:30 – 1:30 pm
P1091, P1111, P1161, P1186, P1195,
P1221, P1244, P1263, P1352, P1358
Monday, 3:30 – 4:15 pm
P1180, P1229, P1237, P1250, P1266,
P1275
Tuesday, 9:30 – 10:15 am
P1070, P1072, P1129, P1183, P1214,
P1219
Tuesday, 12:15 – 1:30 pm
P1132, P1207, P1210, P1216, P1217,
P1247, P1264, P1268
MONITOR #2
located in Hall C
Sunday, 4:00 – 4:45 pm
P1321, P1322, P1333, P1334, P1337,
P1355, P1372
Monday, 10:15 – 11:00 am
P1064, P1128, P1171, P1201, P1227,
P1243, P1262, P1274, P1277, P1294
Monday, 12:30 – 1:30 pm
P1119, P1136, P1146, P1148, P1164,
P1165, P1166, P1205, P1209
Monday, 3:30 – 4:15 pm
P1112, P1232, P1312, P1328, P1346,
P1349
Tuesday, 9:30 – 10:15 am
P1156, P1168, P1208, P1223, P1236,
P1278
Tuesday, 12:15 – 1:30 pm
P1130, P1158, P1170, P1190, P1202,
P1212, P1215, P1272
MONITOR #3
located in Hall C
Sunday, 4:00 – 4:45 pm
P1051, P1059, P1313, P1325, P1373,
P1398, P1406
Monday, 10:15 – 11:00 am
P1144, P1167, P1172, P1191, P1194,
P1254, P1256
Monday, 12:30 – 1:30 pm
P1060, P1138, P1151, P1176, P1222,
P1249
Monday, 3:30 – 4:15 pm
P1285, P1290, P1295, P1303, P1304,
P1327, P1426
Tuesday, 9:30 – 10:15 am
P1074, P1240, P1293, P1300, P1314,
P1396, P1419
Tuesday, 12:15 – 1:30 pm
P1348, P1363, P1389, P1390, P1392
MONITOR #4
located in Hall C
Sunday, 4:00 – 4:45 pm
P1127, P1155, P1178, P1188, P1196,
P1224, P1259
Monday, 10:15 – 11:00 am
P1117, P1133, P1139, P1147, P1149,
P1152, P1185, P1203, P1218
Monday, 12:30 – 1:30 pm
P1065, P1077, P1085, P1098, P1326,
P1407
Monday, 3:30 – 4:15 pm
P1052, P1068, P1198, P1204, P1256,
P1260
Tuesday, 9:30 – 10:15 am
P1078, P1120, P1174, P1175, P1181,
P1193, P1226, P1234, P1241, P1246,
P1416
Tuesday, 12:15 – 1:30 pm
P1076, P1162, P1192, P1225, P1248
MONITOR #5
located in Hall C
Sunday, 4:00 – 4:45 pm
P1058, P1106, P1114, P1141, P1177,
P1286, P1287, P1292, P1302, P1323,
P1361, P1376
Monday, 10:15 – 11:00 am
P1121, P1125, P1145, P1200, P1206,
P1230, P1233, P1235, P1271
Monday, 12:30 – 1:30 pm
P1104, P1331, P1332, P1360, P1414
Monday, 3:30 – 4:15 pm
P1116, P1118, P1124, P1126, P1137,
P1157, P1163, P1169
Tuesday, 9:30 – 10:15 am
P1061, P1067, P1073, P1089, P1110,
P1123, P1150, P1306
Tuesday, 12:15 – 1:30 pm
P1097, P1122, P1336, P1356, P1368,
P1375, P1377, P1386, P1399, P1415
MONITOR #6
located in Hall D
Sunday, 4:00 – 4:45 pm
P1099, P1351, P1383, P1385, P1394,
P1410
Monday, 10:15 – 11:00 am
P1083, P1280, P1281, P1305, P1353,
P1365, P1366
Monday, 12:30 – 1:30 pm
P1057, P1075, P1103, P1105, P1299,
P1309, P1316, P1335
Monday, 3:30 – 4:15 pm
P1131, P1182, P1187, P1228, P1257,
P1267
Tuesday, 9:30 – 10:15 am
P1108, P1342, P1359, P1369, P1384,
P1395, P1418, P1421
*All ePoster presenters are listed first unless otherwise noted.
112
ePoster Presentations
ePoster Presentations (continued)
P1050
MONITOR #8
located outside Ballroom B
Sunday, 4:00 – 4:45 pm
P1050, P1115, P1173, P1184, P1378,
P1379, P1380, P1381, P1382
Monday, 10:15 – 11:00 am
P1101, P1211, P1252, P1270, P1279,
P1319, P1339
Monday, 12:30 – 1:30 pm
P1054, P1056, P1142, P1143, P1154,
P1160, P1231, P1238, P1239
Monday, 3:30 – 4:15 pm
P1102, P1317, P1329, P1338, P1367,
P1405, P1413
Tuesday, 9:30 – 10:15 am
P1055, P1071, P1100, P1284, P1291,
P1297, P1310, P1318, P1324
Clinical Effectiveness and Outcome of Diversion
in Refractory Crohn’s Colitis with and without
Perianal Fistula
Sunday
Monitor #8, Outside Ballroom B
Inflammatory Bowel Disease
K. Mathis, J. Pemberton, E. Tiret, W. Bemelman,
F. Michelassi, J. Soderholm, T. Oresland, F. Remzi,
A. D’Hoore, Rochester, MN; Paris, France;
Amsterdam, Netherlands; New York, NY;
Linkoping, Sweden; Oslo, Norway; Cleveland, OH;
Leuven, Belgium
P1051
Tumor Regression Grade after Preoperative
Chemoradiotherapy in Rectal Cancer: Is it
Related to Nodal Staging?
Sunday
Monitor #3, located in Hall C
Neoplastic Disease
C. Vaccaro, H. Vaccarezza, J. Santino, M. Falconi,
D. Beder, F. Yazyi, G. Ojea Quintana, G. Rossi,
Buenos Aires, Argentina
P1052
Inpatient Hospital Readmission Based on
Discharge Destination after Colorectal Surgery
Monday
Monitor #4, located in Hall C
Outcomes
A. Gabre-Kidan, A. Murray, M. Lightfoot, R. Kiran,
New York, NY
MONITOR #9
located outside Room 304
Monday, 10:15 – 11:00 am
P1140, P1213, P1220, P1242, P1251,
P1258, P1403
Monday, 12:30 – 1:30 pm
P1062, P1066, P1094, P1153, P1159,
P1199, P1340, P1357, P1320, P1402
Monday, 3:30 – 4:15 pm
P1053, P1069, P1301, P1307, P1347,
P1364, P1393, P1417
Tuesday, 9:30 – 10:15 am
P1341, P1350, P1371, P1374, P1387,
P1388, P1401, P1404
P1053
Colorectal Cancer Pathology Reporting: A
Regional Audit (1996-2010)
Monday Monitor #9, located outside Room 304
Neoplastic Disease
R. Birch, P. Finan, E. Morris, P. Quirke, Leeds,
United Kingdom
P1054
Open versus Laparoscopic Colostomy Creation:
An ACS-NSQIP Study
Monday
Monitor #8, Outside Ballroom B
Outcomes
S. Ivatury, S. Holubar, Lebanon, NH
P1055
Transanal Endoscopic Microsurgery (TEM)
versus Total Mesorectal Excision (TME) Radical
Resection for T1 or T2 Rectal Cancer –
A Meta-analysis.
Tuesday
Monitor #8, Outside Ballroom B
Neoplastic Disease
V. Chakravorty, R. Chamberlain, N. Ghlayiae,
Livingston; Tuscon, AZ
P1056
Impact of Operative Approach on
Postoperative Outcomes following Colectomy
for Colon Cancer
Monday
Monitor #8, Outside Ballroom B
Outcomes
C. Papageorge, E. Foley, C. Heise, B. Harms,
E. Carchman, G. Kennedy, Madison, WI
*All ePoster presenters are listed first unless otherwise noted.
113
EPOSTERS
MONITOR #7
located in Hall C Foyer
(by registration)
Sunday, 4:00 – 4:45 pm
P1095, P1282, P1288, P1289, P1330,
P1343, P1354
Monday, 10:15 – 11:00 am
P1079, P1179, P1362, P1400, P1411,
P1425, P1427
Monday, 12:30 – 1:30 pm
P1087, P1113, P1370, P1391, P1397,
P1408, P1409, P1412
Monday, 3:30 – 4:45 pm
P1096, P1107, P1135, P1197, P1308,
P1311, P1315, P1344, P1345
Tuesday, 9:30 – 10:15 am
P1134, P1422, P1423, P1424
ePoster Presentations
P1057
P1058
P1059
P1060
P1061
P1062
Biological Difference of Right versus Left Colon
Cancer: An Analysis of the National Cancer
Database (NCDB) and Surveillance,
Epidemiology and End Results (SEER)
Monday
Monitor #6, located in Hall D
Neoplastic Disease
S. Saha, L. Berbiglia, M. Shaik, J. Gernand, S. Saha,
M. Hicks, M. Arora, D. Wiese, Flint, MI; East
Lansing, MI; Boston, MA
Patients Undergoing Abdominoperineal
Resection for Rectal Cancer with Flap
Reconstruction – Do They Benefit?
Sunday
Monitor #5, located in Hall C
Outcomes
M. Bailey, P. Miller, M. Thomas, D. Beck, T. Hicks,
H. Vargas, C. Whitlow, D. Margolin, New
Orleans, LA
Does One Size Fit All? Risks and Benefits of
Neoadjuvant Chemoradiation in Patients with
Clinical Stage II Rectal Cancer Requiring
Abdominoperineal Resection
Sunday
Monitor #3, located in Hall C
Neoplastic Disease
X. Xhaja, D. Benson, D. Dietz, L. Stocchi,
M. Kalady, J. Ashburn, I. Lavery, F. Remzi,
Cleveland, OH
P1063
Prognostic Implications of Threatened
Circumferential Resection Margin of Locally
Advanced Rectal Cancer
Sunday
Monitor #1, located in Hall C
Neoplastic Disease
M. Albandar, M. Cho, N. Kim, Seoul, Korea
P1064
The Learning Curve of Robotic Rectal Surgery
Can Be Minimized with Expert Assistance
Monday
Monitor #2, located in Hall C
Outcomes
S. Shah, D. Maun, R. Melbert, T. Reidy,
O. Johansen, B. Tsai, Indianapolis, IN
P1065
Number of Regional Negative Lymph Nodes
Affects Survival in Rectal Cancer Patients
Treated for Cure at King Faisal Specialist
Hospital & Research Centre, Saudi Arabia
Monday
Monitor #4, located in Hall C
Neoplastic Disease
M. Mohammed, N. Alsanea, A. Abduljabbar,
L. Ashari, S. Alhomoud, A. Alwusaibie, Riyadh,
Saudi Arabia
P1066
Robotic Colon and Rectal Surgery Results in
Shorter Lengths of Stay and Operative Times
Compared to Open and Laparoscopic Surgery
Monday Monitor #9, located outside Room 304
Outcomes
A. Bastawrous, C. Neighorn, Seattle, WA;
Portland, OR
P1067
Long-Term Survival from Colorectal Cancer
in Jamaica
Tuesday
Monitor #5, located in Hall C
Neoplastic Disease
J. Plummer, Kingston, Jamaica
P1068
Readmission Risk Profiles for Colorectal
Patients Differ Significantly Based on Indication
for Colectomy
Monday
Monitor #4, located in Hall C
Outcomes
M. Morris, A. DeRussy, A. Gullick, D. Gunnells,
J. Cannon, M. Hawn, D. Chu, Birmingham, AL
P1069
Relationship between Socioeconomic Status
and Receipt of Chemotherapy for Advanced
Stage Colorectal Cancer at an Urban Academic
Institution
Monday Monitor #9, located outside Room 304
Neoplastic Disease
M. Harfouche, A. Willis, Philadelphia, PA
Predictors of Length of Stay and Cost in
Enhanced Recovery Colorectal Surgery Protocol
Monday
Monitor #3, located in Hall C
Outcomes
M. Abdelgadir Adam, Z. Sun, J. Migaly, C. Mantyh,
J. Thacker, Durham, NC
Oncologic Benefits of Adjuvant Chemotherapy
in Patients with Good Tumor Response (ypT02N0) after Neoadjuvant Chemoradiotherapy for
Locally Advanced Rectal Cancer
Tuesday
Monitor #5, located in Hall C
Neoplastic Disease
J. Al Sabilah, M. Cho, N. Kim, Seoul, Korea
The Use of Robotic and Laparoscopic Surgical
Stapling Devices during Minimally Invasive
Colon and Rectal Surgery – A Comparison
Monday Monitor #9, located outside Room 304
Outcomes
J. Holzmacher, M. Aziz, S. Luka, S. Agarwal,
V. Obias, Washington, DC
*All ePoster presenters are listed first unless otherwise noted.
114
P1070
Socioeconomic Disparities Lead to Increased
Length of Stay and Mortality in Colon and
Rectal Cancers
Tuesday
Monitor #1, located in Hall C
Outcomes
J. Harris, V. Vichez, D. Davenport, S. Beck,
Lexington, KY
P1077
Lymph Node Identification following
Neoadjuvant Therapy in Locally Advanced
Rectal Cancer: Do Numbers Matter?
Monday
Monitor #4, located in Hall C
Neoplastic Disease
B. Ecker, E. Paulson, J. Datta, A. Jeganathan,
C. Aarons, R. Kelz, N. Mahmoud, Philadelphia, PA
P1071
Transanal Total Mesorectal Excision (taTME) by
Transanal Endoscopic Microsurgery (TEM) as an
Alternative to Abdominoperineal Resection
(APR) in Selected Cases: A Pilot Study
Tuesday
Monitor #8, Outside Ballroom B
Neoplastic Disease
E. Lezoche, S. Quaresima, A. Balla, G. D’Ambrosio,
M. Guerrieri, G. Lezoche, A. Paganini, Rome, Italy;
Ancona, Italy
P1078
The Effectiveness of a Fecal Diverting Device
for the Prevention of Septic Complication in
Case of Colonic Anastomotic Leakage
Tuesday
Monitor #4, located in Hall C
Outcomes
J. Kim, S. Kim, S. Jung, Daegu, Korea
P1079
Prospective Analysis of the Learning Curve for
Laparoscopic Colorectal Cancer Resections
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
F. Blanco-Antona, S. Bahamonde, L. Blanco,
Valladolid, Spain; Salamanca, Spain
P1080
Anorectal Tuberculosis In the Biologic
Therapy Era
Monday
Monitor #1, located in Hall C
Case Report
J. Contreras, M. Blas-Franco, M. Pichardo-Farfan,
E. Mora-Canas, Mexico City, Mexico
P1081
Balancing Harm and Benefit: Oncologic
Outcomes and Quality of Life in Rectal Cancer
Patients with Poor Response to Neoadjuvant
Chemoradiation
Sunday
Monitor #1, located in Hall C
Neoplastic Disease
L. Duraes, L. Stocchi, D. Dietz, I. Lavery, M. Kalady,
Cleveland, OH
P1082
A Case of a T1 Poorly-Differentiated Rectal
Adenocarcinoma Masquerading as a
Submucosal Lipoma
Monday
Monitor #1, located in Hall C
Case Report
S. Koh, H. Yamamoto, C. Tsang, West Hollywood,
CA; Yakushiji, Japan; Singapore
P1083
Detection of Suspicious Families of Lynch
Syndrome within a Colorectal Cancer Screening
Program in Chile
Monday
Monitor #6, located in Hall D
Neoplastic Disease
L. Paqui, A. Ponce, K. Alvarez, A. Zarate, E. Pinto,
A. Wielandt, H. Kawachi, U. Kronberg, F. LopezKostner, Santiago, Chile
P1072
Racial Disparity in Short-Term Outcomes after
Colon Resection for Cancer – A NSQIP Analysis
Tuesday
Monitor #1, located in Hall C
Outcomes
R. Venkat, N. Choudhury*, V. Nfonsam, Tucson, AZ
P1073
Long-term Quality of Life after Elective
Colorectal Cancer Surgery: A Prospective
Cohort Study
Tuesday
Monitor #5, located in Hall C
Neoplastic Disease
T. Poskus, D. Kazanavicius, A. Bausys,
S. Mikalauskas, E. Poskus, N. Samalavicius,
Z. Saladzinskas, K. Strupas, Vilnius, Lithuania;
Kaunas, Lithuania
P1074
P1075
P1076
Transfusion-Free Colorectal Surgeries in
Jehovah’s Witnesses: Rational Approach
vs. Surgical Extremism
Tuesday
Monitor #3, located in Hall C
Outcomes
B. Devaraj, H. Fish, A. Kaiser, Los Angeles, CA
Emergency Surgery for Obstructing Colonic
Cancers: A Comparison between Right-Sided
and Left-Sided Lesions in 71 Consecutive
Patients
Monday
Monitor #6, located in Hall D
Neoplastic Disease
J. Faucheron, B. Paquette, Grenoble, France
Transitional Care after Discharge: Does
Preoperative Anemia Predict Discharge Status?
Tuesday
Monitor #4, located in Hall C
Outcomes
C. Papageorge, G. Leverson, G. Kennedy,
Madison, WI
*All ePoster presenters are listed first unless otherwise noted.
115
EPOSTERS
ePoster Presentations
ePoster Presentations
P1084
Colon Mantle Cell Lymphoma: A Case Report
Monday
Monitor #1, located in Hall C
Case Report
J. Aycinena, J. Cobar, Somerset, PA
P1085
Is Tumor Location a Predictor for Lymph Node
Metastasis in T1 Colorectal Cancer?
Monday
Monitor #4, located in Hall C
Neoplastic Disease
E. Aytac, E. Gorgun, M. Costedio, L. Stocchi,
F. Remzi, H. Kessler, Cleveland, OH
P1086
P1087
P1088
Ischioanal Sarcomas: A Tertiary Center’s
Experience with a Rare Tumor
Monday
Monitor #1, located in Hall C
Case Report
S. Hwang, P. Haigh, E. McLemore, V. Attaluri, Los
Angeles, CA
Radical versus Ultra-Radical Surgical Strategy in
the Management of Locally Recurrent Rectal
Cancer
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
D. Harji, B. Griffiths, S. Peter, Leeds, United
Kingdom
Colonic Tuberculosis Masquerading as
Colorectal Malignancy
Monday
Monitor #1, located in Hall C
Case Report
D. Sarma, London, United Kingdom
P1089
Survival Benefits of Salvage Surgery for Distant
Treatment Failure in Rectal Cancer Patients
Treated with Neoadjuvant Chemoradiation and
CurativeI-Intent Resection
Tuesday
Monitor #5, located in Hall C
Neoplastic Disease
J. Liles, Y. You, A. Cuddy, M. Rodriguez-Bigas,
J. Skibber, G. Chang, Houston, TX
P1090
A Novel Use for Transanal Endoscopic
Microsurgery: Retrieval of Impacted
Rectosigmoid Foreign Bodies
Monday
Monitor #1, located in Hall C
Case Report
M. Tomassi, D. Klaristenfeld, A. Exume,
San Diego, CA
P1091
P1092
Chronic Partial Small Bowel Obstruction since
Early Infancy Continuing into Adulthood:
2 Complex Cases
Monday
Monitor #1, located in Hall C
Case Report
R. Gagliano, R. Serrona, T. Gillespie, Phoenix, AZ
P1093
The Circular Stapler Ostomy Creation: A Novel
Approach to Standardized Ostomy Creation.
Monday
Monitor #1, located in Hall C
Case Report
S. Chan, K. Alavi, D. Czerniach, J. Davids,
J. Maykel, W. Sweeney, P. Sturrock, Worcester, MA
P1094
Natural Orifice Transanal Endoscopic Total
Mesorectal Excision using Robotic and
Laparoscopic Assistance
Monday Monitor #9, located outside Room 304
Neoplastic Disease
G. Molina, L. Bordeianou, D. Berger, P. Sylla,
Boston, MA
P1095
Radiographic Predictors of Response to HighDose Rate Endoluminal Brachytherapy for the
Treatment of Rectal Cancer
Sunday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
R. Craig-Schapiro, M. Sacerdote, M. Pittman,
J. Canner, E. Schneider, I. Kamel, J. Herman,
S. Gearhart, Baltimore, MD
P1096
Surveillance Colonoscopy at One Year following
Colectomy for Colorectal Cancer is Low Yield
for Detection of Advanced Neoplasia
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
N. Cherng, R. Damle, D. Baldor, J. Maykel,
P. Sturrock, J. Davids, W. Sweeney, K. Alavi,
Worcester, MA
P1097
Metformin Enhances the Response to
Radiotherapy in Rectal Cancer
Tuesday
Monitor #5, located in Hall C
Neoplastic Disease
J. Oh, B. Oh, H. Kim, W. Lee, Y. Cho, Y. Park, S. Yun,
J. Huh, Seoul, Korea
P1098
Fat Clearance Technique in Colorectal Cancer
Histopathology Assessment. Single Center
Experience over 7 Years
Monday
Monitor #4, located in Hall C
Neoplastic Disease
J. Roos, H. Andrew, K. Abbas, N. Woodcock,
S. Stojkovic, York, United Kingdom
Colectomy for Colon Cancer in Obese Patients
Monday
Monitor #1, located in Hall C
Neoplastic Disease
T. Ishii, S. Yamaguchi, Hidaka, Japan
*All ePoster presenters are listed first unless otherwise noted.
116
P1099
The Addition of a Staging PET-CT Alters Anal
Cancer Treatment
Sunday
Monitor #6, located in Hall D
Neoplastic Disease
C. Johnson, J. Longo, B. Erickson, K. Ludwig,
T. Ridolfi, Milwaukee, WI
P1100
P1101
P1102
P1103
P1104
P1105
P1106
Total Mesorectal Excision Assisted by
Transanal Approach: Preliminary Series of a
University Hospital
Tuesday
Monitor #8, Outside Ballroom B
Neoplastic Disease
M. Abedrapo, G. Montesinos, M. Diaz, R. Azolas,
J. Llanos, G. Bocic, S. Cortes, Santiago, Chile
Early Outcomes with the Use of Intensity
Modulated Radiation Therapy with
Simultaneous Integrated Boost (IMRT-SIB) as a
Part of Neoadjuvant Therapy with Concurrent
Chemotherapy for Advanced Stage Rectal
Cancers – Central Texas Experience
Sunday
Monitor #5, located in Hall C
Neoplastic Disease
R. Essani, Temple, TX
P1107
Palliative Surgery by Colorectal Surgeons for
Resuming Oral Intake for Patients with
Malignant Bowel Obstruction from NonColorectal Origin Cancers: Impact on Overall
Survival
Monday
Monitor #8, Outside Ballroom B
Neoplastic Disease
Y. Kwon, K. Park, J. Seung-Yong, S. Ryoo, J. Park,
E. Han, B. Park, J. Kim, Seoul, Korea
Successful Endoscopic Polypectomy in
Cases Referred for Surgical Excision:
A Case-Matched Series
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
K. Cologne, L. Liwanag, D. Rosen, G. Hwang,
A. Sahakian, A. Senagore, Los Angeles, LA
P1108
Hyperglycemia Increases Surgical Site
Infections following Colorectal Resections for
Malignancy in a Standardized Patient Cohort
Tuesday
Monitor #6, located in Hall D
Neoplastic Disease
N. Saur, S. Chadi, D. Bekele, H. Amer, E. Weiss,
G. DaSilva, S. Wexner, Weston, FL
P1109
Abundant Mesorectal Volume and Narrow
Pelvis Correlate with Anastomotic Leakage in
Anterior Resection for Rectal Cancer
Sunday
Monitor #1, located in Hall C
Neoplastic Disease
Y. Asada, M. Tsuruta, H. Hasegawa, K. Okabayashi,
T. Shimada, Y. Kitagawa, Tokyo, Japan
P1110
Outcome of Ultralow Anterior Resection and
Coloanal Anastomosis for Distal Rectal Cancer:
The Impact of Minimally Invasive Surgery
Tuesday
Monitor #5, located in Hall C
Neoplastic Disease
W. Law, R. Wei, K. Ng, C. Foo, Hong Kong
P1111
Impact of Weight Loss after Bariatric Surgery
on Adenoma Detection Rate in Colonoscopy:
A Case Control Study
Monday
Monitor #1, located in Hall C
Neoplastic Disease
S. Wexner, A. Cracco, K. Tandon, F. Rodrigues,
M. Imam, R. Rosenthal, F. Castro, G. DaSilva,
Weston, FL
Characterizing Short-Term Outcomes following
Surgery for Rectal Cancer: The Role of Race and
Insurance Status
Monday
Monitor #8, Outside Ballroom B
Neoplastic Disease
P. Suwanaol, R. Damle, J. Davids, W. Sweeney,
P. Sturrock, J. Maykel, K. Alavi, Worcester, MA
Left versus Right Laparoscopic Colectomy:
Does Side Make Any Difference?
Monday
Monitor #6, located in Hall D
Neoplastic Disease
P. Pellegrini, J. Campana, R. Mentz, G. Rossi,
C. Vaccaro, Buenos Aires, Argentina
Is Extended Lymphadenectomy for Colon
Cancer Warranted? Outcomes of D2
Lymphadenectomy in Right Colon Cancer
Monday
Monitor #5, located in Hall C
Neoplastic Disease
G. Clifton, G. Chang, Y. You, J. Skibber, B. Feig,
S. Nguyen, M. Rodriguez-Bigas, Houston, TX
Laparoscopic versus Open Resection for T4
Colon Cancer: A Case-Matched Control Study
Monday
Monitor #6, located in Hall D
Neoplastic Disease
X. Li, Shanghai, China
*All ePoster presenters are listed first unless otherwise noted.
117
EPOSTERS
ePoster Presentations
ePoster Presentations
P1112
Serrated Polyps and Mucus: A Prospective
Study
Monday
Monitor #2, located in Hall C
Neoplastic Disease
R. Charles, Cleveland, OH
P1113
Improved Surgical Results and Oncologic
Outcomes for Rectal Cancer Over Two Decades:
The Impact of Minimally Invasive Surgery and
Neoadjuvant Therapy
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
W. Law, C. Foo, R. Wei, O. Lo, Hong Kong
P1114
P1115
Abdominoperineal Resection as a Negative
Predictor of Adjuvant Chemotherapy
Sunday
Monitor #5, located in Hall C
Neoplastic Disease
D. Shaw, C. Ternent, J. Beaty, G. Blatchford,
N. Bertelson, M. Shashidharan, J. Bikhchandani,
A. Thorson, Omaha, NE
Dysplasia following Stapled Restorative
Proctolectomy for Ulcerative Colitis: Is There a
Correlation between Preop Colorectal Dysplasia
and Development of Postop Dysplasia in the
Rectal Cuff Mucosa?
Sunday
Monitor #8, Outside Ballroom B
Neoplastic Disease
T. Elarini, A. Chadi, G. DaSilva, M. Berho,
S. Wexner, Weston, FL
P1116
The Impact of Mode of Delivery, Parity and Age
in the Prevalence of Posterior Pelvic Floor
Abnormalities in Female with Obstructed
Defecation Syndrome
Monday
Monitor #5, located in Hall C
Other Benign Disease
S. Murad-Regadas, F. Regadas, D. Morano,
D. Lima, L. Rodrigues, A. Vilarinho, J. Siebra,
M. Oliveira, R. Barreto, Fortaleza, Brazil; Cascavel,
Brazil
P1117
How Often is a Cryptoglandular Fistula the
Cause of an Anal Abscess? Results from a
Single Anorectal Department.
Monday
Monitor #4, located in Hall C
Other Benign Disease
J. Jongen, J. Schumacher, H. Peleikis, V. Kahlke,
Kiel, Germany
P1118
Outcomes of Minimally Invasive
Sacrocolpopexy with Ventral Mesh Rectopexy
for Combined Vaginal and Rectal Prolapse
Monday
Monitor #5, located in Hall C
Other Benign Disease
M. Gross, A. Hayman, M. Whiteford,
B. Osmundsen, Portland, OR
P1119
Understanding the Connection between
Internal Intussusception and Rectal Prolapse:
A Prospective Study
Monday
Monitor #2, located in Hall C
Other Benign Disease
A. Hawkins, A. Olariu, L. Savitt, S. Gingipally,
M. Wakamatsu, S. Pulliam, M. Weinstein, B. Nath,
L. Bordeianou, Boston, MA
P1120
Endoscopic Assisted Colostomy with
Percutaneous Colopexy: An Experimental Study
Tuesday
Monitor #4, located in Hall C
Other Benign Disease
L. Bustamante-Lopez, M. Sulbaran, P. Sakai,
E. Moura, C. Nahas, C. Marques, C. Sakai,
I. Cecconello, R. Pinto, S. Nahas, Sao Paulo, Brazil
P1121
Traumatic Pelvic GI-GU Fistula in Wounded
Warriors: Case Series of Complicated Injuries
with Complex Surgical Solutions
Monday
Monitor #5, located in Hall C
Other Benign Disease
W. Kucera, B. O’Brien, G. Stackhouse, J. Jezior,
J. Duncan, Bethesda, MD
P1122
Locally Released Matrix Metalloproteinase
Inhibitor (Doxycylcline) Does Not Enhance
Healing in Stapled Colorectal Anastomosis in
Porcine Model
Tuesday
Monitor #5, located in Hall C
Other Benign Disease
M. Luchtefeld, S. Khoo, R. Nickolov, G. Hostetter,
N. Jrebi, Grand Rapids, MI; Morgantown, WV;
Fayetteville, NC
P1123
Laparoscopic Resection Confers a Survival
Benefit for Stage III Colorectal Cancer Patients
Compared to Open Resection
Tuesday
Monitor #5, located in Hall C
Neoplastic Disease
J. Chiew, B. Lieske, Singapore
*All ePoster presenters are listed first unless otherwise noted.
118
P1124
Bilateral Transcutaneous Posterior Tibial Nerve
Stimulation for Functional Anorectal Pain
Monday
Monitor #5, located in Hall C
Other Benign Disease
S. Takano, Kumamoto, Japan
P1125
Gracilis Muscle Interposition Repair for
Complicated Colonic Pouch-Vaginal Fistula
after Radical Resection of Low Rectal Cancer
Monday
Monitor #5, located in Hall C
Other Benign Disease
T. Ono, Asiya City, Japan
P1126
P1127
P1128
P1129
P1130
P1131
Endoscopic Pilonidal Sinus Treatment with
Additional Crystalized Phenol
Monday
Monitor #6, located in Hall D
Other Benign Disease
I. Gecim, U. Goktug, H. Celasin, Ankara, Turkey;
Kavaklidere, Turkey
P1132
Rectal Dissection Simulator for da Vinci Surgery
– Construct, Face, and Content Validation
Tuesday
Monitor #1, located in Hall C
Outcomes
G. Melich, R. Shoela, A. Pai, K. Kochar, S. Patel,
J. Park, L. Prasad, S. Marecik, Park Ridge, IL
P1133
Multicenter Observational Study with Porcine
Collagen Paste Fistula Treatment: Preliminary
Results
Monday
Monitor #4, located in Hall C
Other Benign Disease
F. Da Pozzo, A. Stuto, A. Braini, P. Narisetty,
L. Lenisa, A. Rusconi, A. Pulvirenti D’Urso,
Pordenone, Italy; Milano, Italy; Catania, Italy
P1134
Less is More: A Pilot Study Using a Novel,
Affordable Simulator to Teach Residents
Anorectal Surgery
Monday
Monitor #2, located in Hall C
Other Benign Disease
S. Langenfeld, J. Thompson, C. Are, S. Steele,
Omaha, NE; Fort Lewis, WA
Is There Anything We Can Modify among
Factors Associated with Morbidity following
Elective Laparoscopic Sigmoidectomy for
Diverticulitis?
Tuesday
Monitor #7, located in Hall C Foyer
(by registration)
Other Benign Disease
J. Silva Velazco, L. Stocchi, M. Costedio,
E. Gorgun, H. Kessler, F. Remzi, Cleveland, OH
P1135
A Cross-Sectional Survey of Health and Quality
of Life of Patients Awaiting Colorectal Surgery
in Canada
Tuesday
Monitor #1, located in Hall C
Outcomes
A. Karimuddin, T. Phang, C. Brown, M. Raval,
G. Liu, R. Crump, J. Sutherland, Vancouver, BC,
Canada; Milwaukee, WI
Differences in Cognitive Function between
Propofol and Midazolam following
Colonoscopy
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Outcomes
E. Changchien, S. Paim, J. Hughes, M. Murday,
J. Waldron, A. Crume, J. Griffin, Salt Lake City, UT
P1136
Patient Goals in Rectal Prolapse
Monday
Monitor #2, located in Hall C
Other Benign Disease
S. Adams, T. Curran, T. Cataldo, V. Poylin, D. Nagle,
Boston, MA
Clinical Study of the TST STARR Plus in the
Treatment of Obstructed Defecation Syndrome
Monday
Monitor #5, located in Hall C
Other Benign Disease
Z. Zhang, Xuzhou, China
Perineal Antropyloric Transposition for Total
Anorectal Reconstruction: Predictors of Graft
Survival and Functional Outcomes
Sunday
Monitor #4, located in Hall C
Other Benign Disease
A. Chandra, S. Kumar, V. Gupta, S. Singh, N. M.,
B. Mishra, U. Ghoshal, A. Kumar, Lucknow, India
Long-Term Outcomes of Conservative
Management following Successful Nonoperative Treatment of Acute Diverticulitis with
Abscess: A Systematic Review
Tuesday
Monitor #2, located in Hall C
Other Benign Disease
A. Kugler, A. Al-Khamis, N. Morin, P. Gordon,
C. Vasilevsky, G. Ghitulescu, J. Faria, M. Demian,
M. Boutros, Montreal, QC, Canada
*All ePoster presenters are listed first unless otherwise noted.
119
EPOSTERS
ePoster Presentations
ePoster Presentations
P1137
Outcomes after Transvaginal Rectocoele Repair
and Levatorplasty
Monday
Monitor #5, located in Hall C
Other Benign Disease
M. Osman, A. Hainsworth, A. Schizas, A. Williams,
London, United Kingdom
P1138
Implementation of an ERAS Pathway in an
Academic Medical Center: Measurement of
Compliance and Results
Monday
Monitor #3, located in Hall C
Outcomes
A. Henry, M. Stopfkuchen-Evans, L. Wolf, A. Bader,
J. Goldberg, R. Kelley, R. Bleday, Boston, MA
P1139
Does Ligation of Intersphincteric Fistula Tract
(LIFT) Stand the Test of Time? An Extended
Review of our Experience with Complex Fistulain-ano
Monday
Monitor #4, located in Hall C
Other Benign Disease
B. MacLaughlin, W. Liu, A. Aboulian, R. Kumar,
Torrance, CA
P1140
A Fading Threat? Does the Severity of FAPassociated Desmoid Tumors Decline with Age?
Monday Monitor #9, located outside Room 304
Other Benign Disease
X. Xhaja, J. Church, Cleveland, OH
P1141
Predictors of Perineal Wound Complications
and Prolonged Time to Perineal Wound Healing
after Abdominoperineal Resection
Sunday
Monitor #5, located in Hall C
Outcomes
A. Althumairi, J. Canner, J. Sacks, S. Gearhart,
B. Safar, E. Wick, S. Fang, J. Efron, Baltimore, MD
P1142
P1143
Open vs. Laparoscopic Colectomy for Sigmoid
Volvulus: An Assessment from the ACS NSQIP
Monday
Monitor #8, Outside Ballroom B
Other Benign Disease
E. Myers, E. Aytac, H. Kessler, Cleveland, OH
P1144
Neutrophil-Lymphocyte Ratio and PlateletLymphocyte Ratio in Chronic Anal Fissure
(CAF) Patients
Monday
Monitor #3, located in Hall C
Other Benign Disease
G. Bugdayci, N. Sengul, O. Arisoy, A. Cakir, Bolu,
Turkey
P1145
Developing a Diagnostic Paradigm for
Identification of Internal Intestinal Fistulas: An
Appraisal of Common Imaging Modalities
Monday
Monitor #5, located in Hall C
Other Benign Disease
I. Esemuede, A. Goel, N. Latchana, A. Harzman,
M. Arnold, S. Husain, Columbus, OH
P1146
Recurrence of Rectal Prolapse following
Rectopexy: A Pooled Analysis of 532 Individual
Patient Data
Monday
Monitor #2, located in Hall C
Other Benign Disease
C. Anderson, M. Bishawi, S. Tou, R. Bergamaschi,
Stony Brook, NY
P1147
Anal Fistula Plug for Treatment of High Anal
Fistula: MRI Evidence
Monday
Monitor #4, located in Hall C
Outcomes
A. Zubaidi, M. Al-Rowais, T. Teraiki, O. Alobeed,
K. AlKhayal, M. Alkubair, Riyadh, Saudi Arabia
P1148
Laparoscopic Total Abdominal Colectomy for
Chronic Constipation has a Safe Complication
Profile: Data from the National Surgical Quality
Improvement Program (NSQIP)
Monday
Monitor #2, located in Hall C
Other Benign Disease
S. Ramakrishnan, C. Klos, M. Mutch, S. Hunt,
E. Birnbaum, S. Dharmarajan, M. Silviera, P. Wise,
S. Glasgow*, Saint Louis, MO
P1149
Ligation of the Intersphicteric Fistula Tract
(LIFT): Best Treatment Option for Complex
Fistula-In-Ano
Monday
Monitor #4, located in Hall C
Other Benign Disease
R. Hegde, N. Kaur, Z. Zhang, Waterbury, CT
Feasibility of Laparoscopic Extended Pelvic
Surgery for Rectal Cancer
Monday
Monitor #8, Outside Ballroom B
Outcomes
H. Nakamura, K. Uehara, A. Arimoto, T. Kato,
T. Ebata, Y. Yokoyama, M. Nagino, Nagoya, Japan
*All ePoster presenters are listed first unless otherwise noted.
120
P1150
Oncologic Outcomes in Rectal Cancer Patients
with Distal Resection Margins ≤ 1 cm
Tuesday
Monitor #5, located in Hall C
Outcomes
D. Kandg, H. Kwak, N. Sung, J. Kwak, J. Kim,
S. Kim, Seoul, Korea
P1151
Study of the Location of Low Perirectal Arteries
during Doppler-Guided Hemorrhoidal Artery
Ligation and Rectoanal Repair (HAL-RAR): The
Principle of the Three Hemorrhoidal Cushions
Revisited in 150 Consecutive Patients
Monday
Monitor #3, located in Hall C
Other Benign Disease
J. Faucheron, H. Pflieger, Grenoble, France
P1152
P1153
P1154
P1155
Complete Preservation of the Anal Sphincter
Complex in Treating Deep Postanal Space
Abscesses and Fistulas: A Paramedian
Approach
Monday
Monitor #4, located in Hall C
Other Benign Disease
S. Ryu, Seoul, Korea
Comparison of Risk Factors for Unplanned
Conversion from Laparoscopic and Robotic to
Open Colorectal Surgery using the Michigan
Surgical Quality Collaborative Database
Monday Monitor #9, located outside Room 304
Outcomes
A. Bhama, C. Kaoutzanis, S. Regenbogen,
S. Collins, A. Mullard, J. Vandewarker, G. Krapohl,
J. Byrn, R. Cleary, Ann Arbor, MI; Iowa City, IA
Electrothermal Bipolar Vessel Sealing System
versus Monopolar Scissors and Clips in
Laparoscopic Sigmoidectomy for Diverticulitis:
A Comparative Study in 191 Consecutive
Patients
Monday, P1154 Monitor #8, Outside Ballroom B
Other Benign Disease
J. Faucheron, B. Trilling, Grenoble, France
Efficacy of Fiber Monotherapy as Initial
Treatment for Fecal Incontinence Patients
Sunday, P1155
Monitor #4, located in Hall C
Other Benign Disease
R. Andrew, A. Stokes, E. Messaris, F. Puleo,
Hershey, PA
P1156
Industry Payments to Faculty Surgeons as a
Potential Conflict of Interest in Colorectal
Surgery Programs: An Assessment of Payments
Identified through the Physician Financial
Transparency Reports
Tuesday
Monitor #2, located in Hall C
Outcomes
S. Patel, E. Pappou, T. Sonoda, New York, NY
P1157
Laparoscopic Ventral Rectopexy with Biologic
Mesh for ODS and Complex Pelvic Floor
Disorders
Monday
Monitor #5, located in Hall C
Other Benign Disease
L. Lenisa, A. Stuto, A. Rusconi, A. Braini, F. Da
Pozzo, J. Megevand, Milano, Italy; Pordenone,
Italy
P1158
Diverticular Abscess Managed with Long-Term
Definitive Nonoperative Intent is Safe
Tuesday
Monitor #2, located in Hall C
Other Benign Disease
R. Garfinkle, A. Kugler, V. Pelsser, N. Morin,
P. Gordon, C. Vasilevsky, G. Ghitulescu, J. Faria,
L. Feldman, M. Boutros, Montreal, QC, Canada
P1159
Laparoscopic and Robotic Colorectal Surgery:
An Institutional Cost Comparison
Monday Monitor #9, located outside Room 304
Outcomes
A. Yang, R. Cleary, K. Welch, S. Winter, Ann Arbor,
MI; Grand Rapids, MI
P1160
Intestinal Obstruction, Totally Laparoscopic
Approach. Texas Endosurgery Institute
Experience
Monday
Monitor #8, Outside Ballroom B
Other Benign Disease
M. Hernandez, San Antonio, TX
P1161
Outcome after Reversal of Hartmann Procedure
by Body Mass Index (BMI)
Monday
Monitor #1, located in Hall C
Other Benign Disease
G. Hwang, D. Rosen, A. Glenn, A. Ortega,
J. Carmichael, S. Mills, A. Pigazzi, K. Cologne,
Orange, CA; Los Angeles, CA
P1162
The Association of Modified Frailty Index (MFI)
with Mortality in Patients Undergoing
Ileostomy Creation
Tuesday
Monitor #4, located in Hall C
Outcomes
A. Chung, P. Nona, C. Reickert, S. Nalamati,
Detroit, MI
*All ePoster presenters are listed first unless otherwise noted.
121
EPOSTERS
ePoster Presentations
ePoster Presentations
P1163
Comparison of Outcomes Undergoing
Laparoscopic Ventral Mesh Rectopexy:
Biological vs Synthetic Mesh
Monday
Monitor #5, located in Hall C
Other Benign Disease
R. Padwick, R. Evans, D. Latham, M. Farmer,
V. Garimella, Leamington Spa, United Kingdom
P1164
Sacral Nerve Stimulation for Chronic
Constipation: Follow-up Results
Monday
Monitor #2, located in Hall C
Other Benign Disease
M. Antonelli, V. Giaccaglia, M. Mazzi, C. Ghini,
M. Radicchi, A. Stazi, Velletri, Italy
P1165
Therapeutic Evaluation of Biofeedback Therapy
in the Treatment of Anterior Resection
Syndrome after Sphincter-Saving Surgery for
Rectal Cancer
Monday
Monitor #2, located in Hall C
Outcomes
Z. Liang, P. Du, L. Cui, Shanghai, China
P1166
P1167
P1168
P1169
Sigmoid Resection Rectopexy with
Concomitant Mesh Sacrocolpopexy: Review of
Safety Profile
Monday
Monitor #2, located in Hall C
Other Benign Disease
A. Ghlandian, T. Li, B. Shanker, B. Murray,
J. Gallagher, B. Kudish, K. Jones, A. Ferrara,
Orlando, FL
Be Acupuncture Combined with Biofeedback
Superior to Biofeedback in Functional
Anorectal Pain Treatment? A Retrospective
Controlled Study from a Referral Center in
China
Monday
Monitor #3, located in Hall C
Other Benign Disease
S. Ding, Y. Ding, Y. Xue, X. Jin, H. Zhou, Nanjing,
China
Access to Care Trends in Rectal Cancer from
2001 to 2012 using the National Cancer
Database
Tuesday
Monitor #2, located in Hall C
Outcomes
K. Butler, C. Shaw, A. Iqbal, S. Tan, Gainesville, FL
P1170
Outcomes in Diverticulitis Patients with
Intramural Abscesses
Tuesday
Monitor #2, located in Hall C
Other Benign Disease
R. Bendl, M. Freitas, C. Littlejohn, Stamford, CT
P1171
Making Sense of Collaboration and Quality in
Colorectal Cancer Surgery – The Ottawa
Communities of Practice (TO-CoP) Model
Monday
Monitor #2, located in Hall C
Outcomes
R. Helewa, M. Fung-Kee-Fung, M. Mamdani,
R. Auer, S. Hawken, K. Abdulaziz, F. Haggar,
R. Boushey, Ottawa, ON, Canada; Toronto, ON,
Canada
P1172
Toward the Ideal Anesthetic for Reducing the
Rate of Urinary Retention after Anorectal
Outpatient Procedures: Hyperbaric Spinal
Anesthesia
Monday
Monitor #3, located in Hall C
Other Benign Disease
C. Johnson, M. Mahmoud, L. Kosinski, K. Ludwig,
T. Ridolfi, Milwaukee, WI
P1173
Clinical Implications of Paradoxical
Contractions on Manometry in Patients with
Ileal Pouch-Anal Anastomosis (IPAA)
Sunday
Monitor #8, Outside Ballroom B
Other Benign Disease
D. Seyidova Khoshknabi, T. Schroeder, B. Shen,
F. Remzi, Cleveland, OH
P1174
Stoma Prolapse – Is There a Superior Approach
to Repair?
Tuesday
Monitor #4, located in Hall C
Outcomes
T. Jalouta, Grand Rapids, MI
P1175
Open Retromuscular Repair of Parastomal
Hernias
Tuesday
Monitor #4, located in Hall C
Other Benign Disease
J. Warren, A. Grant, A. Carbonell, C. McFadden,
J. Rex, W. Cobb, Greenville, NC
P1176
Medical vs. Surgical patients with Clostridium
difficile Infection: Is There any Difference?
Monday
Monitor #3, located in Hall C
Other Benign Disease
J. Silva Velazco, T. Hull, C. Messick, J. Church,
Cleveland, OH; Houston, TX
Translevator Ventral Rectopexy: The PeriOperative and Short-Term Outcomes
Monday
Monitor #5, located in Hall C
Other Benign Disease
A. Techagumpuch, P. Kanjanasilp, S. Malakorn,
J. Pattana-arun, Bangkok, Thailand
*All ePoster presenters are listed first unless otherwise noted.
122
P1177
Does Flap Closure of the Perineal Wound Affect
Organ Space Surgical Infection following
Abdominoperineal Resection?
Sunday
Monitor #5, located in Hall C
Outcomes
P. Solan, R. Madoff, G. Melton-Meaux, M. Kwaan,
St. Paul, MN
P1184
Does One Score Fit All? Measuring Risk in
Ulcerative Colitis
Sunday
Monitor #8, Outside Ballroom B
Outcomes
D. Keller, K. Cologne, R. Tahilramani, J. FloresGonzalez, A. Senagore, E. Haas, Los Angeles, CA;
Cleveland, OH; Houston, TX
P1178
Long-Term Results for 82 Consecutive Patients
Undergoing Sacral Nerve Stimulation for Fecal
Incontinence
Sunday
Monitor #4, located in Hall C
Other Benign Disease
B. Martin-Perez, C. Kang, T. deBeche-Adams,
A. Bertot, K. Badillo, S. Annaberdyev, L. Hunter,
G. Nassif, P. Mancuso, S. Larach, M. Albert,
S. Atallah, Orlando, FL
P1185
Video Endoscopic Treatment for Complex Anal
Fistula: Long-Term Follow-up of the First
Mexican Experience
Monday
Monitor #4, located in Hall C
Other Benign Disease
J. Villanueva-Herrero, M. Sandoval-Martinez,
Y. Alarcon-Bernes, B. Jimenez-Bobadilla, Mexico
City, Mexico
P1186
P1179
Endosponge Treatment of Anastomotic Leaks
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Other Benign Disease
G. Milito, G. Lisi, Marino, Italy
P1180
Evaluating Long-Acting Liposomal Bupivacaine
on Clinical and Financial Outcomes in
Laparoscopic Colorectal Surgery
Monday
Monitor #1, located in Hall C
Outcomes
D. Keller, R. Pedraza, R. Tahilramani, M. Ragupathi,
J. Flores-Gonzalez, S. Ibarra, T. Pickron, E. Haas,
Houston, TX
Do Morbidly Obese Patients have More Clinical
and Manometric Pelvic Floor Abnormalities in
Comparison to Nonobese Patients? Results of a
Case-Matched Study
Monday
Monitor #1, located in Hall C
Other Benign Disease
I. Correa Neto, R. Pinto, S. Nahas, J. Jorge,
L. Bustamante-Lopez, C. Nahas, C. Sparapan
Marques, I. Cecconello, San Paulo, Brazil
P1187
Lay Open (Deroofing) Plus Curettage
vs. Excision with Primary Closure as the
Treatment of Pilonidal Sinus Disease: A MetaAnalysis of Randomized Controlled Trials and a
Systematic Review of Lay Open (Deroofing)
Plus Currettage Procedure for Pilonidal Sinus
Monday
Monitor #6, located in Hall D
Other Benign Disease
P. Garg, V. Gupta, P. Lakhtaria, Panchkula, India;
Chandigarh, India, New York, NY
P1188
Comparison between Sphincteroplasty and
Sacral Nerve Stimulation for Treatment of Anal
Incontinence Patients with Sphincter Injuries
Sunday
Monitor #4, located in Hall C
Other Benign Disease
S. Wexner, F. Rodrigues, S. Chadi, A. Cracco,
G. DaSilva, D. Sands, Weston, FL
P1190
Private Insurance may Influence Operative
Managment in Acute Diverticulitis
Tuesday
Monitor #2, located in Hall C
Other Benign Disease
M. Coburn, J. Mayoral, S. Izfar, San Antonio, TX
P1181
Parastomal Hernia Repairs: To Bring Chaos
Into Order?
Tuesday
Monitor #4, located in Hall C
Other Benign Disease
L. Goldstein, S. Schechter, N. Shah, N. Gibson,
Providence, RI
P1182
Hemorrhoidectomy with Ligasure™
Monday
Monitor #6, located in Hall D
Other Benign Disease
G. Milito, G. Lisi, Marino, Italy
P1183
Evaluating Clinical and Economic Outcomes in
Open versus Minimally Invasive Colorectal
Surgery
Tuesday
Monitor #1, located in Hall C
Outcomes
D. Keller, L. Hashemi, C. Delaney, E. Haas,
Cleveland, OH; Mansfield, MA; Houston, TX
*All ePoster presenters are listed first unless otherwise noted.
123
EPOSTERS
ePoster Presentations
ePoster Presentations
P1191
Anal Acoustic Reflectometry is a Test of the
Internal Anal Sphincter?
Monday
Monitor #3, located in Hall C
Other Benign Disease
J. Nicholson, A. Worthington, W. deMello,
K. Telford, E. Kiff, Manchester, United Kingdom
P1198
Readmission Recidivism, Why and How Often?
Monday
Monitor #4, located in Hall C
Outcomes
B. Almussallam, P. Marcello, P. Roberts,
D. Schoetz, L. Rusin, T. Read, J. Hall, T. Francone,
R. Ricciardi, Burlington, MA
P1192
Gunshot Wounds to the Colon: Predictive Risk
Factors for the Development of Postoperative
Complications during the Libyan Civil War 2011
(A Single Center Experience)
Tuesday
Monitor #4, located in Hall C
Outcomes
O. El-Faedy, R. Sehgal, S. Mansor, Kilkenny,
Ireland; Benghazi, Libya
P1199
Comparing Outcomes from Robotic,
Laparoscopic, and Open Rectopexy: A Single
Group Experience
Monday Monitor #9, located outside Room 304
Other Benign Disease
D. Halleran, D. Nesbitt, J. Nicholson, J. Zeigler,
M. Moffa, M. Plocek, T. Ruddy, Syracuse, NY
P1200
P1193
Making the Most of a Stoma: How Comfortable
are Today’s General Surgery Residents with
Stoma Marking and Perioperative Care
Tuesday
Monitor #4, located in Hall C
Other Benign Disease
L. Araujo, V. Pontieri-Lewis, N. Patel, C. Rezac,
T. Eisenstat, S. Trooskin, East Brunswick, NJ
Treatment of Supralevator Anal Fistula and
Abscess with Electrocauterization of Internal
Opening, Drainage and Curettage of the Tracts
(PERFACT Procedure)
Monday
Monitor #5, located in Hall C
Other Benign Disease
P. Garg, V. Gupta, P. Lakhtaria, Panchkula, India;
Chandigarh, India; New York, NY
P1194
Response of the Anal Canal to Stretch and Anal
Acoustic Reflectometry
Monday
Monitor #3, located in Hall C
Other Benign Disease
J. Nicholson, A. Sharma, K. Telford, E. Kiff,
Manchester, United Kingdom
P1201
P1195
Minimally Invasive Surgery in the Obese,
Morbidly Obese and Super Obese
Monday
Monitor #1, located in Hall C
Outcomes
M. Ragupathi, J. LeFave, S. Ibarra, J. Sandhu,
A. Mahmood, T. Pickron, L. Haubert, E. Haas,
Houston, TX
Quality Improvement Initiatives in Colorectal
Surgery: Process Improvement or Hawthorne
Effect?
Monday
Monitor #2, located in Hall C
Outcomes
J. Waters, P. Marcello, P. Roberts, D. Schoetz,
T. Read, L. Rusin, J. Hall, T. Francone, R. Ricciardi,
Burlington, MA
P1202
Management of Complicated Diverticulitis: First
is Worst
Tuesday
Monitor #2, located in Hall C
Other Benign Disease
P. White, J. Blumetti, V. Chaudhry, J. Harrison,
J. Cintron, H. Abcarian, Chicago, IL
P1203
Role of VAAFT (Video-Assisted Anal Fistula
Treatment) in the Management of Primary and
Recurrent Complex Anal Fistula
Monday
Monitor #4, located in Hall C
Other Benign Disease
A. Stazi, C. Ghini, V. Giaccaglia, M. Mazzi,
M. Radicchi, M. Antonelli, P. Meinero, Velletri,
Italy; Chiavarese, Italy
P1204
Readmissions after Colectomy for Cancer –
A NSQIP Analysis
Monday
Monitor #4, located in Hall C
Outcomes
R. Venkat, C. Martinez, V. Nfonsam, Tucson, AZ
P1196
P1197
Factors Associated with Morbidity following
Sacral Neurostimulation for Fecal Incontinence:
Beware of the High Risk Groups
Sunday
Monitor #4, located in Hall C
Other Benign Disease
A. Cracco, A. Chadi, F. Rodrigues, M. Zutshi,
B. Gurlanb, S. Wexner, G. DaSilva, Weston, FL;
Cleveland, OH
Colonoscopy in the Hispanic Community: Is
Earlier Screening Warranted?
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Other Benign Disease
J. Harrison, J. Blumetti, V. Chaudhry, J. Cintron,
H. Abcarian, Chicago, IL
*All ePoster presenters are listed first unless otherwise noted.
124
P1205
Using Transcutaneous Neuromodulation
Therapy of Posterior Tibial Nerve Stimulation
(TENS) in Adult Patients with Encopresis
Monday
Monitor #2, located in Hall C
Other Benign Disease
M. Rosado, E. Vega Chavarria, H. Solares Sanchez,
Mexico City, Mexico
P1212
Elective Laparoscopic Sigmoidectomy for
Complicated Diverticulitis in a UK Community
Hospital
Tuesday
Monitor #2, located in Hall C
Other Benign Disease
I. Mallick, B. Bandyopadhyay, A. Rahimzada,
K. Sasapu, Grimsby, United Kingdom
P1206
Predictors of Outcome after Local Repairing
Operation for Rectovaginal Fistulas: The
Experience in a Single Institution
Monday
Monitor #5, located in Hall C
Other Benign Disease
J. Fu, P. Du, L. Cui, Shanghai, China
P1213
P1207
Predictors of One-Year Outcomes after
Abdominoperineal Resection
Tuesday
Monitor #1, located in Hall C
Outcomes
S. Binboga, M. Abbas, M. Costedio, L. Stocchi,
D. Dietz, E. Gorgun, Cleveland, OH
Irrigation of Incisions with 0.05% Chlorhexidine
Reduces Surgical Site Infections in Colorectal
Surgery
Monday Monitor #9, located outside Room 304
Outcomes
N. Dotson, S. Rasheid, J. Marcet, J. Sanchez,
Tampa, FL
P1214
A Population Based Comparison of NonElective Open vs. Minimally Invasive Complex
Colorectal Procedures
Tuesday
Monitor #1, located in Hall C
Outcomes
A. Schlussel, M. Lustik, E. Johnson, J. Maykel,
B. Champagne, A. Damle, H. Ross, S. Steele,
Honolulu, HI; Fort Lewis, WA; Worcester, MA;
Cleveland, OH; Philadelphia, PA
P1215
Trends in Emergent Surgical Management of
Diverticulitis: A National Study on Clinical and
Financial Outcomes
Tuesday
Monitor #2, located in Hall C
Other Benign Disease
N. Madhoun, D. Keller, J. LeFave, L. Haubert,
A. Mahmood, T. Pickron, E. Haas, Houston, TX
P1216
Objective Prognostic Preoperative Prediction of
a Difficult Pelvic Dissection: Pelvic Surgery
Difficulty Index
Tuesday
Monitor #1, located in Hall C
Outcomes
A. Raza, A. Khan, S. Tan, S. Hughes, A. Iqbal,
Gainesville, FL
P1217
Patient Engagement and Colorectal Surgery:
The Role of the NSQIP Risk Calculator
Tuesday
Monitor #1, located in Hall C
Outcomes
A. Chin, D. Galante, D. Hobson, C. Wu, E. Wick,
Baltimore, MD
P1208
P1209
P1210
P1211
Acute Healthcare Resource Utilization following
Outpatient Anorectal Procedures
Tuesday
Monitor #2, located in Hall C
Outcomes
R. Brown, J. Fox, J. Tyler, Biloxi, MI; Philadelphia,
PA
Multi-Institutional Experience with Rectal
Prolapse in Men – Functional Outcomes are Not
Well Evaluated
Monday
Monitor #2, located in Hall C
Other Benign Disease
V. Poylin, M. Kapadia, R. Rahbar, J. Irani, Boston,
MA; Iowa City, IA; Chapel Hill, NC
Predictors of Wound Dehiscence and its Impact
on Mortality after Abdominoperineal
Resection: Data from the National Surgical
Quality Improvement Program
Tuesday
Monitor #1, located in Hall C
Outcomes
S. Binboga, E. Gorgun, A. Rencuzogullari,
G. Ozuner, H. Kessler, M. Abbas, Cleveland, OH
EP4 Agonist Decreases the Risk of Anastomotic
Leakage Caused by NSAIDs after Colorectal
Surgery
Monday
Monitor #8, Outside Ballroom B
Outcomes
R. Mizuno, Y. Okuchi, Y. Sakai, Kyoto, Japan
*All ePoster presenters are listed first unless otherwise noted.
125
EPOSTERS
ePoster Presentations
ePoster Presentations
P1218
P1219
P1220
P1221
P1222
P1223
”LIFT (Ligation of the Intersphincteric Fistula
Tract) versus VAAFT (Video Assisted Anal
Fistula Treatment): A Comparative Study of Two
Minimally Invasive Procedures for Perianal
Fistulas Treatment”
Monday
Monitor #4, located in Hall C
Other Benign Disease
V. Giaccaglia, M. Mazzi, C. Ghini, P. Meinero,
M. Radicchi, M. Antonelli, A. Stazi, Velletri, Italy;
Chiavarese, Italy
Impact of Colorectal Specialization in Left
Colonic Perforation – Learning Curve in a
Reference Center over 10 Years
Tuesday
Monitor #1, located in Hall C
Outcomes
T. Golda, E. Kreisler, G. Rodriguez, R. Frago,
L. Trenti, D. Fraccalvieri, J. Lopez-Borao, S. Biondo,
L’Hospitalet de Llobregat, Spain
Incidence of Ischemic Colitis after Abdominal
Aortic Aneurysm Repair: Results from the
National Surgical Quality Improvement
Program database
Monday Monitor #9, located outside Room 304
Outcomes
M. Abou Khalil, J. Abou Khalil, M. Boutros,
P. Gordon, D. Obrand, Montreal, QC, Canada
The Impact of Obesity on the Management of
Horseshoe Fistulas
Monday
Monitor #1, located in Hall C
Other Benign Disease
D. Hiller, J. Bohl, G. Waters, Winston-Salem, NC
Process Improvement for Laparoscopic
Colorectal Surgery with an Enhanced Recovery
Pathway: Does Alvimopan Add Value?
Monday
Monitor #3, located in Hall C
Outcomes
J. LeFave, D. Keller, S. Ibarra, J. Flores-Gonzalez,
M. Ragupathi, A. Mahmood, T. Pickron, E. Haas,
Houston, TX
Screening or Symptoms? How Do We Detect
Colorectal Cancer in an Equal Access Health
Care System?
Tuesday
Monitor #2, located in Hall C
Outcomes
Q. Hatch, K. Kniery, E. Johnson, D. Moiel,
J. Thompson, S. Steele, Lakewood, WA, Tacoma,
WA, Fort Lewis, WA, Portland, OR
P1224
Long-Term Efficacy of the TOPAS™ System for
Treatment of Fecal Incontinence
Sunday
Monitor #4, located in Hall C
Other Benign Disease
D. Fenner, M. Zutshi, V. Lucente, P. Culligan,
A. Mellgren*, Ann Arbor, MI; Cleveland, OH;
Morristown, NJ; Philadelphia, PA; Chicago, IL
P1225
Creation of a Pharmacoeconomic Calculator for
Clinical and Financial Outcomes in Colorectal
Surgery
Tuesday
Monitor #4, located in Hall C
Outcomes
D. Keller, A. Smalarz, J. LeFave, R. Tahilramani,
J. Flores-Gonzalez, S. Ibarra, R. Pedraza, E. Haas,
Houston, TX
P1226
Institution of a Preoperative Stoma Education
Group Class Decreases Rates of Peristomal
Complications in New Stoma Patients
Tuesday
Monitor #4, located in Hall C
Outcomes
A. Stokes, S. Tice, P. Wocn, W. Koltun, F. Puleo,
Hershey, PA
P1227
Venous Thromboembolism Outcomes after
Partial Colectomies in Patients with Colon
Cancer: The Role of Operative Time
Monday
Monitor #2, located in Hall C
Outcomes
N. Changoor, G. Ortega, D. Bezzini, T. Seyoum,
R. Diaz-Acosta, L. Wilson, D. Ford, Washington, DC
P1228
TSTstarr+ versus Stapled Hemorrhoidopexy
for Grade III-IV Prolapsing Hemorrhoids:
A Prospective Clinical Trial
Monday
Monitor #6, located in Hall D
Other Benign Disease
H. Lin, J. Li, D. Ren, Guangzhou, China
P1229
Does Use of Alvimopan Facilitate Earlier
Recovery after Loop Ileostomy Closure?
Monday
Monitor #1, located in Hall C
Outcomes
S. Chao, S. Schechter, J. Machan, A. Klipfel,
M. Vrees, Providence, RI
P1230
Failure of Initial Ligation of Intersphincteric
Fistula Tract does not Preclude Ultimate
Success
Monday
Monitor #5, located in Hall C
Other Benign Disease
F. Chen, U. Wallin, C. Jensen, S. Goldberg, Sylmar,
CA; St. Paul, MN; Iowa City, IA
*All ePoster presenters are listed first unless otherwise noted.
126
P1231
Primary vs. Delayed Perineal Proctectomy –
There is No Free Lunch
Monday
Monitor #8, Outside Ballroom B
Outcomes
V. Poylin, T. Curran, T. Cataldo, D. Nagle, Boston,
MA
P1232
Sessile Serrated Adenoma Detection-Predictive
Factors
Monday
Monitor #2, located in Hall C
Outcomes
R. Daigle, R. Hilsden, W. Buie, I. Datta, J. Heine,
M. Brar, A. MacLean, Calgary, AB, Canada
P1233
P1234
P1235
P1236
Rectovaginal Fistula Repair: What is the ”Gold
Standard?”
Monday
Monitor #5, located in Hall C
Other Benign Disease
K. Stackhouse, T. Hull, A. Nowacki, B. Gurland,
S. Shawki, M. Zutshi, Cleveland, OH
Identifying and Evaluating Postoperative
Complications and Morbidity in Ileostomy
Patients
Tuesday
Monitor #4, located in Hall C
Outcomes
Y. van Loon, M. van Heijst, B. Langenhoff,
I. Martijnse, D. Wasowicz, D. Zimmermann,
Tilburg, Netherlands
Intestinal Failure Secondary to
Enterocutaneous Fistulae: Long-Term Outcomes
in a Tertiary Referral Center – A 15-Year
Experience
Monday
Monitor #5, located in Hall C
Other Benign Disease
M. Quinn, R. McKee, Glasgow, United Kingdom
Age is an Important Determinant of Mortality
following Curative Resections for Mid and Low
Rectal Carcinoma: Results from ACS NSQIP
Database
Tuesday
Monitor #2, located in Hall C
Outcomes
J. Makhlin, A. Kezouh, N. Morin, G. Ghitulescu,
P. Gordon, C. Vasilevsky, M. Demian, M. Boutros,
Montreal, QC, Canada
P1237
A Randomized, Double-Blind, Comparative
Study to Evaluate the Efficacy and Safety of
Ramosetron Injection of Nausea and Vomiting
Associated with Patient-Controlled Analgesia in
Colorectal Cancer Patients Undergoing
Laparoscopic Colectomy
Monday
Monitor #1, located in Hall C
Outcomes
J. Lee, M. Kim, W. Kang, Seoul, Korea
P1238
Hand-Assisted Laparoscopic Approach in
Colorectal Surgery
Monday
Monitor #8, Outside Ballroom B
Outcomes
Z. Moghadamyeghaneh, M. Hanna, J. Carmichael,
S. Mills, A. Pigazzi, M. Stamos, Orange, CA
P1239
Incidence of Incisional Hernias following
Multiport and Single Incision Robotic
Colorectal Surgery
Monday
Monitor #8, Outside Ballroom B
Other Benign Disease
J. Harr, Y. Juo, S. Luka, S. Agarwal, F. Brody,
V. Obias, Washington, DC
P1240
Colorectal Stenting: A Nationwide Appraisal of
Trends and Outcomes
Tuesday
Monitor #3, located in Hall C
Outcomes
M. Hanna, Z. Moghadamyeghaneh, G. Hwang,
L. Malellari, S. Mills, M. Stamos, A. Pigazzi,
J. Carmichael, Orange, CA
P1241
A Randomized, Controlled Study of Stoma
Intubation at the Time of Formation
Tuesday
Monitor #4, located in Hall C
Outcomes
D. Shaw, C. Ternent, J. Beaty, G. Blatchford,
N. Bertelson, M. Shashidharan, J. Bikhchandani,
A. Thorson, Omaha, NE
P1242
Small Bowel Evaluation with Capsule
Endoscopy and Deep Enteroscopy: Initial
Experience of a Brazilian Teaching Hospital
Monday Monitor #9, located outside Room 304
Other Benign Disease
M. Camargo, C. Nagasako, C. Martinez,
J. Fagundes, M. Ayrizono, J. Meirelles-Santos,
R. Leal, C. Coy, Campinas, Brazil
*All ePoster presenters are listed first unless otherwise noted.
127
EPOSTERS
ePoster Presentations
ePoster Presentations
P1243
Preliminary Results of Postdischarge Venous
Thromboembolism Prophylaxis of Patients
Undergoing Colorectal Resections
Monday
Monitor #2, located in Hall C
Outcomes
Z. Gregg, C. Choi, G. Ortenzi, F. Puleo, D. Stewart,
K. McKenna, W. Koltun, E. Messaris, Hershey, PA
P1250
Effect of Exparel® TAP Infiltration on
Postoperative Outcomes after Laparoscopic
Colectomy
Monday
Monitor #1, located in Hall C
Outcomes
E. Lagergren, C. Bourean, J. Reynolds, J. Jaffe,
G. Russell, G. Waters, J. Bohl, Winston Salem, NC
P1244
Surgical Outcomes of Colorectal Cancer
Surgery According to Specific Body Mass
Index Groups
Monday
Monitor #1, located in Hall C
Outcomes
M. Jafari, F. Jafari, M. Phelan, M. Stamos,
J. Carmichael, S. Mills, A. Pigazzi, Orange, CA
P1251
P1245
Anoplasty for Fissures: Risk Factors for
Recurrence and Complications
Monday
Monitor #3, located in Hall C
Other Benign Disease
A. Curry, J. Gallagher, A. Ferrara, M. Renee,
P. Williamson, S. DeJesus, M. Soliman,
A. Ghlandian, B. Shanker, R. Vegeler, J. Zakhaleva,
Orlando, FL
Compliance with Clinical Guidelines is the Most
Important Prognostic Factor in Patients with
Clostridium difficile Infection
Monday Monitor #9, located outside Room 304
Other Benign Disease
K. Crowell, K. Julian, M. Katzman, D. Stewart,
W. Koltun, E. Messaris, Hummelstown, PA,
Hershey, PA
P1252
Assessment of Bowel End Perfusion after
Mesenteric Division: Eye vs. SPY
Monday
Monitor #8, Outside Ballroom B
Outcomes
J. Bornstein, J. Deliz, D. Kruse, M. Sgouros,
C. Chen, S. Khaitov, D. Chessin, T. Ferguson,
S. Gorfine, J. Bauer, New York, NY; Greenville, NC
P1246
Does a Protective Ileostomy Eliminate the
Benefit of Alvimopan in Elective Surgery?
Tuesday
Monitor #4, located in Hall C
Outcomes
M. Sippey, K. Spaniolas, K. Kasten, M. Manwaring,
Greenville, NC
P1254
Short- and Long-Term Results of Anal Fissure
Treatment with Botulinum Toxin
Monday
Monitor #3, located in Hall C
Other Benign Disease
G. Palominos, C. Villalon, D. Palominos, F. Bellolio,
M. Molina, Santiago, Chile
P1247
Neoadjuvant Treatment for Rectal Cancer
Impacts Continence in Patients Undergoing
Transanal Endoscopic Microsurgery
Tuesday
Monitor #1, located in Hall C
Other Benign Disease
J. Zakhaleva, A. Ferrara, J. Gallagher, S. DeJesus,
M. Renee, M. Soliman, R. Vegeler, A. Ghlandian,
Orlando, FL
P1256
Risk Factors Associated with 30-Day
Readmissions: A Snapshot of Regional Practice
Experience in Colorectal Surgery
Monday
Monitor #4, located in Hall C
Outcomes
B. Hensley, R. Cooney, N. Hellenthal, J. Monson,
K. Noyes, K. Kelly, F. Fleming, Rochester, NY;
Syracuse, NY; Cooperstown, NY
P1248
Effect of Transfusion Threshold on Infectious
Complications after Rectal Cancer Surgery
Tuesday
Monitor #4, located in Hall C
Outcomes
V. Ozben, E. Gorgun, L. Stocchi, J. Ashburn, X. Liu,
F. Remzi, Cleveland, OH
P1257
The Association of Levator Ani Syndrome with
Sacroiliac Dysfunction
Monday
Monitor #6, located in Hall D
Other Benign Disease
R. Cali, Tyler, TX
P1258
P1249
Postoperative Ileus is a Significant Problem
after Colorectal Surgery Even in an Enhanced
Recovery Protocol
Monday
Monitor #3, located in Hall C
Outcomes
D. Estrada Trejo, A. van Dalen, R. Teja Pasam,
A. Murray, J. Rein, S. Lee-Kong, D. Feingold,
R. Kiran, New York, NY
Does Early Removal of Urinary Catheter Affect
Urinary Complications after Pelvic Colorectal
Surgery? Practic Changes
Monday Monitor #9, located outside Room 304
Outcomes
C. Benlice, E. Gorgun, L. Stocchi, H. Kessler,
F. Remzi, Cleveland, OH
*All ePoster presenters are listed first unless otherwise noted.
128
P1259
Sacral Neuromodulation for Fecal Incontinence
Associated with Obstetric Anal Sphincter
Injury: Results from SNM-Test
Sunday
Monitor #4, located in Hall C
Other Benign Disease
M. Rydningen, T. Dehli, M. Stedenfeldt, M. Kumle,
R. Lindsetmo, S. Norderval, Tromsoe, Norway;
Narvik, Norway
P1260
Readmission after Rectal Cancer Surgery: Does
Ostomy Status Matter?
Monday
Monitor #4, located in Hall C
Outcomes
M. Hanna, G. Hwang, Z. Moghadamyeghaneh,
M. Phelan, S. Mills, M. Stamos, A. Pigazzi,
J. Carmichael, Orange, CA
P1267
Treatment of Hemorrhoids and Obstructed
Defecation Syndrome with a New Device: TST
STARR Plus
Monday
Monitor #6, located in Hall D
Other Benign Disease
F. Pakravan, C. Helmes, K. Wolff, Duesseldorf,
Germany
P1268
Frailty as a Predictor of Discharge Destination
following Colorectal Surgery
Tuesday
Monitor #1, located in Hall C
Outcomes
A. Stefanou, Y. Lin, K. Welch, R. Cleary, Ypsilanti,
MI
P1270
Increased Operative Time and Intraoperative
Blood Transfusion are Associated with
Postoperative Anastomotic Leak
Monday
Monitor #8, Outside Ballroom B
Outcomes
K. Gross, G. Alex, C. Cortina, J. Smolevitz,
V. Fleetwood, S. Sarvepalli, S. Bakhsh, J. Poirier,
M. Singer, J. Myers, B. Orkin, Chicago, IL
P1262
Anorectal Function after Intersphincteric
Resection for Ultra-low Rectal/Anal Cancer Can
Improve in Long-term Recovery
Monday
Monitor #2, located in Hall C
Outcomes
Z. Gan, X. Wang, R. A, J. Nie, L. Li, Chengdu, China
P1263
Functional Evaluation of Obese Patients with
Pelvic Floor Disorders
Monday
Monitor #1, located in Hall C
Other Benign Disease
D. Lima, G. Kurachi, U. Sagae, F. Regadas,
S. Murad-Regadas, Cascavel, Brazil; Fortaleza,
Brazil
P1271
Anal Fistulas without Internal Opening: Results
of Treatmemt Compared to Anal Fistulas with
Internal Opening
Monday
Monitor #5, located in Hall C
Other Benign Disease
E. Han, S. Ryoo, B. Park, J. Park, E. Choe, S. Moon,
S. Jeong, K. Park, Seoul, Korea
P1264
Utility of MELD Core as an Independent
Predictor of Morbidity and Mortality following
Rectal Surgery
Tuesday
Monitor #1, located in Hall C
Outcomes
G. Hwang, Z. Moghadamyeghaneh, M. Hanna,
J. Carmichael, S. Mills, M. Stamos, A. Pigazzi,
Orange, CA
P1272
National Trends in Short-Term Outcomes
following Surgery for Diverticular Disease
Tuesday
Monitor #2, located in Hall C
Outcomes
C. Papageorge, G. Kennedy, E. Foley, C. Heise,
B. Harms, E. Carchman, Madison, WI
P1274
A Qualitive Exploration of the Attitudes and
Experiences of Patients Diagnosed with
Advanced Stage Colorectal Cancer in a Safetynet Hospital System
Monday
Monitor #2, located in Hall C
Outcomes
S. Millas, M. Leal, B. Karanjawala, R. Escamilla,
D. Lew, L. Kao, Houston,TX
P1266
The Transversus Abdominis Plane Block:
A Prospective Randomized Controlled Trial
using EXPARELE
Monday
Monitor #1, located in Hall C
Outcomes
N. Jrebi, J. Ogilvie, T. Jaluta, R. Figg, N. Dujovny,
M. Luchtefeld, P. Grady, A. Davis, T. Asgeirsson,
Morgantown, WV; Grand Rapids, MI
*All ePoster presenters are listed first unless otherwise noted.
129
EPOSTERS
ePoster Presentations
ePoster Presentations
P1275
P1277
P1278
P1279
Intra-Incisional Depot Bupivacaine Reduces
Pain Intensity and Opioid Consumption for 72
hours following Open Laparotomy, Compared
with Bupivacaine HC
Monday
Monitor #1, located in Hall C
Outcomes
H. Papaconstantinou, J. Marcet, D. Ellis,
J. Meisner, A. Hadj, Temple, TX; Tampa, FL;
Cupertino, CA; Melbourne, VIC, Australia
Pilot Study on the Safety, Usability and
Performance of Lifeseal in Patients Undergoing
an Elective Cicular Stapled Anastomosis within
10CM of the Anal Verge
Monday,
Monitor #2, located in Hall C
Outcomes
L. Pahlman, K. van der Speeten, J. Folkesson,
Y. Van Nieuwenhove, I. Syk, A. Martling,
H. Tulchinsky, A. D’Hoore, Uppsala, Sweden; Gent,
Belgium; Stockholm, Sweden; Tel Aviv, Israel;
Leuven, Belgium
Colorectal Surgeons and Patient Hospital
Experience. How Can HCAHPS Help to
Understand This Relationship?
Tuesday
Monitor #2, located in Hall C
Outcomes
L. Duraes, L. Stocchi, F. Remzi, J. Merlino,
B. Gurland, Cleveland, OH
Determining the Indeterminate: One-Third of
Indeterminate Pulmonary Nodules are
Metastatic Cancer on Follow-Up Scans
Monday
Monitor #8, Outside Ballroom B
Neoplastic Disease
M. Oliveira-Cunha, M. Aslam, W. Thomas,
Leicester, United Kingdom
P1280
Histological Subtypes and KRAS Mutation
Accentuates Poorer Prognosis in the Outcomes
of Colorectal Cancer Peritoneal Carcinomatosis
after Cytoreductive Surgery and HIPEC
Monday
Monitor #6, located in Hall D
Neoplastic Disease
A. Thien, Singapore
P1281
Inhibition of NRF2 Sensitizes Colorectal Cancer
Cells to Irinotecan Cytotoxicity
Monday
Monitor #6, located in Hall D
Neoplastic Disease
J. Evans, B. Winiarski, P. Sutton, P. Rooney,
D. Palmer, N. Kitteringham, Chester, United
Kingdom; Liverpool, United Kingdom
P1282
Carcinoembryonic Antigen Level in the Setting
of Microsatellite Instability
Sunday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
M. Julien, K. Halm, H. Ellison, M. Shabahang,
J. Blansfield, P. Meade, K. Quindlen, Danville, PA
P1283
“Watch and Wait” Strategy after Complete
Clinical Response following Neoadjuvant
Chemoradiotherapy Results in a High Rate of
Organ Preservation and Similar Oncological
Outcomes Compared with Radical Surgery
Sunday
Monitor #1, located in Hall C
Neoplastic Disease
C. Vaccaro, J. Tognelli, G. Ojea Quintana,
F. Bonadeo, F. Yazyi, R. Mentz, M. Sardi, G. Rossi,
Buenos Aires, Argentina
P1284
Local Excision Correlates with Poorer Prognosis
in Patients with Anorectal Melanoma: A Bad
Choice Maybe
Tuesday
Monitor #8, Outside Ballroom B
Neoplastic Disease
N. Chen, L. Wang, J. Gu, Beijing, China
P1285
Cytoreductive Surgery and HIPEC Confers
Prolonged Survival for Colorectal Peritoneal
Metastases
Monday
Monitor #3, located in Hall C
Neoplastic Disease
G. Tan, C. Lim, C. Tham, K. Soo, M. Teo, Singapore
P1286
Are Patients Willing to Accept an Increased Risk
of Local Recurrence for Deferral of Surgery
Relative to Abdominal Perineal Resection
following Clinical Complete Response for Low
Rectal Cancer?
Sunday
Monitor #5, located in Hall C
Neoplastic Disease
S. Schmocker, G. Heine, A. Borowiec, C. Brace,
J. Victor, N. Baxter, R. McLeod, E. Kennedy,
Toronto, ON, Canada; Kingston, ON, Canada;
Edmonton, AB, Canada
P1287
Neoadjuvant Therapy for Locally Advanced
Rectal Adenocarcinoma: Relationship between
Clinical and Pathological Responses
Sunday
Monitor #5, located in Hall C
Neoplastic Disease
C. Vaccaro, J. Santino, G. Ojea Quintana,
F. Bonadeo, M. Falconi, F. Yazyi, R. Mentz, G. Rossi,
Buenos Aires, Argentina
*All ePoster presenters are listed first unless otherwise noted.
130
P1288
Prognostic Significance of Vascular Endothelial
Growth Factor Receptor 3(VEGFR-3) Expression
in Rectal Cancer
Sunday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
S. Sokmen, C. Ulukus, A. Sirin, H. Ellidokuz,
S. Sarioglu, M. Fuzun, Izmir, Turkey
P1289
Defining the Rectosigmoid Junction Using MRI
Sunday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
V. Tudyka, S. Balyasnikova, B. Moran, M. Abulafi,
G. Brown, London, United Kingdom; Basingstoke,
United Kingdom; Croydon, United Kingdom
P1290
Lymphovascular Invasion and Perineural
Invasion are Associated with Advanced Disease
and Poor Survival in Colorectal Cancer
Monday
Monitor #3, located in Hall C
Neoplastic Disease
E. Al-Sukhni, K. Attwood, E. Gabriel, S. Nurkin,
Buffalo, NY
P1291
Design and Development of Prototype:
Distractor Mechanic Endo AnoRectal. Experimental Test in Mixed Simulator
and Cadaver of TEM without Pneumorectum
Tuesday
Monitor #8, Outside Ballroom B
Neoplastic Disease
J. Rodriguez-Garcia, P. Suarez, J. Sierra, S. Moral,
A. Cabrera, Oviedo, Spain; Gijon, Spain
P1292
Preoperative Short-Course Radiotherapy with
Long Interval Surgery in a Series of High-Risk
Patients with Locally Advanced Rectal Cancer
Sunday
Monitor #5, located in Hall C
Neoplastic Disease
M. Flanagan, I. Reynolds, D. McNamara, Dublin,
Ireland
P1293
Endoscopic Stenting of Bstructin Colorectal
Cancer: A Suitable Therapeutic Option? A
Review of Ten Years’ of Data from a Tertiary
Referral Center
Tuesday
Monitor #3, located in Hall C
Neoplastic Disease
V. Chauhan, R. Padwick, M. Newman,
J. Francombe, M. Osborne, Warwick, United
Kingdom
P1294
Early Removal of the Urinary Catheter after
Total Mesorectal Excision for Rectal Cancer is
Safe
Monday
Monitor #2, located in Hall C
Neoplastic Disease
H. Kim, B. Yoo, B. Kye, G. Kim, H. Cho, Suwon,
Korea
P1295
What is the Long-Term Prognosis of Cirrhotic
Patients with a Colorectal Cancer: A CaseMatched Study
Monday
Monitor #3, located in Hall C
Neoplastic Disease
C. Sabbagh, J. Poirot, B. Chauffert, M. Fumery,
J. Regimbeau, Amiens, France
P1296
Perineal Wound Healing and Long-Term
Outcomes after Salvage Abdominoperineal
Resection for Local Failure of Anal Squamous
Cell Carcinoma following Chemoradiation
Sunday
Monitor #1, located in Hall C
Neoplastic Disease
S. Agbroko, E. Aytac, L. Stocchi, F. Remzi, A. Al
Chakaki, D. Dietz, M. Kalady, Parma Heights, OH;
Cleveland, OH
P1297
Transanal Endoscopic Microsurgery: Ten-Year
Outcomes in a Tertiary Referral Center
Tuesday
Monitor #8, Outside Ballroom B
Neoplastic Disease
M. Quinn, L. Moyes, T. Chieng, R. McKee,
Glasgow, United Kingdom
P1298
Immediate Perineal Reconstruction Following
Perineal, Abdominoperineal or Multivisceral
Resection Using Inferior Gluteal Artery
Perforator Flaps: 7-Year Experience and
Follow-Up
Sunday
Monitor #1, located in Hall C
Neoplastic Disease
M. Pramateftakis, H. Creasy, P. Roblin,
P. Mohanna, D. Ross, A. Schizas, M. George,
London, United Kingdom
P1299
T4 Colon Cancers – Elective versus Emergency
in the Modern Era
Monday
Monitor #6, located in Hall D
Neoplastic Disease
D. Harji, J. Dixon, A. King, P. Sagar, Leeds, United
Kingdom
P1300
Colonic Stenting. A Worthwhile Option?
Tuesday
Monitor #3, located in Hall C
Neoplastic Disease
K. Bailey, M. Jha, N. Wadd, A. Reddy, Norton,
United Kingdom
*All ePoster presenters are listed first unless otherwise noted.
131
EPOSTERS
ePoster Presentations
ePoster Presentations
P1301
Tumor Height and Tumor Position Predict TME
Quality
Monday Monitor #9, located outside Room 304
Neoplastic Disease
M. Mendez, R. Wilcox, P. Callas, P. Cataldo,
Burlington, MA
P1302
Do All Patients Benefit from
Chemoradiotherapy for Locally Advanced
Rectal Cancer? A Propensity Score Analysis
Sunday
Monitor #5, located in Hall C
Neoplastic Disease
M. Kim, S. Park, D. Kim, S. Kim, J. Joo, O. Jae
Hwan, Goyang, Korea
P1303
P1304
P1305
Tumor Size as a Prognostic Factor in Patients
with Early Stage Colon Cancer
Monday
Monitor #3, located in Hall C
Neoplastic Disease
G. Rizzo, F. Santullo, A. Biondi, D. D’Ugo,
C. Mattana, C. Coco, R. Persiani, Rome, Italy
Prognostic Impact of Retroperitoneal Resection
Margin Involvement in Colon Cancer
Monday
Monitor #3, located in Hall C
Neoplastic Disease
S. Sokmen, M. Ozbilgin, O. Sagol, H. Ellidokuz,
S. Sarioglu, Izmir, Turkey
Efficacy of Sodium Hyaluronate
Carboxymethylcellulose Absorbable
Antiadhesion Barrier(Seprafilm®) on
Abdominopelvic Adhesions in an Experimental
Rat Peritonectomy Model
Monday
Monitor #6, located in Hall D
Neoplastic Disease
N. Arslan, S. Sokmen, M. Koskderelioglu,
E. Ozkara, O. Yilmaz, S. Sarioglu, Izmir, Turkey
P1306
Pathologic Complete Response (pCR) and
Rectal Cancer: What Does it Really Mean?
Tuesday
Monitor #5, located in Hall C
Neoplastic Disease
S. Patel, A. Meyer, K. Kochar, A. Ralph, E. James,
S. Marecik, J. Park, L. Prasad, Park Ridge, IL
P1307
Multicentric Colorectal Cancer Screening in a
Developing Country
Monday Monitor #9, located outside Room 304
Neoplastic Disease
F. Lopez-Kostner, A. Zarate, U. Kronberg,
A. Ponce, C. Wainstein, H. Kawachi, K. Tanaka,
T. Okada, M. Kobayashi, A. Wielandt, R. Estela,
G. Bannura, S. Karelovic, S. Pasternak, H. Carrasco,
S. Flores, Santiago, Chile; Tokyo, Japan; Punta
Arenas, Chile
P1308
Endoscopic Submucosal Dissection for Early
Colorectal Neoplasms: Initial Experience of a
Brazilian Teaching Hospital
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
M. Camargo, J. Meirelles-Santos, N. Miyajima,
R. Leal, C. Martinez, J. Fagundes, M. Ayrizono,
C. Coy, Campinas, Brazil
P1309
Comparison between Surgical and
Conservative Treatment of Colorectal Cancer in
Patients at the Age of 90 or Greater
Monday
Monitor #6, located in Hall D
Neoplastic Disease
T. Chen, J. Liang, Hsinchu, Taiwan; Taipei, Taiwan
P1310
Local Excision of Rectal Cancer following
Neoadjuvant Therapy: ypT2 = Observation or
Radical Surgery?
Tuesday
Monitor #8, Outside Ballroom B
Neoplastic Disease
N. Lopez-Acevedo, J. Marks, M. Johnson,
J. Frenkel, S. Kakade, A. Denittis, G. Marks,
Wynnewood,PA
P1311
One-Year Follow-up Colonoscopy after Curative
Resection of Colorectal Cancer: Is It
Worthwhile?
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
M. Bun, L. Pereyra, F. Ocariz, N. Panigadi,
D. La Salvia, C. Fischer, D. Cimmino, N. Rotholtz,
Buenos Aires, Argentina
P1312
Risk of Metachronous Advanced Neoplastic
Lesions in Patients with Sessile Serrated
Adenomas Undergoing Surveillance
Colonoscopy
Monday
Monitor #2, located in Hall C
Neoplastic Disease
M. Bun, L. Pereyra, A. Sanchez Ruiz, E. Gomez,
R. Gonzalez, A. Canelas, D. Cimmino, N. Rotholtz,
Buenos Aires, Argentina
P1313
Phase III Multicenter, Prospective, Controlled,
Randomized Trial to Evaluate the Safety and
Efficacy of Treatment of Rectal Cancer T2-T3s
(Superficial) N0, M0 with Preoperative
Chemoradiotherapy and Transanal Endoscopic
Microsurgery versus Total Mesorectal
Sunday
Monitor #3, located in Hall C
Neoplastic Disease
X. Serra-Aracil, L. Mora, C. Pericay, S. Delgado,
E. Targarona, F. Vallribera, T. Golda, A. Reina,
Sabadell, Spain; Barcelona, Spain; Almeria, Spain
*All ePoster presenters are listed first unless otherwise noted.
132
P1314
Delayed Colon Perforation in the Presence of
Self-Expanding Metal Stents (SEMS): A
Common Event?
Tuesday
Monitor #3, located in Hall C
Neoplastic Disease
K. Blaker, J. Anandam, A. Abdelnaby,
F. Araghizadeh, C. Olson, Dallas, TX
P1321
Stage IV Rectal Cancer – Has Potential for Cure
Improved Over Time?
Sunday
Monitor #2, located in Hall C
Neoplastic Disease
N. Rajendran, K. Yap, Y. Kaneko, B. Thomson,
S. Ngan, A. Lynch, S. Warrier, A. Heriot,
Melbourne, VIC, Australia
P1315
Surveillance Interval after a Normal Screening
Colonoscopy: Is It Really Ten Years?
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
M. Bun, L. Pereyra, E. Gomez, M. Omodeo,
N. Panigadi, C. Fischer, D. Cimmino, N. Rotholtz,
Buenos Aires, Argentina
P1322
Pelvic Exenterative Surgery for Primary Rectal
Carcinoma: A Single Center 22-Year Experience
Sunday
Monitor #2, located in Hall C
Neoplastic Disease
R. Radwan, H. Jones*, N. Rawat, M. Davies,
M. Evans, D. Harris, J. Beynon, Swansea, United
Kingdom
P1323
P1316
From Laparoscopic-Assisted to Total
Laparoscopic Right Colectomy with
Intracorporeal Anastomosis: Is the Shift in
Technique Justified?
Monday
Monitor #6, located in Hall D
Neoplastic Disease
U. Hameed, K. Beyfuss, V. Palter, PK Stotland,
A. Okrainec, LV Klein, MA Aarts, S. Ashamalla,
Toronto, ON, Canada
Differential Clinical Benefits of 5-FluorouracilBased Adjuvant Chemotherapy for Patients
with Stage III Colorectal Cancer according to
Tumor Budding Status
Sunday
Monitor #5, located in Hall C
Neoplastic Disease
E. Shinto, A. Shikina, S. Fukazawa, H. Ueno,
Y. Kajiwara, H. Tsuda, J. Yamamoto, K. Hase,
Tokorozawa, Japan
P1324
P1317
Supporting Quality Assurance Initiatives for
Rectal Cancer: Is the CAP Protocol Enough?
Monday
Monitor #8, Outside Ballroom B
Neoplastic Disease
C. MacPherson, A. MacLean, W. Buie, Calgary, AB,
Canada
P1318
TEM-ESD: A New Standard Approach for Large
Rectal Adenomas?
Tuesday
Monitor #8, Outside Ballroom B
Neoplastic Disease
J. Baral, K. Kouladouros, S. Fender, F. Pullig,
M. Schon, Karlsruhe, Germany
Transanal Minimally Invasive Surgery: A
Multicenter Assessment of Feasibility, Safety
and Learning Curve
Tuesday
Monitor #8, Outside Ballroom B
Neoplastic Disease
S. Clermonts, W. Brokelman, D. Lips, W. Zijlstra,
J. Maring, D. Wasowicz, B. Langenhoff,
D. Zimmermann, Den Bosch, Netherlands;
Tilburg, Netherlands
P1325
Primary Tumor Regression Grade after
Preoperative Chemoradiotherapy for Locally
Advanced Rectal Cancer: Its Prognostic Impact
in Patients with ypTanyN+ Disease
Sunday
Monitor #3, located in Hall C
Neoplastic Disease
Y. Park, H. Kim, K. Jung, J. Huh, S. Yun, W. Lee,
H. Chun, Seoul, Korea
P1326
Prognostic Impact of Lymph Node Ratio on
Rectal Cancer after Preoperative
Chemoradiotherapy: A Multicenter
Retrospective Study
Monday
Monitor #4, located in Hall C
Neoplastic Disease
B. Park, J. Park, E. Han, S. Ryoo, H. Park, J. SeungYong, S. Kang, O. Jae Hwan, K. Park, Seoul, Korea;
Goyang, Korea; Seongnam, Korea; Anyang, Korea
P1319
P1320
Management of Tumors of the Ischiorectal
Fossa: Is Percutaneous Biopsy Essential?
Monday
Monitor #8, Outside Ballroom B
Neoplastic Disease
N. Buchs, N. Mortensen, R. Guy, M. Gibbons,
B. George, Oxford, United Kingdom
Comparison of Short-term Outcome between
Robotic-assisted and Laparoscopic Total
Mesorectal Excision for Mid to Low Rectal
Cancer
Monday Monitor #9, located outside Room 304
Neoplastic Disease
C. Foo, W. Law, Hong Kong
*All ePoster presenters are listed first unless otherwise noted.
133
EPOSTERS
ePoster Presentations
ePoster Presentations
P1327
Oncologic and Surgical Outcomes in Colorectal
Cancer Patients with Liver Cirrhosis
Monday
Monitor #3, located in Hall C
Neoplastic Disease
E. Han, S. Ryoo, B. Park, J. Park, E. Choe, S. Moon,
S. Jeong, K. Park, Seoul, Korea
P1328
Similar Polyp Detection Rates among Body
Mass Index Categories at First Screening
Colonoscopy
Monday
Monitor #2, located in Hall C
Neoplastic Disease
J. Terlizzi, A. Zheng, B. Phillips, S. Goldstein,
G. Isenberg, Philadelphia, PA
P1329
A Survey of Colorectal Surgeons on the Factors
Influencing Implementation of the Rectal
Cancer Patient Decision Aid
Monday
Monitor #8, Outside Ballroom B
Neoplastic Disease
R. Wu, R. Boushey, P. Roberts, D. Stacey, B. Potter,
Ottawa, ON, Canada; Boston, MA
P1330
Could Elevated Preoperative C-Reactive Protein
Level Predict Oncologic Outcomes in Patients
who Underwent Curative Resection after
Chemoradiation in Rectal Cancer?
Sunday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
W. KIM, S. Baek, H. Hur, B. Min, K. Lee, N. Kim,
Seoul, Korea
P1331
Extramesenteric Lymphadenectomy for Colon
Cancer with Isolated Para-Aortic Lymph Node
Metastasis
Monday
Monitor #5, located in Hall C
Neoplastic Disease
S. Bae, H. Hur, B. Min, S. Baik, K. Lee, N. Kim,
Seoul, Korea; Daegu, Korea
P1332
Prognostic Value of Lymph Node Number and
Lymph Node Ratio Staging System in Stage 3
Rectal Cancer following Neoadjuvant
Radiochemotherapy
Monday
Monitor #5, located in Hall C
Neoplastic Disease
D. Zhang, J. Gu, M. LI, Beijing, China
P1333
Prognosis of T1-2N0M0 Rectal CancerAdjuvant Chemotherapy or Not
Sunday
Monitor #2, located in Hall C
Neoplastic Disease
D. Zhang, J. Gu, M. LI, Beijing, China
P1334
Rectal Vascular Supply Anatomical Variability is
Prognostic Factor of Lateral Node Metastasis in
Patients with Rectal Cancer
Sunday
Monitor #2, located in Hall C
Neoplastic Disease
A. Zakharenko, M. Beliaev, Saint Petersburg,
Russian Federation
P1335
Functional Outcomes after Laparoscopic Very
Low Anterior Resection
Monday
Monitor #6, located in Hall D
Neoplastic Disease
R. Matsunaga, Y. Nishizawa, M. Yokota, N. Saito,
Kashiwa-shi, Japan
P1336
Clinically Relevant Doses of Standard
Chemotherapeutic Agents are well Tolerated in
the Humanized Mouse Models (NSG/NRG) of
Colon Cancer
Tuesday
Monitor #5, located in Hall C
Neoplastic Disease
J. Davids, J. Maykel, J. Liu, L. Schultz, D. Greiner,
J. Houghton, Worcester, MA; Bar Harbor, MI
P1337
“En-bloc” Seminal Vesicle Excision for Locally
Advanced and Recurrent Sigmoid and Rectal
Cancer
Sunday
Monitor #2, located in Hall C
Neoplastic Disease
S. Manning, J. Keating, R. Studd, E. Dennett,
Wellington, New Zealand
P1338
Preparing for the OSTRICH Consortium
Proposed Standards for Excellence in Rectal
Cancer Treatment: Are We Ready?
Monday
Monitor #8, Outside Ballroom B
Neoplastic Disease
L. Hernandez, A. Estep, T. Stahl, J. Ayscue,
J. Fitzgerald, G. Sigle, A. Kumar, Washington, DC
P1339
Incidental Appendiceal Cancer at
Appendectomy: An Analysis of Incidence,
Trends and Risk Factors
Monday
Monitor #8, Outside Ballroom B
Neoplastic Disease
M. Hanna, G. Hwang, Z. Moghadamyeghaneh,
M. Phelan, J. Carmichael, S. Mills, M. Stamos,
A. Pigazzi, Orange,CA
P1340
Feasibility of Robotic Pelvic Exenteration
Monday Monitor #9, located outside Room 304
Neoplastic Disease
J. Au, C. Bergman, R. Viterbo, S. Reddy, S. Cohen,
J. Meyer, E. Sigurdson, J. Farma, Philadelphia, PA
*All ePoster presenters are listed first unless otherwise noted.
134
P1341
P1342
P1343
P1344
P1345
P1346
Endoluminal Loco-Regional Resection (ELRR) by
Transanal Endoscopic Microsurgery (TEM): 22
year Experience
Tuesday Monitor #9, located outside Room 304
Neoplastic Disease
E. Lezoche, A. Balla, S. Quaresima, M. Guerrieri,
G. D’Ambrosio, G. Lezoche, A. Paganini, Rome,
Italy; Ancona, Italy
Compare Anastomotic Recurrence of Colon
Cancer and Rectal Cancer in Patients Performed
Curative Resection
Tuesday
Monitor #6, located in Hall D
Neoplastic Disease
W. Jung, C. Yu, S. Lim, I. Park, Y. Yoon, C. Kim,
J. Lee, J. Kim, Seoul, Korea
Changes of Microbiota after Surgery for
Colorectal Cancer may Affect the Risk of
Surgical Site Infection
Sunday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
S. Ohigashi, T. Taketa, S. Ohde, F. Sakamoto,
K. Ohta, Tokyo, Japan
The Effect of Preoperative Endoscopic
Tattooing on Distal Surgical Margin and
Ileostomy Rates in Laparoscopic Rectal Cancer
Surgery: A Prospective Randomized Study
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
G. Cipe, M. Cengiz, U. Idiz, E. Yardimci, F. Malya,
Y. Firat, M. Muslumanoglu, Istanbul, Turkey
Are the Results of Magnifying
Chromoendocopy Evaluation of Extra
Peritoneal Rectal Tumors Comparable to
Endorectal Three-Dimensional Ultrasound?
Study Based on the Pathologic Comparison.
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
R. Pinto, F. Kawaguti, I. Correa Neto, S. Nahas,
C. Nahas, C. Marques, U. Ribeiro Junior,
I. Cecconello, Sao Paulo, Brazil
P1347
Comparison of Gender Specific Differences in
Pelvic Sizes using Magnetic Resonance Imaging
(MRI)
Monday Monitor #9, located outside Room 304
Neoplastic Disease
N. Wong, B. Lieske, Singapore
P1348
Prediction of Postoperative Mortality in
Octogenarian Patients with Colorectal Cancer
Tuesday
Monitor #3, located in Hall C
Neoplastic Disease
D. Cuicchi, S. Vaccari, B. Pirrera, F. Lecce, E. De
Raffele, M. Mirarchi, B. Cola, Bologna, Italy
P1349
Advanced Synchronous Adenoma Predicts
Metachronous Colonic Neoplasia in Follow-up
Colonoscopy of Patients with Resected
Colorectal Cancer
Monday
Monitor #2, located in Hall C
Neoplastic Disease
M. Bun, L. Pereyra, N. Panigadi, C. Fischer,
A. Canelas, S. Guckenheimer, D. Cimmino,
N. Rotholtz, Buenos Aires, Argentina
P1350
Transanal Minimally Invasive Surgery (TAMIS):
An Evolving Approach in the Treatment of
Rectal Neoplasms
Tuesday Monitor #9, located outside Room 304
Neoplastic Disease
Y. Halwani, E. Vikis, Vancouver, BC, Canada
P1351
Primary Squamous-Cell Carcinoma of the
Colon: Current Guidelines and Institutional
Experience
Sunday
Monitor #6, located in Hall D
Neoplastic Disease
Y. Hong, A. Chin, E. Hechenbleikner, C. Butler,
K. Khazaeian, M. Bayasi, A. Chudzinski,
Washington, DC
P1352
Impact of Body Mass Index and Tumor Site on
the Staging of Rectal Cancer with Endorectal
Ultrasound
Monday
Monitor #1, located in Hall C
Neoplastic Disease
A. Alzahrani, Riyadh, Saudi Arabia
P1353
MDSCs Accumulate Invasion Front of Primary
Colorectal Cancer through CCL15-CCR1
Chemokine Axis, and Promote Tumor
Progression
Monday
Monitor #6, located in Hall D
Neoplastic Disease
S. Inamoto, K. Kawada, Y. Itatani, T. Yamamoto,
S. Minamiguchi, M. Taketo, Y. Sakai, Kyoto, Japan
Are Some Advanced Adenomas More Advanced
than Others?
Monday
Monitor #2, located in Hall C
Neoplastic Disease
M. Aljarabah, J. Church, Cleveland, OH
*All ePoster presenters are listed first unless otherwise noted.
135
EPOSTERS
ePoster Presentations
ePoster Presentations
P1354
Efficacy of Tridimensional Endorectal
Ultrasound in Comparison to Histopathology
for Evaluation Extra Peritoneal Rectal
Neoplasms
Sunday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
R. Pinto, I. Correa Neto, S. Nahas, C. Nahas,
C. Marques, U. Ribeiro Junior, L. BustamanteLopez., D. Soares, I. Cecconello, Sao Paulo, Brazil
P1360
Risk Factors of Lateral Lymph Node Metastasis
in the Patients without Clinical Lateral Pelvic
Lymph Node Metastasis
Monday
Monitor #5, located in Hall C
Neoplastic Disease
K. Komori, S. Fujita, J. Mizusawa, Y. Kanemitsu,
N. Saito, Y. Kinugasa, M. Ohue, M. Ota, Nagoya,
Japan; Utsunomiya, Japan; Tokyo, Japan; Osaka,
Japan; Yokohama, Japan; Sunto-gun, Japan;
Chiba, Japan
P1355
Outcomes of Radical Resection of
Adenocarcinoma of the Rectum following
Neoadjuvant Therapy in a Midwest Community
Hospital Setting: Optimizing Rectal Cancer Care
in Small-Town and Rural America
Sunday
Monitor #2, located in Hall C
Neoplastic Disease
W. Cirocco, Columbus, OH
P1361
Early Quality of Life Outcomes for Endoluminal
Brachytherapy for the Treatment of Rectal
Cancer
Sunday
Monitor #5, located in Hall C
Neoplastic Disease
A. Althumairi, F. Monn, J. Efron, B. Safar, E. Wick,
J. Herman, S. Gearhart, Baltimore, MD
P1362
P1356
Dysregulation of AHR in Colon Cancer: Does it
Contribute to Chemosensitivity?
Tuesday
Monitor #5, located in Hall C
Neoplastic Disease
P. Carney, B. Megna, M. Nukaya, G. Kennedy,
Madison, WI
The Impact of Anastomotic Leakage on Anal
Function following Intersphincteric Resection
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
M. Yokota, N. Saito, R. Matsunaga, Y. Nishizawa,
A. Kobayashi, M. Ito, Chiba, Japan
P1357
Robotic-Assisted Laparoscopic versus Open
Lateral Lymph Node Dissection for Advanced
Rectal Cancer
Monday Monitor #9, located outside Room 304
Neoplastic Disease
T. Yamaguchi, Y. Kinugasa, A. Shiomi, H. Tomioka,
H. Kagawa, Sunto-gun, Japan
P1363
P1358
The Difference of Prognostic Nutritional Index
during Preoperative Concurrent ChemoRadiotherapy Predicts Long-Term Outcomes of
Locally Advanced Rectal Cancer
Monday
Monitor #1, located in Hall C
Neoplastic Disease
Y. Lee, W. Kim, S. Baek, H. Hur, B. Min, K. Lee,
N. Kim, Seoul, Korea
A New Prediction Model for Local Recurrence
after Curative Rectal Cancer Surgery
Tuesday
Monitor #3, located in Hall C
Neoplastic Disease
K. Hida, R. Okamura, S. Park, J. Park, S. Hasegawa,
K. Kawada, R. Takahashi, S. Hisamori,
G. Nishikawa, K. Murakami, G. Choi, Y. Sakai,
Kyoto, Japan; Daegu, Korea
P1364
Treatment and Outcomes of Colorectal Cancer
in Patients too Young for Average-Risk
Screening
Monday Monitor #9, located outside Room 304
Neoplastic Disease
Z. Abdelsattar, S. Wong, S. Regenbogen,
K. Hardiman, S. Hendren, Ann Arbor, MI
P1365
Is There a Role for Prophylactic Colectomy in
Lynch Syndrome Patients with Inflammatory
Bowel Disease?
Monday
Monitor #6, located in Hall D
Neoplastic Disease
K. McNamara, M. Aronson, Z. Cohen, Toronto, ON,
Canada
P1359
Quality of Life and Anorectal Function of Rectal
Cancer Patients in Long-term Recovery
Tuesday
Monitor #6, located in Hall D
Neoplastic Disease
X. Wang, C. Brown, M. Raval, A. Karimuddin,
T. Phang, Chengdu, China; Vancouver, BC, Canada
*All ePoster presenters are listed first unless otherwise noted.
136
P1366
Intratumoral Heterogeneity of Epigenetic
Factors in Colorectal Cancer: Implications for
Clinical Practice
Monday
Monitor #6, located in Hall D
Neoplastic Disease
H. Jones, R. Radwan, N. Williams, P. Griffiths,
G. Jenkins, J. Beynon, D. Harris, Cardiff, United
Kingdom
P1372
Risk Factors Affecting the Recurrence in
Patients with Locally Advanced Rectal Cancer
Treated with Total Mesorectal Excision
following Neoadjuvant Chemoradiotherapy
Sunday
Monitor #2, located in Hall C
Neoplastic Disease
S. Park, W. Kim, Y. Han, S. Baek, H. Hur, B. Min,
K. Lee, N. Kim, Seoul, Korea
P1367
Involving Patients in the Rectal Cancer Surgery
Consent Process: The Evaluation of the Rectal
Cancer Decision Aid
Monday
Monitor #8, Outside Ballroom B
Neoplastic Disease
R. Wu, D. Stacey, A. Scheer, H. Moloo, R. Auer,
S. Tadros, P. Roberts, B. Potter, R. Boushey,
Ottawa, ON, Canada; Toronto, ON, Canada;
Burlington, MA
P1373
Preoperative Anal Dysfunction is a Predictor of
Permanent Stoma in Rectal Cancer Patients:
Results of the First Prospective Cohort Analysis
of Clinically Relevant Risk Factors
Sunday
Monitor #3, located in Hall C
Neoplastic Disease
M. Ihn, S. Kang, J. Park, I. Son, H. Oh, D. Kim,
Seongnam-si, Korea
P1374
P1368
The Effects of Multiple Chemotherapeutic
Agents Plus Hyperthermic Intraperitoneal
Chemoperfusion on Colonic Anastomosis: An
Experimental Study in a Rat Model
Tuesday
Monitor #5, located in Hall C
Neoplastic Disease
A. Aghayeva, C. Benlice, I. Bilgin, P. Atukeren,
G. Dogusoy, F. Demir, B. Baca, Istanbul, Turkey
Transanal Local Excision versus Radical Surgery
for T1N0 Lower Rectal Adenocarcinom
Tuesday Monitor #9, located outside Room 304
Neoplastic Disease
Y. LIN, H. Hung, Taoyuan County, Taiwan
P1375
Metformin Use Among Patients with Diabetes
Improves Overall Survival after Surgery for
Colorectal Cancer
Tuesday
Monitor #5, located in Hall C
Neoplastic Disease
T. Fransgaard, L. Thygesen, I. Gogenur,
Cophenhagen, Denmark
P1376
What is the Impact of Preoperative
Chemoradiation on the Puborectal Thickness?
Sunday
Monitor #5, located in Hall C
Neoplastic Disease
C. Sabbagh, L. Tartar, C. Chivot, J. Regimbeau,
Amiens, France
P1377
A Novel Sierological Inflammatory Score as
Possible Prognostic Marker in Colorectal Cancer
Tuesday
Monitor #5, located in Hall C
Neoplastic Disease
G. Di Caro, M. Carvello, S. Pesce, M. Sacchi,
M. Erreni, F. Marchesi, P. Allavena, M. Montorsi,
A. Spinelli, Rozzano Milano, Italy
P1378
The Effectiveness of Biological Therapy in the
Prevention of Reoperation in Patients with
Luminal Crohn’s Disease
Sunday
Monitor #8, Outside Ballroom B
Inflammatory Bowel Disease
H. Kimura, R. Kunisaki, K. Tatsumi, K. Koganei,
A. Sugita, I. Endo, Yokohama, Japan
P1369
P1370
P1371
Resection vs. Nonresection Management for
Colorectal Cancer: What About the Also-Rans?
Tuesday
Monitor #6, located in Hall D
Neoplastic Disease
H. James, G. Williams, Wolverhampton, United
Kingdom
Short-Term Outcomes following Turnbull-Cutait
Procedure without Prophylactic, Covering
Stoma for the Treatment of Inferior Rectal
Cancer Compared to Inmediate Coloanal
Anastomosis: A Case-Matched Study
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
C. Gallardo, A. Barrera, G. Bannura, F. Illanes,
C. Melo, Santiago, Chile
Transanal Minimally Invasive Surgery (TAMIS)
for Local Excision for Rectal Adenocarcinoma
Tuesday Monitor #9, located outside Room 304
Neoplastic Disease
C. Kang, B. Martin-Perez, S. Annaberdyev,
G. Nassif, T. deBeche-Adams, S. Larach, S. Atallah,
M. Albert, Orlando, FL
*All ePoster presenters are listed first unless otherwise noted.
137
EPOSTERS
ePoster Presentations
ePoster Presentations
P1379
Acute Surgical Intervention in Crohn’s Disease
Patients has no Difference in Postoperative
Outcome Whether the Patients Presented for
First Time or are Known with Crohn’s Disease
Sunday
Monitor #8, Outside Ballroom B
Inflammatory Bowel Disease
A. El-Hussuna, S. Hadi, I. Iesalnieks, Slagelse,
Denmark; Munich, Germany
P1380
Risk Factors for Fecal Diversion after SphincterPreserving Surgery for Fistula-in-Ano with
Crohn’s Disease
Sunday
Monitor #8, Outside Ballroom B
Inflammatory Bowel Disease
Y. Watadani, H. Ohge, S. Uegami, N. Shigemoto,
N. Shimada, N. Murao, Y. Kameda, N. Kondo,
Y. Hashimoto, K. Uemura, Y. Murakami, T. Sueda,
Hiroshima, Japan
P1381
P1382
P1383
Salvage Surgery after Failure of Endoscopic
Balloon Dilation for Ileocolonic Anastomotic
Stricture Due to Recurrent Crohn’s Disease is
Associated with Increased Perioperative
Adverse Outcomes When Compared with
Upfront Surgery
Sunday
Monitor #8, Outside Ballroom B
Inflammatory Bowel Disease
Y. Li, L. Stocchi, B. Shen, X. Liu, F. Remzi,
Cleveland,OH
Single Incision versus Multiport Laparoscopic
Total Abdominal Colectomy for Medically
Refractory Ulcerative Colitis: A Case Matched
Study
Sunday
Monitor #8, Outside Ballroom B
Inflammatory Bowel Disease
E. Aytac, M. Costedio, R. Williams, L. Stocchi,
H. Kessler, F. Remzi, E. Gorgun, Cleveland, OH
Perianal Paget’s Disease and Associated
Pathologic Findings: The Minnesota Experience
Sunday
Monitor #6, located in Hall D
Neoplastic Disease
S. Ivatury, K. Batts, A. Conway, C. Finne, Hanover,
NH; Minneapolis, MN
P1384
Impact of Intraoperative Blood Loss on
Morbidity and Survival after Radical Surgery
for Colorectal Cancer Patients Aged 80 Years or
Older.
Tuesday
Monitor #6, located in Hall D
Neoplastic Disease
R. Okamura, K. Hida, S. Hasegawa, Y. Sakai,
M. Hamada, M. Yasui, T. Hinoi, M. Watanabe,
Kyoto, Japan; Kochi, Japan; Osaka, Japan;
Hiroshima, Japan; Tokyo, Japan
P1385
Outcomes of Abdominoperineal Resection for
Management of Anal Cancer in HIV-Positive
Patients
Sunday
Monitor #6, located in Hall D
Neoplastic Disease
I. Leeds, H. Alturki, E. Schneider, J. Efron, E. Wick,
S. Gearhart, B. Safar, S. Fang, Baltimore, MD
P1386
Intermediate Neoadjuvant Radiotherapy
Combined with Total Mesorectal Excision for
Locally Advanced Rectal Cancer: Outcome after
a Median Follow-up of 5 Years
Tuesday
Monitor #5, located in Hall C
Neoplastic Disease
L. Wang, T. Zhan, Y. Li, H. Pan, M. LI, N. Chen,
Y. Cai, J. Gu, Beijing, China
P1387
Transanal Endoscopic Microsurgery for
Unanticipated Malignancies – This Unexpected
Finding Does Not Affect Final Outcomes
Tuesday Monitor #9, located outside Room 304
Neoplastic Disease
C. Chernos, E. Crocker, D. Hochman, Winnipeg,
MB, Canada
P1388
Transanal Endoscopic Microsurgery for Giant
Rectal Polyps
Tuesday Monitor #9, located outside Room 304
Neoplastic Disease
C. Chernos, E. Crocker, D. Hochman, Winnipeg,
MB, Canada
P1389
Prognostic Scoring System for Incurable
Metastatic Colorectal Carcinoma – A Tool to
Guide Palliative Resection
Tuesday
Monitor #3, located in Hall C
Neoplastic Disease
W. Tan, S. Dorajoo, S. Koo, W. Tan, M. Chew,
H. Wee, C. Yap, Singapore
*All ePoster presenters are listed first unless otherwise noted.
138
P1390
Combination of Metabolic Equivalents and ASA
Score in Elderly Patients: A Useful Predictor of
Postoperative Complication
Tuesday
Monitor #3, located in Hall C
Neoplastic Disease
H. Ito, Y. Miyakura, M. Morimoto, M. Koizumi,
K. Koinuma, H. Horie, A. Lefor, N. Sata, Y. Yasuda,
Shimotsuke City, Japan
P1397
The Pull-Through Procedure as First Choice
Treatment in High-Risk Patients with Low
Rectal Cancer
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
F. Bianco, S. De Franciscis, A. Belli, V. Ragone,
G. Romano, Naples, Italy
P1391
Early Results of the Two Minimal Invasive
Approaches for Rectal Tumors Compared with
Each Other
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
S. Demirbas, I. Gecim, H. Celasin, N. Ersoz, T. Ozer,
Kavaklidere, Turkey; Ankara, Turkey
P1398
Laparoscopic Colorectal Resection with
Transanal Extraction: Phase II trial
Sunday
Monitor #3, located in Hall C
Neoplastic Disease
J. Rodriguez-Garcia, S. Moral, R. Fresnedo,
C. Alvarez-Laso, G. Carreno, Oviedo, Spain; Gijon,
Spain
P1399
P1392
Colon Cancer with Unresectable Synchronous
Metastases: AAAP Scoring System for
Predicting Outcome after Primary Tumor
Resection
Tuesday
Monitor #3, located in Hall C
Neoplastic Disease
Z. Li, J. Gu, Beijing, China
High Levels of PDGFAA in Tumor Drainage
Blood and HER2 in Peripheral Venous Blood are
Predictors for Colorectal Cancer Liver
Metastasis
Tuesday
Monitor #5, located in Hall C
Neoplastic Disease
H. Pan, Y. Peng, J. Gu, Beijing, China
P1400
P1393
Adherence to Surveillance Guidelines after
Resection of Stage II Colon Cancer: Experience
of a Tertiary Care Institution
Monday Monitor #9, located outside Room 304
Neoplastic Disease
K. Dugan, S. Maithel, C. Staley, C. Moreno,
J. Srinivasan, V. Shaffer, C. Staley, P. Sullivan,
Atlanta, GA
Does Omental Pedicle Flap Reduce
Anastomotic Leak and Septic Complications
after Rectal Cancer Surgery?
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
V. Ozben, E. Aytac, X. Liu, G. Ozuner, Cleveland,
OH
P1401
P1394
HIV Positivity and Anal Cancer Outcomes: A
Single-Center Experience
Sunday
Monitor #6, located in Hall D
Neoplastic Disease
N. Wieghard, K. Kelley, T. Mitin, D. Herzig, K. Lu,
C. Thomas Jr., V. Tsikitis, Portland, OR
Transanal Endoscopic Microsurgery Resection
of Rectal Neuroendocrine Tumors: A Single
Center Canadian Experience
Tuesday Monitor #9, located outside Room 304
Neoplastic Disease
C. Jonker, A. Karimuddin, T. Phang, M. Raval,
C. Brown, Vancouver, BC, Canada
P1395
Survival Time and Trognostic Factors for
Colorectal Cancer Patients with Liver
Metastases: A Single Hosptial Experience
Tuesday
Monitor #6, located in Hall D
Neoplastic Disease
Q. Liu, C. Fu, Shanghai, China
P1402
P1396
Comparision between Emergency Surgery and
Endoscopic Colon Stenting in the Treatment of
Obstructive Left Colon Cancer
Tuesday
Monitor #3, located in Hall C
Neoplastic Disease
J. Barreiro, I. Garcia Bear, C. Ildefonso Cienfuegos,
L. Garcia Florez, P. Fernandez Muniz, Aviles, Spain
Impact of Laparoscopic Surgery on the Time to
Initiation of Adjuvant Chemotherapy for Colon
Cancer
Monday Monitor #9, located outside Room 304
Neoplastic Disease
Y. Jung, E. Park, J. Kang, S. Baik, S. Sohn, I. Kim,
K. Lee, Seoul, Korea
P1403
How Significant is a Variant of Unknown
Significance?
Monday Monitor #9, located outside Room 304
Neoplastic Disease
D. Shaw, C. Ternent, J. Beaty, G. Blatchford,
N. Bertelson, J. Bikhchandani, A. Thorson,
M. Shashidharan, Omaha, NE
*All ePoster presenters are listed first unless otherwise noted.
139
EPOSTERS
ePoster Presentations
ePoster Presentations
P1404
Transanal Endoscopic Microsurgery for Early
Rectal Cancer: A Single Center Experience
Tuesday Monitor #9, located outside Room 304
Neoplastic Disease
C. O’Neill, J. Platz, J. Moore, P. Callas, P. Cataldo,
Burlington, MA
P1405
Patient-Reported Roles, Preferences, and
Expectations Regarding Treatment of Stage I
Rectal Cancer
Monday
Monitor #8, Outside Ballroom B
Neoplastic Disease
C. Ellis, M. Charlton, K. Stitzenberg, Chapel Hill,
NC; Iowa City, IA
P1406
Short-term Outcome of Tumor-specific
Extralevator Abdominoperineal Excision (TSELAPE) for Rectal Cancer
Sunday
Monitor #3, located in Hall C
Neoplastic Disease
J. Han, Z. Wang, G. Wei, Y. Yang, Z. Gao, Beijing,
China
P1407
P1408
P1409
Prediction of Lateral Pelvic Lymph Node
Metastasis by MRI in Patients with Advanced
Low Rectal Cancer Treated with Preoperative
Chemoradiotherapy
Monday
Monitor #4, located in Hall C
Neoplastic Disease
T. Akiyoshi, M. Ueno, Y. Fukunaga, S. Nagayama,
Y. Fujimoto, T. Konishi, T. Yamaguchi, Tokyo, Japan
Laparoscopic Translevator Approach to
Abdominoperineal resection APR) for Rectal
Adenocarcinoma: Feasibility and Short-Term
Oncologic Outcomes
Monday,
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
V. Palter, S. MacLellan, S. Ashamalla, Toronto, ON,
Canada
Laparoscopic versus Hybrid Natural Orifice
Transluminal Endoscopic Surgery (hNOTES)
for Rectal Cancer after Neoadjuvant
Chemoradiation: A Matched Case-controlled
Study
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
C. Chen, S. Yang, Taipei, Taiwan
P1410
Management of Locally Advanced Perianal
Extra-Mammary Paget’s Disease
Sunday
Monitor #6, located in Hall D
Neoplastic Disease
O. Lo, M. Razali Ibrahim, G. Li, W. Law, Hong Kong
P1411
Postoperative Pelvic Sepsis Rates following
Complete Pathologic Response to Neoadjuvant
Therapy in Rectal Cancer
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
D. Mihalicz, M. Brar, I. Datta, A. MacLean, W. Buie,
S. Schmocker, E. Kennedy, J. Heine, Calgary, AB,
Canada; Toronto, ON, Canada
P1412
Laparoscopic-Assisted Extralevator
Abdominoperineal Excision using a Parastomal
Prophylactic Mesh and a Biological Mesh for
Pelvic Floor Reconstruction
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
S. Avital, B. Banjamin, R. Ghinea, I. White,
D. Kidron, B. Shpitz, Tel-Aviv, Israel; Kfar Saba,
Israel
P1413
Adherence to the American Society of Colon
and Rectal Surgeon’s Practice Parameters in the
Management of Rectal Cancer, How are We
Doing?
Monday
Monitor #8, Outside Ballroom B
Neoplastic Disease
K. Khanduja, R. Singh, J. Madhavan,
A. Padhmanabhan, C. Taylor, M. Lindsey,
B. Kerner, T. Colbert, Columbus, OH
P1414
Which Operative Technique Offers the Optimal
Lymph Node Harvest for Patients Undergoing
Right Colectomy?
Monday
Monitor #5, located in Hall C
Neoplastic Disease
M. Honaker, S. Scouten, J. Sacksner, M. Ziegler,
T. Riggs, H. Wasvary, Royal Oak,MI
P1415
Tumor Regression and Tolerability of
Neoadjuvant High-Dose-Rate Endorectal
Brachytherapy in Rectal Cancer: A
Retrospective Cohort Study
Tuesday
Monitor #5, located in Hall C
Neoplastic Disease
F. Rouleau Fournier, A. Martin, S. Drolet,
R. Gregoire, A. Bouchard, P. Bouchard, C. Lavoie,
Quebec, QC, Canada
*All ePoster presenters are listed first unless otherwise noted.
140
P1416
Complications following Low Anterior
Resection for Rectal Carcinoma with and
without Diverting Ileostomy
Tuesday
Monitor #4, located in Hall C
Neoplastic Disease
S. Maroney, C. Chavez De Paz, M. Duldulao,
M. Reeves, K. Kazanjian, N. Solomon, Loma Linda,
CA; Los Angeles, CA
P1424
Long-Term Results Including Local Recurrence
for Laparoscopic Resection of Stage2/ 3 R ectal
Cancer
Tuesday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
R. Kuwahara, S. Yamaguchi, K. Hara, H. Kondo,
J. Tashiro, T. Ishii, Hidaka, Japan
P1417
Anastomotic Site Recurrence after Colorectal
Cancer Surgery: A Rare Entity with Poor
Prognosis
Monday Monitor #9, located outside Room 304
Neoplastic Disease
V. Ozben, M. Valente, M. Costedio, F. Remzi,
E. Gorgun, Cleveland, OH
P1425
P1418
Clinicolpathological Risk Factors and Survival
Outcome for 222 Bone Metastasis of Colorectal
Cancer: A Retrospective Study
Tuesday
Monitor #6, located in Hall D
Neoplastic Disease
F. Liu, J. Zhao, Y. Xu, Shanghai, China
How Accurately Does CRP Predict Anastomotic
Leak after Laparoscopic Colorectal Surgery?
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
P. Waterland, J. Ng*, V. Decaro, K. Goonetilleke,
M. Zilvetti, D. Nicol, S. Lake, S. Pandey, Worcester,
United Kingdom
P1426
Risk Factors for Developing Peritoneal
Dissemination in Laparoscopic Colorectal
Cancer Surgery
Monday
Monitor #3, located in Hall C
Neoplastic Disease
S. Yang, J. Jiang, J. Lin, S. Chang, Taipei, Taiwan
P1427
Is Serum C-Reactive Protein a Reliable Predictor
of Anastomotic Leak in the First Week after
Anterior Resection for Rectal Cancer?
Monday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
I. S. Reynolds, F. Reilly, A. Deasy, M. H. Majeed,
J. P. Burke, J. Deasy, D. A. McNamara, Dublin,
Ireland
P1419
Comparison of Early and Late Surgery
following Colonic Stenting for Obstructive
Colorectal Cancer
Tuesday
Monitor #3, located in Hall C
Neoplastic Disease
W. Jeong, S. Bae, S. Baek, Daegu, Korea
P1421
Prognostic Comparison between Mucinous and
Nonmucinous Adenocarcinoma in Colorectal
Cancer
Tuesday
Monitor #6, located in Hall D
Neoplastic Disease
J. Huh, W. Lee, Y. Park, Y. Cho, S. Yun, H. Kim,
H. Chun, Seoul, Korea
P1422
Laparoscopic Resection for Clinically Suspected
T4 Colorectal Cancer
Tuesday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
J. Huh, H. Kim, Y. Park, Y. Cho, S. Yun, W. Lee,
H. Chun, Seoul, Korea
P1423
Long-term Oncologic Outcomes of Obstructive
Colorectal Cancer Patients who Performed
Single-stage Resection with Immediate
Anastomosis: A Case-Matched Study
Tuesday
Monitor #7, located in Hall C Foyer
(by registration)
Neoplastic Disease
S. Kim, S. Jung, J. Kim, Daegu, Korea
*All ePoster presenters are listed first unless otherwise noted.
141
EPOSTERS
ePoster Presentations
Featured Lecturers and Faculty
Cary B. Aarons, MD, FACS
H. Randolph Bailey, MD, FACS
Joshua I. S. Bleier, MD
Asst. Professor of Surgery, Hospital of
the University of Pennsylvania, Div. of
Colon & Rectal Surgery,
Philadelphia, PA
Professor of Surgery, University of
Texas Medical School, Houston;
Clinical Professor of Surgery, Baylor
College of Medicine, Houston and
Weil/Cornell (Methodist), Houston, TX
Assoc. Professor of Surgery; Chief of
Colorectal Surgery, Pennsylvania
Hospital; Program Director, Colorectal
Surgery Fellowship, University of
Pennsylvania, Philadelphia, PA
Amir Bastawrous, MD, MBA
Liliana Bordeianou, MD, MPH,
FACS, FASCRS
Maher A. Abbas, MD, FACS, FASCRS
Chief, Digestive Disease Institute,
Cleveland Clinic Abu Dhabi, United
Arab Emirates; Professor of Surgery,
Cleveland Clinic Lerner College of
Medicine, Cleveland, OH
Armen Aboulian, MD
Kaiser Permanente Medical Center,
Woodland Hills, CA; University of
California, Los Angeles, CA
Karim Alavi, MD, MPH, FACS,
FASCRS
Program Director, Colon and Rectal
Surgery Fellowship Program,
University of Massachusetts Medical
School, Worcester, MA
John C. Alverdy, MD, FACS
Sarah and Harold Lincoln Thompson
Professor and Executive Vice Chair,
Dept. of Surgery, University of
Chicago, Chicago, Illinois
Bonnie Alvey, ACNS-BC WOCN
Enterostomal Therapy Dept., Wound &
Ostomy Clinical Specialist, Ochsner
Clinic, New Orleans, LA
Medical Director, Swedish Colon and
Rectal Clinic; Program Director,
Swedish Colon and Rectal Surgery
Training Program, Swedish Medical
Center, Swedish Cancer Institute,
Seattle, WA
Director, MGH Colorectal Surgery
Program; Co-Director, MGH Pelvic
Floor Disorders Center; Asst. Professor
of Surgery, Harvard Medical School;
Massachusetts General Hospital,
Boston MA
Nancy Baxter, MD, PhD
Assoc. Professor of Surgery, St.
Michael’s Hospital, Toronto, ON,
Canada
Jennifer S. Beaty, MD, FACS,
FASCRS
Program Director Colon and Rectal
Surgery, Asst. Professor of Surgery,
Creighton University School of
Medicine; Asst. Professor of Surgery,
University of Nebraska College of
Medicine, Omaha, NE
W. Donald Buie, MD
Assoc. Professor of Surgery and
Oncology; Chief, Div. of General
Surgery, Foothills Hospital; Program
Director, Colorectal Surgery Program,
Dept. of Surgery, University of Calgary,
Calgary, AB, Canada
Marcus Burnstein, MD
Assoc. Professor, Dept. of Surgery,
University of Toronto; St. Michael’s
Hospital, Toronto, ON, Canada
David E. Beck, MD, FACS, FASCRS
John Byrn, MD
Professor and Chairman Emeritus,
Dept. of Colon and Rectal Surgery,
Ochsner Clinic Foundation; Professor
of Surgery, University of Queensland
School of Medicine, Ochsner Clinical
School, New Orleans, LA
Clinical Asst. Professor; Chief, Section
of Colorectal Surgery, Div. of
Gastrointestinal, Minimally-invasive
and Bariatric Surgery, Dept. of
Surgery, University of Iowa Hospitals
and Clinics, Iowa City, Iowa
Sandra J. Beck, MD, FASCRS
Jamie Cannon, MD, FACS
Assoc. Professor of Surgery; Chief,
Section of Colon and Rectal Surgery,
University of Kentucky, Lexington, KY
Asst. Professor of Surgery, Div. of
Gastrointestinal Surgery, University
of Alabama at Birmingham,
Birmingham, AL
Wayne Ambroze, MD
Program Director, Colon and Rectal
Surgery, Northside Hospital,
Atlanta, GA
Robin Anderson, BSN, RN
Strategic Services Associate,
Performance Services, Enhanced
Recovery Program Coordinator, Duke
University Health System, Durham, NC
Mariana Berho, MD
Mark Arnold, MD
Mitchell Bernstein, MD, FACS,
FASCRS
Joseph C. Carmichael, MD
Assoc. Professor of Surgery; Director,
Div. of Colon & Rectal Surgery,
NYU Langone Medical Center, New
York, NY
Asst. Professor; Colon and Rectal
Surgery Residency, Program Director,
Dept. of Surgery, University of
California, Irvine, Orange, CA
J. Michael Berry-Lawhorn, MD
Peter Cataldo, MD
Clinical Professor of Medicine, Div. of
Hematology Oncology; Assoc.
Director HPV-Related Clinical Studies,
University of California San Francisco,
San Francisco, CA
Samuel B. and Michelle D. Labow
Professor of Colon and Rectal Surgery
at the University of Vermont Medical
Center, Burlington, VT
Ohio State University Medical Center,
Dept. of Surgery, Columbus, OH
Glenn T. Ault, MD, MSEd
Assoc. Professor & Residency Program
Director, Div. of Colorectal Surgery;
Vice-Chair/Chief of Surgery
(LAC+USC), Dept. of Surgery; Vice
Dean, Keck School of Medicine of
USC, Los Angeles, CA
Heidi Bahna, MD, FACS
Asst. Professor of Clinical Surgery;
Assoc. Director, Colon and Rectal
Residency Program Miller School of
Medicine, University of Miami,
Miami, FL
Cleveland Clinic Staff Physician,
Cleveland Clinic Florida,
Hollywood, FL
Richard Billingham, MD
Clinical Professor, Dept. of Surgery,
University of Washington, Seattle, WA
Teresa L. Carman, MD
Director, Vascular Medicine, University
Hospitals Case Medical Center,
Cleveland, OH
Bradley J. Champagne, MD, FACS,
FASCRS
Assoc. Professor of Surgery, Case
Western Reserve University, Div. of
Colorectal Surgery, University
Hospitals, Case Medical Center;
Program Director, Colorectal
Residency, Cleveland, OH
George J. Chang, MD, MS
Assoc. Professor, Depts. of Surgical
Oncology and Health Services
Research; Chief, Colon and Rectal
Surgery; Assoc. Medical Director,
Colorectal Center; Director of Clinical
Operations, Minimally Invasive and
New Technologies in Oncologic
Surgery Program, The University of
Texas, MD Anderson Cancer Center,
Houston, TX
James M. Church, MD
Victor W. Fazio Chair in Colorectal
Surgery; Director, Sanford R. Weiss,
MD Center for Hereditary Colorectal
Neoplasia; Dept. of Colorectal Surgery,
Digestive Diseases Institute, Cleveland
Clinic, Cleveland, OH
Robert R. Cima, MD, MA, FACS,
FASCRS
Professor of Surgery, Mayo Clinic
College of Medicine; Consultant, Div.
of Colon and Rectal Surgery, Mayo
Clinic, Rochester, MN
Robert K. Cleary, MD, FACS,
FASCRS
Program Director, Colon and Rectal
Surgery Residency, St. Joseph Mercy
Health System, Ann Arbor, MI
Jeffrey L. Cohen, MD, FACS,
FASCRS, CPE
Vice President, Specialty Services,
Hartford HealthCare Medical Group;
Clinical Professor of Surgery,
University of Connecticut, Farmington,
CT; Chief of Colorectal Surgery,
Hartford Hospital, Hartford, CT
Jeffrey S. Cohen, MD
Chief, Div. of Colon and Rectal
Surgery, Wellstar Kennestone Regional
Medical Center, Marietta, GA; Director,
Robotic Surgery Epicenter, Northside
Hospital, Cherokee; Atlanta Colon and
Rectal Surgery, Atlanta, GA
Kyle G. Cologne, MD
Thomas E. Cataldo, MD, FACS,
FASCRS
Beth Israel-Deaconess Medical Center;
Instructor in Surgery, Harvard Medical
School, Boston, MA
142
Asst. Professor of Clinical Surgery, Div.
of Colorectal Surgery, University of
Southern California Keck School of
Medicine, Los Angeles, CA
Featured Lecturers and Faculty
Molly M. Cone, MD
John C. Eggenberger, MD
Fergal Fleming, MD
Timothy Geiger, MD
Asst. Professor of Surgery, Colon and
Rectal Surgery, Vanderbilt University
Medical Center, Nashville, TN
Staff Surgeon, St. Joseph Mercy
Hospital, Ann Arbor, MI; Program
Director of the General Surgery
Residency and Vice-chair of the Dept.
of Surgery, St. Joseph Mercy Hospital,
Ann Arbor, MI; Clinical Asst. Professor,
Dept. of Surgery, University of Toledo;
Clinical Asst. Professor, College of
Osteopathic Medicine, Michigan State
University
Asst. Professor of Surgery and
Oncology; Div. of Colorectal Surgery;
Director, Surgical Health Outcomes
and Research Enterprise (SHORE),
University of Rochester Medical
Center, Rochester, NY
Asst. Professor of Colon and Rectal
Surgery, Vanderbilt University,
Nashville, TN
Certified Wound, Ostomy, Continence
Nurse; Beth Israel Deaconess Medical
Center, Boston, MA
Meaghen Costedio, MD
Cleveland Clinic, Cleveland, OH
Chris Cunningham, MB ChB, MD,
BSc (Hons), FRCSEd
Consultant Colorectal Surgeon,
Honorary Senior Lecturer, Oxford
University Hospitals NHS Trust,
Churchill Hospital, Oxford, United
Kingdom
Michael I. D’Angelica, MD
Enid A. Haupt Chair in Surgery,
Memorial Sloan Kettering Cancer
Center, New York, NY; Attending
Surgeon, Memorial Sloan Kettering
Cancer Center, New York, NY; Assoc.
Professor of Surgery, Cornell
University/Weill Medical College, New
York, NY
André D’Hoore, MD, PhD
Assoc. Professor of Surgery; Chair,
Dept. of Abdominal Surgery,
University Hospital Leuven, Leuven,
Belgium
Bradley R. Davis, MD
Assoc. Professor of Surgery, Div. of
Colon and Rectal Surgery; Director,
Residency Program in General
Surgery; Director, Div. of Surgical
Education, University of Cincinnati;
Cincinnati, OH
Conor P. Delaney, MD, PhD
The Jeffrey L. Ponsky Professor of
Surgical Education; Chief, Div. of
Colorectal Surgery; Vice-Chair, Dept.
of Surgery; Director, CWRU Center for
Skills and Simulation; Surgical
Director, Digestive Health Institute,
University Hospitals Case Medical
Center, Case Western Reserve
University, Cleveland, OH
Alex E. Elobu, MD, MMed, FCSECSA
David W. Dietz, MD
Vice-Chairman and Staff Surgeon,
Dept. of Colorectal Surgery, Digestive
Diseases Institute, Cleveland Clinic,
Cleveland, OH
Seeger Professor and Chairman of
Surgery, Baylor University Medical
Center; Professor of Surgery, Texas
A&M Health Sciences, Dallas, TX
Phillip Fleshner, MD
Colorectal Surgery Unit, Mulago
National Referral Hospital, Makerere
University College of Health Sciences,
Kampala, Uganda
Cedars-Sinai Medical Center, Los
Angeles, CA
Cathy Eng, MD, FACP
Professor, Div. of General Surgery;
Adjunct Professor, Depts. of Public
Health and Pharmacy; Assoc. Chair for
Research, Dept. of Surgery; Medical
Director, Surgical Outcomes Research
Center (SORCE), Seattle, WA
Professor, Dept. of Gastrointestinal
Medical Oncology; Director, Dept. of
Gastrointestinal Medical Oncology,
Network Clinical Research; Assoc.
Medical Director, Colorectal Cancer,
The University of Texas MD Anderson
Cancer Center, Houston, TX
Todd Francone, MD, MPH
Dept. of Colon and Rectal Surgery,
Lahey Hospital and Medical Center,
Burlington, MA; Asst. Professor of
Surgery, Tufts Medical Center,
Boston, MA
David Etzioni, MD
Assoc. Professor, Mayo Clinic College
of Medicine; Chair, Div. of Colon and
Rectal Surgery, Mayo Clinic Arizona,
Phoenix, AZ
Charles M. Friel, MD
Daniel L. Feingold, MD, FACS,
FASCRS
Assoc. Professor of Surgery; Chief,
Section of Colon and Rectal Surgery;
Surgical Director of the Digestive
Health Center, University of Virginia,
Charlottesville, VA
The Stanley Edelman, MD – Stephen
Jarislowsky Assoc. Professor of
Surgery, Columbia University, New
York, NY
Robert D. Fry, MD
Alessandro Fichera, MD, FACS,
FASCRS
Emilie & Roland deHellebranth
Professor of Surgery; Chief, Div. of
Colon and Rectal Surgery, UPHS,
Philadelphia, PA
Professor and Chief, Section
Gastrointestinal Surgery, Div. of
General Surgery, Dept. of Surgery,
University of Washington Medical
Center, Seattle, WA
Julio Garcia-Aguilar, MD, PhD
Robert L. Fine, MD, FACP, FAAHPM
Clinical Director, Office of Clinical
Ethics and Palliative Care, Baylor Scott
and White Health, Dallas, TX; Clinical
Assoc. Professor of Internal Medicine
and Medical Humanities, Texas A&M
College of Medicine
Charles O. Finne, MD
Clinical Professor of Surgery, Div. of
Colon and Rectal Surgery, University
of Minnesota, Minneapolis, MN
Clinical Professor of Surgery, Div. of
Colon and Rectal Surgery, Dept. of
Surgery, University of Minnesota,
Minneapolis, MN
Stephen E. Goldstone, MD, FACS
David R. Flum, MD, MPH
Sekhar Dharmarajan, MD
Washington University School of
Medicine, St. Louis, MO
James Fleshman, MD
Stanley M. Goldberg, MD, FACS,
HonFRACS (Aust), HonFRCS (Eng),
HonAFC (Fr), HonFRCPS (Glasg),
HonFRSM (Eng), HonFPCS (Phil),
HonFRCS (Edin), Honoris Causa
(Lleida), HonSAS (Spain), HonJSS
(Japan)
Chief, Colorectal Service, Stuart H.Q.
Quan Chair in Colorectal Surgery,
Dept. of Surgery, Memorial SloanKettering Cancer Center, New York, NY
Kelly A. Garrett, MD, FACS, FASCRS
Asst. Professor of Surgery, Weill
Cornell Medical College – NY
Presbyterian Hospital, Dept. of
General Surgery, Div. of Colon and
Rectal Surgery, New York, NY
Susan Gearhart, MD
Assoc. Professor of Colorectal Surgery,
Johns Hopkins Hospital,
Baltimore, MD
143
Asst. Clinical Professor of Surgery,
Icahn School of Medicine at Mount
Sinai, New York, NY
I. Emre Gorgun, MD, FACS, FASCRS
Staff Surgeon, Quality Improvement
Officer, Dept. of Colorectal Surgery,
Digestive Disease Institute, Cleveland
Clinic, Cleveland, OH
Wilhelm Graf, MD, PhD
Professor of Gastrointestinal Surgery,
Institution of Surgical Sciences,
Uppsala University; Dept. of Surgery,
Akademiska Sjukhuset, Uppsala,
Sweden
John Griffin, MD
Program Director, Colon and Rectal
Surgery Residency Program, St. Mark's
Healthcare Foundation Colon and
Rectal Surgery Program; Central Utah
Clinic, Salt Lake City, UT
José G. Guillem, MD, MPH
Attending Surgeon, Memorial Sloan
Kettering Cancer Center; Professor of
Surgery, Weill Medical College of
Cornell University, New York, NY
Brooke Gurland, MD
Asst. Clinical Professor of Surgery,
Lerner College of Medicine, Dept. of
Colon and Rectal Surgery, Digestive
Disease Institute, Cleveland Clinic,
Cleveland, OH
Eric M. Haas, MD
President, Colorectal Surgical
Associates; Program Director,
Minimally Invasive Colon & Rectal
Surgery Fellowship, University of Texas
Medical School Houston, Houston, TX
F A C U LT Y
A. Murray Corliss, RN, BSN, CWOCN
Featured Lecturers and Faculty
Jason F. Hall, MD, MPH, FACS
Torbjörn Holm, MD, PhD
Lahey Hospital and Medical Center,
Dept. of Colon and Rectal Surgery,
Burlington, MA; Program Director,
Residency in Colon and Rectal
Surgery, Lahey Hospital and Medical
Center; Asst. Professor of Surgery,
Tufts University School of Medicine,
Boston, MA
Section for Lower Abdominal Surgery
Center of Digestive Diseases,
Karolinska University Hospital,
Stockholm, Sweden; Professor of
Surgery, Dept. of Molecular Medicine
and Surgery, Karolinska Institutet
Amy Halverson, MD
Assoc. Professor, Northwestern
University, Feinberg School of
Medicine, Chicago, IL
Andreas M. Kaiser, MD, FACS,
FASCRS
Professor of Clinical Surgery, USC Div.
of Colorectal Surgery, Keck School of
Medicine of USC, University of
Southern California, Los Angeles, CA
Matthew F. Kalady, MD
Stefan D. Holubar, MD, MS
Asst. Professor of Surgery, Div. of
Colon and Rectal Surgery, DartmouthHitchcock Medical Center, Lebanon,
NH; Geisel School of Medicine at
Dartmouth; The Dartmouth Institute
for Health Policy & Clinical Practice
Heather Hampel, MS, LGC
Assoc. Director, Div. of Human
Genetics; Assoc. Director, Biospecimen
Research; Professor, Internal Medicine;
Licensed Genetic Counselor; The Ohio
State University Comprehensive
Cancer Center, Columbus, OH
Karin Hardiman, MD, PhD
Asst. Professor of Surgery, Div. of
Colorectal Surgery, University of
Michigan, Ann Arbor, MI
Alan E. Harzman, MD
Asst. Professor of Surgery, The Ohio
State University, Columbus, OH
Assoc. Professor of Surgery, Cleveland
Clinic Lerner College of Medicine;
Krause-Lieberman Chair in Colorectal
Surgery, Dept. of Colorectal Surgery,
Digestive Disease Institute, Cleveland
Clinic, Cleveland, OH
Brian R. Kann, MD, FACS, FASCRS
M. Benjamin Hopkins, MD
Duke Colorectal Surgery at Raleigh,
Raleigh, NC
Staff Surgeon, Dept. of Colon and
Rectal Surgery, Ochsner Medical
Center, New Orleans, LA
Jon S. Hourigan, MD, FACS, FASCRS
Sergey V. Kantsevoy, MD, PhD
Assoc. Professor of Surgery, Colon and
Rectal Surgery, University of Kentucky,
Lexington, KY
Professor of Medicine, University of
Maryland School of Medicine;
Director of Therapeutic Endoscopy,
Institute for Digestive Health and
Liver Disease at Mercy Medical Center,
Baltimore, MD
Traci L. Hedrick, MD, FACS
Asst. Professor of Surgery, Section
Colon and Rectal Surgery, University
of Virginia, Charlottesville, VA
Alexander Heriot, MD, MBA,
FRACS, FRCS
Director of Surgery, Peter MacCallum
Cancer Center, Melbourne, VIC,
Australia; Clinical Professor, University
of Melbourne
Daniel O. Herzig, MD
Assoc. Professor of Surgery, Digestive
Health Center and Knight Cancer
Institute, Oregon Health & Science
University, Portland, OR
Tracy Hull, MD
Professor of Surgery, Holder of the
Shafran Family Charitable Trust
Endowed Chair, Dept. of Colon and
Rectal Surgery, Digestive Disease
Institute, Cleveland Clinic,
Cleveland, OH
Vice Chair, Dept. of Colon and Rectal
Surgery, Ochsner Clinic, New Orleans,
LA; Clinical Professor of Surgery, LSU
School of Medicine, New Orleans, LA
Rebecca Hoedema, MD, MS
Spectrum Health Medical Group,
Ferguson Clinic, Center for Digestive
Diseases, Grand Rapids, MI
Anjali S. Kumar, MD, MPH
Colon and Rectal Surgery, MedStar
Washington Hospital Center; Asst.
Professor of Surgery, Georgetown
University School of Medicine,
Washington, DC
Alex Jenny Ky, MD, FACS, FASCRS
Assoc. Professor of Surgery, Dept. of
Surgery, Mount Sinai School of
Medicine, New York, NY; Medical
Director, Mount Sinai Downtown
office
Mayo Clinic College of Medicine, Div.
of Colon and Rectal Surgery, Mayo
Clinic, Rochester, MN
Gregory D. Kennedy, MD, PhD
Asst. Professor of Surgery, Ohio State
University Wexner Medical Center,
Columbus, OH
Assoc. Professor of Surgery; Vice Chair
of Quality, Dept. of Surgery, University
of Wisconsin School of Medicine and
Public Health, Madison, WI
Neil Hyman MD, FACS
Hermann Kessler, MD, PhD, FACS
Chief, Section of Colon and Rectal
Surgery, Professor of Surgery,
University of Chicago Medicine,
Chicago, IL; Co-Director, Center for
Digestive Diseases, University of
Chicago Medicine, Chicago, IL
Section Head, Minimally Invasive
Surgery, Colon and Rectal Surgery,
Digestive Disease Institute, Cleveland
Clinic, Cleveland, OH
Donald Kim, MD
Naomi Jay, RN, NP, PhD
Asst. Clinical Professor, School of
Nursing UCSF; Assoc. Director, HPVRelated Clinical Studies, UCSF Anal
Neoplasia Clinic, Mount Zion Hospital,
San Francisco, CA
Professor of Surgery, University of
Leeds and Leeds Teaching Hospitals,
NHS Trust, Leeds, United Kingdom
Spectrum Health Medical Group,
Grand Rapids, MI
Jin C. Kim, MD
Professor, Div. of Colorectal Surgery,
Dept. of Surgery, University of Ulsan
College of Medicine and Asan Medical
Center, Seoul, Korea
Jorge Lagares-Garcia, MD, FACS,
FASCRS
Chief, Div. of Colon and Rectal
Surgery; Director, Robotic Colorectal
Epicenter, Roper Hospital, Charleston
Colorectal Surgery, Charleston, SC
Sean Langenfeld, MD
Asst. Professor of Surgery; Assoc.
Program Director, General Surgery
Residency, University of Nebraska
Medical Center, Omaha, NE
Sergio W. Larach, MD
Florida Hospital Orlando; Asst.
Professor of Surgery, University of
Central Florida College of Medicine,
Orlando, FL; Asst. Professor, Florida
State University, Tallahassee, FL
David W. Larson, MD, MBA, FACS,
FASCRS
Professor of Surgery, Chair of
Colorectal Surgery, Consultant, Dept.
of Surgery, Mayo Clinic, Rochester, MN
Sanghyun Kim, MD
Sang W. Lee, MD
Mount Sinai School of Medicine, New
York, NY
Cindy Kin, MD
Assoc. Professor of Surgery; Vice Chief,
Colon and Rectal Surgery, NY
Presbyterian Hospital, Weill-Cornell
Medical College, New York, NY
Asst. Professor of Surgery, Stanford
University, Stanford, CA
Paul-Antoine Lehur, MD, PhD
Eric K. Johnson, MD, FACS, FASCRS
Assoc. Professor of Surgery,
Uniformed Services University of the
Health Sciences, Madigan Army
Medical Center, Fort Lewis, WA
Chief, Gastrointestinal Surgery Dept.,
Institute of Digestive and Metabolic
Diseases, Hospital Clinic de Barcelona;
Professor of Surgery, Universitat de
Barcelona; Director, Institute of
Surgery, Hospital Quiron; President,
Barcelona International Medical
Academy (BIMA), Barcelona, Spain
Scott R. Kelley, MD, FACS
Syed Husain, MD
David Jayne, MB BCh MD FRCS
Terry C. Hicks, MD
Assoc. Professor of Surgery, University
of Washington, Dept. of Surgery,
Seattle, WA
Antonio M. Lacy, MD, PhD
Imran Hassan, MD
Clinical Assoc. Professor, University of
Iowa, Iowa City, IA
Mukta Krane, MD
Natalie Kirilcuk, MD
Asst. Professor of Surgery, Stanford
Hospital and Clinics, Stanford, CA
144
Professor of Digestive Surgery,
University Hospital of Nantes, Nantes,
France
Featured Lecturers and Faculty
Ann C. Lowry, MD, FASCRS
Slawomir Marecik, MD, FACS,
FASCRS
James T. McCormick, DO, FACS,
FASCRS
Colorectal Surgery Attending,
Advocate Lutheran General Hospital,
Park Ridge, IL; Assoc. Professor of
Clinical Surgery, University of Illinois
at Chicago College of Medicine,
Chicago, IL
Program Director, General Surgery,
Allegheny Health Network; Chief, Div.
of Colon and Rectal Surgery, Forbes
Hospital; Assoc. Professor of Surgery,
Temple University School of Medicine,
Pittsburgh, PA
Allison B. McCoy, PhD
Kirk Ludwig, MD
David A. Margolin, MD, FACS,
FASCRS
The Vernon O. Underwood Professor,
Professor of Surgery; Chief, Div. of
Colorectal Surgery, Dept. of Surgery,
Medical College of Wisconsin,
Milwaukee, WI
Professor and Director, Colon and
Rectal Surgical Research, The Ochsner
Clinic Foundation, New Orleans, LA;
The University of Queensland School
of Medicine, Ochsner Clinical School
Asst. Professor, Dept. of Biostatistics
and Bioinformatics, Tulane University
School of Public Health and Tropical
Medicine; Center for Health
Research, Ochsner Health System,
New Orleans, LA
Helen MacRae, MD
Jeffrey M. Marks, MD, FACS, FASGE
Michael F. McGee, MD, FACS
Professor of Surgery, University of
Toronto, Toronto, ON, Canada
Professor of Surgery; Director, Surgical
Endoscopy; Program Director, Case
Surgery, University Hospitals Case
Medical Center, Cleveland, OH
Asst. Professor of Surgery, Colorectal
Surgery, Div. of Gastrointestinal and
Oncologic Surgery, Northwestern
Memorial Hospital, Northwestern
University Feinberg School of
Medicine, Chicago, IL
Clinical Professor of Surgery, Div. of
Colon and Rectal Surgery, University
of Minnesota, Minneapolis, MN
Martin Luchtefeld, MD
Chief, Div. of Colon and Rectal
Surgery, Spectrum Health Medical
Group, Grand Rapids, MI
James Merlino, MD
Consultant Staff, Dept. of Colorectal
Surgery, Cleveland Clinic; President
and Chief Medical Officer, Strategic
Consulting Div., Press Ganey
Associates, Inc., Chicago, IL
Craig Messick, MD
Asst. Professor of Surgery, Dept. of
Surgical Oncology, Section of Colon
and Rectal Surgery, University of Texas
MD Anderson Cancer Center, Houston,
TX; University of Texas MD Anderson
Cancer Center, Regional Care Center,
Sugar Land, TX
John Migaly, MD
Professor of Surgery; Medical
Director, William C. Bernstein, MD
Familial Cancer Registry; Stanley M.
Goldberg, MD Chair and Chief, Div. of
Colon and Rectal Surgery, Dept. of
Surgery, University of Minnesota,
Minneapolis, MN
John H. Marks, MD
Chief of Colorectal Surgery, Main Line
Health Systems; Director of Minimally
Invasive Colorectal Surgery and Rectal
Cancer Management Fellowship,
Lankenau Medical Center; Professor,
Lankenau Institute of Medical
Research, Wynnewood, PA
Najjia N. Mahmoud, MD
Assoc. Professor of Surgery; Chief, Div.
of Colon and Rectal Surgery,
University of Pennsylvania Health
System, Philadelphia, PA
David J. Maron, MD, MBA
Vice Chairman, Dept. of Colorectal
Surgery; Director, Colon and Rectal
Surgery Residency Program, Cleveland
Clinic Florida, Weston, FL
Tony Wing Chung Mak, MD
Asst. Professor, Div. of Colorectal
Surgery, Chinese University of Hong
Kong, Hong Kong
Joseph Martz, MD
Chief, Div. of Colon and Rectal
Surgery, Mount Sinai Beth Israel
Medical Center, New York, NY
Ronnie Mathew, MD, MBBS
Asst. Professor of Surgery, Rutgers –
Robert Wood Johnson Medical School,
New Brunswick, NJ
Consultant in General and Colorectal
Surgery, University Hospitals Leicester
NHS Trust, Leicester, United Kingdom
Mark L. Manwaring, MD
Klaus E. Matzel, MD, Hon FASCRS,
EBSQColoproct.
Peter W. Marcello, MD, FACS,
FASCRS
Chairman, Dept. of Colon and Rectal
Surgery, Lahey Hospital and Medical
Center, Burlington, MA
Jorge Marcet, MD
Professor of Surgery; Chief, Section of
Colon and Rectal Surgery; Director,
Colon and Rectal Surgery Residency,
Tampa General Hospital, University of
South Florida, Tampa, FL
Head, Section of Coloproctology,
Dept. of Surgery, University Erlangen;
Professor of Surgery, Friedrich
Alexander University, Erlangen/
Nurnberg, Erlangen, Germany
Justin A. Maykel, MD
Chief, Div. of Colorectal Surgery;
Assoc. Professor of Surgery, UMass
Memorial Medical Center,
University of Massachusetts Medical
School, Worcester, MA
Chief, Colorectal Surgery; Director,
Minimally Invasive Surgery Center,
Kaiser Permanente LA Medical Center,
The Teaching and Tertiary Referral
Center for Southern California
Permanente Medical Group,
Los Angeles, CA
Chief, Colon and Rectal Surgery;
Jerome J. DeCosse Professor of
Surgery; Executive Director, Center for
Advanced Digestive Care (CADC);
Executive Director, Minimally Invasive
New Technologies (MINT); Weill
Cornell Medical College/New York
Presbyterian Hospital, New York, NY
John R. T. Monson, MD
Robin S. McLeod, MD
Professor of Surgery and Health Policy
Management and Evaluation,
University of Toronto, Mount Sinai
Hospital, Toronto, ON, Canada
M. Shane McNevin, MD
Nell Maloney Patel, MD, FACS,
FACRS
Colorectal Surgery, Asst. Professor of
Surgery, East Carolina University,
Greenville, NC
Jeffrey W. Milsom, MD
Elisabeth (Lisa) C. McLemore, MD,
FACS, FASCRS
Surgical Specialists of Spokane;
Director, Providence Continence
Center, Spokane, WA
Armando Melani, MD
Assoc. Professor of Minimally Invasive
Surgery, Section of Colon and Rectal
Surgery; Scientific Director of the
IRCAD Latin American; Ribeirão Preto
School of Medicine, University of São
Paulo, Barretos, São Paulo, Brasil
Anders Mellgren, MD, PhD, FACS,
FASCRS
Professor, Chief Colon & Rectal
Surgery, Dept. of Surgery, University
of Illinois at Chicago, Chicago, IL
Genevieve Melton-Meaux, MA, MD,
FACS, FASCRS
Assoc. Professor of Surgery and
Informatics, University of Minnesota;
Chief Health Information Officer,
Fairview Health Services, and
University of Minnesota Physicians,
Minneapolis, MN
145
Professor of Surgery and Oncology;
Chief, Div. of Colorectal Surgery and
Vice-Chairman of Surgery; ViceChairman of Quality and Outcomes;
Director, Surgical Health Outcomes
and Research Enterprise (SHORE),
University of Rochester Medical
Center, Rochester, NY
Arden M. Morris, MD, MPH
Assoc. Professor of Surgery; Chief, Div.
of Colorectal Surgery, University of
Michigan, Ann Arbor, MI
Sthela Murad-Regadas, MD, PhD,
FASCRS
Assoc. Professor of Surgery, Federal
University of Ceara Medical School;
Coordinator of Section of Anorectal
Physiology and Pelvic Floor, Clinical
Hospital and Sao Carlos Hospital,
Forteleza, CE, Brazil
Jamie Murphy, BChir, PhD, FRCS
NIHR Lecturer in Surgery, University of
London, London, United Kingdom
M. Margarita Murphy, MD, FASCRS
Medical Director, Colorectal
Endosurgery Institute of the Carolinas,
Roper Mt. Pleasant Hospital, East
Cooper Regional Medical Center,
Mount Pleasant, SC
F A C U LT Y
Robert D. Madoff, MD, FACS,
FASCRS, FRCSEd (hon)
Program Director, General Surgery
Residency; Assoc. Professor, Colon
and Rectal Surgery, Div. of Advanced
GI and Oncologic Surgery, Duke
University Medical Center,
Durham, NC
Featured Lecturers and Faculty
Matthew G. Mutch, MD
Bruce A. Orkin, MD
Hiram C. Polk, Jr., MD
Assoc. Professor of Surgery, Section of
Colon and Rectal Surgery, Washington
University School of Medicine, St.
Louis, MO
Professor of Surgery; Vice Chair for
Academic Affairs, Dept. of General
Surgery; Chief, Section of Colon and
Rectal Surgery, Rush University
Medical Center, Chicago, IL
Ben A. Reid, Sr. Professor of Surgery,
Emeritus; Former Chair, Dept. of
Surgery, School of Medicine,
University of Louisville, Louisville, KY
Deborah Nagle, MD
Chief, Div. of Colon and Rectal
Surgery, Beth Israel Deaconess
Medical Center, Harvard Medical
School, Boston, MA
Darren Pollock, MD
Joel Palefsky, MD, CM, FRCP(C)
Infectious Disease Specialist, Professor
of Medicine and Laboratory Medicine,
University of California, San Francisco,
San Francisco, CA
Govind Nandakumar, MD
Asst. Professor, Dept. of Surgery, Div.
of Colorectal Surgery, NYPH/Weill
Cornell Medical Center, New York, NY
Ian M. Paquette, MD
Asst. Professor of Surgery, University
of Cincinnati College of Medicine,
Cincinnati, OH
Johan Nordenstam, MD, PhD
University of Illinois at Chicago,
Chicago, IL
Eduardo Parra-Davila, MD, FACS,
FASCRS
Professor of Surgery, Chairman, Dept.
of Colorectal Surgery, Rupert B.
Turnbull, Jr., MD Endowed Chair in
Colorectal Surgery, Digestive Disease
Institute; Director, Center for
International Medical Education,
Cleveland Clinic, Cleveland, OH
Harry Reynolds, Jr., MD
Vitaliy Poylin, MD
Jevon Puckett, MBBS
Assoc. Professor of Surgery, Case
Western Reserve University; Director
Colon and Rectal Cancer Surgery,
University Hospitals Case Medical
Center, Div. of Colorectal Surgery,
Cleveland, OH
Dept. of Surgery, The University of
Auckland, Auckland, New Zealand
Craig Rezac, MD, FACS, FASCRS
Div. of Colon and Rectal Surgery, Beth
Israel Deaconess Medical Center,
Boston, MA
Heidi Nelson, MD
Fred C. Andersen Professor of Surgery;
Chair, Dept. of Surgery; Mayo Clinic,
Rochester, MN
Staff Colon and Rectal Surgeon,
Swedish Cancer Institute, Swedish
Medical Center, Seattle, Washington
Feza H. Remzi, MD, FACS, FASCRS,
FTSS (Hon)
Director for Minimally Invasive &
Colorectal Surgery; Director of Hernia
and Abdominal Wall Reconstruction,
Florida Hospital Celebration,
Celebration, FL
Janice Rafferty, MD
John H. Pemberton, MD
Sonia Ramamoorthy, MD, FACS,
FASCRS
Professor of Surgery; Chief, Div. of
Colon and Rectal Surgery, University
of Cincinnati College of Medicine,
Cincinnati, OH
Assoc. Professor of Surgery, Rutgers
Medical School; Section Chief, Colon
and Rectal Surgery; Chief of Robotic
Surgery, RWJUH Div. of General
Surgery, New Brunswick, NJ
Rocco Ricciardi, MD, MPH
Juan J. Nogueras, MD, MBA, FACS,
FASCRS
Clinical Professor of Surgery, Florida
International University; Affiliate
Professor of Clinical Biomedical
Science, Florida Atlantic University,
Weston, FL
Professor of Surgery, Mayo Clinic
College of Medicine; Consultant, Div.
of Colon & Rectal Surgery, Mayo Clinic
College of Medicine, Rochester, MN
Rodrigo Oliva Perez, MD, PhD
Assoc. Professor of Surgery; Chief,
Section of Colon and Rectal Surgery,
Rebecca and John Moores Cancer
Center, UC San Diego Medical Center,
La Jolla, CA
Asst. Professor of Surgery; Director,
Div. of Colon and Rectal Surgery,
George Washington University,
Washington, DC
University of São Paulo School of
Medicine, Colorectal Surgery Div.;
Angelita & Joaquim Gama Institute
Colorectal Surgery Div.; Ludwig
Institute for Cancer Research – São
Paulo Branch, Brazil
David O’Brien, MD
W. Brian Perry, MD
The Oregon Clinic PC, Portland, OR
Chief of Surgery, Audie L. Murphy VA
Medical Center, San Antonio, TX
Chief of Surgery at Memorial
Hermann Northeast Hospital; Staff
surgeon, Houston Methodist
Willowbrook Hospital, St. Luke's
Hospital at the Vintage, Houston
Northwest Medical Center and
Cypress-Fairbanks Medical Center,
Humble, TX
P. Ronan O’Connell, MD, FRCSI,
FRCS (Glas), FRCS (Edin)
Walter R. Peters, Jr., MD, MBA
Elizabeth Raskin, MD
Head, Section of Surgery and Surgical
Specialties, University College Dublin;
Consultant Surgeon, St Vincent’s
University Hospital, Dublin, Ireland
President, Columbia Surgical
Associates; Clinical Assoc. Professor of
Surgery, University of Missouri,
Columbia, MO
Colon and Rectal Surgery Associates,
St. Paul, MN
Frank G. Opelka, MD, FACS
Alessio Pigazzi, MD, PhD
Medical Director, Quality and Health
Policy, The American College of
Surgeons; Professor of Surgery and
Executive Vice President, Louisiana
State University, New Orleans, LA
Assoc. Professor of Clinical Surgery;
Chief, Div. of Colon and Rectal
Surgery, University of California,
Irvine, Orange, CA
Vincent J. Obias, MD
Assoc. Professor of Clinical Surgery;
Chief, Section of Colon and Rectal
Surgery, Adjunct Assoc. Professor of
Clinical Surgery, Tulane School of
Medicine/Dept. of Surgery, New
Orleans, LA
Thomas E. Read, MD, FACS, FASCRS
Senior Staff Surgeon, Dept. of Colon
and Rectal Surgery, Lahey Hospital
and Medical Center, Burlington, MA;
Professor of Surgery, Tufts University
School of Medicine, Boston, MA
University of Chicago, Dept. of
Medicine, Section of Hematology/
Oncology, Chicago, IL
David E. Rivadeneira, MD, MBA,
FACS, FASCRS
Vice Chair, Surgical Strategic Initiatives
for North Shore-LIJ Health System;
Director, Surgical Services and
Colorectal Surgery at Huntington
Hospital; Professor of Surgery, Hofstra
University School of Medicine,
Woodbury, NY
Bruce Robb, MD
Assoc. Professor of Surgery, Section
Chief, Colon and Rectal Surgery,
Indiana University School of Medicine,
Indianapolis, IN
Patricia L. Roberts, MD, FACS,
FASCRS
Senior Staff Surgeon, Dept. of Colon
and Rectal Surgery; Chair, Div. of
Surgery, Lahey Hospital and Medical
Center, Burlington, MA; Professor of
Surgery, Tufts University School of
Medicine, Boston, MA
Lester Rosen, MD
Craig Reickert, MD
Blase Polite, MD, MPP
Guy R. Orangio, MD
Tal Raphaeli, MD, FACS
Chief Scientific Officer, Lahey Hospital
and Medical Center, Burlington, MA
Senior Staff Surgeon, Div. of Colon
and Rectal Surgery; Program Director,
Residency in Colon and Rectal
Surgery; Director of the Center for
Simulation, Education and Research,
Henry Ford Hospital; Asst. Professor of
Surgery, Wayne State University,
Detroit, MI
146
Staff Colon and Rectal Surgeon,
Cleveland Clinic Florida, West Palm
Beach; Affiliate Professor of Clinical
Biomedical Science, Charles Schmidt
College of Medicine at Florida Atlantic
University; Clinical Professor of
Surgery, Florida International
University, Herbert Wertheim College
of Medicine
Featured Lecturers and Faculty
Michael J. Rosen, MD, FACS
Giulio A. Santoro, MD, PhD
David Shibata, MD, FACS, FASCRS
Scott A. Strong, MD
Professor of Surgery, Medical Director,
Comprehensive Hernia Center,
Cleveland Clinic, Cleveland, OH
Consultant Colorectal Surgeon,
Cleveland Clinic Abu Dhabi, United
Arab Emirates
Howard Ross, MD, FACS, FASCRS
David Schoetz, Jr., MD
Professor and Chief, Div. of Colon and
Rectal Surgery, Temple University
School of Medicine, Philadelphia, PA
Tufts School of Medicine Academic
Dean at Lahey Hospital and Medical
Center; Chief Education Officer, Lahey
Hospital and Medical Center,
Burlington, MA; Designated
Institutional Official, Graduate Medical
Education; Chairman Emeritus, Dept.
of Colon and Rectal Surgery; Professor
of Surgery, Tufts University School of
Medicine, Boston, MA
Senior Member, Professor of Surgery
and Oncology; Vice-Chair, Dept. of
Gastrointestinal Oncology; Chief,
Section of Colorectal Oncology, H. Lee
Moffitt Cancer Center and Research
Institute, Tampa, FL
Staff Physician, Holder of the
Thomas C. and Sandra S. Sullivan
Family Endowed Chair, Dept. of
Colon and Rectal Surgery, Digestive
Disease Institute, Cleveland Clinic,
Cleveland, OH
Steven W. Siegel, MD
Patricia Sylla, MD
Director of Metro Urology’s Center for
Continence Care, Woodbury, MN
Asst. Professor of Surgery, Mount Sinai
Hospital, Div. of Colon and Rectal
Surgery, New York, NY
Asst. Professor of Surgery, University
Colon and Rectal Surgery; Assoc.
Program Director, General Surgery
Residency, Dept. of Surgery, University
of Tennessee Medical Center,
Knoxville, TN
Rudolph B. Rustin, MD, FACS,
FASCRS
Human Resources for Health Program,
Huye, Rwanda, University of Virginia
Dept. of Surgery
Michael J. Snyder, MD
James Picker Professor and Chairman,
Dept. of Radiology, Columbia
University Medical Center;
Radiologist-in-Chief, New York
Presbyterian Hospital, Columbia, New
York, NY
Clinical Assoc. Professor of Surgery,
The University of Texas Health Science
Center at Houston, Houston, TX
Anthony J. Senagore, MD, MS, MBA
Professor, Div. of Colorectal Surgery,
University Hospitals/Parma Medical
Center, Parma, OH
Timothy S. Sadiq, MD
Asst. Professor, Dept. of Surgery,
University of North Carolina at Chapel
Hill, Chapel Hill, NC
Peter Sagar, BSc, MD, FRCS
Consultant Surgeon, Clinical Assoc.
Professor, St. James’s University
Hospital, Leeds, United Kingdom
Stephen M. Sentovich, MD, MBA
Chief, Section of Colon and Rectal
Surgery; Clinical Professor of Surgery,
City of Hope National Medical Center,
Los Angeles, CA
Virginia O. Shaffer, MD
Asst. Professor of Surgery, Emory
University, Atlanta, GA
Jaime E. Sanchez, MD, MSPH
Asst. Professor of Surgery , Div. of
Colon & Rectal Surgery, Morsani
College of Medicine, University of
South Florida, Tampa, FL
Nishit Shah, MB ChB
Dana R. Sands, MD, FACS, FASCRS
Skandan Shanmugan, MD
Staff Surgeon, Cleveland Clinic Florida;
Director, Colorectal Physiology Center,
Cleveland Clinic Florida, Weston, FL;
Affiliate Assoc. Professor of Surgery,
Florida Atlantic University; Clinical
Assoc. Professor of Surgery, Florida
International University; Voluntary
Asst. Professor of Surgery, University
of Miami
Asst. Professor of Surgery, Div. of
Colon and Rectal Surgery, University
of Pennsylvania, Pennsylvania
Hospital, Philadelphia, PA
Cesar A. Santiago, MD, FACS,
FASCRS
Medical Director, Advanced Center for
Robotic Surgery, St. Joseph Hospital,
Tampa, FL
Asst. Professor, Section of Colon and
Rectal Surgery, Rush University
Medical Center, Chicago, IL
Lawrence H. Schwartz, MD
Theodore Saclarides, MD
Professor of Surgery and Director of
the Div. of Colon and Rectal Surgery,
Loyola University, Maywood, IL
Marc Singer, MD
Dept. of Surgery, Warren Alpert
Medical School of Brown University,
Providence, RI
Yury Shelygin, MD, PhD
Profesor of Surgery; Director, State
Scientific Center of Coloproctology,
Moscow, Russia; Associated
Professor, Russian Medical Academy
of Postgraduate Education,
Moscow, Russia
Eric J. Szilagy, MD, FACS, FASCRS
Asst. Professor of Surgery, Wayne
State University School of Medicine,
Detroit, MI; Service Chief, Colon and
Rectal Surgery, Henry Ford West
Bloomfield Hospital, West
Bloomfield, MI
Larissa Temple, MD, FACS, MSc
Michael J. Stamos, MD
The John E. Connolly Professor and
Chair, Dept. of Surgery, University of
California, Irvine, Orange, CA
Assoc. Attending Surgeon, Memorial
Sloan Kettering Cancer Center; Assoc.
Professor of Surgery, Weill Cornell
Medical Center, New York, NY
Scott R. Steele, MD, FACS, FASCRS
Charles Ternent, MD
Chief, Colon & Rectal Surgery,
Madigan Army Medical Center, Fort
Lewis, WA; Clinical Assoc. Professor of
Surgery, University of Washington,
Seattle, WA
Assoc. Clinical Professor, Dept. of
Surgery, Section of Colon and Rectal
Surgery, Creighton University School
of Medicine; Adjunct Assoc. Professor
of Clinical Surgery, Dept. of General
Surgery, University of Nebraska
College of Medicine, Omaha, NE
Randolph Steinhagen, MD
Chief, Div. of Colon and Rectal
Surgery, Mount Sinai Hospital;
Program Director, Colon and Rectal
Surgery Fellowship Program, Mount
Sinai Hospital, New York, NY
Julie Thacker, MD
Duke University School of Medicine,
Durham, NC
Robert H. Thiele, MD
Andrew RL Stevenson, MB BS,
FRACS
Study Chair – AlaCaRT (Australasian
Laparoscopic Cancer Rectum Trial);
Assoc. Professor, University of
Queensland; Director, Colorectal
Surgery, Royal Brisbane Hospital;
Australian Colorectal Endosurgery,
Chermside, QLD, Australia
Asst. Professor, Depts. of
Anesthesiology and Biomedical
Engineering Divs. of Cardiac, Thoracic,
and Critical Care Anesthesiology
Director; Technology in Anesthesia &
Critical Care Group Co-Director; UVA
Enhanced Recovery after Surgery
(ERAS) Program University of Virginia
School of Medicine, Charlottesville, VA
David B. Stewart., Sr., MD, FACS,
FASCRS
Christopher C. Thompson, MD,
MHES
Assoc. Professor of Surgery, Dept. of
Surgery/Div. of Colorectal Surgery,
Pennsylvania State University, Hershey
Medical Center, Hershey, PA
Director of Developmental Endoscopy,
Div. of Gastroenterology, Brigham and
Women’s Hospital, Boston, MA; Asst.
Professor, Harvard Medical School
Lisa Strate, MD, MPH
Amy J. Thorsen, MD
Assoc. Professor of Medicine, Dept. of
Medicine, University of Washington
School of Medicine, Div. of
Gastroenterology, Seattle, WA
Clinical Asst. Professor of Surgery,
Div. of Colon and Rectal Surgery,
University of Minnesota,
Minneapolis, MN
147
F A C U LT Y
Andrew J. Russ, MD
Featured Lecturers and Faculty
Kiran K. Turaga, MD, MPH
Martin R. Weiser, MD
Charles B. Whitlow, MD
Asst. Professor, Surgical Oncology,
Medical College of Wisconsin,
Milwaukee, WI
Stuart HQ Quan Chair, Colorectal
Surgery; Attending Surgeon,
Memorial Sloan Kettering Cancer
Center; Professor of Surgery, Cornell
Weill Medical College, New York, NY
Residency Program Director, Colon
and Rectal Surgery, Ochsner Clinic,
New Orleans, LA
Konstantin Umanskiy, MD, FACS
Asst. Professor, Surgery; Program
Director, Colon and Rectal Surgery
Residency Program; Assoc. Program
Director, General Surgery Residency
Program, The University of Chicago,
Chicago, IL
Elizabeth Wick, MD
Assoc. Professor of Surgery, Johns
Hopkins University, Baltimore, MD
Mark Lane Welton, MD, MHCM
Harry A. Oberhelman Professor; Chief,
Colon and Rectal Surgery, Stanford
University School of Medicine; Vice
Chief of Staff, Stanford Hospital and
Clinics, Stanford, CA
Paul E. Wise, MD
Assoc. Professor of Surgery, Section of
Colon and Rectal Surgery; General
Surgery Program Director, Washington
University in St. Louis School of
Medicine, St. Louis, MO
Brian T. Valerian, MD, FACS, FASCRS
Assoc. Professor of Surgery, Albany
Medical College, Albany, NY
Steven D. Wexner, MD, PhD(Hon),
FACS, FRCS, FRCS(Ed)
Jon Vogel, MD
Director, Digestive Disease Center;
Chair, Dept. of Colorectal Surgery;
Cleveland Clinic Florida, Weston, FL;
Affiliate Professor Florida Atlantic
University College of Medicine;
Clinical Professor Florida International
University College of Medicine
Assoc. Professor of Surgery, University
of Colorado, Aurora, CO
Richard L. Whelan, MD
H. David Vargas, MD, FACS, FASCRS
Staff Surgeon, Dept. of Colon and
Rectal Surgery, Ochsner Clinic
Foundation, New Orleans, LA
Sarah A. Vogler, MD, MBA
Clinical Asst. Professor of Surgery, Div.
Colon and Rectal Surgery, University
of Minnesota, Minneapolis, MN
Theodoros Voloyiannis, MD, FACS,
FASCRS
Colon & Rectal Surgery, Memorial
Hermann Medical Group, Memorial
Hermann Hospital Southeast;
Clinical Asst. Professor in Surgery,
University of Texas Houston, Health
Sciences Center, Houston, TX
James Yoo, MD
Asst. Professor, Tufts University School
of Medicine; Chief, Div. of Colon and
Rectal Surgery, Tufts Medical Center;
Co-Director, Tufts Colorectal Cancer
Program, Boston, MA
Yi-Qian Nancy You, MD, MHSc
Professor of Surgery; Chief, Colon and
Rectal Surgery; Chief, Surgical
Oncology, St. Luke’s Roosevelt
Hospital, New York, NY
Assoc. Professor, Section of Colorectal
Surgery, Dept. of Surgical Oncology;
Medical Director, Familial High-risk
Gastrointestinal Cancer Clinic,
University of Texas MD Anderson
Cancer Center, Houston, TX
Mark H. Whiteford, MD, FACS,
FASCRS
Massarat Zutshi, MD
Gastrointestinal & Minimally Invasive
Surgery Div., The Oregon Clinic, PC;
Director, Colon and Rectal Surgery,
Providence Cancer Center; Affiliate
Professor of Surgery, Oregon Health &
Science University, Portland, OR
Assoc. Professor of Surgery; Staff
surgeon, Cleveland Clinic, Dept. of
Colorectal Surgery; Joint Appointment
Dept. of Biomedical Engineering,
Lerner Research Institute,
Cleveland, OH
148
Disclosures
Disclosure Policy and Disclosures
As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American
Society of Colon and Rectal Surgeons (ASCRS) policy, all educational planners, presenters, instructors, moderators, authors,
reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant
financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of
interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and
appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the
start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant
financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or
devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the
information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in
interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect
the opinions of the ASCRS.
All identified conflicts of interest have been resolved.
H. Randolph Bailey, MD
Consultant: Ethicon, Inc.
Louis Barfield, MD
Consultant: Cook Medical; Speaker: Cook
Medical
Amir Bastawrous, MD
Honorarium: Intuitive Surgical, Salix
Pharmaceuticals; Speaker: Salix Pharmaceuticals;
Teacher: Intuitive Surgical
David Beck, MD
Consultant: Pacira; Honorarium: Mallinckrodt
Pharm, Pacira; Speaker: Pacira
Mariana Berho, MD
Consultant: Mediri
Joshua Bleier, MD
Consultant: Medtronic; Honorarium: Medtronic,
Cook; Speaker: Medtronic, Cook; Teacher:
Medtronic, Cook
Liliana Bordeianou, MD
Royalty: Up to Date; Kinetic Concepts
Incorporated (KCI); Research Support: Kinetic
Concepts Incorporated (KCI)
Jamie Cannon, MD
Honorarium: Intuitive Surgical; Speaker: Intuitive
Surgical; Teacher: Intuitive Surgical
Joseph Carmichael, MD
Honorarium: Salix Pharmaceuticals, Ethicon
Endosurgery; Speaker: Salix Pharmaceuticals;
Teacher: Ethicon Endosurgery; Educational
Grant: Ethicon Endosurgery
James Church, MD
Honorarium: Exact Sciences; Speaker: Exact
Sciences
Robert Cleary, MD
Honorarium: Intuitive; Speaker: Intuitive
Jeffrey S. Cohen, MD
Honorarium: Intuitive; Speaker: Intuitive;
Teacher: Intuitive
Philip Cole, MD
Consultant: Christus North La.
Margot Damaser, MD
Research Grant: Lily Pharmaceuticals, Beech Tree
Labs, Acorda Labs
Bradley Davis, MD
Consultant: Ethicon Endo; Honorarium: Ethicon
Endo
Sandra de Montbrun, MD
Research Grants: 1)2013 SSAT Career
Development Award for Clinical/Outcomes/
Education Research (primary Investigator), The
Society for Surgery of the Alimentary Tract.
Conor Delaney, MD
Consultant/Research Trial Development:
Edwards Lifesciences; Honorarium: Covidien;
Speaker: Covidien; Royalty/Licenced Patent:
Ethicon; Intellectual Property Rights: Socrates
Analytics; Ownership Interest (ie
stocks)/Inventor and Founder: Socrates
Analytics; Royalty/Licensed Simulator: Simbionix
Cathy Eng, MD
Consultant: Bayer, Genentech; Research Grant:
Daiichi and Keryx
Virgilio George, MD
Consultant: Cook Medical, Ethicon EndoSurgery, Inc, LifeCell Corporation; Honorarium:
Lifecell Corporation; Research Grant: Cook,
W. L. Gore & Associates, Inc, Helsinn Company,
ACOSOG, Covidien, Durect, Corp, Durect, Corp,
LifeCell, Inc
Stephen Goldstone, MD
Consultant/Advisory Committee: Merck and Co.,
Conmed Inc., Covidien; Honorarium: Merck and
Co.; Research Grant: Merck and Co., Covidien;
Speaker: Merck and Co.; Investigator: Merck
and Co.
Brooke Gurland, MD
Honorarium: Salix, Medtronic; Speaker: Salix;
Education: Medronic
Heather Hampel, MD
Honorarium: Quest Diagnostics, Invitae
Laboratories; Research Grant: Myriad Genetic
Laboratories, Inc.; Speaker: Quest Diagnostics,
Invitae Laboratories
Alan Herline, MD
Consultant: Third Dimension Technologies,
Pathfinder Therapeutics, Inc. (founder); Royalty:
Pathfinder Therapeutics, Inc.; Ownership
Interest: Pathfinder Therapeutics, Inc.
Terry Hicks, MD
Honorarium: Pennsylvana Society of CRS,
Greater Baltimore Hospital; Royalty: Improved
Outcomes in Colon and Rectal Surgery book
published
Michael Hopkins, MD
Consulting: American Medical Systems
Sandy Fang, MD
Research Grant: Cigarette Restitution Fund Grant
Steven Hunt, MD
Honorarium: Cook Medical
George Chang, MD
Research Grant: Agendia; Consultant: Johnson &
Johnson Ethicon
Todd Francone, MD
Consultant: Olympus; Honorarium: Covidien,
Olympus; Teacher: Covidien, Olympus
Gerald Isenberg, MD
Research Grant: Ventrus Biosciences anal fissure
study
Hueylan Chern, MD
Research Grant: WGEA, intramural
Kelly Garrett, MD
Honorarium: Olympus; Teacher: Olympus
Eric Johnson, MD
Honorarium: Cook Medical, Cubist; Teacher:
Cook Medical; Speaker: Cubist
*Will be discussing off-label products.
149
DISCLOSURES
Bonnie Alvey, RN
Advisory Board: Coloplast; Honorarium:
Coloplast; Per Diem: Calmoseptine; Independent
Contractor: Calmoseptine
Disclosures
Andreas Kaiser, MD
Honorarium: GI Health Foundation; Speaker: GI
Health Foundation; Royalty: McGraw Hill
Publisher, Up to date; Author: McGraw Hill
Publisher, Up to date
Matthew Kalady, MD
Consultant: Precision Therapeutics; Honorarium:
Precision Therapeutics; Speaker: Precision
Therapeutics
Sergey Kantsevoy, MD
Consultant: Boston Scientific Corporation,
Olympus America; Honorarium: Boston Scientific
Corporation, Olympus America; Ownership
Interest (ie stocks)/co-founder and shareholder:
Apollo Endosurgery Inc
Joshua Katz, MD
Consultant: Speakers Bureau Cubist
Pharmaceuticals; Medical Review Committee,
LifeCell Corporation stoma reinforcement trial
2010-2012; Expert Witness Malpractice
Consultant list available on request; Royalty: Life
Cell Corporation, Cubist Pharmaceuticals;
Ownership Interest: Stocks held by mutual funds
in which I have invested
Karamjit Koko Khanduja, MD
Consultant: President, Colon and Rectal Surgery
Inc.; Program Director, Mount Carmel Health
System, Colorectal Surgery Fellowship;
Colorectal Advisor, Mount Carmel Health
System, Columbus, Ohio; President, Green St.
Surgery Center. Columbus, Ohio
Walter Koltun, MD
Consultant: Dr Reddy's Laboratories; Research
Grant: Philadelphia Health Care Trust,
Pennsylvania DOH Tobacco CURE grant
Mary Kwaan, MD
Research Grant: U54 NIMHD
Kim Lu, MD
Consultant: Former: Glaxo-Smith-Kline/Cubist
Vincent Lucente, MD
Consultant: American Medical Systems, Kimberly
Clark, Astellas, Coloplast, Medtronic
Honorarium: American Medical Systems,
Allergen, Bard, Kimberly Clark, Astellas,
Coloplast, Medtronic; Speaker: American
Medical Systems, Allergen, Coloplast; Research
Grants: American Medical Systems, Kimberly
Clark, Coloplast; Expert Witness: Bard
Genevieve Melton-Meaux, MD
Salary: St. Jude Medical (spouse is employee),
Matonich Persson, NIH, AHRQ; Consultant:
Matonich Persson; Research Grants: NIH, AHRQ
Robert Madoff, MD
Consultant/Advisory Committee: LifeBond Ltd.,
Torax Medical Inc.; Consultant: Tsumura USA
James Merlino, MD
Ownership interest (ie stocks): Emmi Solutions
(Board member)
Najjia Mahmoud, MD
Research Grant: 3M, Inc.
John Migaly, MD
Consultant: CareFusion
Peter Marcello, MD
Consultant: Applied Medical, Covidien, Olympus;
Honorarium: Applied Medical Covidien,
Olympus; Teacher: Covidien
Jeffrey Milsom, MD
Research Grant: Olympus Corp.; Teacher:
Olympus Corp.
Jorge Marcet, MD
Honorarium: Covidien, Applied Medical, Merck,
Pacira; Teacher: Covidien, Applied Medical,
Pacira; Speaker: Merck
John Marks, MD
Consultant: Covidien, Intuitive, Stryker, Wolf,
Cubist; Speaker: Cubist
Jeffrey Marks, MD
Advisory Committee: Apollo Endosurgery;
Consultant: GI Supply, US Endoscopy, Merck,
Olympus; Honorarium: GI Supply, US Endoscopy,
Merck, Apollo Endosurgery, Olympus
Jorge Lagares-Garcia, MD
Honorarium: Intuitive Surgical; Teacher: Intuitive
Surgical
Sean Langenfeld, MD
Honorarium: Sanofi; Speaker: Sanofi
Catherine Matthews, MD
Consultant: Pelvalon
Sergio Larach, MD
Consultant: Applied Medical; Ownership interest
(ie stocks): Applied Medical
Klaus Matzel, MD
Advisory Committee: Medtronic, Oceana;
Consultant: Medtronic, Oceana; Honorarium:
Medtronic, Covidien, Oceana, Uroplasty;
Speaker: Medtronic, Covidien, Uroplasty;
Teacher: Medtronic, Covidien
Michael Leitman, MD
Research Grant: New York State Department of
Health, AHRQ
Anne Lin, MD
Research Grant: Center for Health Quality
Initiatives Grant, UCLA, PI, Center for Health
Quality Intiatives Grant, UCLA, Co-PI, Reducing
Perioperative Complications after Colorectal
Surgery
Anders Mellgren, MD
Advisory Committee: American Medical Systems,
Medtronic; Consultant: American Medical
Systems, Medtronic; Honorarium: American
Medical Systems, Medtronic, Salix; Speaker:
Medtronic, Salix
Martin Luchtefeld, MD
Ownership interest (ie stocks): Pacira, Amgen,
Stryker, Baxter, Actavis
Joseph Martz, MD
Honorarium: Novadaq, Intuitive Surgical, Cubist;
Speaker: Novadaq, Cubist; Teacher: Intuitive
Surgical
Paul Lehur, MD
Consultant: Torax Medical Inc.; Honorarium:
Torax Medical Inc.; Speaker: Torax Medical Inc.;
Teacher: Torax Medical Inc.
Armando Franchini Melani, MD
Consultant/Advisory Committee: Covidien,
Ethicon Medical Brazil; Speaker: Covidien;
Teacher: Covidien, Ethicon Medical Brazil
James McCormick, MD
Honorarium: McCormick; Speaking: McCormick;
Teaching: McCormick
Elisabeth McLemore, MD
Consultant: Covidien; Honorarium: Applied
Medical, Covidien, Ethicon EndoSurgery,
Novadaq, Genomic Health; Speaking: Genomic
Health; Teaching: Applied Medical, Ethicon
EndoSurgery, Novadaq; Research: Novatract
Surgerical; Ownership interest (ie stocks): Cubist
*Will be discussing off-label products.
150
Roberta Muldoon, MD
Research Grant: PI for Randomized, Control Trial
with Duke Clinical Research Institute
M. Margarita Murphy, MD
Honorarium: Medtronic; Teacher: Medtronic
Deborah Nagle, MD
Consultant: Cohera, Intuitive, ConMed;
Honorarium: Intuitive; Speaker: Intuitive;
Teacher: Intuitive
Govind Nandakumar, MD
Honorarium: Olympus; Teacher: Olympus
Heidi Nelson, MD
Royalty: Titan; American College of Surgeons
Oncology Group – Co-Chair. NIH, Role of the
Microflora
Mikio Nihira, MD
Consultant: American Medical Systems;
Honorarium: American Medical Systems;
Research Grant: American Medical Systems,
Ethicon, Coloplast, Salix, Cook, Proaccess
Vincent Obias, MD
Consultant: THD America; Honorarium: Intuitive
Surgical; Teacher: Intuitive Surgical; Research:
THD America; Honorarium: Intuitive Surgical;
Speaker: Intuitive Surgical; Teacher: Intuitive
Surgical
Joel Palefsky, MD
Consultant: Research Grants: Merck & Co.,
Hologic, Qiagen; Research Grants: Merck & Co.,
Hologic; Research: Merck & Co., Hologic; Board
Member: Merck & Co.; Stock shareholder: Aura
Bioscience
Disclosures
Eduardo Parra-Davila, MD
Consultant: Ethicon, Intuitive, BARD/DAVOL;
Honorarium: Ethicon, Intuitive, BARD/DAVOL;
Speaker: Ethicon, Intuitive, BARD/DAVOL;
Research Study: BARD/DAVOL; Research:
BARD/DAVOL
Walter Peters, Jr., MD
Honorarium: Ethicon EndoSurgery; Speaker:
Ethicon EndoSurgery; Teacher: Ethicon
EndoSurgery
Alessio Pigazzi, MD
Consultant: Xodus, Novadaq, Intuitive;
Honorarium: Intuitive Surgical Inc., Covidien,
Ethicon, Cook, Novadaq; Teacher: Intuitive
Surgical Inc., Covidien, Ethicon, Cook;
Educational Grants: Ethicon, Cook, Covidien,
Cubist; Royalty: Xodus
Janice Rafferty, MD
Consultant: Aptalis; Honorarium: Lifecell, Aptalis,
IFlow, Novadaq; Speaker: Lifecell, IFlow, Novadaq
Elizabeth Raskin, MD
Consultant: Intuitive Surgical Inc.; Honorarium:
Intuitive Surgical Inc.; Speaker: Intuitive Surgical
Inc.; Teacher: Intuitive Surgical Inc.
Harry Reynolds, MD
Honorarium: Covidien; Teacher: Covidien
Holly Richter, MD
Consultant: Pelvalon
Timothy Ridolfi, MD
Research Grant: We Care Research Award for
Medical Innovation
David Rivadeneira, MD
Honorarium: Sanofi, TEI Bioscience, Pacira, Salix,
Genomic Health; Speaker: Sanofi, TEI Bioscience,
Pacira, Salix, Genomic Health; Teacher: Spring
Publishing; Research: Salix; Royalty: Up to Date,
Springer Publishing; Review Panel: Up to Date
Patricia Roberts, MD
Ownership interest (ie stocks): Merck
Michael Rosen, MD
Honorarium: Bard, W. L. Gore; Speaker: Bard;
Research: W. L. Gore
Howard Ross, MD
Consultant: Intuitive Surgical; Honorarium:
Intuitive Surgical
Theodore Saclarides, MD
Honorarium: Richard Wolf; Teacher: Richard Wolf
Jaime Sanchez, MD
Advisory Board: IrriMax; Consultant: Salix
Pharmaceuticals; Honorarium: Covidien, Applied
Medical, IrriMax, Salix Pharmaceuticals; Speaker:
Salix Pharmaceuticals; Teacher: Covidien,
Applied Medical, Salix Pharmaceuticals
Dana Sands, MD
Honorarium: Pacira; Teacher: Pacira
Kiran Turaga, MD
Consultant: Ethicon, CARIS
Steven Schechter, MD
Consultant: Speaker for Cubist Pharmacia and
Salix Pharmaceutical; Honorarium: Cubist
speaker, Salix; Research Grant: Ethicon, Inc
Kelly Tyler, MD
Consultant: Legal review - Brown Paradis and
Scott Hartford CT 2008-2014/Concluded
David Schoetz, Jr., MD
Salary: American Board of Colon and Rectal
Surgery (management position/Executive
Director), Elsevier (Editor-in-chief, Seminars in
Colon and Rectal Surgery); Honorarium: Elsevier
Steven Siegel, MD
Advisory Committee: Medtronic, QIG, Allergen,
Uroplast; Consultant: Medtronic, Allergen,
Honorarium: Medronic, Allergen; Speaker:
Medtronic, Allergen, Uroplast; Teacher:
Medtronic, Allergen; Research: Medtronic,
Allergen; Review Panel: Medtronic; Equity
Interest: QIG
Marc Singer, MD
Consulting: Olympus; Honorarium: Pacira;
Speaker: Parira
Bradford Sklow, MD
Research Grant: Was involved in multi-center
clinical trial funded by W.L. Gore
Michael Snyder, MD
Honorarium: Salix Pharmaceuticals, THD
America, Pacira Pharmaceuticals; Speaker: Salix
Pharmaceuticals, THD America, Pacira
Pharmaceuticals
Michael Stamos, MD
Consultant: Ethicon, Novadaq, Boston Scientific,
Olympus, Edwards Life Science, Neomend/Bard;
Honorarium: Ethicon, Novadaq, Boston
Scientific, Olympus, Neomend/Bard; Speaker:
Ethicon, Novadaq, Boston Scientific, Olympus,
Neomend/Bard; Teacher: Ethicon, Olympus;
Research: Novadaq; Royalty: Elsevier; Review
Panel: Elsevier; Author: Elsevier
Scott Steele, MD
Honorarium: Ethicon Endosurgery, Sanofi
Genzyme; Speaker: Ethicon Endosurgery, Sanofi
Genzyme; Teacher: Ethicon Endosurgery, Sanofi
Genzyme
H. David Vargas, MD
Consultant: Ethicon Endosurgery Inc, consultant,
speaker Applied Medical, consultant
Madhulika Varma, MD*
Consultant: Pelvalon
Sarah Vogler, MD
Honorarium: Medtronics; Teacher: Medtronics
Theodoros Voloyiannis, MD
Honorarium: Applied Medical Inc.; Teacher:
Applied Medical Inc.
Eric Weiss, MD
Consultant: Pacira, Baxter, Bovie, Olympus;
Speaker: Pacira
Steven Wexner, MD
Advisory Committee: Medtronic, CareFusion,
Edwards Lifesciences; Consultant: Medtronic,
Mederi Therapeutics, Karl Storz Endoscopy,
Medtronic, Novadaq, GIView, NovoGI;
Honorarium: Mediri Therapeutics, Incontinence
Devices, Johnson and Johnsonn Medical
Precision Therapeutics, Pacira, CareFusion,
Edwards Lifesciences; Teacher: Mederi
Therapeutics, Precision Therapeutics, Pacira,
Medtronic; Intellectual Property Rights: Karl
Storz Endoscopy, Covidien, NovoGI; Intellectual
Property License: Covidien, Karl Storz
Endoscopy; Royalty: Covidien, Karl Storz
Endoscopy; Ownership Interest (ie stocks):
NovoGI
Paul Wise, MD
Research Grant: Cancer Prevention
Pharmaceuticals; Research: Cancer Prevention
Pharmaceuticals
Massarat Zutshi, MD*
Consultant: AMS; Honorarium: Salix, AMS;
Speaker: Salix; Research Grant: Cook Medical,
AMS
Lisa Strate, MD
Consultant: GSK; Honorarium: American College
of Gastroenterology, Oak Ridge Associated
Universities; Speaker: American College of
Gastroenterology; Research: GSK; Royalty: Up To
Date; Author: Up To Date; Review Panel: Oak
Ridge Associated Universities
DISCLOSURES
Ian Paquette, MD
Advisory Committee: Medtronic; Consultant:
Medtronic; Honorarium: Medtronic; Teacher:
Medtronic
Julie Thacker, MD
Consultant: Premier, Edwards Lifesciences,
Cheetah Medical; Speaker: Cheetah Medical
Amy Thorsen, MD
Salary: Medtronic, Salix Pharmaceuticals,
Tsumura; Honorarium: Medtronic, Salix
Pharmaceuticals; Teacher: Medtronic; Research:
Salix Pharmaceuticals, Tsumura
*Will be discussing off-label products.
151
Disclosures
The following have no relevant financial relationships to disclose:
Cary Aarons, MD
A. Corliss, MD
Kerry Hammond, MD
Maher Abbas, MD
Meagan Costedio, MD
Mark Hanna, MD
Armen Aboulian, MD
Jonathan Cowley, MD
Karin Hardiman, MD
Jennifer Agnew, MD
Alejandro Cracco, MD
Melike Harfouche, MD
Karim Alavi, MD
Benjamin Crawshaw, MD
Alan Harzman, MD
Ahmed Al-Khamis, MD
Jay Crockett, MD
Imran Hassan, MD
Suraj Alva, MD
Chris Cunningham, MD
Lisa Haubert, MD
John Alverdy, MD
Michael D'Angelica, MD
Elizabeth He, MD
Wayne Ambroze, MD
Sekhar Dharmarajan, MD
Traci Hedrick, MD
Robin Anderson, RN
Andre D'Hoore, MD
Alexander Heriot, MD
Mark Arnold, MD
David Dietz, MD
Daniel Herzig, MD
Amir Aryaie, MD
Gary Dunn, MD
Afshin Heydari, MD
Susan Asuncion, RN
John Eggenberger, MD
Caitlin Hicks, MD
Glenn Ault, MD
Alex Elobu, MD
Rebecca Hoedema, MD
Jennifer Ayscue, MD
David Etzioni, MD
Torbjörn Holm, MD
Heidi Bahna, MD
Jeffrey Farma, MD
Stefan Holubar, MD
Matthew Bailey, MD
Daniel Feingold, MD
Jon Hourigan, MD
Badma Bashankaev, MD
Melissa Felinski, DO
Tracy Hull, MD
Nancy Baxter, MD
Alessandro Fichera, MD
Syed Husain, MD
Jennifer Beaty, MD
Robert Fine, MD
Grace Hwang, MD
Sandra Beck, MD
Emily Finlayson, MD
Neil Hyman, MD
Irina Bernescu, MD
Charles Finne, MD
James Iannuzzi, MD
Mitchell Bernstein, MD
Fergal Fleming, MD
Atif Iqbal, MD
J. Berry-Lawhorn, MD
James Fleshman, Jr., MD
Jennifer Irani, MD
Fabiana Bettoni, MD
Phillip Fleshner, MD
Mehraneh Jafari, MD
Richard Billingham, MD
Dave Flum, MD
Naomi Jay, MD
Elisa Birnbaum, MD
Joseph Frenkel, MD
David Jayne, MD
Sarah Boostrom, MD
Charles Friel, MD
Arjun Jeganathan, MD
Shayna Brathwaite, MD
Robert Fry, MD
Barry Jenkins, MD
Marc Brozovich, MD
Ashley Gabiou, RN
Christine Jensen, MD
Nicolas Buchs, MD
Aakash Gajjar, MD
Huw Jones, MD
W. Buie, MD
Julio Garcia-Aguilar, MD
Brian Kann, MD
Marcus Burnstein, MD
John Garry, MD
Kevork Kazanjian, MD
John Byrn, MD
Susan Gearhart, MD
Scott Kelley, MD
Teresa Carman, MD
Timothy Geiger, MD
Gregory Kennedy, MD, PhD
Peter Cataldo, MD
Amandeep Ghuman, MD
Hermann Kessler, MD
Thomas Cataldo, MD
Stanley Goldberg, MD
Donald Kim, MD
Gentry Caton, MD
Lori Gordon, MD
HyungJin Kim, MD
Varun Chakravorty, MD
I. Emre Gorgun, MD
Jin Kim, MD
Bradley Champagne, MD
Wilhelm Graf, MD
Sanghyun Kim, MD
Christin Choi, MD
John Griffin, MD
Cindy Kin, MD
Heidi Chua, MD
Jose Guillem, MD
Pokala Ravi Kiran, MD
Robert Cima, MD
Brian Gulack, MD
Natalie Kirilcuk, MD
Jeffrey L. Cohen, MD
Michael Guzman, MD
David Kleiman, MD
Jessica Cohan, MD
Eric Haas, MD
Kevin Kniery, MD
Dorin Colibaseanu, MD
Angelita Habr-Gama, MD
Ira Kodner, MD
Kyle Cologne, MD
Glenn Hall, MD
Sarah Koller, MD
Molly Cone, MD
Jason Hall, MD
Toru Kono, MD
Tara Connelly, MD
Amy Halverson, MD
Mukta Krane, MD
*Will be discussing off-label products.
152
Anjali Kumar, MD
Paul O’Mahoney, MD
Josef Shehebar, MD
Alex Ky, MD
Frank Opelka, MD
Paul Shellito, MD
Antonio Lacy, MD
Guy Orangio, MD
Yury Shelygin, MD
David Larson, MD
Bruce Orkin, MD
Marc Sher, MD
Sang Lee, MD
Gokham Ozuner, MD
Matthew Sherman, MD
Ira Leeds, MD
Sushil Pandey, MD
David Shibata, MD
Daniel Leonard, MD
Harry Papaconstantinou, MD
Kinga Skowron, MD
L. Li, MD
Jitesh Patel, MD
Ricardo Sordo-Mejia, MD
Charles Littlejohn, MD
Sunil Patel, MD
Randolph Steinhagen, MD
Wendy Liu, MD
John Pemberton, MD
Andrew Stevenson, MD
Ann Lowry, MD
Rodrigo Perez, MD
David Stewart, Sr., MD
Kirk Ludwig, MD
W. Brian Perry, MD
Luca Stocchi, MD
Allan Mabardy, MD
Francisco Pinheiro Regadas, MD
Scott Strong, MD
Helen MacRae, MD
Madeleine Poirier, MD
Gokulakkrishna Subhas, MD
Mari Madsen, MD
Blase Polite, MD
Patrick Sullivan, MD
Krishnaraj Mahendraraj, MD
Hiram Polk, Jr., MD
Li Sun, MD*
Tony Mak, MD
Darren Pollock, MD
Zhifel Sun, MD
Nell Maloney Patel, MD
Vitaliy Poylin, MD
Patricia Sylla, MD
Mark Manwaring, MD
Jevon Puckett, MD
Eric Szilagy, MD
Slawomir Marecik, MD
Jan Rakinic, MD
Sanda Tan, MD
David Margolin, MD
Sonia Ramamoorthy, MD
Larissa Temple, MD
David Maron, MD
Jose Ramirez, MD
Charles Ternent, MD
Marianne Masse, MD
Tal Raphaeli, MD
Robert Thiele, MD
Ronnie Mathew, MD
Jennifer Rea, MD
Alan Thorson, MD
Justin Maykel, MD
Thomas Read, MD
Melissa Times, MD
Ryan McColl, MD
Craig Reickert, MD
Ester Trinos, NP
Allison McCoy, MD
Feza Remzi, MD
Judith Trudel, MD
Michael McGee, MD
Craig Rezac, MD
Konstantin Umanskiy, MD
Robin McLeod, MD
Rocco Ricciardi, MD
Brian Valerian, MD
Michael McNevin, MD
Bruce Robb, MD
Alessio Vinci, MD
Bryant Megna, MD
Mary Roen, RN
Jon Vogel, MD
George Melich, MD
Lester Rosen, MD
Mercy Wagner, MD
Craig Messick, MD
Andrew Russ, MD
Avery Walker, MD
Peter Miller, MD
Andrew Russell, MD
Zhenjun Wang, MD
Jeffrey Mino, MD
Rudolph Rustin, MD
Martin Weiser, MD
Nitin Mishra, MD
Timothy Sadiq, MD
Mark Welton, MD
Jason Mizell, MD
Bashar Safar, MD
Richard Whelan, MD
Husein Moloo, MD
Peter Sagar, MD
Mark Whiteford, MD
John Monson, MD
Chitra Sambasivan, MD
Charles Whitlow, MD
Arden Morris, MD
Cesar Santiago, MD
Elizabeth Wick, MD
Melanie Morris, MD
Guilio Santoro, MD
Kirsten Wilkins, MD
David Mukkar Krishnamurty, MD
Tereza Sardinha, MD
Lawrence Yee, MD
Sthela Murad-Regadas, MD
David Schneider, MD
James Yoo, MD
Jamie Murphy, MD
Caleb Schroeder, MD
Y. Nancy You, MD
Matthew Mutch, MD
Lawrence Schwartz, MD
D. Mark Zebley, MD
Caio Nahas, MD
Anthony Senagore, MD
R. Scott Nelson, MD
Stephen Sentovich, MD
Juan Nogueras, MD
Xavier Serra-Aracil, MD
Johan Nordenstam, MD
Virginia Shaffer, MD
David O'Brien, MD
Nishit Shah, MD
P. Ronan O'Connell, MD
Skandan Shanmugan, MD
*Will be discussing off-label products.
153
DISCLOSURES
Disclosures
Program Participants
Aarons, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .106
Abbas, M. . . . . . . . . . . . . . . . . . . . . . . . .49, 65, 70, 103
Aboulian, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55
Agnew, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .85
Alavi, K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .52
Al-Khamis, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .70
Alverdy, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .57
Alvey, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .78
Ambroze, W. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .69
Anderson, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .105
Arnold, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .61
Aryaie, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .97
Ault, G. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .50
Ayscue, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62
Bahna, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .102
Bailey, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .72
Bailey, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .70
Bashankaev, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103
Bastawrous, A. . . . . . . . . . . . . . . . . . . . . . . . .39, 41, 66
Baxter, N. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .54
Beaty, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .93
Beck, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .78, 105
Beck, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .78
Berho, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43
Bernescu, I. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103
Bernstein, M. . . . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45
Berry-Lawhorn, J. . . . . . . . . . . . . . . . . . . . .36, 37, 38
Bettoni, F. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .90
Billingham, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . .72, 95
Bleier, J. . . . . . . . . . . . . . . . . . . . .18, 34, 35, 43, 44, 45
Bordeianou, L. . . . . . . . .34, 43, 44, 45, 51, 58, 102
Brathwaite, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100
Brozovich, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .88
Buchs, N. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62
Buie, W. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .51, 65
Burnstein, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .50
Byrn, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .46
Cannon, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .46
Carman, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .57
Carmichael, J. . . . . . . . . . . . . .40, 41, 78, 83, 89, 102
Cataldo, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34, 35
Cataldo, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .79
Chakravorty, V. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .70
Champange, B. . . . . . . . . . . . . . . . . . . . . . . . . . . .69, 94
Chang, G. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .47, 82
Choi, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84
Church, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .59
Cima, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .54
Cleary, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .47, 66
Cohan, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84, 88
Cohen, J. L. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53
Cohen, J. S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .47
Cologne, K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .92
Cone, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .59
Connelly, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89
Corliss, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .83
Costedio, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55
Cowley, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73
Cracco, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73
Crawshaw, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .85
Cunningham, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .56
D'Angelica, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .99
Davis, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .51
Delaney, C. . . . . . . . . . . . . . . . . . . .51, 61, 92, 95, 105
Dharmarajan, S. . . . . . . . . . . . . . . . . . . . . . . . . . .80, 97
D'Hoore, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43
Dietz, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .80
Eggenberger, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .57
Elobu, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .76
Eng, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .99
Etzioni, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55, 78
Feingold, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48
Felinski, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84
Fichera, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .96, 99
Fine, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .75
Finne, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .35
Finlayson, E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89
Fleming, F. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .82, 89
Fleshman, Jr., J. . . . . . . . . . . . . . . . . . . . . . .64, 69, 78
Fleshner, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .78, 94
Flum, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .106
Francone, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .52, 94
Friel, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .61
Garcia-Aguilar, J. . . . . . . . . . . . . . . . . . .66, 82, 95, 99
Garrett, K. . . . . . . . . . . . . . . . . . . . .43, 44, 45, 55, 78
Gearhart, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .61
Geiger, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .80, 106
Ghuman, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103
Goldberg, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65
Goldstone, S. . . . . . . . . . . . . . . . . . . . . . . . . .36, 37, 38
Gorgun, I. . . . . . . . . . . . . . . . . . . . . . . . . . . . .47, 48, 77
Graf, W. . . . . . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45, 89
Griffin, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .40, 41
Guillem, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .67
Gulack, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62
Gurland, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65
Guzman, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .97
Haas, E. . . . . . . . . . . . . . . . . . . . . . . . . . .34, 35, 77, 105
Habr-Gama, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62
Hall, G. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .98, 103
Hall, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . .56, 60, 89, 93
Halverson, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73, 78
Hampel, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .59
Hanna, M. . . . . . . . . . . . . . . . . . . . . . . . . . . .70, 85, 100
Hardiman, K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55
Harfouche, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100
Harzman, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .39, 41
Hassan, I. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .39, 41, 88
Haubert, L. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84
He, E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84
Hedrick, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . .34, 35, 70
Heriot, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .82
154
Herzig, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .40, 41
Heydari, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73
Hicks, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60, 68, 75
Hicks, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73
Hoedema, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .52
Holm, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .67
Holubar, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .54
Hopkins, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .93
Hourigan, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .78
Hull, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .50, 58
Husain, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .79
Hwang, G. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .70, 84
Hyman, N. . . . . . . . . . . . . . . . . . . . . . . . . . . . .83, 88, 94
Iannuzzi, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .97
Jafari, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100
Jay, N. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .36, 37, 38
Jayne, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .66
Jeganathan, A. . . . . . . . . . . . . . . . . . . . . . . . . . . .89, 98
Johnson, E. . . . . . . . . . . . . . . . . . . . .39, 40, 41, 77, 95
Jones, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62
Kaiser, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43
Kalady, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .59, 65
Kann, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .79
Kantsevoy, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48
Kennedy, G. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .52
Kelley, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .66
Kessler, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55, 96
Kim, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .93
Kim, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .88
Kim, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .66
Kim, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55
Kin, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .52
Kirilcuk, N. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .87
Kleiman, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103
Kniery, K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100
Kodner, I. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .75
Koller, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .85
Kono, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .88
Krane, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89, 100
Kumar, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .51
Ky, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .58
Lacy, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .63, 67
Lagares-Garcia, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . .47
Langenfeld, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . .51, 93
Larach, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34, 35, 67
Larson, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .47
Lee, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .51
Leeds, I. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84
Lehur, P. . . . . . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45, 71
Leonard, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .63
Li, L.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89
Liu, W. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .70
Lowry, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .72, 81, 95
Luchtefeld, M. . . . . . . . . . . . . . . . . . . . . . . . .68, 78, 92
Ludwig, K. . . . . . . . . . . . . . . . . . . . . . . . .57, 61, 78, 99
Mabardy, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .88
MacRae, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .64
Madoff, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65, 67
Mahendraraj, K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84
Mahmoud, N. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .50
Maloney Patel, N. . . . . . . . . . . . . . . . . . . . . . . . . .39, 41
Mak, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .88
Manwaring, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .57
Marcello, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48, 96
Marcet, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .35
Marecik, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . .40, 41, 67
Margolin, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60
Marks, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .49
Marks, J. H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .47
Maron, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53, 56
Martz, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .46
Masse, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84
Mathew, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103
Matzel, K. . . . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45, 58
Maykel, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .52, 80
McColl, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62
McCormick, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .93
McCoy, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .54
McGee, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .57
McLemore, E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34, 35
McLeod, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .61
McNevin, S. . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45, 50
Megna, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89
Melani, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55
Melich, G. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100
Mellgren, A. . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45, 58
Melton-Meaux, G. . . . . . . . . . . . . . . . . . . . . . . . . . . . .54
Merlino, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53, 57
Messaris, E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89
Messick, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .59
Migaly, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .87
Miller, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .97
Milsom, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .49
Mino, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100
Mizell, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73, 74
Monson, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .82
Morris, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .54
Morris, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62
Mukkai Krishnamurty, D. . . . . . . . . . . . . . . . . . . . . .97
Muldoon, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60
Murad-Regadas, S. . . . . . . . . . . . . . . . .43, 44, 45, 73
Murphy, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55
Murphy, M. . . . . . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45
Mutch, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55, 80
Nagle, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .47, 54
Nahas, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62
Nandakumar, G. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
Nelson, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .57
Nogueras, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65
Nordenstam, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43
Obias, V. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .46, 77, 79
O’Brien, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53
O'Connell, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .18, 79
O'Mahoney, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100
Opelka, F. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53, 92
Orangio, G. . . . . . . . . . . . . . . . . . . . . . . . . . . .53, 65, 92
Orkin, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .35
Palefsky, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .37, 38
Paquette, I. . . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45, 58
Parra-Davila, E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .47
Patel, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103
Pemberton, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .61
Perez, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34, 90, 95
Perry, W. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53, 95
Peters, Jr., W. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .95
Pigazzi, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .56, 67
Polite, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .96
Polk, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .75
Pollock, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .40, 41
Poylin, V. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .79
Prosst, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .77
Puckett, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .70
Rafferty, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .87
Ramamoorthy, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . .77
Ramirez, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103
Raphaeli, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .40, 41
Raskin, E. . . . . . . . . . . . . . . . . . . . . . . . . .34, 35, 46, 79
Rea, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .70
Read, T. . . . . . . . . . . . . . . . . . . . . . . . . . . .65, 67, 76, 86
Reickert, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .95
Remzi, F. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .88
Reynolds, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .57
Rezac, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .66
Ricciardi, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65, 87
Rivadeneira, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48
Robb, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .87
Roberts, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .86, 106
Rosen, L. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .72
Rosen, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .83
Ross, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .66
Russ, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .69
Rustin, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .57
Saclarides, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34, 35
Sadiq, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .59
Sagar, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .82
Sanchez, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34, 35
Sands, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .34, 35, 102
Santiago, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .46
Santoro, G. . . . . . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45
Schneider, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103
Schoetz, Jr., D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .86, 94
Schroeder, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .97
Schwartz, L. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .96
Senogore, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .68
Sentovich, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53, 65
Shaffer, V. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .102
Shah, N. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .79
Shanmugan, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34
155
Shellito, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60
Shelygin, Y. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .99
Shibata, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .96
Siegel, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45
Singer, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . .39, 41, 80
Skowron, K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .88
Snyder, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .93
Sordo-Mejia, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84
Stamos, M. . . . . . . . . . . . . . . . . .61, 65, 68, 69, 72, 92
Steele, S. . . . . . . . . . . . . . . . . . . . . . .34, 35, 51, 56, 64
Steinhagen, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .78
Stevenson, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .67
Stewart, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .80, 89
Strate, L. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .81
Strong, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .95, 106
Subhas, G. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89
Sun, L. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89
Sun, Z. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62
Sylla, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34, 35, 67
Szilagy, E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .95, 97
Temple, L. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .54, 87
Ternent, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65
Thacker, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .54, 105
Thiele, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .105
Thorsen, A. . . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45, 52
Times, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89
Turaga, K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .99
Tyler, K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60
Umanskiy, K. . . . . . . . . . . . . . . . . . . . . .40, 45, 89, 100
Valerian, B. . . . . . . . . . . . . . . . . . . . . . . .34, 35, 84, 100
Vargas, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60
Varma, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73
Vinci, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84
Vogel, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55
Vogler, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45
Voloyiannis, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . .34, 35
Wagner, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84
Walker, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84
Wang, Z. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .74
Weiser, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .96
Weiss, E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103
Welton, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .87, 88
Wexner, S. . . . . . . . . . . . . . . . . .44, 45, 60, 61, 63, 72
Whelan, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48, 64
Whiteford, M. . . . . . . . . . . . . . . . . . . . . . . . . .34, 35, 55
Whitlow, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .64, 93
Wick, E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .54, 105
Wilhelm, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .77
Wise, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .59
Yoo, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .106
You, Y. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55, 82
Zutshi, M. . . . . . . . . . . . . . . . . .43, 44, 45, 58, 73, 102
P R O G R A M P A R T I C I PA N T S
Program Participants
Product Theaters
These are commercial presentations conducted by exhibiting companies in a specially constructed theater on
the exhibit floor. This year the Product Theater will be Exhibit Halls C & D where the following sessions will be
presented each day during the lunch breaks. Product Theaters are non-CME forums organized by industry and
designed to enhance your learning experience.
Monday, June 1
12:35 – 1:30 pm
Supported by Intuitive Surgical, Inc.
Lunch and Learn: Three Cases That Could Have Kept Me Up at Night
Presented by:
Benyamine Mizrahi, MD
Craig Rezac, MD
How did I deal with low set rectal tumors, acute inflammatory bowel disease & difficult patient
presentations? Presenters will show three videos of their cases that required skill and the help of new
technology in order to achieve the desired outcome.
Also, visit Intuitive Surgical, Inc. at Booth #401
-
Tuesday, June 2
12:20 – 1:30 pm
Supported by ConvaTec, Inc.
Risk Mitigation of Infection Following Colorectal Surgery
Presented by:
Mark A. Singer, MD
Joseph R. Cali, MD
Bidhan Das, MD
The presentation will cover advances in surgical techniques and post-operative wound protocols to
reduce the risk of infections following colorectal surgery.
Also, visit ConvaTec, Inc. at Booth #142
156
NOT FOR
CREDIT
Exhibits
The American Society of Colon & Rectal Surgeons (ASCRS) established as
part of its Annual Scientific Meeting, an Exhibit Hall to facilitate the
sharing and dissemination of information regarding industry products and
services. The exhibition is made available for information purposes. The
participation of any exhibitor in the Exhibit Hall does not constitute an
endorsement or representation of any kind regarding the qualifications,
quality, expertise, capabilities, skill, message, value or competence of the
exhibitor or of the exhibitor’s products or services. All information
contained in the exhibits is provided by the individual exhibitors and has
not been independently reviewed or verified by the Society. The ASCRS
does not endorse exhibit hall products or services.
By attending the ASCRS Annual Scientific Meeting, you acknowledge and
accept that ASCRS has assumed no duty to review, investigate or
otherwise approve and has not reviewed, investigated or otherwise
approved the qualifications, quality, expertise, capabilities, skill, message,
nature, value or competence of the exhibitor or of any product or service
marketed by attendees and exhibitors. ASCRS specifically disclaims any
liability for any damage to person or property arising out of your
attendance at the Exhibit Hall and/or arising out of any exhibitor product
or service. You further waive any and all claims, demands, actions or
causes of action of any kind you may have directly or indirectly against
ASCRS of any of its directors, officers, employees, agents and other
representatives resulting from, arising out of, or in any way related to your
attendance at the Exhibit Hall and/or your use or reliance on any exhibitor
product or service.
ASCRS Product/Service Endorsement Policy
It is the policy of the American Society of Colon & Rectal Surgeons not to
endorse commercial products or services.
157
EXHIBITS
Exhibition Hall and Exhibitor Disclaimer
Exhibits
Exhibits are located in Exhibit Halls C&D (2nd Floor) and will be open the following hours:
Sunday:
3:00 – 5:00 pm
Monday:
9:00 am – 4:30 pm
Tuesday:
9:00 am – 2:00 pm
11Health & Technologies, LLC
Booth 136
Kinetic Business Centre
Borehamwood, Herts WD6 4PJ
UK
Phone: 44 7866 621 956
Website: www.11health.com
Contact Email: [email protected]
11health was founded by Michael Seres after becoming the
11th patient in the UK to undergo an intestinal transplant
in Oxford. The company has developed the first ever sensor
device for Ostomy care known as The Ostom-i Alert sensor.
This is a discrete innovative device that alerts patients as to
how full their ostomy/stoma bags are so that they can
decide if and when to empty them.
The device clips on to any ostomy pouch sending
Bluetooth alerts to an app on your mobile device telling
you that your pouch is filling up. You can set individual
alerts as to when you wish to be notified. The device also
captures guidance information about volume of output
over a time period and allows you to email that
information. In addition this data is stored safely on our
website allowing you to access it at any given time.
ACell, Inc.
Booth 126
6640 Eli Whitney Dr
Columbia, MD 21046
Phone: (800) 826-2926
Fax: (410) 715-4511
Website: www.acell.com
Contact Name: Customer Service
Contact Email: [email protected]
ACell’s patented ECM devices address important clinical
needs, while providing safe, effective, economical and
therapeutic outcomes to the wound care and surgical
communities. These devices, trademarked as MatriStem®,
are comprised of naturally-occurring porcine urinary
bladder matrix (UBM). The products are non-cross linked,
completely resorbable, acellular, and feature naturallyoccurring collagens and an epithelial basement membrane
surface that is not available in synthetic materials.
MatriStem completely incorporates into the surrounding
tissue during the healing process and leaves new tissue
where scar tissue formation is normally expected. The result
is constructively remodeled, site-specific tissue for a variety
of medical procedures.
Agency for Medical Innovations (AMI)
Booth 134
25 Washington Ave
Natick, MA 01760
Phone: (508) 655-1200
Fax: (508) 655-0012
Website: www.amisurgical.com
Contact Name: Andrew Bendheim
Contact Email: [email protected]
AMI (Agency for Medical Innovations) is an Austrian based
device manufacturer developing innovative products and
treatment methods in numerous areas including
coloproctology. AMI’s HAL/RAR and Trilogy devices are
leading technologies for Doppler guided treatment of
hemorrhoid disease. They offer safe minimally invasive
treatment to patients who want less pain and faster
recovery. AMI’s comfort drain is a knotless seton for anal
fistulas, which helps patients avoid the irritation of a knot.
Ambry Genetics
Booth 522
15 Argonaut
Aliso Viejo, CA 92656
Phone: (949) 900-5500
Fax: (949) 900-5501
Website: www.ambrygen.com
Contact Email: [email protected]
American College of Surgeons
Booth 531
633 N St Clair St
Chicago, IL 60611
Phone: (312) 202-5263
Fax: (312) 202-5029
Website: www.surgicalpatienteducation.org
The ACS Ostomy Home Skills Kit supports patients with
education and simulation materials to learn and practice
the skills needed for optimal postoperative recovery. The kit
supports the entire surgical team with quality,
comprehensive education. The standardized interactive
program has been developed by the American College of
Surgeons (ACS) in collaboration with the American Society
of Colon and Rectal Surgeons (ASCRS), American Urological
Association (AUA), Certified Enterostomal Therapy Nurses
(CETN), Wound, Ostomy and Continence Nurses Society
(WOCN), and the United Ostomy Associations of America
(UOAA).
158
Exhibits
PLATINUM PARTNER
Booth 206
1 Spring Knoll Court
Lutherville, MD 21093
Phone: (410) 302-2021
Fax: (410) 293-1739
Contact Name: Francesca Grasso
Contact Email: [email protected]
Applied Medical
Booth 411
22872 AvenidaEmpresa
Rancho Santa Margarita, CA 92688
Phone: 949-713-8687
Website: www.appliedmedical.com
Contact Name: Lauren Mariorenzi
Contact Email: [email protected]
American Distributors of Colon and Rectal Supplies ADCRS, LLC offers a whole line of high quality disposable
devices for hospital and office based proctology procedures
as hemorrhoids elastic banding ligation, anoscopy,
proctoscopy, infrared coagulation, trans-anal excision of
rectal polyps, fistulotomy and more.
ADCRS LLC is the only authorized importer and distributor
of SAPI MED products for the USA. The SAPI MED line
includes Self Light anoscopes, proctoscopes, anal and rectal
retractors, disposable hemorrhoidal banding ligators and
the innovative patients accessible cryo-thermic anal and
stomaldilators.
Applied Medical is committed to advancing minimally
invasive colorectal surgery by offering sophisticated
training, clinical solutions and breakthrough
technologies, including the GelPOINT® Path transanal
access platform, Alexis® wound protector/retractors and
Voyant® Intelligent Energy System. Applied’s minimally
invasive procedural workshops, clinical symposia, and
Simsei® laparoscopic trainer enable surgeons to enhance
their skills and their patient outcomes.
To register for a workshop, visit
www.appliedmedical.com.
SILVER PARTNER
Bard Davol
American Medical Systems, Inc.
Booth 130
10700 Bren Rd W
Minnetonka, MN 55343
Phone: (952) 930-6463
Website: www.americanmedicalsystems.com
Contact Name: Lisa Dahlstrom
Contact Email: [email protected]
American Medical Systems (AMS), headquartered in
Minnetonka, Minn., is a diversified supplier of medical
devices and procedures to treat benign prostatic
hyperplasia (BPH), urinary incontinence, fecal
incontinence, sexual dysfunction, and other pelvic
disorders in men and women. AMS continues to develop
new therapies to restore bodily functions enabling
people to regain control of their lives. These therapies
provide new options for patients, providers and payers,
and are often inspired by the urologists, gynecologists
and urogynecologists who choose AMS as their solutions
partner.
Booth 208
100 Crossing Blvd
Warwick, RI 02886
Phone: (800) 556-6756
Website: www.davol.com
Contact Email: [email protected]
Bard Davol offers a variety of innovative soft tissue
reconstruction products including aresorbable synthetic
mesh and the first antimicrobial-coated biologic graft for
hernia repair.
For more information, visit www.davol.com.
Bellevue Pharmacy
Booth 132
212 Millwell Drive
Maryland Heights, MO 63043
Phone: (800) 728-0288
Fax: (800) 458-9182
Website: www.bellevuerx.com
Bellevue Pharmacy is the leader in individualized medicine.
We are a state-of-the-art pharmacy headquartered in St.
Louis, Missouri. Our team of experienced pharmacists offers
more than 200 years of combined experience in
compounded medication to bring our physicians and their
patients the highest level of service, quality, and care.
159
EXHIBITS
American Distributors of
Colon & Rectal Supplies, LLC
Exhibits
biolitec biomedical technology, GmbH
Booth 135
BRONZE PARTNER
Otto-Schott Str 15
Jena, 07445
Germany
Phone: 49 228 9796 768
BK Ultrasound
As a global pioneer in laser technique, biolitec introduced
the first medical 1470 nm diode laser in 2006 to improve
the outcome of soft tissue laser use. Since then biolitec has
developed different minimally invasive treatment
modalities in proctology like for hemorrhoids (HeLP and
LHP) and Fistulas (FiLaC). FiLaC ensures highest patient
comfort and sphincter protection during anal fistulas
therapy. Using the 360° ring light energy distribution to
homogeneously illuminate the fistulas tract and the
intersphinkteric space it traces back the origin of the
disease.
Birchwood Laboratories, Inc.
BK Ultrasound systems are the leading choice for
colorectal procedures. Offering premium performance in
a small, lightweight system, our Flex Focus system is
designed to help you clearly visualize the anal canal and
rectum on a high resolution 19” monitor. Our easy-to-use
anorectal transducer provides complete 360 degrees
imaging and encapsulated automatic 3D, enabling you to
image all layers of the rectal wall, see the extent of fistula
tracts, visualize rectal tumors and assess anal sphincter
tears. Our dedicated solution helps you plan preoperative
treatment and postoperative detection with increased
diagnostic confidence.
Booth 222
7900 Fuller Road
Eden Prairie, MN 55344
Phone: (952) 937-7900
Fax: (952) 937-7979
Website: www.birchlabs.com
Birchwood Laboratories LLC is a privately held medical
manufacturer committed to providing healthcare
professionals and their patients quality products for wound
care and prevention, incontinence and associated skin
conditions,personal care and the exam room. FDA
registered for the manufacture of both drugs and medical
devices, Birchwood lines include AER Witch Hazel, B-Sure
Incontinence Care, Scopettes Large-Tip Applicators and
LiquiCell wound care products. Founded in 1948 as Fuller
Pharmaceutical Company, Birchwood has a long-standing
tradition of providing quality products and service to the
Acute Care, Long-Term Care and Retail markets.
Today Birchwood Laboratories LLC manages both the
production and distribution of its products from the
company headquarters in Eden Prairie, MN.
Booth 209
8 Centennial Drive
Peabody, MA 01960
Phone: (978) 326-1300
Fax: (978) 326-1399
Website: www.bkultrasound.com
Contact Email: [email protected]
Braintree Laboratories, Inc.
Booth 425
PO Box 850929
Braintree, MA 02184
Phone: (781) 348-0732
Fax: (781) 843-7932
Website: www.braintreelabs.com
Braintree Laboratories is a privately held phannaceutical
company founded in 1982 in Braintree, Massachusetts.
Braintree Labs currently has four bowel preparations
available in the US market.
The product line is diverse and consists of the following
products:
GoLYTELY®, NuL YTELY®, SUPREp® Bowel Prep Kit and
Suclear®. Braintree Laboratories is a fully integrated
specialty phannaceutical company maintaining its own
manufacturing, warehousing operations facilities, sales and
marketing divisions and a pioneering research and
development team. Visit us at www.braintreelabs.com.
160
Exhibits
Booth 202
6655 N MacArthur Blvd, 3rd Floor
Irving, TX 75039
Phone: (612) 695-6080
Website: www.carislifesciences.com
Contact Name: Cindy Fleshman
Contact Email: [email protected]
Caris Life Sciences® is a leading biosciences company
focused on fulfilling the promise of precision medicine
through quality and innovation. Caris Molecular
Intelligence®, provides oncologists with the most
potentially clinically actionable treatment options available
to personalize cancer care today. Using a variety of
advanced profiling technologies to assess relevant
biological changes in each patient’s tumor, CarisMolecular
Intelligence connects biomarker data generated from a
tumor with biomarker-drug associations supported by
evidence in the relevant clinical literature.
CONMED
Booth 431
525 French Rd
Utica, NY 13502
Phone: (315) 624-3170
Fax: (315) 797-4528
Website: www.conmed.com
Contact Name: Alan Fink
Contact Email: [email protected]
The Hyfrecator® is the most compact of Conmed’s
Advanced Energy generators. Since its introduction in 1937,
the Hyfrecator® has become a world leader in office-based
electrosurgery. The Hyfrecator® 2000 is used by physicians
to achieve two main outcomes: the destruction of all types
of cutaneous lesions and to precisely control bleeding.
BRONZE PARTNER
ConvaTec
Cine-Med, Inc
Booth 216
127 Main St N
Woodbury, CT 06798
Phone: (203) 263-0006
Fax: (203) 263-4839
Website: www.cine-med.com
Cleveland Clinic Departments of
Colorectal Surgery
Booth 538
9500 Euclid Ave
Cleveland, OH 44195
Phone: (216) 445-3832
Fax: (216) 445-1079
Website: www.ccf.org
Contact Name: Kathrina Allen
Contact Email: [email protected]
Colon Cancer Alliance
Booth 204
1025 Vermont Ave NW, Ste 1066
Washington, DC 20005
Phone: (202) 628-0123 x132
Website: www.ccalliance.org
Contact Name: Ervin Pinckney
Contact Email: [email protected]
Coloplast
Booth 312
1601 W River Rd
Minneapolis, MN 55411-3431
Phone: (800) 788-0293
Website: www.coloplast.us
Contact Name: Hailey Wachlarowicz
Contact Email: [email protected]
Coloplast develops products and services that make life
easier for people with very personal and private medical
conditions. Working closely with the people who use our
products, we create solutions that are sensitive to their
special needs. We call this intimate healthcare. Our business
includes ostomy care, urology and continence care, and
wound and skin care.
Booth 142
1160 Route 22
Bridgewater, NJ 08807
Phone: (800) 422-8811
Website: www.convatec.com
Contact Name: Patrick Gillespie
Contact Email: [email protected]
Cook Medical
Booth 527
PO Box 489
Bloomington, IN 47402
Phone: (800) 468-1379/(812) 339-2235
Fax: (812) 339-3704
Website: www.cookmedical.com
Together with surgeons, Cook Medical leads workshops on
advanced procedures and develops next-generation
devices.
In 1963, Cook Medical’s founder, Bill Cook, worked with a
surgeon to launch the field of minimally invasive medicine.
Now we continue his vision worldwide, through
educational programs like Cook Vista and through
technology like Biodesign and Zenapro.
Our goal is to deliver devices that give the best outcomes
to surgeons, hospitals, and —most importantly—patients.
Learn more about us at www.cookmedical.com.
CooperSurgical, Inc.
Booth 523
75 Corporate Dr
Trumbull, CT 06611
Phone: (203) 601-5200
Fax: (203) 601-4741
Website: www.coopersurgical.com
Contact Email: [email protected]
CooperSurgical will be featuring our highly recognized and
clinically successful products including the Lone Star SelfRetaining Retractor System and our Carter-Thomason Port
Site Closure System for use in both open and laparoscopic
colon and rectal procedures. Visit us at booth #523
161
EXHIBITS
Caris Life Sciences
Exhibits
Curaseal, Inc.
GOLD PARTNER
Covidien
Booth 301
5920 Longbow Drive
Boulder, CO 80303
Phone: (303) 581-6997
Fax: (303) 581-6898
Website: www.covidien.com/surgical/
Covidien is a leading global healthcare products
company that creates innovative medical solutions for
better patient outcomes and delivers value through
clinical leadership and excellence. Please visit www.
covidien.com/surgical/
CRC Press/Taylor & Francis Group
Booth 104
6000 Broken Sound Parkway NW Ste 300
Boca Raton, FL 33487
Phone: (561) 998-2507
Fax: (561) 998-2559
Website: www.crcpress.com
Contact Name: Charmaine Lowe
Contact Email: [email protected]
CRC Press – Taylor & Francis Group is a global publisher of
world-class references, handbooks, journals, and textbooks
for the medical, scientific and technical communities
including academics, professionals, and students. Our
award-winning CRCnetBASE has our eBook collections. For
a complete catalog of our colorectal publications including
bestselling and forthcoming titles, or to sign up for our
email list to receive exclusive offers, visit www.crcpress.com
today or contact us at 1-800-634-7064, or +44 (0) 1235400
524.
CS Surgical, Inc.
Booth 314
662 Whitney Dr
Slidell, LA 70461
Phone: (985) 781-8292
Fax: (985) 781-8244
Website: www.cssurgical.com
Contact Name: Craig Simpson
Contact Email: [email protected]
CS Surgical is your leading supplier of surgical instruments
for the Colon & Rectal surgeon. Our exhibit will feature the
new FERGUSON PLASTIC RETRACTORS, the industry’s
widest variety of deep pelvic retractors, the newest Cima–
St. Mark’s retractor for Hand Assisted Laparoscopic Deep
Pelvic Surgery, our table mounted retractor system,
hemorrhoidalligators, latex and non-latex bands for the
ligator, suction ligators, anoscopes, rectal retractors,
intestinal clamps, scissors, needle holders, probes and
directors, and Welch Allyn products.
Booth 537
2231 Calle de Luna
Santa Clara, CA 95054
Phone: (408) 565-8787
Fax: (408) 986-8643
Website: www.curaseal.com
Contact Email: [email protected]
Based in Santa Clara, CA Curaseal, Inc. is improving patient
quality of life through combining tissue engineering and
minimally invasive techniques to deliver next generation
benchmark devices, creating better surgical outcomes.
Introducing a CE cleared implantable device for treatment
of anorectal fistulas, the Curaseal AF™, Curaseal’s next
generation benchmark fistula repair technology, combining
internal ostium sealing, tissue engineering and device
fixation in minimally invasive techniques.
Featuring an Engineered Seal, simple procedure (mucosal
flap/internal stitching or stapling not required), treatment
of high and low fistulas, Curaseal AF delivery catheter,
Curaseal AF collagen matrices and integrated secure
anchoring.
www.curaseal.com
Deltex Medical
Booth 722
330 E. Coffee Street
Greenville, SC 29601
Phone: (884) 527-5913
Fax: (864) 527-5914
Website: www.deltexmedical.com
Contact Name: Melissa Till
Contact Email: [email protected]
Deltex Medical’s EDM+ is a fluid management and cardiac
output monitoring system which measures both flow and
pressure directly. EDM+ helps anesthetists guide
individualized fluid management during Surgery. It is
highly responsive in tracking changes in Stroke Volume and
Cardiac Output during intervention and is widely used in
Enhanced Recovery Programs (ERP).
The benefits of ERP show improved outcomes and shorter
hospital stays in surgical specialties, including: Colorectal,
endocrine, gynaecological, urological, vascular and
orthopaedic surgeries.
It is rewarding working with leading institutions across the
country to adopt individualized fluid management as the
initial or part of a bigger enhanced recovery program.
162
Exhibits
Entera Health, Inc.
Edwards Lifesciences
Booth 712
1 Edwards Way
Irvine, CA 92614
Phone: (949) 250-2500
Website: www.edwards.com/esr
Contact Name: Carol Fields
Contact Email: [email protected]
ERBE USA, Inc.
Enhanced Surgical Recovery Resource Center – an initiative
by Edwards Lifesciences. You can reduce post-surgical
complications such as AKI, anastomotic leaks, and
pneumonia in your moderate to high-risk patients. Take
action now to reduce variability and standardize care with
hemodynamic optimization through PGDT. Evaluate the
clinical evidence of how you can reduce LOS, complications
and associated costs, and inform patient transitions from
OR to ICU. Start here or visit Edwards.com/ESR.
Electro Surgical Instrument Company
Booth 622
Booth 223
2225 Northwest Parkway
Marietta, GA 30067
Phone: (770) 955-4400
Fax: (770) 955-2577
Website: www.erbe-usa.com
Contact Name: Howard Justan
Contact Email: [email protected]
ERBE USA offers the next generation ESU with Power
Dosing Technology and APC™ workstation, VIO®/APC™ 2,
with multiple possibilities for open, laparoscopic and
endoscopic procedures featuring ENDO CUT® and
proprietary PRECISE™, PULSED™ and FORCED™ APC – Argon
enhanced tissue effects. In addition, ERBE brings you
ERBEJET® 2 Hydrodissection Technology.
37 Centennial St
Rochester, NY 14611
Phone: (585) 235-1430
Fax: (585) 235-1438
Website: www.electrosurgicalinstrument.com
PLATINUM PARTNER
Ethicon
Electro Surgical Instrument Company (ESI) offers a wide
array of fiberoptic lighted instruments for the colon and
rectal surgeon including anoscopes, specula and deep
pelvic retractors. We offerrepair service on ESI
manufactured instruments as well as instruments of other
manufacturers.
Elsevier, Inc.
Booth 718
2000 Regency Parkway, Suite 255
Cary, NC 27518
Phone: (515) 963-7569
Website: www.enterahealth.com
Contact Name: Tom Heck
Ethicon US LLC , a Johnson & Johnson company,
commercializes a broad range of innovative surgical
products, solutions and technologies used to treat some
of today’s most prevalent medical issues, such as:
colorectal and thoracic conditions, women’s health
conditions, hernias, cancer and obesity. Learn more at
www.ethicon.com, or follow us on Twitter @Ethicon.
Booth 108
1600 JFK Blvd, Ste 1800
Philadelphia, PA 19103
Phone: (215) 239-3722
Fax: (215) 239-3494
Website: www.elsevierhealth.com
Contact Name: Kim Pollock
Contact Email: [email protected]
ELSEVIER is a leading publisher of health science
publications, advancing medicine by delivering superior
reference information and decision support tools to
doctors, nurses, health practitioners and students. With an
extensive media spectrum — print, online and handheld,
we are able to supply the information you need in the most
convenient format.
Booth 601
4545 Creek Rd
Cincinnati, OH 45242
Phone: 877-ETHICON 384-4266
Website: www.ethicon.com
Ferring Pharmaceuticals, Inc.
Booth 530
100 Interpace Pkwy
Parsippany, NJ 07054
Phone: (973) 796-1600
Fax: (973) 796-1660
Website: www.ferringusa.com
Ferring Pharmaceuticals is a research-driven
biopharmaceutical company devoted to identifying,
developing and marketing innovative products in the fields
of gastroenterology, reproductive health, obstetrics,
osteoarthritis and urology. To view all of our US offerings,
please visit www.ferringusa.com.
163
EXHIBITS
SILVER PARTNER
Exhibits
General Surgery News
Booth 137
Halo Medical Technologies, LLC
Booth 106
545 W 45th St, 8th Flr
New York, NY 10036
Phone: (212) 957-5300
Fax: (212) 957-7230
Website: www.generalsurgerynews.com
Contact Name: Diane Lodse
Contact Email: [email protected]
1805 Foulk Road
Wilmington, DE 19810
Phone: (302) 475-2300
Fax: (302) 475-2301
Website: www.halomedtech.com
Contact Name: Jennifer Kinney
Contact Email: [email protected]
General Surgery News is a monthly newspaper designed to
keep general surgeons abreast of the latest developments
in the field online, in print, and around the world. The
publication features extensive meeting coverage, analysis
of journal articles, educational reviews, and information on
new drugs and products.
Endoanal, Transrectal, and Transperineal Ultrasound.
Optional Anorectal Manometry. The Catalyst – affordable,
intelligent ultrasound for diagnosing fecal incontinence,
staging rectal cancer, and investigating other pelvic floor
disorders. Portable and all-in-one cart models.Optimized
imaging and proprietary software designed specifically for
CRS requirements. True video recording, complete postprocessing capabilities, and EMR-automated reports.
Uniquely-configured USB probes are interchangeable
during exam, for one comprehensive report. Also available
as combined ultrasound/ARM system with Medspira
software, on one hardware platform (see separate
description under Medspira, booth #428). Entire ultrasound
system costs less than half of leading competitive system.
Visit us at Booth #106.
GI Supply
Booth 200
200 Grandview Ave
Camp Hill, PA 17011
Phone: (440) 669-9031
Fax: (717) 761-0216
Website: www.gi-supply.com
Contact Name: Lisa Szpak
Contact Email: [email protected]
GI Supply is a medical manufacturer of specialty,
endoscopic assist and diagnostic products. Signature
products include: Spot® – the first and only FDA cleared
non-India ink endoscopic tattoo; Taewoong Through-TheScope (TTS) Stent – the only Esophageal TTS Stentavailable
in the US; Polar Wand® –cryotherapy system which ablates
tissue throughout the GI tract; RenovaRP™, an automatic
paracentesis pump for fast, safe removal of ascites –without
glass vacuum bottles; HpFast™ and HpOne™, accurate, easyto-use rapid urease tests for the presumptive identification
of H. pylori gastritis. Biteblocs™ – available in a wide range
of sizes and styles, designed for specific needs of patients
and endoscopic procedures.
GMed
Booth 211
2125 N Commerce Pkwy
Weston, FL 33326
Phone: (954) 659-9310
Fax: (954) 659-9326
Website: www.gmed.com
gMed provides the gastroenterology industry with a fully
integrated platform consisting of an Electronic Health
Record, Endoscopy Report Writer, Practice Management
solution, Patient Portal, a Data Analytics tool and Revenue
Cycle Management. Fully scalable through the cloud or
using an on-site server, gMed’s products are all Meaningful
Use Certified and ICD-10 compliant. To find the right
gGastro solution for your practice visit www.gmed.com or
call 888.577.8801.
Halyard Health
Booth 422
43 Discovery Suite 100
Irvine, CA 92618
Phone: (949) 293-9298
Website: www.halyardhealth.com
Contact Name: Trina Grazier
Contact Email: [email protected]
Halyard Health is a medical technology company focused
on preventing infection, eliminating pain and speeding
recovery. Come to our booth to learn about the ON-Q* Pain
Relief System which reduces narcotic usage and provides
better pain relief than narcotics alone in post-surgical
patients. For more information, visit
www.halyardhealth.com.
Hawaiian Moon
321 S. Missouri Ave
Clearwater, FL 33756
Phone: (888) 256-3276
Website: www.aloecream.biz
Contact Email: [email protected]
164
Booth 423
Exhibits
Booth 225
SILVER PARTNER
2516 Jane St
Pittsburgh, PA 15203
Phone: (412) 559-1813
Website: www.helomics.com
KARL STORZ Endoscopy-America, Inc.
Helomics™ Corporation, a privately-held personalized
healthcare company. We are dedicated to improving
patient outcomes through personalized comprehensive
tumor profiles that help to inform effective treatment
selection. We utilize a proprietary set of laboratory
platforms leveraging both live and fixed cellular analysis
allowing physicians to characterize their patient’s malignant
tumors on a personalized basis. Our novel molecular and
cellular markers along with our bioinformatics services can
inform medical practice with specific biological processes
of each individual’s cancer.
Hitachi ALOKA Medical
Konsyl Pharmaceuticals, Inc.
Hitachi Aloka Medical’s commitment to ultrasound for
surgeons offers a wide range of consoles and specifically
designed transducers to meet the needs of every surgeon.
Recognized for our superior image quality, system reliability
and use of cutting edge technology, we remain the
standard in the field of ultrasound for surgeons.
PLATINUM PARTNER
Booth 401
1020 Kifer Rd
Sunnyvale, CA 94086
Phone: (510) 882-6948
Website: www.intuitivesurgical.com
Intuitive Surgical is the global leader in minimally
invasive, robotic-assisted surgery. Its da Vinci® System –
with a 3D-HD vision system and EndoWrist®
instrumentation – enables surgeons to offer a minimally
invasive approach for a range of complex procedures.
With more than 2,500 Systems installed in hospitals
around the world, the da Vinci System is enabling
surgeons to redefine the standard-of-care in a range of
specialties: urology, gynecology, head and neck, general
surgery, cardiac and thoracic surgery.
Irrisept
KARL STORZ offers a range of state-of-the-art products
for surgical procedures, including colorectal procedures.
Among the technology solutions we offer are KOH macro
needle holders that can be dismantled and re-assembled
for separate cleaning and sterilization, and our 3-mm
Mini laparoscopy Instrument Set that offers an ideal
alternative to single-site procedures.
Booth 430
10 Fairfield Blvd
Wallingford, CT 06492
Phone: (203) 269-5088/(800) 872-5652
Fax: (203) 269-6075
Website: www.hitachi-aloka.com
Contact Email: [email protected]
Intuitive Surgical, Inc.
Booth 619
2151 E Grand Ave
El Segundo, CA 90245-2838
Phone: (800) 421-0837
Website: www.karlstorz.com
Contact Name: Julia Benoit
Contact Email: [email protected]
Booth 318
8050 Industrial Park Rd
Easton, MD 21601
Phone: (410) 822-5192
Fax: (410) 822-5264
Website: www.konsyl.com
Contact Name: Kim Vaccari
Contact Email: [email protected]
LABORIE
Booth 133
400 Ave D, Ste. 10
Williston, VT 05495-7828
Phone: (800) 522-6743
Fax: (802) 878-1122
Website: www.laborie.com
Contact Name: Craig Middleton
Contact Email: [email protected]
LABORIE, the leader in Pelvic Floor Diagnostics and
Rehabilitation, is your source for Complete Colorectal
Assessment, including Anorectal Manometry – to analyze
pressure and function of the rectum and anal sphincter;
Electro diagnostics - to evaluate patients with suspected
pathologies with neurological involvement; Pelvic Floor
Rehabilitation - for a conservative treatment option; and
Transrectal Ultrasound - a portable and easy-to-use probe
for anal canal visualization. We offer a full range of
solutions for all budgets, clinical and research needs.
Welcome to our MEDIWATCH CUSTOMERS - Learn how we
are here to support you!
Booth 139
1665 Lakes Pkwy, Ste 102
Lawrenceville, GA 30043
Phone: (770) 807-3355
Fax: (866) 788-1079
Website: www.irrisept.com
Contact Email: [email protected]
165
EXHIBITS
Helomics
Exhibits
Lexion Medical
Booth 322
Mederi Therapeutics, Inc.
Booth 214
545 Atwater Circle
St. Paul, MN 55103
Phone: (651) 635-0000
Fax: (651) 636-1671
Website: www.lexionmedical.com
Contact Email: [email protected]
800 Connecticut Ave
Norwalk, CT 06854
Phone: (203) 930-9980
Website: www.secca-therapy.com
Contact Name: Sheila Doyle
Contact Email: [email protected]
LEXION Medical is a world leader in the design and
manufacturing of advanced technologies for gas
conditioning in minimally invasive surgical procedures. Our
goal is to provide innovative technologies that help
patients return to their normal, productive lives faster.
Appropriately conditioning the gas before it enters the
body and when it leaves the patient can dramatically help
patients, surgeons, and make operating rooms more
efficient with improved clinical outcomes.
Mederi Therapeutics manufactures innovative non-ablative
radiofrequency (RF) therapies for GI disorders. Secca for
bowel incontinence fills the void between failed conservative therapies and invasive and expensive alternatives, like
surgery or implants. Secca uses controlled delivery of RF
energy to the muscle of the IAS. Recent studies show the
underlying mechanism of Secca is a regeneration of muscle
tissue, including a growth in muscle fibers and an improvement in collagen. This allows restored sphincter function
and explains how Secca provides relief for patients with
fecal incontinence. Secca therapy is minimally invasive,
outpatient, and is available in more than 35 countries.
LifeCell
Booth 224
95 Corporate Drive
Bridgewater, NJ 08807
Phone: (908) 9471667
Website: www.acelity.com
Contact Name: Shawn Kennedy
Contact Email: [email protected]
Medical Measurement Systems (MMS)
LifeCell Corporation, an Acelity Company, develops and
markets innovative products for reconstructive, cosmetic
and general surgery. Core LifeCell™ products include:
AlloDerm® Regenerative Tissue Matrix and Strattice™
Reconstructive Tissue Matrix for breast reconstruction,
revision and abdominal wall repair surgery; and REVOLVE™
System for high-volume fat processing.
GOLD PARTNER
Mallinckrodt Pharmaceuticals
Booth 329
12481 High Bluff Drive Ste 200
San Diego, CA 92130
Phone: (858) 436-1464
Fax: (858) 436-1401
Website: www.mallinckrodt.com
Contact Name: Joe Robitaille
Contact Email: [email protected]
Mallinckrodt is a global specialty biopharmaceutical and
medical imaging business that develops, manufactures,
markets and distributes specialty pharmaceutical
products and medical imaging agents. Mallinckrodt is an
industry leader in intravenous analgesia for acute pain
management. Visit www.mallinckrodt.com to learn more.
Booth 716
53 Washington Street, Suite 400
Dover, NH 03820
Phone: (800) 236-9310
Fax: (603) 750-3155
Website: www.mmsusa.net
Contact Name: Rebecca Schmitt
Contact Email: [email protected]
MMS offers GERD diagnostic and GI Motility products. Our
Ohmega Ambulatory Impedance-pH recorder is an easy to
use, small and lightweight recorder that combines
impedance and pH recording offering complete reflux
measurement. MMS supplies a broad range of impedance
and pH catheters. Our Solar GI HRM/HRIM/HRAM systems
have revolutionary QuickView software with the automatic
classification per the latest edition of the Chicago
classification. HRM analysis becomes easier, quicker and
better. The 3D Esophageal Pressure Topography and 360
degrees tube view for LES and HRAM provide even more
information. MMS HRM can be performed with solid state
or single-use/multi-use water perfused catheters.
Medspira, LLC
Booth 428
2718 Summer St NE
Minneapolis, MN 55413
Phone: (800) 345-4502
Fax: (612) 789-2708
Website: www.medspira.com
Contact Name: Judy Carter
Contact Email: [email protected]
Medspira partners with leading medical institutions to
develop and market medical devices that provide cost
effective diagnosis and treatment for a variety of medical
conditions. Medspira’s mcompass is a portable solution to
navigating precision anorectal manometry, and now we are
happy to be able to include biofeedback pelvic floor retraining (pending FDA approval). The mcompass is a mobile,
portable, and affordable device designed to help patients
suffering from fecal incontinence and chronic constipation.
166
Exhibits
Microline Surgical, Inc.
Medtronic
Booth 311
710 Medtronic Parkway
Minneapolis, MN 55432
Phone: (763) 514-4000
Fax: (763) 514-4879
Website: www.medtronic.com
At Medtronic, we’re committed to Innovating for life by
pushing the boundaries of medical technology and
changing the way the world treats chronic disease. Our
medical technologies help make it possible for millions of
people to resume everyday activities, return to work, and
live better, longer. Products include the InterStim®
System, providing Sacral Neuromodulation for Bowel
Control and Bladder Control.
Memorial Healthcare System
Booth 140
4320 Sheridan Street
Hollywood, FL 33021
Phone: (954) 265-0902
Fax: (954) 989-7959
Website: www.memorialphysician.com/mhs.net
Contact Name: Ken Bolis
Contact Email: [email protected]
Microline Surgical utilizes a reposable platform to deliver
high-quality laparoscopic instruments to healthcare
facilities worldwide. Our reusable, ergonomically designed
hand pieces are paired with single-use tips to configure
hybrid disposable/re-usable devices offering precision and
cost-effectiveness.
neoSurgical, Inc.
Booth 138
275 Grove St., Suite 2-400
Newton, MA 02466
Phone: (617) 663-4999
Email: [email protected]
Website: www.neosurgical.com
Novadaq
Booth 213
5090 Explorer Drive
Mississauga, ON L4W 4T9
Canada
Phone: (800) 230-3352
Fax: (800) 888-2419
Website: www.novadaq.com
Contact Email: [email protected]
BRONZE PARTNER
Merck & Company
Booth 613
50 Dunham Road
Beverly, MA 01915
Phone: (978) 922-9810
Fax: (978) 922-9209
Website: www.microlinesurgical.com
Booth 317
600 Corporate Drive
Lebanon Township, NJ 08833
Phone: (908) 236-1125
Fax: (908) 236-4717
Website: www.merck.com
Today's Merck is working to help the world be well.
Through our medicines, vaccines, biologic therapies, and
consumer and animal products, we work with customers
and operate in more than 140 countries to deliver
innovative health solutions. Merck. Be Well. For more
information, visit www.merck.com.
Never before in the history of worldwide healthcare, has
there been such a need to achieve and demonstrate the
highest quality of care and outcomes, at a lower cost.
NOVADAQ’s global mission is to empower medical
professionals and hospitals by providing clinically-relevant,
innovative fluorescence imaging solutions to enhance the
lives of patients and their surgeons, while reducing
healthcare costs. As pioneers, NOVADAQ developed SPY
fluorescence imaging technology to provide surgeons and
medical practitioners with real-time visualization of blood
flow or perfusion, leading to improved outcomes and
reduced costs without exposing the patient to harmful
ionizing radiation or contrast dye toxicity.
167
EXHIBITS
PLATINUM PARTNER
Exhibits
NovaTract Surgical, Inc.
Booth 426
170 Fort Path Road, Suite 13
Madison, CT 06433
Phone: (203) 533-9710
Website: www.novatract.com
Contact Email: [email protected]
NovaTract Surgical, Inc. offers multiple minimally invasive
retraction options for conventional, reduced-port and
robotic procedures. Both the NovaTract™ Laparoscopic
Dynamic Retractor and the NovaGrasp™ Laparoscopic
Tethered Grasper are single-use, 5mm devices, offering
improved tissue manipulation, an exclusive tension
adjusting system, and the ability to easily modify the angle
of retraction as needed. Not requiring a dedicated port, the
NovaTract™ family of products helps facilitate improved
visualization during complex laparoscopic and robotic
procedures.
OBP Medical
Booth 620
360 Merrimack St, Bldg 9
Lawrence, MA 01843
Phone: (978) 291-6853
Fax: (866) 636-2718
Website: www.obpmedical.com
Contact Name: Matthew Traub
Contact Email: [email protected]
OBP Medical is the leading global developer of single-use,
self-contained, illuminating medical devices. Our single-use
lights are the brightest on the market, allowing for optimal
visualization during procedures. Our innovative products
are used in physician offices, surgery centers and more
than 2,000 hospitals throughout the U.S., as well as
healthcare facilities worldwide.
SILVER PARTNER
Olympus America Inc.
Booth 513
3500 Corporate Pkwy
Center Valley, PA 18034
Phone: (484) 896-5000
Fax: (484) 896-7133
Olympus is advancing minimally invasive surgical
solutions designed to help Surgeons improve clinical
outcomes through our innovative world’s only
technologies: ENDOEYE FLEX 3D, the only articulating HD
3D video laparoscope; THUNDERBEAT, the only
integration of both advanced bipolar and ultrasonic
energies delivered simultaneously from a single, multifunctional instrument for laparoscopic and open
procedures. Our commitment to clinical support,
professional education, flexible service and financing
packages, and knowledgeable local account
management make Olympus the partner of choice.
Through innovative diagnostic and therapeutic solutions,
Olympus is transforming the future of minimally invasive
surgery. Visit our Booth to discover where innovation can
take you.
Otto Trading, Inc.
Booth 220
1921 Carnegie Ave Suite C
Santa Ana, CA 92705
Phone: (714) 540-5595
Fax: (949) 660-8073
Website: www.irestmassager.com
Contact Name: AdemKutlug
Contact Email: [email protected]
Ovesco Endoscopy USA, Inc.
Booth 100
455 Los Gatos Blvd., Suite 101
Los Gatos, CA 95032
Phone: (408) 884-8976
Fax: (408) 608-2077
Website: www.ovesco.com
Contact Name: Geoffrey Yates
Contact Email: [email protected]
Ovesco Endoscopy USA is a medical device company
operating in the fields of flexible endoscopy and
endoluminal surgery. The company develops, manufactures
and markets innovative products for the treatment of
gastrointestinal disease. Innovative endoscopic clipping
systems are Ovesco’s hallmark. The OTSC – Over-The-Scope
Clip is Ovesco’s product platform for the treatment of
gastrointestinal hemorrhage and for endoscopic digestive
organ wall closure.
Please visit our website www.ovesco.com for more
information.
Pacira Pharmaceuticals, Inc.
Booth 212
5 Sylvan Way
Parsippany, NJ 07054
Phone: (973) 254-3575
Fax: (973) 267-0060
Website: www.pacira.com
Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical
company focused on the development of products that
meet the needs of acute care practitioners and their
patients. Its lead product, EXPAREL® (bupivacaine liposome
injectable suspension), was launched in 2012. EXPAREL
utilizes the Pacira proprietary delivery technology
DepoFoam®. For more information, visit
http://www.pacira.com.
Plasma Surgical
1129 North Meadow Parkway, Suite 100
Roswell, GA 30076
Phone: (678) 892-6730
Website: www.plasmasurgical.com
Contact Email: [email protected]
168
Booth 218
Exhibits
Booth 623
336 W Passaic St
Rochelle Park, NJ 07662
Phone: (201) 845-3990
Fax: (201) 845-3993
Website: www.irc2100.com
Contact Name: Andrew Gould
Infrared Coagulation has long been the leading treatment
for early and mid-stage hemorrhoids. Now, it is also utilized
to treat AIN. The IRC2100™ is easy to use, safe, and well
tolerated. Its clinical effectiveness has been proven for
thirty years. Please visit us for more information as to how
infrared coagulation can benefit your practice.
ResiCal, Inc.
Booth 120
PO Box 489
Orchard Park, NY 14127
Phone: (716) 472-0021
Fax: (716) 662-5871
Website: www.resical.com
Contact Name: Brooks Cole
Contact Email: [email protected]
ResiCalInc provides patient samples for Calmol 4 ®
Hemorrhoidal Suppositories. Calmol 4 is non-prescription
and available by special order at any pharmacy counter.
Active ingredients are Cocoa Butter and Zinc Oxide which
lubricate and heal hemorrhoids, fissures, inflamed tissues
and other anorectal disorders. Calmol 4 contains no topical
steroids, no anesthetics, no vaso constrictors or other active
ingredients that can be absorbed internally or can interact
with other internal medications. Calmol 4 contain no
package warnings for high blood pressure, diabetes, heart,
prostate or thyroid disease. Calmol 4 Patient samples and
clinical information may be requested at www.Calmol4.com
SILVER PARTNER
Richard Wolf Medical Instruments Corp. Booth 308
353 Corporate Woods Pkwy
Vernon Hills, IL 60061
Phone: (800) 323-WOLF (9653)
Fax: (847) 913-6846
Website: www.richardwolfusa.com
Contact Name: Evan Mix
Contact Email: [email protected]
We are a global business with headquarters in Germany
and over a century of tradition and expertise in the field
of endoscopy. We develop, manufacture and market
specific system solutions for minimally invasive human
medicine.
Sandhill Scientific
Booth 528
9150 Commerce Center Circle, #500
Highlands Ranch, CO 80129
Phone: (303) 470-7020
Fax: (303) 470-2975
Website: www.sandhillsci.com
Contact Name: Stuart Wildhorn
Contact Email: [email protected]
Sandhill Scientific continues to be a recognized global
leader in G.I. Diagnostics. The broad capabilities of our new
insight Ultima Manometry Platform include multiple
configurations of High Resolution Anorectal
Manometry(HRAM) using either directional or
circumferential sensors, as well as linear and radial air
charged configurations. The BioVIEW Acquisition and
Analysis software program features SyncVIEW, a multidimensional wireframe representation of the anal canal.
And our industry leading Sandhill University provides the
most comprehensive training and education options to
meet the clinical needs of users around the world.
Sanofi Biosurgery
Booth 323
55 Cambridge Parkway
Cambridge, MA 02142
Phone: (908) 268-1229
Website: www.sanofi.com
Sanofi Biosurgery takes a diversified approach to medicine.
As part of the Patient Centered Solutions group, we address
patients’ unmet medical needs by providing best-in-class
products for symptomatic relief and regenerative care.
These include a wide range of innovative devices and
biologics across a variety of indications, include:
• Osteoarthritis pain relief
• Adhesion prevention following surgery
• Temporary endovascular occlusion of blood vessels
• Cartilage repair
• Treatment of severe burns
Sanofi Biosurgery provides unique, differentiated, and
innovative products for large and growing populations,
resulting in sustainable growth opportunities.
Sebela Pharmaceuticals, Inc.
Booth 316
645 Hembree Pkwy Ste I
Roswell, GA 30076
Phone: (678) 736-5204
Fax: (678) 736-5201
Website: www.sebelapharma.com
Contact Name: Autumn Akin
Contact Email: [email protected]
Sebela Pharmaceuticals Inc. is a gastroenterology focused
company located in Roswell, GA.
Sebela’s product portfolio includes Analpram HC Cream,
Analpram Lotion and Analpram Advanced Kit.
169
EXHIBITS
Redfield Corporation
Exhibits
Shire
Booth 219
550 Hills Drive, 3rd Floor
Bedminster, NJ 07921
Phone: (908) 375-7596
Website: www.shire.com
Shire enables people with life-altering conditions to lead
better lives. Our strategy is to focus on developing and
marketing innovative specialty medicines to meet
significant unmet patient needs.
Please visit www.shire.com
Sigma Tau Pharmaceuticals
Booth 521
9841 Washingtonian Blvd, Ste 500
Gaithersburg, MD 20878
Phone: (301) 670-2185
Website: www.sigmatau.com
Contact Name: Mary Oenean
Contact Email: [email protected]
Booth 429
7248 S Tucson Way
Centennial, CO 80112
Phone: (303) 790-9411
Fax: (303) 792-2606
Website: www.sontecinstruments.com
Contact Name: Dennis Scanlan
Contact Email: [email protected]
Booth 122
333 Quarry Rd
Milford, CT 06460
Phone: (203) 799-2400
Fax: (203) 799-2401
Website: www.surgiquest.com
SurgiQuest, Inc. is the maker of The AirSeal® System, the
world’s first and only integrated access system for
Minimally Invasive Surgery that provides stable pneumo,
continuous smoke evacuation, and valve-free cavity access
to enhance surgeon capabilities, improve anesthesia
parameters, protect OR staff, and reduce OR time in both
robotic and laparoscopic surgery.
TEI Biosciences, Inc.
Sigma-Tau Pharmaceuticals, Inc. manufactures and
distributes refrigerated VSL#3, a potent probiotic medical
food. VSL#3 is for the dietary management of an ileal
pouch, ulcerative colitis or irritable bowel syndrome. VSL#3
is one of the most clinically evaluated probiotics available,
with over 140 published citations listed. The five
formulations of VSL#3 in the USA deliver from 112. 5 to 900
billion bacteria per serving making VSL#3 one of the most
potent probiotics available.VSL#3 Double Strength (DS) is
only available with a prescription due to its potency.
Sontec Instruments, Inc.
SurgiQuest, Inc.
Booth 617
1000 Winter St, Suite 4900
Waltham, MA 02451
Phone: (866) 524-0022
Fax: (888) 623-2259
Website: www.teibio.com
Contact Name: Customer Service
Contact Email: [email protected]
TEI Biosciences is a Boston-based, leading biomedical
company, applying its expertise inregenerative medicine to
develop and commercialize novel biologicdevices for a
broad spectrum of soft tissue repair, reinforcement, and
reconstruction applications.
THD America
Booth 627
9 Tech Circle, Suite 103
Natick, MA 01760
Phone: (866) 375-9442
Fax: (813) 626-0303
Website: www.thdamerica.com
Contact Email: [email protected]
The Medicines Company
Booth 524
Sontec offers a comprehensive selection of exceptional
hand held surgical instruments, headlights and loupes
available to the discriminating surgeon. There is no
substitute for quality, expertise and individualized service.
Sontec’s vast array awaits your consideration at our booth.
8 Sylvan Way
Parsippany, NJ 07054
Phone: (973) 290-6000
Fax: (973) 656-9898
Website: www.themedicinescompany.com
Contact Name: Siobhan Macre
Contact Email: [email protected]
Stryker
The Medicines Company’s Purpose is to save lives, alleviate
suffering, and contribute to the economics of healthcare by
focusing on 3,000 leading acute/intensive care hospitals
worldwide in its vision is to be a leading provider of
solutions in three areas: acute cardiovascular care, surgery
and perioperative care, and serious infectious disease care.
The company operates in the Americas, Europe and the
Middle East, and Asia Pacific regions with global centers
today in Parsippany, NJ, USA and Zurich, Switzerland.
Booth 436
77 Great Valley Parkway
Malvern, PA 19355
Phone: (610) 407-5209
Fax: (215) 253-5006
Website: www.stryker.com
Contact Name: Stephen Chou
Contact Email: [email protected]
Stryker is the dedicated to providing cutting edge medical
solutions in a variety of surgical specialties. This year we are
proud to exhibit Vitagel, our revolutionary Surgical
Hemostat formulated with Microfibrillar Collagen.
170
Exhibits
Booth 210
43 New Scotland Ave, MC 28
Albany, NY 12208
Phone: (518) 262-5079
Fax: (518) 262-5528
Website: www.oley.org
Contact Email: [email protected]
The Oley Foundation, the home nutrition support
community’s Help along the way, provides medical
information and peer support to enhance the lives of home
tube-fed and IV-fed adults and children through
newsletters, an online community forum, annual and
regional conferences, regional volunteers, advocacy, a video
library, and more. Founded in 1983 by a patient and
clinician, the foundation serves 14,000+ people worldwide.
All services, including membership are free of charge.
Medical information is peer reviewed. Enjoy a visit to
www.oley.com and be sure to stop by booth #210.
The Prometheus Group
Booth 626
1 Washington St, Ste 303
Dover, NH 03820
Phone: (603) 749-0733
Fax: (603) 749-0511
Website: www.theprogrp.com
Contact Name: Richard Poore
Contact Email: [email protected]
Torax Medical, Inc.
United Ostomy Association
of America, Inc
Booth 217
PO Box 512
Northfield, MN 55057
Phone: (800) 826-0826
Fax: (507) 645-5168
Website: www.ostomy.org
Contact Email: [email protected]
The United Ostomy Associations of America, Inc. (UOAA) is
dedicated to advocating for the intestinal/urinary diversion
community and to providing information and service to,
and for, its affiliated support groups and their members.
UOAA has 350 Affiliated Support Groups in the United
States which are organized for the benefit of people who
have or will have intestinal or urinary diversions, and their
caregivers. UOAA works toward a society where people
with ostomies and intestinal or urinary diversions are
universally accepted and supported socially, economically,
medically, and psychologically. All are welcome at our
National Conference in St. Louis September 1-6, 2015.
Wolters Kluwer Health
Booth 144
Two Commerce Square
Philadelphia, PA 19103
Phone: (612) 259-8114
Fax: (612) 677-3059
Contact Name: Joey-Rose Jester
Contact Email: [email protected]
Booth 102
4188 Lexington Ave North
Shoreview, MN 55126
Phone: (651) 361-8900
Fax: (651) 361-8910
Website: www.toraxmedical.com
Contact Name: Maggie Wallner
Contact Email: [email protected]
Torax® Medical, Inc. is a privately held medical device
company headquartered in St. Paul, Minnesota that
develops and markets products designed to treat sphincter
disorders utilizing its technology platform, Magnetic
Sphincter Augmentation (MSA). The FENIX® Continence
Restoration System is comprised of interlinked titanium
beads with magnetic cores. The magnetic attraction
between the beads augments the anal sphincter muscles in
patients with severe fecal incontinence. The device is
implanted via a perineal incision. The FENIX device is CE
marked and is not available for sale in the United States.
For more information, please visit www.toraxmedical.com.
Wolters Kluwer Health is a global provider of information,
business intelligence and point-of-care solutions for the
healthcare industry. We are the proud publisher of Diseases
of the Colon & Rectum, the world’s leading publication in
colorectal surgery and the Official Journal of the American
Society of Colon and Rectal Surgeons (ASCRS). Additional
brands include Lippincott Williams & Wilkins, Lippincott
Nursing Solutions and Ovid online. We proudly offer
specialized publications and software for physicians, nurses,
students and clinicians. Please visit our booth to browse
our comprehensive product line.
Xodus Medical, Inc.
Booth 326
702 Prominence Dr
New Kensington, PA 15068
Phone: (724) 337-5500
Fax: (724) 337-0555
Website: www.xodusmedical.com
Xodus Medical is featuring its Pink Pad® Patient Positioning
System, the clinically-preferred product for increasing patient
safety in steep Trendelenburg, preventing patient slippage in
colorectal procedures. The Pink Pad places no pressure on
the neck, shoulders or arms; safeguarding against nerve
damage; while protecting the skin from breakdown and
pressure ulcers. The single-use design eliminates potential
cross-contamination, standardizes preparation, reduces setup time and saves money. It is now also available in a longer
version, The Pink Pad® XL, providing a better fit for taller
patients. See our new One-Step face and arm protectors and
full line of surgical safety products.
171
EXHIBITS
The Oley Foundation, Inc.
ePoster
Theater
172
ePoster
Station
#2
ePoster
Station
#4
154
#3
#5
Merck
Executive Suite
ePoster
Station
ePoster
Station
ePosters
Wolters
Kluwer
Health
144
#1
ePoster
Station
142
140
Memorial
138
139
Irrisept
& Tech
136
137
General
Surgery
News
System
neoSurgical, 11Health
ConvaTec Healthcare
Inc.
Product
Theater
AMI
134
132
#7
ePoster
Station
130
Bellevue American
Pharmacy Medical
133
biolitec Laborie
135
637
613
Microline
Surgical
617
TEI
Biosciences
619
Karl Storz
Endoscopy
120
CCF
437
423
Hawaiian
Moon
425
Braintree
Labs
429
Sontec
431
CONMED
ENTRANCE
401
Stryker
108
F&B
323
Sanofi
329
Mallinckrodt
Pharmaceuticals
337
106
104
CRC Press/
Taylor &
Francis
Xodus
Medical
Ovesco
Endoscopy
USA, Inc
100
227
209
BK
Ultrasound/
BK
Medical
211
gMed
213
Novadaq
Tech
217
United
Ostomy
219
Shire
223
ERBE
USA
225
Helomics
F&B
102
308
Richard
Wolf
Medical
312
Coloplast
314
CS
Surgical
316
Sebela
318
Konsyl
Pharmaceuticals
322
Lexion
Medical
326
Torax
Medical
301
Covidien
311
Medtronic
317
Merck &
Company
422
Halyard
Health
426
NovaTract
Surgical
428
Medspira
430
Hitachi
Aloka
Medical
436
Halo
Elsevier,
Medical
Inc
Tech
411
Applied
Medical
Lounge
522
Ambry
Genetics
524
The
Medicines
Company
528
Sandhill
Scientific
530
Ferring
Pharmaceuticals
537
Curaseal
Intuitive
Surgical
513
Olympus
521
Sigma-Tau
Pharmaceuticals
523
Cooper
Surgical
527
Cook
Medical
531
American
College of
Surgeons
538
F&B
OBP
Medical
620
ResiCal
Inc
601
Ethicon
712
Edwards
Lifesciences
716
Medical
Measurement
Systems
718
Entera
Health,
Inc
622
Electro
Surgical
Instrument
623
Deltex
Medical
722
626
The
Prometheus
Group
630
627
Redfield
Corp
THD USA
F&B
736
ACell, Inc SurgiQuest
126
122
#6
ePoster
Station
LifeCell
A KCI
200
GI
Supply
202
Caris Life
Sciences
204
Colon
Cancer
Alliance
206
American Dist of
Colon & Rectal
Supplies
208
Bard
Davol
210
The Oley
Foundation
212
Pacira
Pharmaceuticals
214
Mederi
Therapeutics
216
Cine-Med
218
Plasma
Surgical
220
Otto
Trading
222
Birchwood
Lab
224
Exhibit Hall Map
W
M
173
200
Up
202
Speaker Ready Room
201
207
W
M
M
W
204
Boylston Hallway
203
208
Registration
MAPS
Product Theater
ePosters
General Session
Online
CME
HALL C
South
Lobby
AUDITORIUM
M
W
Level 2
205
209
W
M
ENTRANCE
Exhibits
HALL D
206
210
On-Going
Video
Room
Hynes Convention Center
#8
ePoster Station
174
#9
ePoster
Station
Level 3
Hynes Convention Center
Sheraton Boston Hotel
Second Floor, Plaza Level
ENTRY
D
REPUBLIC
FOYER
A
REPUBLIC
BALLROOM
B
REPUBLIC CORRID.
C
BACK BAY
BALLROOM
EAST
IND.
FOYER
WEST
EAST
GRAND
BALLROOM
INDP.
BLLRM
B
A
LIBERTY BALLROOM
A
B
C
GRAND BALLROOM PREFUNCTION
CONSTITUTION
BALLROOM
A
B
175
MAPS
WEST
Sheraton Boston Hotel
Third Floor
C
COMMONWEALTH
BOARDROOM
H
B
G
A
F
E
KENT
D
JEFFERSON
HAMPTON
FAIRFAX
GARDNER
CONF.
EXETER CLARENDON
DALTON
BERKELEY
176
BEACON
COMPLEX
A-H
Ethicon is committted
to enabling your success
s
in colorectal surgery.
Ethicon’s innovations work with your preferred surgical approach, to meet the
unique challenges of minimally invasive colo
orectal surgery.
Whether your case calls for a laparoscopic, robot-assisted or open approach,
Ethicon has a full range of solutions designe
ed to satisfy the needs of your
technique choice.
ECHELON FLEX™ GST System
HARMONIC ACE®+7 Shears
with Advanced Hemostasis
Endo
Endo
doscco
opic
pic Cur
C ved
Cu
Intralumin
uminal
um
miinal
nal St
n
Stapler
Staple
pler
Come see us at Bo
ooth 601 to learn more
about Ethicon's off
fferings in colorecctal surgery.
© 2015 Ethicon, Inc. All rights reserved. 028376-150122